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New York DSRIP Terminology Guide
Abbreviations
AST

Account Support Team

AHRQ

Agency for Healthcare Research and Quality

ACO

Accountable Care Organization

CAHPS

Consumer Assessment of Healthcare Providers and Systems

CG-CAHPS

Clinician & Group Consumer Assessment of Providers and Systems

CMS

Centers for Medicare and Medicaid Services

DSRIP

Delivery System Reform Incentive Payment

DY

Demonstration Year

ED

Emergency Department

EHR

Electronic Health Record

EMR

Electronic Medical Record

FQHC

Federally Qualified Health Center

HEDIS

Healthcare Effectiveness Data and Information Set

HIT

Health Information Technology

IA

Independent Assessor

IE

Independent Evaluation

LGBTQ

Lesbian, Gay, Bisexual, Transgender, and Queer

MAPP

Medicaid Analytics Performance Portal

MAX Series

Medicaid Accelerated eXchange Series

MDW

Medicaid Data Warehouse

MY

Measurement Year

MRT

Medicaid Redesign Team
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NCQA

National Committee for Quality Assurance

NewCo

New Corporation

NYC

New York City

NYS DOH

New York State Department of Health

P4P

Pay/Payment for Performance

P4R

Pay/Payment for Reporting

PCG

Public Consulting Group

PCMH

Patient-Centered Medical Home

PPR

Potentially Preventable Readmission(s)

PPS

Performing Provider System(s)

PPV

Potentially Preventable Emergency Room Visit(s), Full Attributed Population

PPVBH

Potentially Preventable Emergency Room Visit(s), Behavioral Health
Population

QE

Qualified Entity

ROS

Rest of State

RQ

Research Question

SHIN-NY

Statewide Health Information Network for New York

SPARCS

Statewide Planning and Research Cooperative System

STC

Special Terms and Conditions

SUNY RF

State University of New York Research Foundation

VBP

Value Based Payment
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Performing Provider Systems
Acronym Preferred Name
AHI
Adirondack Health Institute
ABHC

Alliance for Better Health

BHNNY

Better Health for Northeast New
York
Bronx Health Access
Bronx Partners for Healthy
Communities
Care Compass Network

BHA
BPHC
CCN

CNYCC
CCB
CPWNY
FLPPS

LCHP
MCC
MHVC
MSPPS
NQP
NYPQ
NYP
NCI
NYUL
HHC
RCHC

Central New York Care
Collaborative
Community Care of Brooklyn
Community Partners of Western
New York
Finger Lakes PPS

Leatherstocking Collaborative
Health Partners
Millennium Collaborative Care
Montefiore Hudson Valley
Collaborative
Mount Sinai PPS
Nassau Queens PPS
New York-Presbyterian Queens
PPS
NewYork-Presbyterian PPS
North Country Initiative
NYU Langone Brooklyn
OneCity Health

SOMOS

Refuah Community Health
Collaborative
SOMOS

SIPPS
SCC

Staten Island PPS
Suffolk Care Collaborative

Counties Served
Clinton, Essex, Franklin, Fulton, Hamilton, St.
Lawrence, Saratoga, Warren, Washington
Albany, Fulton, Montgomery, Rensselaer,
Saratoga, Schenectady
Albany, Columbia, Greene, Saratoga,
Warren
Bronx
Bronx
Broome, Chemung, Chenango, Cortland,
Delaware, Schuyler, Steuben, Tioga,
Tompkins
Cayuga, Lewis, Madison, Oneida, Onondaga,
Oswego
Kings (Brooklyn), Queens
Chautauqua, Erie, Niagara
Allegany, Cayuga, Chemung, Genesee,
Livingston, Monroe, Ontario, Orleans,
Seneca, Steuben, Wayne, Wyoming, Yates
Delaware, Herkimer, Madison, Otsego,
Schoharie
Allegany, Cattaraugus, Chautauqua, Erie,
Genesee, Niagara, Orleans, Wyoming
Dutchess, Orange, Putnam, Rockland,
Sullivan, Ulster, Westchester
Kings (Brooklyn), New York (Manhattan),
Queens
Nassau, Queens
Queens
New York (Manhattan)
Jefferson, Lewis, St. Lawrence
Kings (Brooklyn)
Bronx, Kings (Brooklyn), New York
(Manhattan), and Queens
Orange, Rockland
Bronx, Kings (Brooklyn), New York
(Manhattan), Queens
Richmond (Staten Island)
Suffolk
7

Acronym Preferred Name
WMC
WMCHealth

Counties Served
Delaware, Dutchess, Orange, Putnam,
Rockland, Sullivan, Ulster, Westchester
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New York DSRIP Program Timeline of Demonstration and Measurement
Years
Demonstration Years

DY0
DY1
DY2
DY3
DY4
DY5

April 2014 – March 2015
April 2015 – March 2016
April 2016 – March 2017
April 2017 – March 2018
April 2018 – March 2019
April 2019 – March 2020

Measurement Years
MY0
MY1
MY2
MY3
MY4
MY5

June 2014
July 2014 – June 2015
July 2015 – June 2016
July 2016 – June 2017
July 2017 – June 2018
July 2018 – June 2019

Source: Adapted from the New York State Department of Health DSRIP Timeline Poster .1
Abbreviations: Demonstration Year (DY), Measurement Year (MY)
Notes: The implementation and process component of the Interim Report relied primarily on data collected by the
Independent Evaluator and covered the period from the beginning of DY0 (April 2014) through the middle of DY4
(October 2018). The time series analysis and comparative analysis components of the Interim Report relied on
secondary data, collected according to measurement year, to assess New York DSRIP program performance from
MY0 (June 2014) to the end of MY3 (June 2017).

1

New York State Department of Health (2016, January). Retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/2016/docs/2016-0129_dsrip_timeline_poster.pdf
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New York DSRIP Program Implementation Timeline and Key Program
Benchmarks
Focus on Infrastructure
Development/System
Design

----~A~---~

,--_ __,!,___. . .,

Focus on Project
Outcomes/Sustainability

---~A~---~\

(

April 2015

April 2016

April 2017

April 2018

April 2019

01102103104

01102103104

01102103104

ID I02I031~

011021031~

DYl

Submission/Approval of
Project Plan

Focus on Continued
System/Clinical
Improvement

DY2

DY3

DY4

DYS

• PPS Project Plan Valuation
• PPS first DSRIP Payment
• PPS Subm ission of
Implementation Plan and
First Quarterly Report

Domain 4: PPS working in collaboration with community and diverse set of service providers
to address statewide public health priorities; system improvements and increased quality of
care will positively impact health outcomes oftotal population .

Source: Adapted from New York State Department of Health DSRIP overview materials. 2
Abbreviations: Demonstration Year (DY), Pay for Performance (P4P), Performing Provider System(s) (PPS), Quarter
(Q)

2

New York State Department of Health (2016, October 21). DSRIP program: An overview (slide deck). Retrieved
from http://medicaidmattersny.org/cms/wp-content/uploads/2016/10/Medicaid-Matters-DSRIP_102116-VF.pdf
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1. Executive Summary
1.1. Overview
New York’s Delivery System Reform Incentive Payment (DSRIP) program is the main mechanism
by which the state is implementing its Section 1115 Medicaid Redesign Team (MRT)
Demonstration Waiver Amendment. The DSRIP program intentions are to achieve the triple-aim
of improving health care quality, improving health, and reducing costs by fundamentally
restructuring New York’s health care delivery system through investments in the Medicaid
program and participating providers. Its primary stated goal is to reduce avoidable inpatient
and emergency department hospital use by 25% over five years,3 with broader goals of
sustainable system transformation and improvements in population health.
Of the estimated $17.1 billion in federal savings from MRT reforms, New York was authorized
to reinvest $8 billion, with $6.42 billion allocated to the DSRIP program. The DSRIP program
comprises 25 regional Performing Provider Systems (PPS) – coalitions of safety net hospitals,
clinics, and other eligible providers with clear business relationships – that work together to
implement specific projects targeting Medicaid members and the uninsured. The DSRIP payouts
to PPS are based upon their measured performance on structural, process, and outcome
milestones related to system transformation, clinical management, and population health. 4
As part of the team conducting the Independent Evaluation (IE), the State University of New
York Research Foundation (SUNY RF) is implementing a robust, mixed methods, statewide
evaluation of New York’s DSRIP program to:
•
•
•

Assess program effectiveness on a statewide level, with respect to the MRT triple-aim;
Obtain information on the effectiveness of specific projects and strategies selected and
the factors associated with program success; and
Obtain feedback from stakeholders, including PPS administrators and providers and
Medicaid members served under the DSRIP program, regarding the program’s planning
and implementation, and on the health care service experience under DSRIP reforms.

Evaluation results are reported regularly to the PPS, the New York State Department of Health
(NYS DOH), and the Centers for Medicare and Medicaid Services (CMS). This report serves as
the interim evaluation covering implementation and process through the middle of
Demonstration Year (DY) 4 (October 2018),5 and outcomes through Measurement Year (MY) 3
(June 2017). A final report, to be released in 2021, will include findings from the last two years
of the DSRIP program, and the overall outcomes of the program.

3

New York State Department of Health. (n.d.). DSRIP overview. Retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/overview.htm
4
Ibid.
5
Data were collected about stakeholder experiences covering Demonstration Year 0 through the first month of
quarter 3 in Demonstration Year 4.
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Consistent with the specifications outlined in the New York DSRIP program’s Special Terms and
Conditions (STC), Sections VII.21 through VII.33, the evaluation is guided by seven overarching
research questions (see Exhibit 1.1).6
Exhibit 1.1. Overarching research questions for the Independent Evaluation
Research questions
• RQ-A: What were the successes and challenges with respect to PPS planning,
implementation, operation, and plans for program sustainability from the perspective
of DSRIP program planners, administrators, and providers; and why were they
successful or challenging? (CMS RQ7)
• RQ-B: Did health care quality improve as a result of clinical improvements in the
treatment of selected diseases and conditions? (CMS RQ2)
• RQ-C: Did population health improve as a result of implementation of New York’s
DSRIP initiative? (Sub-question: Were racial and ethnic disparities on specific
population measures reduced following the DSRIP program?7) (CMS RQ3)
• RQ-D: Did utilization of behavioral health care services increase as a result of the
DSRIP program? (CMS RQ4)
• RQ-E: Was avoidable hospital utilization reduced as a result of the DSRIP program?
(CMS RQ5)
• RQ-F: To what extent did PPS achieve health care system transformation, including
increasing the availability of behavioral health care? (CMS RQ1)
• RQ-G: Did the DSRIP program reduce health care costs? (Sub-question: Was the DSRIP
program cost effective in terms of New York and federal governments receiving
adequate value for their investments?) (CMS RQ6)
Source: Adapted from the Request for Proposal and the CMS-approved Independent Evaluation plan.
Abbreviations: Research Question (RQ), Hypothesis (H)

The Interim Evaluation consists of an implementation and process component to address RQ-A,
and a time series and comparative analysis component that analyzes DSRIP performance
measures to address RQ-B through RQ-F. The last research question (RQ-G), which examines
the DSRIP program’s influence on costs, will be addressed in the final summative report and not
the Interim Evaluation because the program is still underway and would likely be limited in its
findings due to the initial time period where PPS efforts were focused on start-up activities and
initiating implementation.

6

The research questions presented in Exhibit 1.1 are edited slightly and reordered from the original Request for
Proposal and CMS-approved Independent Evaluation plan to be consistent with the presentation of results in
Section 4. The original research question number in the CMS-approved Independent Evaluation plan is indicated in
parentheses at the end of each research question. See Appendix 3 for a comprehensive crosswalk to the updated
research questions and hypotheses and the rationale behind these changes.
7
Specific measures for this sub-question are: premature deaths, newly diagnosed cases of HIV, preterm births,
adolescent pregnancy rate per 1,000 females aged 15-17, percentage of unintended pregnancy among live births,
and infants exclusively breastfed while in the hospital.
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The Interim Evaluation presents a detailed description of the DSRIP program’s implementation
and its early successes and challenges, preliminary findings about the overall effect of DSRIP on
the triple-aim, and a synthesis of lessons learned and implications for practice. It is important to
note the PPS project implementation timeframe compared to the measurement years. The PPS
applications and valuation awards were finalized in April 2015, the start of DY1, while MY2
began in July 2015 when much of the infrastructure for implementation was being initiated.
Further, the last measurement period of MY5 ends 9 months before the end of DY5 when
implementation is still occurring. Because the DSRIP program is still ongoing and the data
available on performance measures was limited to a small number of years before and after
initiation of the DSRIP program, it is too early to draw conclusions about the impact of the
DSRIP program on quality, cost, service utilization, and overall system transformation.
Therefore, the findings presented here are preliminary, subject to data limitations, and may
change as the program continues to be implemented. However, early results promote
transparency, provide feedback to diverse stakeholders, and offer insights for continued
implementation.

1.2. Findings
1.2.1. Early Findings on DSRIP Program Performance Measures
The analysis of DSRIP performance measures examines trends over time for each performance
measure, covering the period before and after the initiation of the DSRIP program, and
estimating both statewide and PPS-specific trends.8 A smaller subset of measures relevant to
the most common clinical focus areas of the projects were used to make the effort more
focused, to ensure that the findings are clear and easy to understand, and to design an analysis
that was feasible given the type of data, time, and resources available. Additional measures will
be added to the summative evaluation.

1.2.1.1. Statewide Performance Trends
Analyses of statewide pre-post DSRIP initiation trends for 27 performance measures showed
encouraging results. Overall, performance improved post-DSRIP initiation for 13 measures,
remained steady for 13 measures, and worsened for only one measure (Exhibit 1.2). The
majority of performance measures in behavioral health and population health were improved
in the interim evaluation period. Additionally, results for asthma medication ratio improved, as
did early indicators of system change such as members’ connectedness to providers (usual
source of care) and reduction in uninsured use of emergency department (self-pay ED visits). It
is perhaps not surprising that half the performance measures remained steady given the short
post-DSRIP initiation time period, during which many PPS were still focusing on infrastructure
development and design. It often takes time to see improvements when implementing new
interventions for a program of this magnitude that require effort to establish new processes

8

All analyses of the performance measures in this report used the start of MY2 (July 2015) as the first month of the
post-DSRIP initiation period, with all prior months assigned to the pre-DSRIP initiation period. This provided 13
months of pre-DSRIP initiation measurement time and 24 months of post-DSRIP initiation measurement time.
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and familiarize staff with them. Some of the measures remaining steady were noted to have
high levels of performance which can also limit the ability to demonstrate improvement. For
example, performance measures of patient experience with coordinated care were associated
with high levels of performance (Care Transition and Up-to-Date Coordination). Both measures
would be positive indications for early system change success.
Although it is important to examine statewide performance among DSRIP attributed Medicaid
members, these early statewide findings need to be interpreted in the context of other factors,
such as variability across PPS, as shown for MY3 in Exhibit 1.2. Individual PPS performance and
results of the comparative analysis are discussed in more detail in Section 1.2.1.2.
Specific statewide findings on performance measures are presented below.
Quality: To examine clinical quality improvements (RQ-B), the Interim Report focused on a
limited set of measures, related to asthma care among PPS that selected an asthma project (13
of 25 PPS). Statewide results showed that the post-DSRIP initiation trend significantly improved
for one of the asthma measures and remained steady for the other asthma measure.
Improvement was noted for the ratio of asthma controller medication, indicating more
members with asthma are receiving controller medications in at least equal proportion to
rescue medications. This is an initial step for improving long term medication compliance with
controller medication. This is a first step towards a more in-depth evaluation of clinical quality
improvements. A broader set of quality outcomes, including those relevant to other PPS will be
examined for the final summative report.
Population Health: Eleven measures of population health were examined to address the impact
of the DSRIP program on population health (RQ-C). Six of the eleven population measures
showed improvement following DSRIP initiation.9 Improvement in areas of premature death,
new HIV cases and people in poor mental health were noted. Performance on population
health measures in the Interim Report should be considered a snapshot of New York’s
performance using trends from MY0 to MY3. It is anticipated that there would be a longer lag
time between the implementation of the DSRIP program and population health. It is also
difficult to attribute changes in population health to specific PPS in regions where there are
multiple PPS that have overlapping geographic boundaries and/or PPS covering multiple
counties. Additionally, many of the data sources used for population health measures involve
the larger statewide population beyond the Medicaid population.
Behavioral Health Care Utilization: Integration of behavioral health and primary care, and
improvement in behavioral health care overall is an important emphasis of the New York DSRIP
program. The statewide post-DSRIP initiation trend significantly improved for three of the four
measures used to assess behavioral health utilization (RQ-D). These improvements on the
behavioral health utilization measures are consistent with findings from the implementation
and process component of the evaluation that found that PPS partners and key informants
perceived improvements in integration of primary care with behavioral health care. The only
9

All measures used to assess population health were annual measures. Statistical tests were not done on these
measures due to limited data points.
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behavioral health utilization measure that did not show any significant change following the
initiation of the DSRIP program was initiation of drug or alcohol treatment.10 The index number
of cases presenting for drug or alcohol dependence treatment increased, likely due to the
state’s opioid epidemic. Lack of improvement on the initiation of drug or alcohol treatment
measure may reflect an increase in the denominator of people presenting for care, rather than
a reduced or stable performance in meeting care needs.
Hospital Utilization: A major overall goal of the DSRIP program is to reduce avoidable inpatient
and emergency department hospital use by 25% over five years. Preliminary statewide results
showed that although the downward trend for potentially preventable hospital readmissions
(PPR) did not significantly change in the short period post-DSRIP initiation, substantial progress
is being made towards the 25% reduction goal due to an overall decrease in preventable
readmissions between MY0 and MY3 (RQ-E). The preliminary statewide results for potentially
preventable emergency room visits (PPV) were somewhat similar to those for PPR. The postDSRIP initiation trend for PPV did not significantly change, but there was a small overall
decrease in PPV between MY0 and MY3. Although preliminary statewide results suggest that
potentially preventable emergency room visits among the behavioral health population
(PPVBH) significantly worsened in the short post-DSRIP initiation period, the absolute percent
change in the PPVBH rate compared to baseline was relatively small (0.82% increase from
baseline to MY3). These preliminary findings do not reflect impact from PPS projects developed
in the MAX series specifically addressing hospital and emergency department utilization by
‘super-utilizers’. The initial projects were developed during the interim period and are
continuing to be spread to other facilities. Impact from these efforts will be examined in the
summative evaluation.

10

Initiation of drug or alcohol treatment is defined as having an inpatient admission, intensive outpatient
encounter, or partial hospitalization within 14 days of presenting to care with a new episode of alcohol or drug
dependence.
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Exhibit 1.2. Summary of Statewide Analyses of DSRIP Program Performance Measures
Research
Question

Outcome Measure

Measure
Data
Source

RQ-B: Did health
care quality
improve as a
result of clinical
improvements
in the treatment
of selected
diseases and
conditions?
RQ-C: Did DSRIP
improve
population
health?

Asthma Medication
Ratioa
Asthma Medication
Management (75%
days covered)a

Claims

Percent
Change
BaselineMY3
-0.50

Claims

4.05

Binge Drinkingb
Poor Mental Healthb

eBRFSS
eBRFSS

2.81
-4.46

Suicide Death Rateb

Vital
Statistics
eBRFSS
eBRFSS
Vital
Statistics
HIV
Surveillance
System
Vital
Statistics

Colorectal Screeninga
Cigarette Smokingb
Premature Deathsb
Newly Diagnosed HIV
Case Rateb

RQ-D: Did DSRIP
impact use of
behavioral
health services?

Ratio of Premature
Deaths: Non-Hispanic
Black to NonHispanic Whiteb
Ratio of Premature
Deaths: Hispanic to
Non-Hispanic Whiteb
Newly Diagnosed HIV
Case Rate: NonHispanic Black to
Non-Hispanic Whiteb
Newly Diagnosed HIV
Case Rate: Hispanic
to Non-Hispanic
Whiteb
Initiation of Drug
Treatmenta
Engagement in Drug
Treatmenta
Adherence to
Antipsychotic
Medicationa
Follow Up after
Hospitalization
within 30 Daysa

PPS MY3
Low/High

57.2%
70.6%
24.6%
37.0%

Progress
Towards
25%
Reduction
NA

Trend PostDSRIP Initiation

Improving

NA

No change

NA
NA

NA
NA

No change
Improving

0.00

NA

NA

No change

-1.15
-8.97
1.69

NA
NA
NA

NA
NA
NA

No Change
No Change
No Change

-16.23

NA

NA

Improving

-2.99

NA

NA

Improving

Vital
Statistics

-5.56

NA

NA

Improving

HIV
Surveillance
System

-20.72

NA

NA

Improving

HIV
Surveillance
System

-14.23

NA

NA

Improving

Claims

-3.27

NA

No change

Claims

-6.21

NA

Improving

Claims

-0.16

31.50%
52.89%
13.31%
29.98%
53.62%
88.89%

NA

Improving

Claims

12.46

50.74%
75.36%

NA

Improving
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Research
Question

Outcome Measure

Measure
Data
Source

RQ-E: Did DSRIP
reduce inpatient
stays and
emergency
department
visits?

Potentially
Preventable
Readmissionsb
Potentially
Preventable
Emergency Room
Visitsb
Potentially
Preventable
Emergency Room
Visits, Behavioral
Health Populationb
Bidirectional
Exchange with
Qualified Entitya
Participating
Agreement with
Qualified Entitya
Care Transitiona

RQ-F: Did DSRIP
transform the
system?

PPS MY3
Low/High

Claims

Percent
Change
BaselineMY3
-15.03

Claims

-1.32

6.2
56.9

5.28

No change

Claims

0.82

34.4
150.2

0.0

Worsening

Qualified
Entity
Survey
Qualified
Entity
Survey
HCAHPS
survey
CG-CAHPS
survey
CG-CAHPS
survey
Claims

22.43

39.85%
90.47%

NA

Improving

-0.26

45.29%
99.47%

NA

No change

122.8
1269.5

Progress
Towards
25%
Reduction
60.12

Trend PostDSRIP Initiation

No change

-0.11

90.00%
NA
No change
96.14%
Usual Source of Carea
10.56
79.51%
NA
Improving
92.74%
Up-to-Date
0.12
78.85%
NA
No change
Coordinationa
87.64%
No Preventive
8.65
4.90%
NA
No change
Services b
14.60%
Self-pay Emergency
Claims
-26.32
2.34%
NA
Improving
Room Visitsb
24.12%
Abbreviations: Clinician & Group Assessment of Healthcare Providers and Systems (CG-CAHPS), Delivery System
Reform Incentive Payment (DSRIP), Expanded Behavioral Risk Factor Surveillance System (eBRFSS), Hospital
Consumer Assessment of Healthcare Providers and Systems (HCAHPS), Human Immunodeficiency Virus (HIV),
Research Question (RQ)
Notes: HIV case rates refer to newly diagnosed cases. Findings for RQ-B, RQ-D, and RQ-E are based on analyses of
monthly data; findings for RQ-C and RQ-F are based on annual data. All data for RQ-C (population health) reflect
the New York State general population and are not limited to Medicaid members; no PPS specific results are
available for RQ-C. Post-DSRIP initiation trends for RQ-B, RQ-D, and RQ-E are based on the sign and significance of
the Trend*DSRIP interaction coefficient in interrupted times series regression models; the interaction term
represents the slope of the post-DSRIP initiation trend. Results were considered significant at the p<0.1 level. PostDSRIP initiation trends for RQ-C and RC-F are based on a descriptive summary data; no statistical tests for trend
were performed on the annual data due to limited data points. For RQ-C and RQ-F, outcomes that remained
largely steady during the study period were reported as “no change”. Analyses of the asthma measures (RQ-B)
were limited to the 13 PPS that selected the Domain 3 asthma clinical improvement projects. Analyses of the “no
preventive services” and “self-pay emergency room visits” measures (RQ-F) were limited to the 14 PPS that were
eligible for and selected the eleventh Project 2.d.i (patient activation). Data were only available for MY2 and MY3
for the two health information technology measures (bidirectional exchange and participating agreements) and
MY1 through MY3 for the three care coordination measures used to assess RQ-F. aFor these measures, higher rates
are better. bFor these measures, lower rates are better.

System Transformation: The New York DSRIP program ultimately aims to fundamentally
transform the health care system in New York. To assess progress on system transformation
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seven measures using annual data11 were used to examine health care delivery integration,
health care coordination, and utilization among the uninsured, non-utilizing, and low-utilizing
populations (RQ-F).12 Improvements were seen in the percent of providers who conduct
bidirectional exchange with Qualified Entities, the percent of patients reporting a provider as
their usual source of care, and the percent of emergency room visits from self-pay patients.
Performance on the remaining system transformation measures remained steady. Although
there were no major changes in care transition and up-to-date care coordination, the
overwhelming majority of Medicaid members had consistently positive experiences in these
areas during the study period.
Recognizing the importance of patient-centered care to system transformation, all primary care
practices in PPS were expected to meet National Committee for Quality Assurance (NCQA)
Level 3 patient-centered medical home (PCMH) standards by the end of DY3 (March 31, 2018).
Because the interim evaluation addresses performance outcomes up to MY3, it would not
adequately capture the DY3 PCMH milestone. Therefore, PCMH measures will be examined in
more detail in the summative evaluation and are not included in the Interim Report. However,
internal analyses by the NYS DOH using data up to June 30, 2018 suggest that the DSRIP
program has had a positive impact on increasing the number of new PCMH providers and
providers who moved up to Level 3, especially compared to providers who are not partnered
with a PPS.
Cost: A detailed cost assessment of the demonstration was not possible in time for the Interim
Report to address RQ-G and would likely be limited in its findings due to the initial time period
where PPS efforts were focused on start-up activities and initiating implementation. For the
Interim Report, the Independent Evaluator examined where there might be other information
regarding Medicaid costs that would help inform the reader as to the state’s performance on
cost trends. The state reported on the Statewide Accountability Milestones (SWAM) for DY3 in
its Demonstration Year 3 Quarter 4 report to CMS.13 The SWAM measure 3 is the Medicaid
spending milestone and New York reports passing the DY3 milestone measure where costs for
inpatient and emergency room spending were below the target trend rate. The DY4 SWAM
information is not yet available. The final summative report will contain more detailed analyses
of how costs have shifted over time, and differences across PPS over the entire course of the
demonstration period.

1.2.1.2. PPS-Level Descriptive Analyses

11

Data were only available for MY2 and MY3 for the two health information technology measures (bidirectional
exchange and participating agreements) and MY1 through MY3 for the three care coordination measures used to
assess RQ-F.
12
Analyses of the non-use of preventive services among Medicaid members and emergency room use among the
uninsured population were examined only for PPS that selected the 11th “patient activation” Project 2.d.i (14 of 25
PPS).
13
New York State Department of Health, Office of Health Insurance Programs (2018, May). New York DSRIP 115
Quarterly Report. January 1, 2018-March 31, 2018. Year 3, fourth quarter. Retrieved from:
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/quarterly_rpts/year3/q4/2018_janmar_report.htm
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As previously noted, focusing only on statewide trends for all Medicaid members attributed to
the DSRIP program may mask changes at the individual PPS-level due to the high level of
variation across PPS and the time it takes to see changes at the statewide level. Each PPS is
inherently different, due to variation in size, lead entity type, patient mix, findings from their
community needs assessment, and other factors.
For the Interim Report, initial descriptive analyses were used to examine PPS-level performance
from MY0 through MY3, for most measures. While performance remained unchanged on
several performance measures at the overall statewide level, some PPS showed progress while
others showed room for improvement. For some measures, a small number of PPS were able to
show progress when most other PPS did not. For example, among the 6 PPS that had
improvements in performance on the initiation of drug or alcohol treatment measure, most
only improved by 1% to 2% in MY3 compared to MY0. However, two PPS improved by at least
8%. As noted previously, lack of improvement on this measure for most PPS may be attributed
to the number of persons being identified as having a substance use disorder and linked to
care. Nevertheless, a small number of PPS were able to show some improvement.
Even among PPS that improved or worsened on a given performance measure between MY0
and MY3 there was wide variation, although variation tended to be greater for PPS that
improved than those that worsened. For example, although rates of potentially preventable
admissions improved between MY0 and MY3 for the majority of PPS (22 of 25), the
improvement ranged from 7.02% to 67.86% (data not shown).
Variation across and within PPS will be explored further in the summative report. For example,
the Independent Evaluator will explore whether PPS have had more successes with some
projects than others and examine variation in project performance within PPS.

1.2.1.3. Comparative Analysis
The comparative analysis extended the statewide time series analysis to examine how four PPSlevel characteristics (size, behavioral health patient mix, geographic location, and selection of
the 11th project) were associated with overall differences in performance, and differential postDSRIP initiation performance changes. Comparative analyses were only performed for the
monthly performance measures to assess behavioral health utilization (RQ-D) and avoidable
hospital utilization (RQ-E). The final summative report will include a more extensive analysis of
PPS-level performance, including comparing performance on specific DSRIP program projects
and examining additional PPS characteristics.
Exhibit 1.3 summarizes the findings related to the comparative analysis and post-DSRIP
initiation trends. Findings were largely mixed for both the behavioral health care utilization and
hospital utilization measures, making it difficult to draw conclusions at this time. With the
exception of PPS in the rest of the state having a significantly worsening trend on all behavioral
health utilization measures compared to PPS in New York City, variation was noted for PPS with
the same characteristic and will be explored further in the summative report. These results
should be considered preliminary; more refined categorizations of PPS characteristics may be
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needed. For example, aggregating all PPS outside of New York City into a single category (Rest
of State) masks regional variations, which will be explored in more detail in summative report.

Exhibit 1.3. Summary of Comparative Analysis of PPS-Level DSRIP Program Performance
Measures
Research
Question

PPS
Characteristic

Trend Post-DSRIP Initiation

RQ-D:
Behavioral
Health Care
Utilization

Large PPS vs.
Small

Mixed results with variation noted for PPS with same
characteristics. Unable to draw conclusions at this time. This will
be explored further in the summative report.

High BH vs. Low

Mixed results with variation noted for PPS with same
characteristics. Unable to draw conclusions at this time. This will
be explored further in the summative report.

ROS vs. NYC

All four measures were noted to have worsening trend for ROS.

11th Project
Selected vs. Not

Mixed results with variation noted for PPS with same
characteristics. Unable to draw conclusions at this time. This will
be explored further in the summative report.

Large PPS vs.
Small

Mixed results with variation noted for PPS with same
characteristics. Unable to draw conclusions at this time. This will
be explored further in the summative report.

High BH vs. Low

Mixed results with variation noted for PPS with same
characteristics. Unable to draw conclusions at this time. This will
be explored further in the summative report.

ROS vs. NYC

Mixed results with variation noted for PPS with same
characteristics. Unable to draw conclusions at this time. This will
be explored further in the summative report.

11th Project
Selected vs. Not

Mixed results with variation noted for PPS with same
characteristics. Unable to draw conclusions at this time. This will
be explored further in the summative report.

RQ-E: Hospital
Utilization

Abbreviations: Performing Provider System (PPS), Behavioral Health (BH), Rest of State (ROS), New York City (NYC)
Notes: Interpretations are based a triple interaction term used to examine differences in post-DSRIP initiation
trends between PPS with and without the characteristic in comparative analysis regressions. Comparative
regression analyses were not conducted for the annual measures (RQ-C and RQ-F) or the monthly asthma
measures used to assess RQ-B, which was limited to the 13 PPS that selected Domain 3 asthma clinical
improvement projects.

1.2.2. Implementation and Process Early Successes and Challenges
1.2.2.1. Early Successes
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The implementation and process component of the evaluation comprises a detailed description
of the DSRIP program’s evolution (RQ-A) and provides a context for interpreting the DSRIP
performance measures. The implementation and process study triangulates data from four
data sources to capture the experiences of diverse DSRIP stakeholders: PPS key informant
interviews, regional partner focus groups, a statewide partner survey, and a patient survey.
The early years of the DSRIP program were important for capacity building and laying the
foundation for improving clinical and population outcomes. Exhibit 1.4 briefly summarizes the
successes and challenges related to the DSRIP program’s implementation and processes from
DY0 (April 2014) through part of DY4 (October 2018) and are described in this section.
The structure of the New York DSRIP program, with coalitions of partners forming PPS to work
on a specific set of projects, necessitates collaboration and the breaking down of “silos”
between a broad range of provider types, and investments in infrastructure development and
capacity building (e.g., governance, technology, human resources). Although this is challenging
and takes time for the full results of these efforts to be realized, data collected from PPS key
informants and engaged-partners indicate that the DSRIP program has been a catalyst for
changing the way many providers and organizations think about and provide care to Medicaid
members and to the population as a whole. This was seen early on during the start-up phase
when PPS were forming, selecting projects, and setting “speed and scale targets” in
Demonstration Year 0, and has continued through implementation and the early years of
operations.
New collaborations were established between providers and organizations that had never
worked together before, considered themselves competitors, or who were previously
mistrustful of each other. In the beginning, this was not always easy and obtaining buy-in and
aligning different objectives took time. The general consensus was that involving a broad-based
group of partners early on was vital to a well-functioning group and continued engagement.
Shared accountability, which many stakeholders viewed as a major step for the health care
system, has further encouraged providers and organizations to develop connections that
encourage them to work together to maintain responsibilities for their patients. In particular, a
majority of PPS key informants interviewed saw their new work with community-based
organizations as a vital change to the health care system. Community-based organizations that
had not previously considered their organizations to be part of the health care system also
began seeing their roles differently.
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Exhibit 1.4. Summary of Implementation and Process Findings

RQ-A: What were the Successes and Challenges of PPS Planning, Implementation, and Operation
from the Perspective of DSRIP Program Planners, Administrators, and Providers?
Implementation and
Process Aspect

Early Successes

Early Challenges

PPS Organizational
Development and Early
Operations

Increased collaboration and crosssector partnerships

PPS and project start-up were
time and resource intensive
Multiple competing demands in
early stages while still learning
DSRIP program requirements and
expectations

Partners’ Perceived
Effectiveness of DSRIP
program

Patient Experience

Most partners perceived DSRIP as
effective.

Some perceptions of increased
bureaucratic requirements

Partners had positive perceptions
of DSRIP’s impact on population
health and services/clinical care
Patient satisfaction with providers
was high and has remained high
since DSRIP initiation
Patient continuity of care has
improved since DSRIP initiation

Abbreviations: Delivery System Reform Incentive Payment (DSRIP), Performing Provider System (PPS)

Consistent with increased collaboration and shared accountability, PPS key informants and
focus group participants most often cited improved care transitions, the integration of primary
care with behavioral health care, and encouragement of innovation as specific positive
outcomes of the DSRIP program so far. These are all goals of the DSRIP program, and prerequisites for a high-performing health care system.
The results of the partner survey provide further evidence that providers have observed
positive changes in the way care is being delivered since the initiation of the DSRIP program.
The majority of partner survey respondents in 2018 reported that services at their organization
have changed for the better since the initiation of the DSRIP program.14 Findings did vary
somewhat by organization type, with respondents working at hospitals most likely to report
having observed positive changes and respondents working at community-based organizations
among those least likely. Similar to key informants and focus group participants, the most
14

Direct comparison to the 2017 statewide partner survey is not possible for this survey item due to some wording
changes to improve clarity.
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commonly cited benefit from the DSRIP program observed by 2018 partner survey participants
was coordinated care, with a substantial portion of respondents also reporting improved
understanding of patient needs and reduced avoidable utilization as benefits of the program.
These findings also varied somewhat by provider type.
Value based payment is a key component of the DSRIP program and overall Medicaid redesign
in New York. Changing health systems in an environment where both fee-for-service and value
based payment operate simultaneously is challenging and requires organizational focus and
capital. In addition to educational resources provided by the NYS DOH, most PPS provided
educational tools for their partners, especially primary care, behavioral health, and communitybased partners, and some PPS provided direct infrastructure support (e.g., data analytics) to
help partners shift to value based payment. These efforts have been well received and most
partners report an improved understanding of value based payment and that the organizations
have made changes to prepare for value based payment.
Given the complex nature of the DSRIP program and the major reinvestment of Medicaid
funding, support and accountability structures were built into the program. Some challenges
were experienced early on, when the program was just starting but communication and
guidance improved over time. Data tools, such as the Salient Interactive Miner, which provides
in-depth access to the state’s Medicaid claims and encounter data, and the Medicaid Analytics
Performance Portal, which houses DSRIP program performance tools, were seen as useful and
critical to the work of PPS and partners. Many PPS developed their own internal data systems,
including dashboards or other platforms which largely made use of partner portals to gather
partner data. Some PPS data analytics teams were able to use partners’ electronic health record
data along with state-provided data to share aggregate results and guide performance
improvement efforts. Many PPS and their partners found their efforts around developing data
tools, especially those that provide real-time information, among the most important work that
had been done to support closing gaps in patient care and meet performance targets as quickly
as possible.

1.2.2.1. Early Challenges
The New York DSRIP program is an ambitious program to fundamentally transform New York’s
Medicaid system into a “financially viable, high-performing health system.”15 Any large,
complex program is likely to encounter challenges when trying to reform a health care system
that is equally complex, especially in the context of a five-year demonstration program.
Although these challenges need to be recognized, it is also important to note that many DSRIP
program participants have been able to overcome early challenges and move forward in their
efforts.
The New York DSRIP program has required considerable time and resources on the part of
participants, including investment in relationship-building, governance, staff, technical
expertise, education, and technology resources. Challenges were sometimes encountered
15

New York State Department of Health. (n.d.). DSRIP Project Toolkit. Retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/docs/dsrip_project_toolkit.pdf.
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during PPS formation and application development, including alignment on key issues,
allocation of resources, and leadership structure. This was particularly the case in regions
where many competitors were organized into a small number of PPS. These challenges were
often addressed and resolved, allowing the group to develop a better functioning relationship
by the final application phase, but this took time and effort. Overall, PPS that already had some
existing structures in place, such as those evolving from a unified health system or those that
had previously begun DSRIP-like initiatives, were able to quickly pivot to the requirements of
PPS formation and related work. Other PPS with no existing infrastructure in place faced
additional early challenges with project implementation and partner engagement. It was
difficult for them to simultaneously build infrastructure for a new organization, engage
partners, and adhere to the breadth and pace of DSRIP program project requirements.
Some PPS encountered other challenges with start-up and the early stages of implementation,
making it difficult to set speed and scale targets. These particular challenges occurred at the
beginning of the DSRIP program when all entities, including the NYS DOH, were working on
multiple start-up tasks simultaneously, resulting in what many PPS perceived to be continually
changing requirements and a lack of clear and consistent information.
Operational challenges mainly occurred in the areas of PPS overlap, value based payment
preparation, funds flow, and data and information technology. Partners working with multiple
PPS were sometimes frustrated by differing interpretations of DSRIP program rules by each PPS,
overwhelmed by working with multiple PPS administrations, and struggled to meet DSRIP
project reporting requirements. However, while PPS key informants acknowledged challenges
with overlapping PPS at the design and initial implementation phase, some felt they had
overcome these challenges by collaborating with other PPS to develop similar reporting
requirements and alignment of other procedures.
Although many of the efforts by PPS and the NYS DOH to prepare for the shift to value based
payment have been well received and resulted in improved understanding and infrastructure
investments on the part of PPS and their partners, perceived challenges remain for some
organizations. In particular, focus group participants from community-based organizations at
the time of this research felt that value based payment models were not structured to include
them and expressed their concern about the sustainability of their work if they did not have the
ability to demonstrate their value for value based payment, a concern shared by multiple types
of focus group participants.
Some challenges with funds flow was encountered by some PPS and partners, especially early
on in the program. The amount of time it took for PPS to establish contracts with individual
providers and organizations, and ultimately distribute funds, varied. Many PPS were able to
move funds to partners quickly and felt that this improved relationships, while others took a
more deliberate approach. New Corporation PPS (“NewCos”) without established
infrastructures tended to struggle more often with delays and lapses in the flow of funds.
Likewise, several partner organizations, particularly non-hospital participants, expressed
concerns about the time it took for them to receive funds. Several organizations, especially
non-hospital participants, also reported that the level of funding was not commensurate with
the effort they were putting in to the DSRIP projects.
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Transformation to a coordinated, patient-centered system of care requires ready access to
clinical, administrative, and financial data. Both PPS and partners were often frustrated by
difficulties accessing data provided by the NYS DOH, and PPS were not always able to access the
data their partners were collecting. Respondents reported substantial challenges with data lag,
data access, and data sharing. The need for real-time data to measure real-time impacts was a
common theme across PPS key informants and partners. Challenges were also encountered by
PPS in their attempt to share data with their partners, due to patient privacy regulations or
uncertainty about privacy regulations. Although data challenges were encountered, PPS and
their partners were often able to address these challenges, and often considered these efforts
successes.

1.3. Conclusions and Future Work
Preliminary findings from the Interim Evaluation suggest that New York is making progress
towards its goal of fundamentally restructuring New York’s health care delivery system in order
to achieve the triple-aim. The early years of the program required considerable effort and
resources for participants to build infrastructure and capacity in a short time-frame. Although
this presented multiple challenges, and some challenges continue, results of the Interim
Evaluation indicate that New York’s DSRIP program has contributed to more collaborative care
and has laid important groundwork necessary for improving clinical and population outcomes
and reducing costs.
The Interim Evaluation also analyzed the impact of the DSRIP program on specific DSRIP
performance measures using administrative data. Preliminary findings for performance
measures were encouraging with almost all results improving or remaining steady. However,
because the New York DSRIP program is still ongoing and the data available on performance
measures was limited to a small number of years after initiation of the DSRIP program, it is still
too early to draw conclusions about the impact of the DSRIP program on quality, cost, service
utilization, and overall system transformation. The final summative evaluation will include
additional years of data and additional analyses to provide a more complete understanding of
the DSRIP program’s impact on performance.
In addition to including data from all New York DSRIP program demonstration years, analyses
for the summative evaluation will examine program costs, include additional performance
measures, and provide a more extensive analysis of PPS-level performance, including
comparing performance on specific DSRIP program projects.16 The summative evaluation will
also include further feedback on the implementation and process of the New York DSRIP
program from the perspectives of PPS administrators, providers, and Medicaid members,
through a final round of partner surveys, key informant interviews, focus groups, and analysis
of patient survey data.

16

The final summative report is due to CMS on March 28, 2021. A preliminary and draft final report will be
submitted to the NYS DOH and CMS in mid-2020 and late-2020.
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1.4. Limitations
Although the Interim Evaluation relies on a robust, mixed methods approach, there are
limitations, as summarized below.
The following limitations apply to the implementation and process study:
•
•
•

•
•
•
•
•
•

The implementation and process data are subject to the standard interview and focus
group limitations, such as non-response bias and social desirability bias.
Key informant interviews were conducted in a small group via telephone. There is
potential that interviewees moderated their contributions to the discussion based on
the other people present.
While many of the PPS had members of the original team present for the interview,
there were several entities where there had been full staff turnover, and no respondent
was able to accurately provide historical data on start-up related questions.
Engaged partners who were invited to participate in the partner survey and focus
groups were identified by PPS, and a complete list may not have been provided.
Focus groups have not yet been conducted in Central or Western New York.
While qualitative conclusions are supported by stakeholder quotes, there is a possibility
that some experiences in the DSRIP program will not be represented by the findings.
The perspectives of patient care within the DSRIP program design may not yet be fully
informed. The Independent Evaluator is assessing the possibility of conducting and
gathering data from patient focus groups in the future.
As data were retrospectively focused on DY0 through part of DY4, there is a possibility
that some information was not recalled correctly.
Due to the recommended case mix adjustments to the CAHPS survey data, the ability to
examine trends over time is limited.

The following limitations apply to the analysis of the DSRIP performance measures:
•

•
•

The analysis only includes data for New York. Although the comparative regression
framework explicitly controls for statewide trends, internal validity would be higher with
an external comparison group. Conceptually, it is difficult to identify an ideal “control”
state as comparison, given large inter-state variations in Medicaid implementation and
ongoing waivers. States that are typically used as comparisons for New York based on
program size or similar region (e.g., California, New Jersey, and Texas) already have
DSRIP waivers and a comparison of New York to other states was beyond the scope of
this evaluation.
A small number of pre-DSRIP initiation years limits the assessment of the DSRIP
program’s effect on statewide trends.
The current analysis assumes that pre- and post-DSRIP initiation trends are linear.
Additional specifications will be explored for the final summative report after additional
years of data and information about the implementation and process are available.
Future work might include distinguishing early and late implementation periods.
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•

•
•

•
•

•

•

•

•

•

The monthly DSRIP performance measures are 12-month rolling average values, and
hence the full effect of the DSRIP program will show up on the performance with a 12month lag. However, the inclusion of the first MY1 in the definition of pre-DSRIP
initiation period will mitigate this lagged effect to some extent.
The annual performance measures cannot be analyzed in a regression framework due to
an insufficient number of data points for a robust multivariate regression, limiting their
analysis to a more descriptive presentation.
During the study period, the billing codes changed from the International Classification
of Diseases (ICD) version 9, to ICD-10. Following consultation with NYS DOH, measures
affected by this change were not included in the Interim Report although they will be
considered for the final summative report.
Most DSRIP performance measures are process outcomes rather than clinical outcomes,
due to the nature of the underlying data.
Potentially Preventable Readmissions are defined as 30-day readmissions in the total
attributed population, rather than 30-day admissions as a percentage of index
admissions. Changes in this measure could reflect higher or lower index admissions,
irrespective of readmissions.
There was a change in the health plan encounter intake system (EIS) that occurred in
October 2015 (between MY1 and MY2). This change led to differences in how
emergency room encounters were reported and could, in particular, affect assessment
of the level change immediately after DSRIP initiation (between MY1 and MY2) in the
regression analyses.
The monthly measures for Potentially Preventable Emergency Room
Visits and Potentially Preventable Emergency Room Visits among Behavioral Health
Members only have 31 time points due to missing data at the time of analysis.
Consequently, regression results may be under-powered and findings may be biased if
the months with missing data have different trends. Results should be interpreted with
caution, and the final summative report will use a complete set of monthly data.
The measures of initiation of and engagement in drug/alcohol abuse treatment are
defined as a percentage among index cases. The denominator is changing over time as a
result of the opioid crisis, and so no change or a worsening trend in this measure could
reflect increased index cases.
The DSRIP program is implemented concurrently with other important New York
initiatives to achieve the triple-aim, making it difficult to isolate its marginal effect on
system transformation. Due to its large size, it is presumed that much of the observed
difference is due to the DSRIP program although external policies and activities may also
play a role in facilitating changes in performance measures.
One of the DSRIP program’s overall goals is to enable broader system transformation,
beyond Medicaid. Enabling other aspects of the health care system to move towards the
triple-aim is an important outcome but is not fully captured in the performance
measures available in the DSRIP Dataset.
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2. Demonstration Description
2.1. New York’s Medicaid Crisis and the Medicaid Redesign Team
In 2010, New York’s Medicaid system was in crisis. At the time, there were 5 million Medicaid
recipients, incurring $53 billion, with a 14% increase in spending over the prior 5 years. On a per
member basis, New York’s Medicaid costs were twice the national average.17 In that time
period, the Commonwealth Fund’s 2009 edition of the State Scorecard on Health System
Performance analyzed data from the prior few years and reported that New York ranked 50th in
the nation for avoidable hospital use and costs, and 21st for overall health system quality. New
York was slightly above the median rankings for access (18th), prevention and treatment (22nd),
and healthy lives (17th),18 and scored in the top quartile for equity (11th). Its lower ranking for
overall system performance was driven by its low score for avoidable hospital use and costs. 19
To address the Medicaid crisis, Governor Andrew M. Cuomo issued Executive Order No. 5 to
create the New York Medicaid Redesign Team (MRT).20 Its 27 stakeholders, representing
diverse health care delivery system sectors, created a multi-year action plan comprising both a
vision and a set of specific recommendations.21 Guided by the Center for Medicare and
Medicaid Services’ (CMS) triple-aim, the MRT concluded that the underlying problem is “not
due to a lack of access to vital services” but instead that “for far too many people, care is not
effectively managed” and that health disparities persist. The MRT also aspired that health care
delivery system reforms from its Medicaid system redesign would spill over into New York’s
overall health care delivery system, beyond Medicaid.
The activities outlined in the MRT’s multi-year action plan are organized along the triple-aim:
•

To improve care, New York is creating fully-integrated care management for all
Medicaid members, ensuring universal access to high quality primary care,
implementing Patient-Centered Medical Homes, developing a robust health care
workforce for the 21st century, improving the interoperability of electronic health
records, and improving behavioral health integration with primary care.

17

New York State Department of Health. (2011). A plan to transform the Empire State’s Medicaid program. Better
care, better health, lower costs multi-year action plan. Retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/mrtfinalreport.htm
18
The healthy lives measure comprises “indicators that measure the degree to which a state’s residents enjoy long
and healthy lies, as well as factors such as smoking and obesity that affect health and longevity” (Commonwealth
Fund, 2009, p. 25).
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Commonwealth Fund. (2009, October). Aiming higher: results from a state scorecard on health system
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•

•

To improve health, New York is pursuing strategies to reduce disparities in health
outcomes, expanding access to affordable and supportive housing, and redesigning the
Medicaid benefit to ensure access to clinically effective and efficiently delivered
services.
To reduce costs, New York developed a new statutory “global cap” on the state’s share
of Medicaid spending, is strengthening and transforming the health care safety net,
engaging in medical malpractice reform and payment reform, and redefining state and
local relationships around Medicaid financing.

Having established the MRT’s multi-year plan, New York sought a Medicaid Section 1115 waiver
amendment to “both allow the state to reinvest in its health care infrastructure as well as to
give the state the freedom to innovate”.22 In April 2014, CMS approved New York’s Section
1115 Medicaid waiver amendment request allowing New York to reinvest $8 billion of its
anticipated $17.1 billion federal savings over 5 years towards the MRT action plan, with $6.42
billion of waiver funds allotted for its DSRIP program. The remainder of the MRT reinvestment
is allocated to the Interim Access Assurance Fund ($500 million) and other Medicaid Redesign
purposes including supporting the development of health homes, and investments in long-term
care, workforce, and enhanced behavioral health services ($1.08 billion).23
New York’s DSRIP program is not implemented in isolation. It is one of several New York
initiatives to facilitate broader changes in the state’s health care environment, and leverages
other programs and infrastructure. Other relevant activities include:
•
•
•
•
•
•

•

A larger portfolio of MRT projects, which encompass over 400 completed or ongoing
MRT projects being implemented in eight phases;24
The implementation of the Affordable Care Act;
Continued focus on moving from fee-for-service to Medicaid managed care, including
Health and Recovery Plans (HARPs) for adults with significant behavioral health needs;
A Medicaid global spending cap;
The Patient-Centered Medical Home and Advanced Primary Care (APC) initiative;
Ongoing efforts to improve health information connectivity through the Statewide
Health Information Network for New York (SHIN-NY), the technology platform that
connects Qualified Entities across the state to exchange electronic clinical information;
and
A broader movement towards value based payment (VBP) modeling by government and
private insurers.

This interim report focuses on New York’s DSRIP program, but it is important to recognize that
it is one mechanism in a broad set of programs and policies to achieve the triple-aim. Caution is
22

Ibid, p. 41.
New York State Department of Health. (n.d.). DSRIP overview. Retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/overview.htm
24
New York State Department of Health. (2018, August). MRT projects compilation table updates. Retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/progress_updates/projects_compilation_table.htm
23
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warranted when interpreting changes in performance metrics, as it is difficult to isolate the
DSRIP program’s impact from this broader context. The DSRIP program’s influence on system
transformation may also facilitate the implementation of other programs; enabling other
programs to be successful is an important outcome but may not be captured in DSRIP
performance metrics.

2.2. DSRIP Goals, Objectives, and Activities
2.2.1. Overview of DSRIP Goals and Objectives
New York’s DSRIP program is embedded within its MRT Waiver Amendment’s overarching
triple-aim vision.25 As the largest component of the MRT Waiver Amendment, the DSRIP
program aims to achieve a 25% reduction in avoidable inpatient and emergency department
hospital use over five years, and to use incentives to drive system transformation, and
improvements in clinical management and population health. Four core measures are used to
evaluate the DSRIP program’s success in meeting its avoidable hospital utilization goal:
potentially preventable emergency room visits, potentially preventable hospital readmissions,
adult prevention quality indicators, and pediatric prevention quality indicators. In addition to
these measurable objectives, New York’s DSRIP aims to leverage managed care payment reform
to ensure that delivery system transformation continues beyond the waiver period, provides
near-term financial support for vital safety net providers at immediate risk of closure, and
increases collaboration by requiring communities of eligible providers to partner on DSRIP
projects.
To achieve its goals, New York’s DSRIP program created 25 PPS, coalitions of safety net
hospitals, clinics, and other eligible providers with clear business relationships. The PPS
implement DSRIP projects towards the primary goal of reduced avoidable hospital use, and
meeting broader objectives of system transformation and improved clinical management and
population health. In selecting projects, PPS were required to respond to their communities’
needs. The PPS are responsible for attributed Medicaid members and populations of uninsured
people, which are assigned to them through an algorithm that considers characteristics such as
geographic region and members’ affiliations with providers.26 Partners within each PPS earn
incentive payments based on their documented performance towards measurable goals.
Section 2.3 includes additional details on the attribution of Medicaid members to PPS and
project payments.
25

Information on the DSRIP program comes from the following New York State Department of Health sources,
unless noted otherwise: (1) DSRIP frequently asked questions (FAQs), retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/dsrip_faq/section2_faqs.htm; (2) Special Terms
and Conditions Attachment I – NY DSRIP program funding and mechanics protocol , retrieved from
https://www.health.ny.gov/health_care/managed_care/appextension/docs/2017-07-20_rev_att1.pdf; (3) Special
Terms and Conditions Attachment J – NY DSRIP strategies menu and metrics, retrieved from
https://www.health.ny.gov/health_care/managed_care/appextension/docs/2018-01-18_attj_rev.pdf; (4) DSRIP
Project Toolkit, retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/docs/dsrip_project_toolkit.pdf.
26
As described in section 2.3, only PPS that selected project 2.d.i, or the “11th project,” have uninsured or low/nonutilizing populations attributed to them for valuation and performance.
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In addition to incentive payments for PPS to reach their project-related performance goals, the
PPS are responsible for collectively meeting statewide accountability milestones (SWAM), listed
below. The SWAM target values change across DSRIP Demonstration Years (DY), reflecting a
desire for increasing performance over time. Failure to meet the SWAM milestones triggers
funding penalties of 5% of funds from CMS in Demonstration Year (DY) 3, 10% of funds in DY4,
and 20% of funds in DY5.27
•
•
•
•

Statewide performance metrics: At least 50% of measures must be determined to be
improving or maintaining, versus worsening. Sixteen statewide measures were selected
for this SWAM milestone.
Success of projects statewide: At least 50% of eligible PPS-level measures must meet
their Annual Improvement Target thereby triggering awards to PPS.
Total Medicaid spending: Statewide total Medicaid spending (in DY4 and DY5) and total
inpatient and emergency room spending (in DY3, DY4, and DY5) among attributed
members must meet annual targets measured on a per member per month basis. 28
Managed care plan: A minimum percentage of total Medicaid managed care
organization expenditures must be in specific levels of VPB contracts.

2.2.2. Conceptual Framework Guiding DSRIP Activities
New York’s DSRIP program takes a holistic approach to system transformation (see Exhibit 2.1).
As described by the NYS DOH, the underlying conceptual framework places the social
determinants of health at the foundation.29 The second level is to introduce “system-ness” into
health care, emphasizing a focus on broader systems and cross-sector collaboration rather than
working in silos. Higher levels include investing in primary care, including investment in health
information technology and patient-centered medical homes; working with key subpopulations
with high cost of care, such as people living with HIV/AIDS or with intellectual and/or
developmental disabilities; and tracking quality measures at all levels of care.30

27

New York State Department of Health. (2018, April 30). Statewide accountability milestones monthly status
update (slide deck).
28
The DY3 milestone on statewide spending was reported to CMS as passed (total inpatient and emergency room
spending was under the target spending rate). The DSRIP program’s influence on cost will be addressed in the final
summative report and not the interim report because the program is still underway.
29
Helgerson, J. (2016, October 17). NYS DSRIP Whiteboard – An Eye toward the Future [Video file]. Retrieved from
https://www.youtube.com/watch?v=gAUqU7RSers
30
Kiernan, D. and Cooper, J. (2017, April 10). DSRIP overview presentation to the DSRIP Independent Evaluator
team, p. 20.
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Exhibit 2.1. Holistic approach to system transformation

quality and access to primary care. Invest in health information
technology and patient centered medical homes.
Integrate providers, share data in real-time, and make health
care a team sport.
Integrate social care providers into PPS activities. Address
social determinants in a culturally competent manner.

Source: Adapted with permission from New York State Department of Health.

Ultimately, the DSRIP program should reduce total costs to New York’s Medicaid program by
changing the mix of health care services delivered and facilitating the transition from fee-forservice to VBP contracting. Exhibit 2.2 illustrates a high-level conceptual logic model of how the
DSRIP program’s delivery system reforms are intended to reduce total costs by shifting health
care services upstream, and achieve a value based health care system. The DSRIP program’s
large emphasis on VBP reform relates to its objective of long-term sustainability.31
Value in health care is a function of the health outcomes that matter to patients and the true
cost.32 Conceptually, improved value can be measured in several domains. In Exhibit 2.2, the
upward pointing orange arrows illustrate important outcomes that are expected to improve:
patient and caregiver experiences, care coordination, patient safety, care for at-risk
populations, and preventative health. Overall costs will be lowered as a result of increased use
of less costly preventive services and coordinated primary care, and subsequent reduced use of
emergency departments, inpatient hospital visits, pharmacy benefits, and institutional longterm care (downward pointing blue arrows). In the conceptual model, reductions in emergency
department and inpatient visits are highlighted to reflect New York's core program objective to
"reduce avoidable hospital use by 25% through transforming the New York State health care
system into a financially viable, high performing system."33
Investment in governance, staff, technical expertise, technology resources, and associated
activities can transition Medicaid providers to VBP. Changing health systems in an environment
where both fee-for-service and VBP operate simultaneously is challenging, and requires
organizational focus and capital. For example, shifting from a business model of ensuring daily
31

A complete DSRIP-related website describing VBP and offering tools for DSRIP providers is accessible at
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/vbp_reform.htm
32
Porter, M.E. & Lee, T.H. (2013). The strategy that will fix health care. Harvard Business Review. Retrieved from
https://hbr.org/2013/10/the-strategy-that-will-fix-health-care.
33
New York State Department of Health. (n.d.). DSRIP Project Toolkit, p. 2. Retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/docs/dsrip_project_toolkit.pdf.
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patient visit volume to delivering health prevention strategies to prevent readmissions and
expensive tertiary care (relevant to both DSRIP program Domains 3 and 4) require significant
resources, including provider and staff time, to educate and build relationships between
patients and providers. New York’s DSRIP program enables a shift towards increased primary
care services and decreased emergency and inpatient services, and the development of VBPfocused infrastructure through: grant funding, technical assistance, data sharing, training and
support to PPS. Activities such as collaborative care, chronic disease management, and data
analytics are designed to drive success on both health outcomes, and the total cost of care.

Exhibit 2.2. Overview of DSRIP activities, outputs, outcomes, and impact
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Source: Authors’ synthesis of DSRIP program materials
Abbreviations: Emergency Department (ED), Experiences (Exp), Inpatient (IP), Institutional (Inst), Long-term Care
(LTC)

2.2.3. Development of Performing Provider Systems
Following the DSRIP program’s focus on “system-ness,” entities pursuing DSRIP projects were
required to develop integrated networks of public hospitals and safety-net providers who were
collectively accountable for performance.34 The “Performing Provider Systems” refers to the
performance network of lead entities and their associated partners. An entity could be
associated with a PPS as a partner or as an outside contractor. The distinction is that partners
were in formal performance-based collaborative relationships to implement PPS project plans.

34

Entities without a safety-net provider designation can participate as members, but they are only eligible for up
to 5% of the PPS’s total performance payments.
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Under leadership by the PPS, the collective performance of PPS partners drives achievement of
DSRIP milestones to enable payments to the PPS and to its partners.
Each PPS is led by an entity that is either a safety net provider or else a group of safety net
providers collaborating to form a new governing structure (“NewCo”). To qualify as a lead
entity, safety net providers also had to demonstrate qualifications to manage the PPS, such as
prior collaborative experience, leadership and administrative capabilities, and financial stability.
The PPS lead entities were required to form partnerships with community providers
representing diverse partner types, including hospitals, health homes, skilled nursing facilities,
federally qualified health centers, behavioral health providers, and community-based
organizations. The inclusion of an array of partners, including providers of supportive services
such as housing, was intended to address the entire continuum of care including the social
determinants of health. In some regional areas, a single provider can be a member of multiple
PPS.
The STC specify that 95% of the PPS achieved performance payments must go to safety net
providers. PPS partners are eligible for performance payments (described in section 2.3) if they
meet safety net criteria.35 Hospitals were defined as “safety net” upon meeting at least one of
the following criteria: (1) being a public hospital, critical access hospital, or sole community
hospital; (2) having at least 35% of outpatient consumers and at least 30% of inpatient
consumers with Medicaid, Medicaid/Medicare dual insurance, or no insurance; or (3) serving at
least 30% of all members who have Medicaid, Medicaid/ Medicare dual insurance, or no
insurance in their communities. Non-hospital providers received a CMS-approved safety net
status, and thus eligible for DSRIP performance payments, if they participated as part of a statedesignated health home; or at least 35% of consumers had Medicaid, Medicaid/Medicare dual
insurance, or no insurance. Non-safety net providers including community-based organizations
such as housing providers who have no Medicaid billing reports, private doctors, and
independent practice associations who did not have sufficient Medicaid payor mix were
allowed to join the PPS. However, these non-safety net providers could only receive up to 5% of
the PPS’ performance payments.
In the early years of the DSRIP program, the PPS were able to adjust their performance
networks over time.36 New partners were able to join PPS during annual network re-openings
until MY5 begun in July 2018. The PPS were allowed to drop partners only during the mid-point
assessment in December 2016.

35

On a case-by-case basis, “vital access provider” exceptions were made by CMS to allow non-safety net providers
to be considered “qualifying safety net providers” for the purpose of the DSRIP program. The vital access providers
had to meet one of three CMS criteria: (1) location in a community without a safety net provider willing or able to
develop and lead a PPS; (2) hospitals with one or more unique qualifications to be PPS lead entities (available
services, financial viability, community relationships, and/or past success in reducing avoidable hospitalizations);
and (3) state-designated health homes.
36
The DSRIP program distinguishes performance and valuation networks. The annual network re-openings and
one-time drop during the midpoint assessment period refer to the performance network of partners actively
collaborating on DSRIP projects to meet performance goals. The valuation network represents the PPS partner
membership on December 1, 2014, and used to attribute members for valuation. Unlike the evolving performance
networks, the valuation networks do not change over time.

34

In total, there are 25 PPS located across the state (see Exhibit 2.3), covering each of the 62
counties across New York. In New York City and Long Island, some PPS cover only one county
and ten PPS serve the five boroughs with some overlap. In contrast, the PPS in upstate New
York regions serve multiple counties that cover a larger and more diverse geographic area but
with a lower population density and in some cases may be the only PPS in that county. (see the
New York DSRIP Terminology Guide at the front of the report for a full list of PPS and their
counties served.)
Exhibit 2.3. Geographic distribution of New York’s Performing Provider Systems across the 11
DSRIP planning regions
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Source: Authors’ synthesis of PPS website.37
Notes: See the New York DSRIP Terminology Guide at the front of the report for a list of the PPS acronyms. The 11
regions were developed for DSRIP planning purposes only.

2.2.4. Selection of Projects by Performing Provider Systems
The DSRIP program’s projects are classified by domain, with Domain 1 focused on overall PPS
organization and Domains 2, 3, and 4 focused on various areas of transformation.38

37

New York State Department of Health. (n.d.) DSRIP Performing Provider Systems (PPS): PPS by County. Available
at https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/pps_map/index.htm
38
A comprehensive list of DSRIP projects and descriptions is included in the DSRIP Project Toolkit, available at
https://www.health.ny.gov/health_care/medicaid/redesign/docs/dsrip_project_toolkit.pdf
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•

•

•

•

Domain 1 outputs are structurally-focused, related to setting up the PPS networks,
projects, capacity, and structural changes that are foundational to program operations.
Instead of projects, Domain 1 focuses on organizational implementation milestones.
Domain 2 outcomes are related to system transformation. Project categories are:
creating integrated delivery systems, implementing care coordination and transitional
care programs, connecting settings, and “patient activation” to expand access to
community-based care for special populations.
Domain 3 outcomes focus on clinical improvement. Projects are categorized by health
condition: behavioral health, cardiovascular health, diabetes care, asthma, HIV/AIDS,
perinatal care, palliative care, and renal care.39 DSRIP has a special focus on behavioral
health, as all PPS were required to select a behavioral health project.
Domain 4 outcomes focus on population health. These DSRIP projects mirror the goals,
objectives, and strategies of the state’s Prevention Agenda.40 New York’s 2013-2018
Prevention Agenda contains detailed goals and measurable objectives, recommended
strategies (analogous to DSRIP projects), technical assistance, and a data dashboard that
stakeholders can use to inform their community needs assessments and view progress
towards their Prevention Agenda goals.

The four domains were deliberately additive (see Exhibit 2.4); for example, PPS capacity
(Domain 1), organizational structures to facilitate system transformation (Domain 2), and
clinical improvement interventions (Domain 3) are all pre-conditions for promoting population
health (Domain 4). Domain 1 measurable objectives are program outputs, whereas measurable
objectives from Domains 2, 3, and 4 represent short, medium, and long-term program
outcomes.

39

The PPS chose projects in 7 of the 8 clinical categories in Domain 3. None of the PPS selected the project on renal
care (project 3.h.i, specialized medical home for chronic renal failure).
40
The Prevention Agenda 2013-2018 contains five priority areas and associated state and local action plans, as well
as a focus on improving health equity. Its focus areas are: (1) preventing chronic diseases; (2) promoting a healthy
and safe environment; (3) promoting healthy women, infants, and children; (4) promoting mental health and
substance abuse; and (5) preventing HIV, sexually transmitted diseases, vaccine-preventable diseases, and health
care-associated infections. These line up with the DSRIP projects with the exception of promoting a healthy and
safe environment; the recommended interventions for these projects (e.g., increasing the percentage of residents
with fluoridated drinking water and improving the design and maintenance of home environments) cannot be
modified directly through DSRIP’s clinically-focused interventions. Retrieved from
https://www.health.ny.gov/prevention/prevention_agenda/2013-2017/
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Exhibit 2.4. Schematic of the additive effect of projects in four DSRIP domains
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Population
Health

Source: Authors’ synthesis of NYS DOH program materials.

New York’s DSRIP program offered the PPS a defined list of 44 projects. The 44 potential
projects outlined in the Project Toolkit (see Exhibit 2.5) were designed to meet the core DSRIP
program goals of reducing avoidable hospital use and transforming the New York health care
system into a financially viable, high performing system. A limited project list was required by
CMS, and state administrators predicted that a focused project menu could improve overall
success, project evaluation efforts, and state oversight.41

Exhibit 2.5. List of New York DSRIP program projects
Project No. Description
Domain 2: System Transformation Projects
A.
Create Integrated Delivery Systems
2.a.i
Create Integrated Delivery Systems that are focused on Evidence-Based
Medicine/Population Health Management
2.a.ii
Increase certification of primary care practitioners with PCMH certification
and/or Advanced Primary Care Models (as developed under the NYS Health
Innovation Plan (SHIP))
2.a.iii
Health Home At-Risk Intervention Program: Proactive management of higher
risk patients not currently eligible for Health Homes through access to high
quality primary care and support services
2.a.iv
Create a medical village using existing hospital infrastructure
2.a.v
Create a medical village/alternative housing using existing nursing home
infrastructure
B.
Implementation of Care Coordination and Transitional Care Programs
2.b.i
Ambulatory Intensive Care Units (ICUs)
41

Bachrach, D., Bernstein, W., Augenstein, J., Lipson, M., & Ellis, R. (2016, April 21). Implementing New York’s
DSRIP program: implications for Medicaid payment and delivery system reform, p. 13. Retrieved from
https://www.commonwealthfund.org/publications/fund-reports/2016/apr/implementing-new-yorks-dsripprogram-implications-medicaid

--===-------
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Project No. Description
2.b.ii
Development of co-located primary care services in the emergency department
(ED)
2.b.iii
ED care triage for at-risk populations
2.b.iv
Care transitions intervention model to reduce 30 day readmissions for chronic
health conditions
2.b.v
Care transitions intervention for skilled nursing facility (SNF) residents
2.b.vi
Transitional supportive housing services
2.b.vii
Implementing the INTERACT project (inpatient transfer avoidance program for
SNF)
2.b.viii
Hospital-Home Care Collaboration Solutions
2.b.ix
Implementation of observational programs in hospitals
C.
Connecting Settings
2.c.i
Development of community-based health navigation services
2.c.ii
Expand usage of telemedicine in underserved areas to provide access to
otherwise scarce services
D.
Utilizing Patient Activation to Expand Access to Community Based Care for
Special Populations
2.d.i
Implementation of Patient Activation Activities to Engage, Educate and
Integrate the uninsured and low/non-utilizing Medicaid populations into
Community Based Care
Domain 3: Clinical Improvement Projects
A.
Behavioral Health
3.a.i
Integration of primary care and behavioral health services
3.a.ii
Behavioral health community crisis stabilization services
3.a.iii
Implementation of evidence-based medication adherence programs (MAP) in
community based sites for behavioral health medication compliance
3.a.iv
Development of Withdrawal Management (e.g., ambulatory detoxification,
ancillary withdrawal services) capabilities and appropriate enhanced abstinence
services within community-based addiction treatment programs
3.a.v
Behavioral Interventions Paradigm (BIP) in Nursing Homes
B.
Cardiovascular Health—Implementation of Million Hearts Campaign
3.b.i
Evidence-based strategies for disease management in high risk/affected
populations (adult only)
3.b.ii
Implementation of evidence-based strategies in the community to address
chronic disease – primary and secondary prevention projects (adult only)
C.
Diabetes Care
3.c.i
Evidence-based strategies for disease management in high risk/affected
populations (adults only)
3.c.ii
Implementation of evidence-based strategies to address chronic disease –
primary and secondary prevention projects (adults only)
D.
Asthma
3.d.i
Development of evidence-based medication adherence programs (MAP) in
community settings– asthma medication
3.d.ii
Expansion of asthma home-based self-management program
38

Project No. Description
3.d.iii
Implementation of evidence-based medicine guidelines for asthma
management
E.
HIV/AIDS
3.e.i
Comprehensive Strategy to decrease HIV/AIDS transmission to reduce
avoidable hospitalizations – development of a Center of Excellence for
Management of HIV/AIDS
F.
Perinatal Care
3.f.i
Increase support programs for maternal & child health (including high risk
pregnancies) (Example: Nurse Family Partnership)
G.
Palliative Care
3.g.i
Integration of palliative care into the PCMH Model
3.g.ii
Integration of palliative care into nursing homes
H.
Renal Care
3.h.i
Specialized Medical Home for Chronic Renal Failure
Domain 4: Population Wide Projects: New York’s Prevention Agenda
A.
Promote Mental Health and Prevent Substance Abuse (MHSA)
4.a.i
Promote mental, emotional and behavioral (MEB) well-being in communities
4.a.ii
Prevent Substance Abuse and other Mental Emotional Behavioral Disorders
4.a.iii
Strengthen Mental Health and Substance Abuse Infrastructure across Systems
B.
Prevent Chronic Diseases
4.b.i
Promote tobacco use cessation, especially among low SES populations and
those with poor mental health.
4.b.ii
Increase Access to High Quality Chronic Disease Preventive Care and
Management in Both Clinical and Community Settings (Note: This project
targets chronic diseases that are not included in domain 3, such as cancer
C.
Prevent HIV and STDs
4.c.i
Decrease HIV morbidity
4.c.ii
Increase early access to, and retention in, HIV care
4.c.iii
Decrease STD morbidity
4.c.iv
Decrease HIV and STD disparities
D.
Promote Healthy Women, Infants and Children
4.d.i
Reduce premature births
Source: Reproduced from the New York DSRIP Project Toolkit.42

The PPS were required to perform stakeholder-engaged community needs assessments to
understand their local demographics and health care needs, and available health care and
community resources. Based on their findings, the PPS chose between five and 10 projects for
valuation and scoring purposes following decision criteria specified in the DSRIP Project Toolkit
(see Exhibit 2.6). With the exception of the behavioral health Domain 3 measures, if the PPS’s
pre-DSRIP initiation performance on the majority of Domain 3 measures relevant to a project

42

New York State Department of Health. New York State Delivery System Reform Incentive Payment Program
Project Toolkit. Retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/docs/dsrip_project_toolkit.pdf
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was close to the high performance goal, the project would not be approved. These decision
criteria ensured that PPS implemented projects in each domain, with an emphasis on
behavioral health and tailoring projects to local community needs.
Each PPS submitted a DSRIP Project Plan comprising:
• A selection of Domain 2, 3, and 4 projects,
• A rationale for selecting the projects,
• Specific goals,
• A description of how the projects would change the system,
• A list of partners attesting to join their PPS network,
• A description of project activities, and
• A justification for the funding.

Exhibit 2.6. Decision criteria guiding the selection of DSRIP projects
Domain
Domain 2

Domain 3

Domain 4

Selection Requirements for Project Valuation and Scoring
• Between two and four projects
• Selection based on community needs assessment
• At least one project from strategy sub-list A, and at least one project
from strategy sub-lists B or C
• If qualified, project 2.d.i. allowed as an additional project from this list
(also referred to as the “11th project”)
• Between two and four projects
• Selection based on community needs assessment
• At least one project from strategy sub-list A
• Between one and two projects
• Based on community needs assessment
• Consistent with, but not duplicate, Domain 3 projects
• Applicable to the full service area population

Source: Authors’ synthesis of the New York DSRIP Project Toolkit.43

Some PPS, primarily the major public hospitals, received NYS DOH approval to pursue an 11th
project in their area (project 2.d.i.). The goal of the 11th project was to incorporate uninsured
members into the DSRIP program and to reach out to non-utilizing and low-utilizing Medicaid
members who might otherwise end up in the hospital for a preventable visit. To be eligible for
the 11th project, a PPS had to already be pursuing 10 projects, demonstrate its network had
sufficient capacity to undertake the additional project, and have a network that was suitable for
serving the uninsured and non-utilizing and low-utilizing Medicaid populations in its geographic
area. If a public hospital PPS in a county was eligible for and received approval for the 11 th
project, no other PPS in the county could pursue it (“right of first refusal”). If a county did not
43

New York State Department of Health. New York State Delivery System Reform Incentive Payment Program
Project Toolkit. Retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/docs/dsrip_project_toolkit.pdf
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have a public hospital PPS or else the public hospital PPS elected to not pursue the 11 th project,
then one or more other PPS could be approved to pursue it in that county.
The DSRIP project plan applications were reviewed in 2014 by the Independent Assessor to
ensure their compliance with the DSRIP program’s STC. The Independent Assessor also scored
each DSRIP project plan and provided its recommendations for their approval or rejection. The
Project Approval and Oversight Panel, a panel of non-conflicted experts and public stakeholders
reviewed the Independent Assessor’s recommendations and made decisions to accept, reject
or modify them. These were then passed on to the New York State Commissioner of Health for
final determination.

2.3. Attribution and Project Valuation
Project payments are based on project performance, with funding disbursed to the PPS who
then pay their PPS partners based on their individual contract terms.44 A unique feature of New
York’s DSRIP program is that in addition to the PPS collective performance of its diverse
partners, New York’s federal funding is also tied to achieving the statewide accountability
milestones (SWAM) beginning in DSRIP Demonstration Year 3.45 Domain 1 infrastructurebuilding payments are linked to reporting (Pay for Reporting [P4R]) and payments for projects
in domains 2, 3, and 4 are linked to performance (Pay for Performance [P4P]). Over the fiveyear DSRIP program period, many P4R payments transition to P4P, with some exceptions such
as Domain 4 which are P4R throughout all DSRIP years (see Exhibit 2.7).
Exhibit 2.7. Shift in funding from pay for reporting to pay for performance
Domain
Domain 1: Project Process Milestones
Domain 2: System Transformation and
Financial Stability Milestones
Domain 3: Clinical Improvement
Measures
Domain 4: Population Health
Outcomes
Total

Payment
Type
P4R
P4P
P4R
P4P
P4R
P4R

Annual Funding Percentages
DY1
DY2
DY3
DY4
DY5
80%
60% 40% 20%
0%
0%
0%
50% 72%
93%
20%
40% 10%
8%
7%
0%
30% 50% 70%
90%
20%
10% 10% 10%
10%
20%
40% 60% 80% 100%
100%

100% 100% 100%

100%

46

Source: Adapted from the Special Terms and Conditions (STC), Attachment I
Abbreviations: Demonstration Year (DY), Pay for Performance (P4P, Pay for Reporting (P4R)

44

While PPS could include non-safety net providers in their performance networks, at least 95% of the total DSRIP
payments earned by PPS had to be distributed to its safety net providers.
45
Felland, F., Lipson, D., & Heeringa, J. (2018, April). Examining New York’s Delivery System Reform Incentive
Payment System: achievement at the demonstration’s midpoint and lessons for other states. Retrieved from
https://www.medicaid.gov/medicaid/section-1115-demo/downloads/evaluation-reports/ny-dsrip-case-study.pdf
46
Special Terms and Conditions Attachment I – NY DSRIP program funding and mechanics protocol, retrieved from
https://www.health.ny.gov/health_care/managed_care/appextension/docs/2017-07-20_rev_att1.pdf.
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Notes: The sum of the Domain 1 P4R percentage and the percentages of the P4R and P4P in each of the remaining
Domains totals 100%. For example, total funding for Domain 2 in DY3 is based 40% on reporting Domain 1
milestones (P4R), 50% on Domain 2 performance (P4P), and 10% on reporting Domain 2 milestones (P4R).

The Independent Assessor determined project valuations for each PPS DSRIP project plan
following a methodology specified in the STC. Maximum application values, the highest
financial payment that each PPS could receive during their DSRIP program participation, were
based on factors such as the projects selected, the DSRIP Project Plans’ application scores,
“scale and speed” commitments (i.e., the number of sites, providers, and entities; percent of
safety net providers; number of actively engaged members and the timelines for project
implementation and patient engagement), and the size of the attributed Medicaid population
for each project.47 In setting their scale and speed commitments, PPS had to consider trade-offs
between setting aggressive targets that might calculate high potential payments versus the risk
of underperforming and potentially missing payments altogether.48
An attribution methodology assigned each Medicaid member and a portion of uninsured
individuals in each region to one and only one PPS, with a separate attribution for valuation and
performance. The attribution for valuation was based on membership on December 1, 2014; it
represents the maximum funding that a PPS could receive over its DSRIP duration. This fixed
amount does not change even if the PPS drop or add partners over time. The attribution for
performance adjusts annually and reflects the number of attributed Medicaid members based
on the current partners in the PPS performance networks.
The basic features of the attribution logic are shown in Exhibit 2.8, with additional details in
Appendix 2. Medicaid members with partial Medicaid coverage or supplemental coverage from
other insurances were not included in attribution. The non-utilizing, low-utilizing, and
uninsured populations were attributed to the local PPS undertaking the 11th project. For the
remainder of Medicaid members with full Medicaid coverage, geography, patient visit
information, and patients’ primary care provider assignments were used to first classify
members into one of four health populations or “swim lanes” (developmental disabilities, longterm care, behavioral health, or other). A “loyalty” algorithm within each “swim lane” was then
used to assign the member to the PPS that contained the providers where most of the
members’ services were received. In addition to the loyalty algorithm, some members were
attributed to a PPS based on their total claims, their assigned primary care provider, or via their
ZIP code.

47

The full project valuation methodology is outlined in the STC Attachment I, retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/docs/program_funding_and_mechanics.pdf.
48
Helgerson, J. (2014, November 14). NYS DSRIP whiteboard – project plan scale and speed of implementation.
[Video file]. Retrieved from https://www.youtube.com/watch?v=f2UP3rQh1SQ&feature=youtu.be
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Exhibit 2.8. Overview of Performing Provider System attribution methodology

York Medicaid Beneficiaries
State ran attribution algorithm

'IV

'

Non-utilizing, low-utilizing, and uninsured
populations

Attributed to local PPS undertaking "Project 11"

Beneficiaries with developmental disabilities,
receiving long-term care services, or with a
behavioral health condition

Attributed to PPS based on loyalty algorithm

All othe, beneficiaries

Attributed to PPS based on a loyalty algorithm
incorporating health home affiliation , primary
care provider connectivity, and other utilization

Source: Adapted with permission from Bachrach et al. 2016.49 See Appendix 2 for additional details.
Notes: If a PPS is the only one in a county, its attribution includes all beneficiaries receiving a plurality of services in
that county. Non-utilizing members are defined as Medicaid members who have not used services in a given year.
Low-utilizing Medicaid members are defined as using three or fewer services per year and having no relationship
with their primary care provider or care manager.

49

Bachrach, D., Bernstein, W., Augenstein, J., Lipson, M., & Ellis, R. (2016, April 21). Implementing New York’s
DSRIP program: implications for Medicaid payment and delivery system reform. Retrieved from
https://www.commonwealthfund.org/publications/fund-reports/2016/apr/implementing-new-yorks-dsripprogram-implications-medicaid
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3. Independent Evaluation Study Design
3.1. Research Questions and Hypotheses
The Independent Evaluation is guided by seven overarching research questions (RQ) and
corresponding hypotheses (see Exhibit 3.1).50 Consistent with the mixture of Pay for Reporting
(P4R) and Pay for Performance (P4P) payments (see Section 2.3), there are both process and
outcome measures. All hypotheses and definitions of “improvements” are in comparison to the
statewide pre-DSRIP initiation trend. For example, if utilization of behavioral health services
(hypothesis 3) were increasing statewide in the pre-DSRIP initiation period, there should be a
more rapid rate of increase in the post-DSRIP initiation period.51 If total health care costs were
increasing in the pre-DSRIP initiation period, then the rate of cost growth would be slower in
the post-DSRIP initiation period (hypothesis 13). If the outcome of total costs improved, the
post-DSRIP initiation trend could: (a) continue to increase but at a slower rate than in the preDSRIP initiation period, (b) remain at a steady level thereby having a slower growth rate
compared to the pre-DSRIP initiation period, or (c) decline.
Exhibit 3.1. Overarching research questions and hypotheses for the Independent Evaluation
Research questions
• RQ-A: What were the successes and challenges with respect to PPS planning,
implementation, operation, and plans for program sustainability from the perspective
of DSRIP program planners, administrators, and providers; and why were they
successful or challenging?
• RQ-B: Did health care quality improve as a result of clinical improvements in the
treatment of selected diseases and conditions?
• RQ-C: Did population health improve as a result of implementation of New York’s
DSRIP initiative? (Sub-question: Were racial and ethnic disparities on specific
population measures reduced following the DSRIP program?52)
• RQ-D: Did utilization of behavioral health care services increase as a result of the
DSRIP program?
• RQ-E: Was avoidable hospital utilization reduced as a result of the DSRIP program?
• RQ-F: To what extent did PPS achieve health care system transformation, including
increasing the availability of behavioral health care?

50

Some of the research questions and hypotheses were edited slightly from the original Request for Proposals and
CMS-approved Independent Evaluation plan. See Appendix 3 for a comprehensive crosswalk to the updated
research questions and hypotheses and the rationale behind the changes.
51
Nearly all time point observations in the study are during the period when the DSRIP program is underway. The
“pre/post” language is standard for time series analysis. The “pre” period refers to the early stages when the PPS
are forming, and the “post” initiation period refers to the middle stages of the DSRIP program when the PPS are
implementing their projects.
52
Specific measures for this sub-question are: premature deaths, newly diagnosed cases of HIV, preterm births,
adolescent pregnancy rate per 1,000 females aged 15-17, percentage of unintended pregnancy among live births,
and infants exclusively breastfed while in the hospital.
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•

RQ-G: Did the DSRIP program reduce health care costs? (Sub-question: Was the DSRIP
program cost effective in terms of New York and federal governments receiving
adequate value for their investments?)

Hypotheses
• H1: Health care quality will increase in the following areas: (a) behavioral health, (b)
cardiovascular health, (c) diabetes care, (d) asthma, (e) HIV/AIDS, (f) perinatal care, (g)
palliative care, and (h) renal care.53
• H2a: Population health measures will improve in the following areas: (a) mental
health and substance abuse, (b) prevention of chronic diseases, (c) prevention of HIV
and STDs, and (d) health of women, infants, and children.
• H2b: Racial and ethnic disparities in premature deaths, newly diagnosed cases of HIV,
preterm births, adolescent pregnancy rates, percentage of unintended pregnancy
among live births, and infants exclusively breastfed in the hospital will decrease.
• H3: Behavioral health care service utilization will increase.
• H4: Primary care utilization will increase.
• H5: Avoidable hospital utilization will decrease.
• H6: Health care service delivery integration will increase.
• H7: Health care coordination will increase.
• H8a: Primary care, behavioral health, and dental service utilization among the
uninsured, non-utilizing, and low-utilizing populations will increase.
• H8b: Emergency department utilization among the uninsured, non-utilizing, and lowutilizing populations will decrease.
• H9: Costs for primary care services will increase.
• H10: Costs for behavioral health care services will increase.
• H11: Costs for emergency department services will decrease.
• H12: Costs for hospital inpatient services will decrease.
• H13: Total cost of care will decrease.
Source: Adapted from the Request for Proposals. RQ-A, RQ-E, RQ-F, and RQ-G are formerly CMS RQ-7, CMS RQ-1,
and CMS RQ-6, respectively. See Appendix 3 for a comprehensive crosswalk of the original RQs and hypotheses
and their reordering and adaptation for the interim report. 54
Abbreviations: Hypothesis (H), Research Question (RQ)
Notes: All hypotheses reflect changes compared to the baseline trend, e.g., if costs were increasing pre-DSRIP
initiation then the total cost of care will either have a slower growth rate, remain constant, or decline.

A description of each RQ and associated hypotheses follows. There is some overlap among RQs,
hypotheses, and DSRIP domains: some hypotheses relate to multiple RQs, each domain is
associated with one or more RQs, and some RQs relate to multiple domains.
RQ-A: What were the successes and challenges with respect to PPS planning,
implementation, operation, and plans for program sustainability from the perspective
53

Hypothesis 1 includes renal care per the Request for Proposal and CMS-approved Independent Evaluation plan.
However, it should be noted that no PPS selected the Domain 3 project on renal care (project 3.h.i, specialized
medical home for chronic renal failure).
54
Request for Proposals RFP # 16336, Independent Evaluation of the New York State Delivery System Reform
Incentive Payment Program, issued December 29, 2015, pp. 6-7.
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of DSRIP program planners, administrators, and providers; and why were they
successful or challenging?
This RQ is relevant to Domain 1 (PPS capacity-building), and the overarching DSRIP program
goal to make system transformation sustainable. For the purposes of the Independent
Evaluation, these qualitative findings provide critical contextual information for interpreting the
quantitative performance outcomes relevant to the remaining RQ-B through RQ-G. For
example, PPS reporting higher implementation challenges may have lower performance, or
implementation delays common to all PPS would lead to observed time lags in the time series
analyses of performance measures.
Hypotheses are not applicable to the qualitative research conducted to answer this RQ (focus
groups and interviews), or the descriptive analyses of the close-ended surveys completed by
patients and PPS partners. No hypotheses are provided for RQ-A, as they are not appropriate
for these analyses.
RQ-B: Did health care quality improve as a result of clinical improvements in the
treatment of selected diseases and conditions?
This RQ is associated with Domain 3 clinical improvement projects. It is linked to hypothesis H1.
RQ-C: Did population health improve as a result of implementation of New York’s
DSRIP initiative? (Sub-question: Were racial and ethnic disparities on specific
population measures reduced following the DSRIP program?55)
This RQ is related to Domain 4 population-wide projects, which align with New York’s
Prevention Agenda (with the exception of the “promote a healthy and safe environment” focus
area, which is not a component of the DSRIP program). It is linked to hypotheses H2a and H2b.
RQ-D: Did utilization of behavioral health care services increase as a result of the
DSRIP program?
Similar to RQ-B, this question is related to the Domain 3 clinical improvement projects but with
a particular focus on behavioral health (Projects 3.a.i, 3.a.ii, 3.a.iii, 3.a.iv, and 3.a.v). Whereas
RQ-B focuses on health care quality, RQ-D focuses on utilization. It is linked to hypothesis H3.
RQ-E: Was avoidable hospital utilization reduced as a result of the DSRIP program?
This RQ addresses the DSRIP program’s primary goal of achieving a 25% reduction in avoidable
inpatient and emergency department hospital utilization over five years. Its measures are not
tied to specific projects, but conceptually if the Domain 2 and 3 projects are successful then

55

Specific measures for this sub-question are: premature deaths, newly diagnosed cases of HIV, preterm births,
adolescent pregnancy rate per 1,000 females aged 15-17, percentage of unintended pregnancy among live births,
and infants exclusively breastfed while in the hospital. Disparities are measured as ratios.
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patients with improved access to and utilization of high-quality primary care services will have
fewer hospitalizations. It is linked to hypotheses H4 and H5.
RQ-F: To what extent did PPS achieve health care system transformation, including
increasing the availability of behavioral health care?
This RQ is relevant to Domain 2 system transformation projects, including the patient activation
project (Project 2.d.i.) and some Domain 3 clinical improvement projects. System
transformation would also enable changes in population health (Domain 4). It is linked to
hypotheses H3, H6, H7, H8a, and H8b.
RQ-G: Did the DSRIP program reduce health care costs? (Sub-question: Was the DSRIP
program cost effective in terms of New York and federal governments receiving
adequate value for their investments?)
This RQ is relevant to the Medicaid Redesign Team (MRT)’s alignment with the triple-aim of
improved care, improved health, and reduced costs. As access to and utilization of high-quality
primary care increases, emergency department and inpatient hospital admissions will decline. It
is linked to hypotheses H9, H10, H11, H12, and H13.

3.2. Study Design for Evaluation of the Implementation and Process
3.2.1. Framework for Evaluation of the Implementation and Process
The evaluation of the implementation and process comprises a detailed description of the
DSRIP program’s evolution. This serves several purposes. First, this component of the
independent evaluation highlights early successes and challenges with the DSRIP program’s
implementation and operations to share with the PPS, NYS DOH, CMS, and other stakeholders.
Second, it provides valuable context for interpreting the DSRIP performance metrics, such as
inter-PPS differences and the anticipated timing of observed changes in outcomes.
While the analysis of DSRIP performance metrics (see Section 3.3) uses administrative data
prepared by NYS DOH for the purposes of the DSRIP program, the implementation and process
study triangulates information from four data sources: PPS key informant interviews, regional
partner focus groups, a statewide partner survey, and a patient survey. These capture the
experiences of diverse DSRIP stakeholders. The Independent Evaluator collected the first three
data sources, while the fourth was collected by the NYS DOH and made available to the
Independent Evaluator.
Exhibit 3.2 summarizes the key data sources, and Exhibit 3.3 describes the areas of inquiry
covered by each. The subsequent sections describe each in detail.
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Exhibit 3.2. Overview of data sources used to study the implementation and process
PPS Key Informant Interviews
Topic
Addressed
Method
Data
collection
periods

PPS organizational development
(cycle 1), project implementation
(cycle 2), and perceived
performance (cycles 1 and 2)
Semi-structured telephone
interviews
DY3: 07/2017-08/2017
DY4: 06/2018-08/2018

Regional PPS Partners Focus
Statewide Partner Survey
Groups

Patient Survey (Clinician & Group
CAHPS Survey version 3.0)

PPS perceptions of the DSRIP Functioning of individual
program
projects

Patient experiences with health care
providers and services

In-person facilitated focus
groups

Web-based survey

Mail and phone surveys

DY3: 11/2017
DY4: 08/2018

DY3: 09/2017-11/2017
DY4: 09/2018-10/2018

DY1: 09/2015-10/2015
DY2: 09/2016-11/2016
DY3: 09/2017-12/2017

Partners engaged in PPS
projects

Medicaid members ages 18-64 who
were attributed to a PPS and had at
least one visit with a primary care
provider in the PPS network

DY3: 897 (RR: 32.1%)
DY4: 1,071 (RR: 49.3%)

DY1: 10,884 (RR: 30.8%)
DY2: 7,915 (RR: 28.1%).
DY3: 10,238 (RR: 29.8%)

Statewide

Statewide

DY3: PPS administrators who were
most knowledgeable about DSRIP
start-up, implementation, and
Target
ongoing operations
Partners engaged in PPS
population DY4: PPS administrators and staff projects
directly responsible for launching
DSRIP projects and overseeing
project implementation
DY3: 25 PPS, with 1 to 10
informants per PPS
DY3: 33
Sample size
DY4: Total 25 PPS, with 2 to 18
DY4: 58
informants per PPS
DY3: Adirondack and Capital
Geographic
District regions
Statewide
scope
DY4: New York City and Long
Island regions

Abbreviations: Demonstration Year (DY), Measurement Year (MY), Response Rate (RR).
Notes: This table aligns with the tables on pages 12-14 of the CMS-approved Independent Evaluation plan. The patient survey comprises the Clinician & Group
Consumer Assessment of Healthcare Providers and Systems Survey (version 3.0) (CG-CAHPS). The Independent Evaluator analyzed CG-CAHPS data made
available by NYS DOH. The CG-CAHPS survey data is collected based on DSRIP MY, but is reported to PPS based on DY. To maintain consistency across
Implementation and Process data sources CG-CAHPS survey results are reported by DY.
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Exhibit 3.3. Areas of inquiry covered by each data source in the implementation and process
study

Topics Covered
Program planning, operations, and
effectiveness
Program outcomes and challenges
Plans for program sustainability
Effectiveness of governance structure
and provider linkages
Facilitators and barriers to PPS
achieving progress on P4R/P4P
metrics
Contractual and financial
arrangements
Challenges in the delivery of patient
care
Effect of other ongoing health care
initiatives on DSRIP implementation
and operation
Progress and perceived effectiveness
of projects focused on system
transformation
Progress and perceived effectiveness
of projects focused on behavioral
health
Progress and perceived effectiveness
of projects focused on clinical
improvement and population health
Patient satisfaction and experience

PPS Key
Informant
Interviews

Regional
Partner
Focus
Groups

Statewide
Partner
Survey

X

X

X

X
X

X

X
X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

X

Patient
Survey

X

X

To be
Determined
in DY5

X
X

X

X

X

Abbreviations: Pay for Performance (P4P), Pay for Reporting (P4R), Demonstration Year 5 (DY5)
Notes: The data sources and the topics in this table align with pages 12-13 of the CMS-approved Independent
Evaluation plan.

3.2.2. Data Collection and Analysis for Key Informant Interviews
3.2.2.1. Sampling and Recruitment
There were two cycles of key informant interviews with PPS administrators and staff. Purposive
sampling was used in the first cycle to identify executive leadership at each of the 25 PPS who
were knowledgeable about DSRIP program start-up, implementation, administration
components, and challenges, and in the second cycle to identify administrators and staff who
were directly responsible for launching DSRIP projects and overseeing project
implementation.56 Unlike random sampling which is commonly used for population surveys,
purposive sampling deliberately selects participants who have particular characteristics or
represent diverse viewpoints in order to explore a phenomenon in detail and capture a range of
perspectives.57,58,59 Consequently, the findings are a description of the implementation process,
projects, successes, and challenges; and should not be interpreted as representative beliefs.
During the first research cycle, the Independent Evaluator identified administrators at each of
the 25 PPS who were most knowledgeable about the DSRIP program’s start-up,
implementation, ongoing processes, administrative components, and challenges in the first two
DY. If a single person did not possess the necessary knowledge and background in each of these
areas, additional people were included in the interview. Generally, the sample included one or
more of the following individuals within each PPS:
•
•
•
•
•

Chief Executive Officer,
Chief Operating Officer, or the individual currently responsible for all operations,
Someone with authority who was involved in PPS start-up,
Fiscal officer or individual involved in financial transactions, and
Other individuals identified by either the NYS DOH or the PPS who were vital to the
ongoing operations of the PPS.

During the second cycle, the Independent Evaluator recruited individuals who were directly
responsible for launching DSRIP projects and overseeing project implementation. These were
typically project managers during the implementation phase. By DY4, most PPS had
restructured, and many project managers were phased out. Consequently, the key informants
for the second cycle had a variety of job titles.
To recruit study participants, the Public Consulting Group (PCG) DSRIP Account Support Team
(AST) provided a contact at each PPS who would assist in identifying key informants. Telephone
56

For the final report, a third cycle will interview leadership again.

57 Bryman, A. (2012). Social Research Methods (4th ed.). Oxford, UK: Oxford

University Press.
Creswell, J.W. (2013). Qualitative inquiry and research design: Choosing among five approaches (3rd ed.).
Thousand Oaks, CA: Sage Publications, Inc.
59
Patton, M.Q. (2002). Qualitative research and evaluation methods (3rd ed). Thousand Oaks, CA: Sage
Publications, Inc.
58
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calls were scheduled directly by the researchers with these contacts to explain this component
of the independent evaluation and request the e-mail addresses of these staff. These contacts
also assisted in scheduling the interviews.
All 25 PPS participated in the key informant interviews in each cycle. In the first cycle, there
were between one to 10 key informants within in each PPS and between two to 18 key
informants in the second cycle. In the first cycle an additional interview was conducted with an
exiting leader at one PPS who was deemed to have pivotal information about the formation
and development of the PPS. With a couple of exceptions, the key informants in the two cycles
were different people.

3.2.2.2. Data Collection Procedures
Semi-structured interview guides (see Appendix 4) were developed for each key informant
interview cycle. The interview guides for both cycles contained questions about the following
topics: (1) early operations, (2) challenges and successes, and (3) perceived outcomes and
recommendations. The interview guide for cycle 1 also contained questions about initial
formation of the PPS and administrative issues and structural configurations. Each question
included a series of prompts to generate more specific examples or experiences. The interview
guide was designed to align with the scope of the DSRIP program evaluation research question
(RQ-A; see Section 3.1) and received input and final approval from NYS DOH.
Prior to each interview, the interview guide was tailored to each key informant’s individual role
and PPS. For example, some PPS had legacy staff who were with the project since initial
formation and other PPS experienced full turnover. As such, questions were developed to be
flexible within the knowledge scope of interview participants. Prior to each interview, the
interviewers prepared by reviewing relevant publicly available documents such as PPS
Quarterly Reports and the Mid-Point Assessment Reports to understand the context of each
PPS. For the second research cycle, the key informants received a pre-interview survey. These
brief surveys collected information about each participant’s role in project implementation to
help prepare evaluation staff for the interview.
Interviews were conducted via telephone, with at least two interviewers participating in each
interview to improve reliability. Interviews were recorded and subsequently transcribed by one
of the researchers. The interviewers supplemented the audio files with hand-written notes.
Interviews lasted on average one hour.

3.2.2.3. Data Analysis
Familiarization with the data, including the transcripts and the interview guide, yielded a list of
important topics that arose from the data. These topics were sorted into a hierarchy of themes
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and subthemes, creating an initial thematic framework.60 This process generated nine major
themes that were relevant to both research cycles: formation, challenges, successes,
committees, data, technical assistance, value based payment, health care, and governance.
Transcripts were indexed to themes and sub-themes to identify initial commonalities, repeating
themes, and items not discussed by all PPS.
Analytic matrices were developed for each theme, and organized in spreadsheets.61 Each
theme’s matrix comprised a case identification column (indicating the PPS’s name) as well as
columns for each subtheme. Data were extracted from interview transcripts and entered into
their respective subtheme columns as data summaries and/or direct quotes. After all
transcripts were indexed and data extracts were inputted into the matrices, the researchers
read through each case, pulling detected elements within each subtheme’s response, and
entered them into a separate column. Detected elements identified the range of perceptions,
experiences, and behaviors that were collected and the aspects that differentiated them.
Multiple researchers were engaged in all aspects of the analysis to discuss findings iteratively
and improve inter-rater reliability.

3.2.3. Data Collection and Analysis for Regional Partner Focus Groups
3.2.3.1. Sampling and Recruitment
A series of regional focus groups with project-associated partners was conducted to elicit
information about how the DSRIP program and its system transformation outcomes have
affected various partners. In contrast to one-on-one interviews, the inter-participant
interaction within focus groups allows for a wider range of responses, as respondents
collectively discuss topics and react to others’ comments. These guided discussions can activate
forgotten details of participants’ experiences and release inhibitions.
Focus groups function best when groups are somewhat homogenous, which fosters greater
cooperation, greater willingness to communicate, and less conflict among group members.62
Thus, the initial plan to host one focus group per PPS was replaced with a hybrid geographic
and provider-category based plan. Nine PPS regional service areas were defined based on the
integration of New York’s Economic Development map with service areas provided by PPS.

60 Spencer, L., Ritchie J., O’Connor W., Morrell, G., & Ormston, R. (2003). Analysis in practice. In Ritchie, J., Lewis, J.,

McNaughton Nicholls, C., & Ormston, R. (Eds.), Qualitative research practice: A guide for social science students
and researchers (pp. 295-345). Thousand Oaks, CA: Sage Publications, Inc.
61
Miles, M.B., Huberman, A.M., & Saldana, J. (2013). Qualitative data analysis: A methods sourcebook (3rd ed.).
Thousand Oaks, CA: Sage Publications, Inc.
62 Stewart, D.W., & Shamdasani, P.N. (2015). Focus Groups: Theory and Practice (3rd ed.). Thousand Oaks, CA:
Sage Publications, Inc.
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In the first and second cycles of data collection, PPS from the following regions were recruited
to participate in the focus groups: Capital District, Adirondack regions, New York City, and Long
Island. In the first cycle, 33 individuals representing five PPS participated; and in the second
cycle, 58 individuals representing 15 PPS participated. The third data collection cycle will
include other regions, and eventually each region across New York State will be represented in
the final evaluation report.
Within each region, there were separate focus groups for categories of partners.63 These
categories were developed based on the types of project partnerships, the categories of
partners derived from the Medicaid Analytics Performance Portal (MAPP) network tool, and
stakeholder commonalities. The four categories are:
•
•
•
•

Group 1: Primary care physicians, clinic managers, health home organizations, and
specialists
Group 2: Mental health and substance use professionals
Group 3: Hospitals, nursing home, hospice, and home care professionals
Group 4: Community-based organization professionals

For each focus group, partners were identified based on lists of engaged partners created for
the statewide partner survey (described in detail in section 3.2.4). Focus group invitations were
sent electronically to engaged providers identified in each focus group-region. The invitation
emails contained a link to an online sign-up form that allowed participants to select a preferred
focus group date and location from a list of available slots within their provider type.

3.2.3.2. Data Collection Procedures
Four customized focus guides were developed by the IE team and reviewed and approved by
NYS DOH, one for each provider group (see Appendix 5). The focus group guides were designed
to align with the scope of the DSRIP program evaluation research question, with prompts to
generate more specific examples or experiences for some questions. Specifically, the focus
group guides contained questions about the following topics:
•
•
•
•

Engagement with DSRIP program activities and projects
Reflections on what worked well and less well
Value based payment
Recommended changes

63 Because the Adirondack region focus groups were conducted in a less populated area, they drew fewer

participants and were separated into two focus groups. The first focus group included participants from Group 1
(primary care physicians, clinic managers, health home organizations, and specialists) and Group 3 (hospitals,
nursing homes, hospice, and home care professionals). The second focus group included participants from Group 2
(mental health and substance use professionals). Community-based organizations from Adirondack Health
Institute were present at the focus group held in the Capital District region.
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Focus groups were conducted in-person, with two qualitative researchers participating in each
focus group. A trained facilitator conducted each focus group to ensure consistency, while a
separate note taker recorded details and impressions. With permission of the participants,
focus groups were audio-recorded using digital voice recorders. A meal was provided for each
focus group as an incentive, and to convey appreciation for the participants’ time. Each focus
group lasted approximately 1.5 hours.

3.2.3.3. Data Analysis
All focus groups recordings were transcribed, coded, and analyzed for patterns and themes
using the same process for the key informant interviews (see Section 3.2.2.3). The primary
themes were: successes, challenges, infrastructure, partnerships, value based payment, funds
flow, health care, and sustainability.

3.2.4. Data Collection and Analysis for Statewide Partner Survey
3.2.4.1. Sampling, Recruitment, and Data Collection Procedures
Annual electronic partner surveys collected information about perceptions of the DSRIP
program and the function of individual projects. The key informant interviews and focus groups
had flexible interview guides designed to allow participants to elaborate on topics for a deeper
understanding, and used purposive sampling. In contrast, the surveys were designed to collect
information about representative viewpoints through a uniform survey (i.e., all participants
received an identical survey) and invitations for all PPS engaged partners to participate.
To identify respondents in the first survey cycle, the Independent Evaluator built a unique
contact list of partners for each of the 25 PPS by merging the Medicaid Analytics Performance
Portal (MAPP) network tool with the Provider Export/Import Tool (PIT)/ Provider Export/Import
Tool-Revised (PIT-R). The list reflected PPS networks in DY2. Each PPS primary contact was sent
the list of partners generated for their PPS and asked to: (1) identify which partners were
engaged with projects, and (2) provide contact and engagement status information for any
additional partners engaged with projects. Twenty-four of the 25 PPS responded and returned
an updated list of engaged partners. For the remaining PPS, survey invitations were sent to all
partners in the DSRIP DY2 network list.
A similar approach was used to identify respondents in the second survey cycle. A new list of
partners, based on PPS networks in DY3, was obtained from the NYS DOH’s vendor that
manages the Medicaid Data Warehouse. The new lists were compared to the lists used in the
first survey cycle to identify any new providers. Each PPS was asked to review the updated list
that included engaged partners identified the previous year as well as new providers, identify
additional engaged partners that were not yet on the list, and indicate if any partners were no
longer engaged. All 25 PPS responded for research cycle 2 and returned an updated list of
engaged partners.
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A survey invitation was sent to each email address corresponding to an engaged provider, with
a personalized link to the survey in Qualtrics. In total, survey links were sent to 2,794 email
addresses in the first cycle, and 2,171 valid email addresses in the second cycle. Fewer
invitations were sent in the second cycle because PPS were better able to specifically identify
engaged partners and all PPS returned an updated list of engaged partners. As some partners
were part of several PPS, in the first data collection cycle they received multiple requests for
the survey. These multi-PPS partners were asked to respond to one survey only.
Simultaneously, contacts at each PPS were encouraged to alert their provider network to the
survey and encourage completion. This partner survey reminder was shared via PPS
newsletters, Project Advisory Committee meetings and other PPS events. As an incentive to
complete the Independent Evaluation survey, participants in the first cycle were informed that
three respondents would win a $100 Amazon gift card.
Providers could be individual practitioners or organizations. In some cases, only one email
address was available for multiple providers (e.g., a medical practice may have provided one
contact email for multiple staff doctors, or a community-based organization with multiple
involved staff members may have used one business email). Because of this, participants were
allowed to forward the invitation to other members of their organization. As such, there is no
direct correspondence between email address and individual respondents.
For the first cycle, the survey launched in September 2017 on the Qualtrics online survey
platform and closed in November 2017. Potential participants who had not completed the
survey were sent eight reminders over the response period; some PPS also elected to send
reminders of their own. A total of 1,235 completed surveys from unique individuals were
returned. A total of 315 respondents opened the survey but did not answer any questions, and
23 more were determined to be unusable for various reasons (e.g., two participants did not
provide a coherent response in any text box, including their name). These methods resulted in
897 usable responses, for a final response rate of 32.1%. Individual respondents could answer
project evaluation questions for up to three projects, resulting in a total of 1,689 project-based
evaluations.
For the second cycle, the survey launched in September 2018 and closed in October 2018, with
eight reminder emails. A total of 1,071 completed surveys from unique individuals were
returned, for a final response rate of 49.3%. For this cycle, individual respondents could answer
project evaluation questions for all the projects they were actively involved with, rather than
just three projects as in the first cycle. This resulted in a total of 3,621 project-based
evaluations.

3.2.4.2. Survey Design
The partner survey (see Appendix 6) was developed to gather information on progress within
individual projects, barriers and facilitators to project implementation, perceived effectiveness
of the projects, and the DSRIP program overall. The NYS DOH provided feedback on and final
approval for the Independent Evaluator’s designed survey. Most questions were Likert scales,
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with supplemental open-ended questions where participants could elaborate on their
responses.
Survey topics included:
• Service provision and project operations
• Factors that helped or hindered their implementation
• Level of satisfaction with project operations
• Reflections on what worked well and less well
• Overall perception of the DSRIP program
• Overall perception of DSRIP projects
• Preparations for value based payment
Each respondent was allowed to select projects to evaluate individually. Thereafter, they
received a battery of questions corresponding to each project they selected. This yielded more
project-based responses than number of participants.
Most survey items were kept consistent across cycles to allow for interpretation of changes
over time. Some questions were modified in the second cycle, based on feedback from the first
cycle and emerging topics. Changes included adjusted time frames, dropping questions about
early implementation, and adding items about the specific resources needed to transition to
value based payment (see Appendix 6).

3.2.4.3. Data Analysis
Survey responses were first de-duplicated. In each cycle, about 100 respondents opened the
survey multiple times. In the case of multiple responses from one person (same name and
organization provided), the more complete response was kept (e.g., if a participant opened the
survey but did not complete anything past entering his or her name, and then reopened the
survey later and completed it, the second entry was used), but if they completed similar
amounts each time, the first response was kept. If a participant in the first cycle had multiple
survey entries and responded about different projects in each, the first three evaluations were
kept. For example, if a participant responded about two DSRIP program projects in one survey
entry, then retook the survey and answered regarding another different project, the responses
from the second survey were added to those of the first, and the second survey record was
deleted.
Response data quality was then examined by PPS and project. In the first cycle, of the 1,753
potentially usable individual project evaluations received, 265 (15.1%) were for a project that
had not been implemented in the selected PPS. For example, across the sample, 70 (4.0%)
responses were received for Project 2.a.ii in PPS that were not implementing 2.a.ii.
When possible, these responses were recoded.
Respondents were first assumed to have selected the correct PPS but the wrong project: if the
organization or PPS was involved in a similar project in the same subdomain or grouping, the
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response was recoded. If the selected PPS was not involved in a similar project but the
participant had also responded about another PPS which was involved in that project, the PPS
name was corrected. Using these procedures, 201 responses were corrected. A total of 64
responses were unable to be recoded and so these were not included in any further analyses,
leaving 1,689 project-based responses, inclusive of all 25 PPS.
The final set of 1,689 project-based evaluations (see Exhibit 3.4) in cycle 1 covered all DSRIP
projects and included all 25 PPS across New York. There was a wide range in the number of
responses a PPS received. On average, PPS received about 68 responses each (standard
deviation of 37). Two PPS (Bronx Health Access and NY Presbyterian) received fewer than 20
evaluations; three PPS (Central NY Care Collaboration, Finger Lakes, and OneCity Health)
received over 120 evaluations. There were no project responses for Projects 3.b.ii, 3.d.i, 3.h.i,
4.c.iii, and 4.c.iv, as they were not implemented by any PPS. A total of 3,621 project-based
evaluations were received in cycle 2; on average PPS received about 145 responses each
(standard deviation of 79) (see Exhibit 3.4). A total of 34 of these responses were for a project
that the selected PPS was not implementing. These responses were recoded as described
above.
Exhibit 3.4. displays the number of responses per PPS, and project responses per PPS for each
survey cycle.
Exhibit 3.4. Number of usable responses received for the statewide partner survey
Cycle 1

PPS
Adirondack Health Institute
Advocate Community Providers/SOMOS
Alliance for Better Health
Better Health for Northeast New York
Bronx Health Access
Bronx Partners for Healthy Communities
Care Compass Network
Central New York Care Collaborative
Community Care of Brooklyn
Community Partners of Western New York
Finger Lakes PPS
Leatherstocking Collaborative Health Partners
Millennium Collaborative Care
Montefiore Hudson Valley Collaborative
Mount Sinai PPS
Nassau Queens PPS

N
Responses
55
40
29
40
14
23
48
77
43
66
65
33
80
45
52
33

N Project
Evaluations
within PPS
105
47
48
63
16
36
87
149
63
92
138
49
113
68
64
43

Cycle 2
N
Responses
63
72
33
41
34
50
83
64
75
109
104
47
107
56
59
40

N Project
Evaluations
within PPS
167
231
88
115
57
143
188
241
155
260
314
89
248
188
104
72
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Cycle 1

PPS
New York-Presbyterian PPS
New York-Presbyterian Queens PPS
North Country Initiative
NYU Langone Brooklyn
OneCity Health
Refuah Community Health Collaborative
Staten Island PPS
Suffolk Care Collaborative
WMCHealth
Total Number of Unique Usable Responses and
Project Evaluations

Cycle 2

N
Responses
10
23
35
24
101
17
38
49
45

N Project
Evaluations
within PPS
14
36
78
32
135
22
61
70
60

897

1,689

37
29
46
36
128
23
41
32
63

N Project
Evaluations
within PPS
49
54
179
57
238
39
111
66
168

1,071

3,621

N
Responses

Abbreviations: Number (N)
Notes: The totals at the bottom of columns 1 and 3 are the total number of unique usable responses in each
research cycle and not the sum of these columns. Individual respondents could respond about multiple PPS if they
were engaged with more than one PPS. In research cycle 1 respondents could answer project evaluation questions
for up to three projects; in research cycle 2 respondents could answer project evaluation questions for all projects
with which they were actively involved. The number of responses for each PPS in columns 1 and 3 are the number
of responses relevant to that PPS.

Survey responses were summarized descriptively as means and the percentage of respondents
selecting each item in the five-point scales. The “do not know” responses were not combined
with the neutral response (e.g., “did not improve or worsen”) because conceptually, they are
distinct.
Responses were not compared across PPS due to two important considerations. First, the PPS
have variable response rates. If there were systematic reasons why some PPS had higher
percentages of participants overall and by partner type (e.g., different levels of engagement
with the Independent Evaluation team’s initial outreach to refine the participant lists,
additional inducements to participate or higher motivation to participate), nonresponse bias
and non-representativeness of partners who completed surveys, reminders sent by PPS to
partners, might affect results. Given the nature of the sampling design, it is infeasible to
quantify the nonresponse bias in a manner that could be adjusted for in a comparative analysis.
Second, there were instances of only one or several project-specific responses for a specific PPS
which results in insufficient statistical power to compare project differences across PPS.

3.2.5. Data Collection and Analysis for Patient Survey
3.2.5.1. Sampling, Recruitment, and Data Collection Procedures
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The Clinician & Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS)
(version 3.0) survey was used to assess patient perspectives among the Medicaid population in
New York. The CG-CAHPS survey is conducted annually for each of the 25 PPS through a CAHPS
certified vendor (i.e., DataStat). The vendor generates a random sample from the eligible
Medicaid members for each PPS in August, then deploys the survey between September and
December, and provides results in the spring of the following year. The results are provided to
the PPS with PPS specific reports. Some CG-CAHPS items are also used in calculating DSRIP
performance metrics, as described in Section 3.3.
The surveys were administered to a sample of Medicaid members, aged 18 to 64, who were
attributed to a PPS and had at least one visit with a primary care provider from January to June
prior to the survey administration. Each year’s survey targeted 1,500 adults from each of the 25
PPS. Surveys were sent to 37,500 members with a combined mail and phone methodology
(three mailings, with a phone call follow-up to non-responders). Some intended survey
respondents were deemed ineligible for participation and were excluded from the total sample
population size when determining the response rate. Intended participants were considered
ineligible if they were deceased, had a language barrier that prevented them from completing
the survey, were mentally or physically unable to complete the survey, or responded that they
did not receive care from the provider indicated in the first survey question in the last six
months.
The CG-CAHPS data presented in this report were collected by DSRIP Measurement Year. The
MY1 survey was conducted between September 14, 2015 and December 7, 2015. A total of
10,884 usable responses were received out of a total of 35,356 eligible participants, resulting in
a response rate of 30.8%. The MY2 survey was conducted between September 16, 2016 and
November 30, 2016. A total of 7,915 usable responses were received, resulting in a response
rate of 28.1%. The MY3 survey was conducted between September 18, 2017 and December 3,
2017. A total of 10,238 usable responses were received, resulting in a response rate of 29.8%.
While the CG-CAHPS data were collected by DSRIP Measurement Year, they were reported to
PPS by Demonstration Year. To maintain consistency across the reporting of results for each of
the implementation and process data sources, the CG-CAHPS survey results for the
implementation and process component of the evaluation were reported by Demonstration
Year.
An additional CG-CAHPS survey is administered directly by each PPS for the uninsured if the PPS
participates in Project 2.d.i.64 Results from these surveys were not analyzed for the Interim
Evaluation, but may be analyzed for the final report and will, therefore, be described briefly.
The PPS participating in Project 2.d.i. conduct the survey of the uninsured annually following
guidelines developed by the NYS DOH in alignment with standards created by the Agency for
Healthcare Research and Quality, and must submit a minimum of 30 completed surveys in

64

Project 2.d.i., also known as the “11th project”, is implementation of patient activation activities to engage,
education, and integrate the uninsured, low, and non-utilizing Medicaid populations into community-based care.
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order to qualify for the achievement values based on this measure.65 The eligible survey
population includes self-identified and provider-identified uninsured adults 18 years or older
who have at least one primary or preventive care visit within the PPS during the measurement
period. Performance reports are based on four composite measures (access to care; provider
communication; helpful, courteous, and respectful office staff; and patient’s rating of provider),
comprised of 10 individual survey items. Surveys are considered complete if respondents
answered affirmatively to the question asking about receipt of care from the indicated provider
in the last six months and responses are recorded for at least one of the ten questions that
comprise the four required composite measures.

3.2.5.2. Survey Design
The survey included the CG-CAHPS (version 3.0) core survey, a nationally vetted tool to assess
the performance of clinicians and medical groups. Items addressed several domains of patient
experiences, such as receipt of timely care, communication with doctors, and overall
satisfaction with their provider. In addition, the survey included 18 supplemental questions of
interest to NYS DOH concerning health literacy, health promotion, and care coordination.

3.2.5.3. Data Analysis
The CG-CAHPS data for the Medicaid population were made available to the Independent
Evaluator in aggregate form, with results reported by PPS. For example, responses to the CGCAHPS survey question “How often did this provider explain things in a way that was easy to
understand?” were provided to the Independent Evaluator as the percentage of survey
participants selecting a response of “usually” or “always”. To control for inter-PPS differences in
member populations, the CG-CAHPS vendor’s aggregate results were case-mix adjusted for age,
health status, and education.
For the Interim Report, data from the first three measurement years were summarized focusing
on the composite scores for the following variables:
•
•
•
•

Getting timely appointments, care, and information
How well providers communicate with patients
Care coordination
Helpful, courteous, and respectful office staff

In addition, the following variables were reported:
•
•

65

Proportion rating providers as “8 or higher” on a 0-10 scale
Patients’ ongoing relationships with their providers (having a usual source of care, and
seeing the same provider for at least one year)

New York State Department of Health (n.d.) CG-CAHPS for the Uninsured Guidelines.
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Statistical tests of significance for comparisons between groups were not conducted because
individual-level data were not available for analysis. Following consultation with the CG-CAHPS
vendor and the NYS DOH Office of Quality and Patient Safety, data were not trended across
years because of potential changes in the population case mix which cannot be adjusted for in
statistical analysis.

3.3. Study Design for Evaluation of DSRIP Program Measures
3.3.1. Framework for the Time Series and Comparative Analysis of
Administrative Data
For the interim report, CMS RQ1 through RQ6 (relabeled in the interim report as RQ-B through
RQ-G) were assessed using administrative data developed by NYS DOH for the purposes of the
DSRIP program, covering the measurement period June 2014 through June 2017. These data
contained information about PPS member attribution, provider networks, project selection,
service area, and the performance measures used for PPS valuation and DSRIP payments in
Demonstration Year 3. The performance measures comprised both monthly and annual data
elements, depending on the underlying source (see Section 3.3.2).
Descriptive analyses examined trends for performance measures statewide and by PPS. For the
monthly measures, interrupted time series regressions examined changes in post-DSRIP
initiation trends statewide, compared to the baseline pre-DSRIP initiation trend. These
regressions tested the hypotheses regarding whether performance measures increased or
decreased after the DSRIP program’s implementation, compared to expected trends in the
absence of DSRIP. Each PPS is inherently different, due to variation in their provider network
characteristics, member attribution size, lead entity type, patient mix, findings from their
community needs assessments that influenced project selection, and other factors. The PPSlevel comparative regression framework examined how PPS characteristics are associated with
changes in performance overall, and whether PPS with different characteristics had divergent
post-DSRIP changes.66
Analyzing performance differences pre- and post-DSRIP initiation required selecting a specific
month for the change point to denote the two periods.67 As shown in Exhibit 3.5, New York’s
DSRIP program followed two timelines relevant for the evaluation: demonstration years (DY)
66

The Interim Report focused on four PPS characteristics that were identified as potentially important to
performance. The final summative report will examine additional PPS characteristics and differences across PPS
that selected different projects.
67
The “pre/post” terminology is standard language for an interrupted time series research design, where the
statistical analysis determines how an outcome changes after a major event (here, the implementation of the
DSRIP program). At the time of this report, the DSRIP program is currently underway and almost all observations
are during the period when the DSRIP program is operational. The “pre” period refers to the first year with early
activities from the PPS to become operational. The “post” period refers to the time period when the PPS have
matured and are actively implementing their projects. The final summative report will examine alternative
specifications for the time trend, such as potentially identifying different phases of implementation.
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and measurement years (MY). (see the New York DSRIP Terminology Guide at the front of the
report for a detailed listing of DY and MY.) The six DY (DY0 through DY5) cover the period from
April 2014 to March 2020, with DY0 considered an early development and planning year for the
PPS. There are five MY (MY1 through MY5), starting July 2014 and ending June 2019. Although
the DSRIP program started in April 2014 (DY0), the program’s initial phase encompassed PPS
formulation and infrastructure development (Domain 1). The first payments tied to Domain 2
activities (system transformation) used MY1 information, spanning July 2014 through June
2015. It is common in time series analysis to include a lag time for the “post” period to reflect
the time to implement a program.68 The power of the interrupted time series regression
increases when there are a similar number of time points before and after the intervention.69
Following standard practice, this analysis considered the start of MY2 (July 2015) to be the first
month of the post-DSRIP initiation period, with all prior months assigned to the pre-DSRIP
initiation period. This provided 13 months of pre-DSRIP initiation measurement time and 24
months of post-DSRIP initiation measurement time.70 Using the start of MY2 as the post-DSRIP
initiation period, rather than selecting a month in the middle of a MY, also allowed for
consistent time periods when evaluating monthly and annual measures. This decision was
vetted with NYS DOH and is also consistent with findings from the implementation and process
study, which identified delays in implementation times.
Exhibit 3.5. Timeline of DSRIP demonstration and measurement years

2014

Pre-DSRIP Initiation

2015

2016

2017

2018

2019

2020

Post-DSRIP Initiation

Source: Adapted from the New York State Department of Health DSRIP Timeline Poster.71
Abbreviations: Demonstration Year (DY), Measurement Year (MY)

68

Bernal, J.L., Cummins, S., & Gasparrini, A. (2017). Interrupted time series regression for the evaluation of public
health interventions: a tutorial. International Journal of Epidemiology, 46 (1) 348–355.
69
Zhang, F., Wagner, A.K., & Ross-Degnan, D. (2011). Simulation-based power calculation for designing interrupted
time series analyses of health policy intervention. Journal of Clinical Epidemiology, 64 (11): 1252-1261.
70
There are 13 pre-DSRIP months because the DSRIP Dataset contains one month of data from June 2014, prior to
the MY1 start date of July 2014.
71
New York State Department of Health (2016, January). Retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/2016/docs/2016-0129_dsrip_timeline_poster.pdf
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Notes: Nearly all time point observations in the study are during the period when the DSRIP program is underway.
The “pre/post” language is standard for time series analysis. The “pre” period refers to the early stages when the
PPS are forming, and the “post” initiation period refers to the middle stages of the DSRIP program when the PPS
are implementing their projects.

3.3.2. Data Sources
The Interim Report used selected performance measures from the DSRIP Dataset, which at the
time of analysis contained performance data for 140 measures from Domains 2, 3, and 4.
Domain 1 measures were project process milestones and not included in the DSRIP Dataset.
The Domains 2 and 3 data elements came from multiple sources:
•

•
•
•
•
•
•
•

•
•
•

Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey,
documenting health care consumers’ experiences with their services with “clinicians and
groups” (GG-CAHPS) and hospital inpatient care (HCAHPS)
Integrated palliative care outcome scale (IPOS) survey of the palliative care needs of
patients and their families
Medicaid Data Warehouse (MDW), with claims records for Medicaid members
Medical record reviews
Minimum Data Set (MDS), documenting comprehensive assessments of functional
capabilities of residents in Medicare- or Medicaid-certified nursing homes
New York State Perinatal Quality Collaborative Scheduled Delivery Form System
(NYSPQC SDFS)
New York State Provider Network Data System (PNDS)
National Committee for Quality Assurance Recognition program organization-level
measures of patient-centered medical home (PCMH) and Advanced Primary Care
standards
Patient Activation Measure® (PAM) patient survey of their underlying knowledge, skills,
and confidence related to their personal health management
Statewide Planning and Research Cooperative System (SPARCS), with patient-level
information on hospital inpatient and outpatient discharges across all payers
Survey of Qualified Entities

The Domain 4 performance measures were from New York’s 2013-2018 Prevention Agenda,
which reports county- and state-level measures on a public dashboard.72 Its measures were
available on an annual basis with data from the following sources. (Not all measures are
relevant to New York’s DSRIP program, as Domain 4 projects do not cover the “promote a
healthy and safe environment” Prevention Agenda focus area.)
•
•

National Survey on Drug Use and Health
New York City Fitnessgram data

72

New York State Department of Health. (n.d.). Prevention Agenda 2013-2018: New York State’s health
improvement plan. Retrieved from https://www.health.ny.gov/prevention/prevention_agenda/2013-2017/
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•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

NYS Behavioral Risk Factor Surveillance System and Expanded Behavioral Risk Factor
Surveillance System
NYS Department of Environmental Conservation
NYS DOH Bureau of Dental Health
NYS DOH Healthy Neighborhoods program tracking
NYS DOH HIV Surveillance System
NYS DOH Office of Quality and Patient Safety
NYS DOH STD Surveillance System
NYS DOH Student Weight Status Category Reporting System
NYS DOH Youth Tobacco Survey
NYS Hospital-Acquired Infection Program
NYS Immunization Information System
NYS Safe Drinking Water Information System
NYS Vital Records
SPARCS
U.S. Census Bureau (Small Area Insurance Estimates and American Community Survey)
U.S. Department of Agriculture Food Environment Atlas
U.S. Environmental Protection Agency Air Quality System Data Mart
Youth Risk Behavior Survey

The performance measures for Domains 2, 3 and 4 were reported either monthly or annually,
depending on the source. The monthly measures were predominately claims-based data from
MDW, or else from medical records review. The annual measures comprised non-claims
measures from Domains 2 or 3 (e.g., from CAHPS patient surveys) or else Domain 4 measures
that were reported on the Prevention Agenda dashboard on an annual basis.
The monthly performance measures reported in the DSRIP Dataset were calculating for rolling
12-month periods; i.e., the October 2015 observation reflects average values from November
2014 through October 2015. Although this smoothed month-to-month variation in
performance measures, it may have also generated lags in observed changes.
Following consultation with NYS DOH, a limited list of 27 measures were identified for detailed
analysis in the Interim Report. The following considerations guided the selection of these
measures:
•
•
•
•

•

Clear connection to the six quantitative research questions and associated hypotheses
Related to projects that were selected by multiple PPS
Available for all PPS involved in the projects
Ability to be trended over multiple years (for example, some measures were only
available starting in MY3, and others had changes to their operational definitions
midway through the study period)
Data updates were not planned for the immediate future, ensuring consistency in the
measures between the Interim Report and final summative report
64

Appendix 7 contains details on the 27 measures, including the measure steward and
specification, associated projects, description of the numerator and denominator, data source,
and years available for trending.
A smaller subset of measures relevant to the most common clinical focus areas of the projects were
used to make the effort more focused, to ensure that the findings are clear and easy to understand, and
to design an analysis that was feasible given the type of data, time, and resources available. Additional
measures will be added to the summative evaluation.

In addition to the performance measures, the DSRIP Dataset contained information on the
following PPS characteristics:
•
•
•
•
•
•

Annual achievement targets for each PPS
Demographics of attributed members (age, gender, race/ethnicity, county of residence,
and years eligible in Medicaid)
Listing of providers in each PPS and their categorization of service type
Number of attributed members per month
Patient mix (the percent of members in each swim lane, following the attribution logic
described in Appendix 2)
Project selection (specific projects selected and total number of projects selected)

3.3.3. Data Analysis
3.3.3.1. Analyses for Monthly Performance Measures
The analysis of the monthly measures comprised:
• Descriptive analyses to illustrate statewide trends
• Interrupted time series regressions to quantify changes in statewide performance in the
two MY following DSRIP implementation
• Comparative regressions to examine: (1) how PPS-level characteristics were associated
with inter-PPS differences in performance throughout the study period, and (2) how
PPS-level characteristics were associated with changes in performance after DSRIP
initiation
3.3.3.1.1. Descriptive Analyses of Monthly Performance Measures
For the monthly measures, the descriptive analyses encompassed visual presentations of
statewide trends. Fitted lines illustrate the overall statewide trends across the pre- and postDSRIP initiation period.73 Additional clustered bar charts displayed PPS-level values for each

73

Note: Nearly all time point observations in the study are during the period when the DSRIP program is
underway. The “pre/post” language is standard for time series analysis. The “pre” period refers to the early stages
when the PPS are forming, and the “post” implementation period refers to the middle stages of the DSRIP program
when the PPS are implementing their projects.
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outcome in the last month of MY0, MY1, MY2, and MY3. Those visualizations allow for a more
detailed understanding of how the values of each outcome differed across PPS, and variation in
trends over time within PPS. As each monthly observation is a rolling average from the past 12
months, the monthly value from the last month of a MY represents the average performance
from the entire MY.
Statewide trends for the monthly measures used to assess utilization of behavioral health
services (RQ-D) and avoidable hospital utilization (RQ-E) included data from all PPS because all
PPS had to select a behavioral health project and avoidable hospital utilization is an overall
DSRIP program goal. During project selection, PPS that were already performing well on
measures relevant to a given Domain 3 (clinical improvement) project were not allowed to
select that project. For example, PPS doing well pre-DSRIP on the asthma measures used to
assess the Domain 3 asthma projects would not be approved for selections of those asthma
projects. Therefore, statewide trends of the two monthly asthma measures used to assess
health care quality (RQ-B), were limited to PPS that selected the associated asthma clinical
improvement projects (13 of 25 PPS).74
3.3.3.1.2. Interrupted Time Series Regression Framework for Statewide Trends
For the monthly performance measures, an interrupted time series regression framework
quantified changes in the statewide trends before and after the DSRIP program’s initiation.
Following the schematic of the distinct pre- and post-DSRIP initiation periods (Exhibit 3.5),
changes following the DSRIP program’s initiation were assessed using a segmented regression
whereby there is a linear trend for the pre-DSRIP initiation period, a dummy variable to capture
a level change after implementation, and a time interaction term to capture a slope change
after implementation. These “impact models” are a common framework to evaluate public
health interventions, particularly when there is no clear control group.75 For the statewide
interrupted time series, the level of analysis was at the state-level using the total attributed
Medicaid population.
The statewide interrupted time series regression framework follows:
yt = α + β1Montht + β2DSRIPt + β3(Montht ∗ DSRIPt) + εt
In the equation, yt is the value of a performance measure such as Potentially Preventable
Readmissions, where t subscripts the month. The DSRIPt variable is an indicator that is equal to
1 in MY2 and MY3, and equal to 0 otherwise; that captures whether a given monthly
observation is in the pre- or post-DSRIP initiation period. The coefficient β1 measures the linear
74

The Domain 3 asthma clinical improvement projects are: 3.d.i, development of evidence-based medication
adherence programs (MAP) in community settings – asthma medication; 3.d.ii, expansion of asthma home-based
self-management program; and 3.d.iii, implementation of evidence-based medicine guidelines for asthma
management.
75
Bernal, J.L., Cummins, S., & Gasparrin, A. (2017). Interrupted time series regression for the evaluation of public
health interventions: a tutorial. International Journal of Epidemiology, 46(1), 348-355.
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trend in the pre-DSRIP initiation period. The coefficient β2 measures whether there is a level
change, or immediate decline in the outcome values, in the post-DSRIP initiation period. The
coefficient β3 evaluates whether there is a change in the slope in the post-DSRIP initiation
period. The constant term, denoted by α, is the initial value of y at the start of the study period
when time t = 1. The random error εt represents the effect of all unobserved factors that could
not be measured, and has expected value zero.
The regression assumed a linear functional form for time. Other functional forms including nonparametric specifications (no functional form assumed) and non-linear specifications (including
logarithmic time transformation, inverse time (i.e., 1/t), and a quadratic time (i.e., t 2)) were also
considered in earlier versions of the model. The linear form was used in the final models
because it was the best fit to model pre- and post-DSRIP initiation statewide performance and
the most simple to present for the interim report. The linear trend may no longer be
appropriate once additional data become available, as the implementation of programs may
yield different changes in the outcome such as slope changes following a longer lag time,
temporary level changes whereby levels of the outcome initially increase and subsequently
revert back to their pre-program values, or temporary slope changes leading to subsequent
level changes.76 Other specifications will be explored in detail for the final summative report as
more years of data become available for analysis and there are additional insights from the
implementation and process study about how the DSRIP program has influenced the activities
of PPS partners during different stages of implementation.
3.3.3.1.3. PPS-level Comparative Regression Framework
For the monthly performance measures to assess behavioral health utilization (RQ-D) and
avoidable hospital utilization (RQ-E), the comparative analysis extended the statewide
interrupted time series to examine how PPS-level characteristics were associated with: (1)
overall differences in performance, and (2) differential post-DSRIP initiation performance
changes. This component of the analyses used multi-level models for nested data structures,
also referred to as mixed effects or random effects models. In the case of the DSRIP program,
observations over time (level 2) are nested within the 25 PPS (level 1). Observations over time
within each PPS share common characteristics, and heterogeneity in observations over time
within a PPS drive the level 2 variations. Failure to account for the commonality of observations
over time within PPS would lead to incorrect hypothesis testing.77
Comparative analyses were not performed for the monthly asthma measures used to assess
health care quality (RQ-B). The summative evaluation will include a more extensive analysis of
PPS level performance, including comparing performance on specific DSRIP program projects.
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Bernal, J.L., Cummins, S., & Gasparrin, A. (2017). Interrupted time series regression for the evaluation of public
health interventions: a tutorial. International Journal of Epidemiology, 46(1), 348-355.
77
Chatterji, P., Dohyung, K., & Lahiri, K. (2014). Birth weight and academic achievement in childhood. Health
Economics, 23 (9): 1013-1035.
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The PPS-level characteristics evaluated in the interim report, all derived from the DSRIP
Dataset, follow. The CMS final summative report will examine additional PPS characteristics.
•

•

•

•

PPS size—This time-varying characteristic was measured as the number of PPS members
in each month. Larger PPS might have improved outcomes due to greater capacity, or
vice versa a smaller PPS may have improved outcomes due to efficient integration
within a smaller network. For simplicity and ease of interpretation, this was transformed
into a dichotomous indicator variable for large versus small size, based on whether the
PPS size was higher than or equal to the median value across PPS. The median value for
PPS size is time-varying, as the number of members per PPS changes over time. The
dichotomous "large versus small" indicator was determined monthly for each MY and
may vary somewhat across the study period. See Exhibit 4.3 for the total number of
attributed members for each PPS based on the last month of MY3; this rolling year
covers July 2016 to June 2017.
Behavioral health patient mix—This time-varying characteristic was measured as the
percent of PPS members attributed to the behavioral swim lane in each month.
Although there were four swim lanes (developmental disabilities, long-term care,
behavioral health, and “all other”), the regression only included a variable for the
percent in the behavioral health swim lane because this is a large focus of the DSRIP
program. For simplicity and ease of interpretation, this was transformed into a
dichotomous indicator variable for “high BH” versus “low BH,” based on whether the
percentage of members in the behavioral health swim lane was higher than or equal to
the median value across PPS.
Geography—The analysis included a dichotomous indicator for New York City versus
rest of state (ROS), with New York City as the reference group. New York has large
intrastate regional differences, the New York City region has multiple overlapping PPS in
the same area, and NYS DOH analyses commonly distinguish between New York City and
ROS.
Selection of the “eleventh project”—This was a dichotomous indicator for whether the
PPS was eligible for and selected the patient activation project (Project 2.d.i.). The PPS
that selected the eleventh project were inherently different because of the project’s
eligibility requirements (selecting ten other projects, and in regions with multiple PPS
the networks with a safety net hospital as the lead entity had the first right of refusal).
Early implementation and process data identified challenges to implementing this
project.

The main functional form of the model was specified as follows:
Yit = β0i + β1Montht + β2DSRIPt + β3Montht*DSRIPt + β4LargeSizeit + β5LargeBHit +
β6ROSi + β7Eleventhi + εit
The model also includes a random effect error term to account for the clustering of monthly
observations within each PPS. The interpretation of β1, β2, and β3 is identical to their
interpretation in the statewide interrupted time series, measuring the pre-DSRIP initiation
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linear trend, the post-DSRIP initiation level change, and the post-DSRIP initiation slope change,
respectively. LargeSize is a time-varying dichotomous indicator variable, which is equal to 1 for
PPS i whose number of attributed members (size) is greater than or equal to the median value
for all PPS at time t, and equal to 0 for PPS whose size is less than the median value of all PPS’s
membership sizes at time t. LargeBH is a time-varying dichotomous indicator variable for
whether each PPS i has a percentage of members in the behavioral health swim lane that is
greater than or equal to the median value of all PPS’s behavioral swim lane membership at time
t. The ROS variable is a dichotomous indicator variable for whether a PPS i is located in rest of
state (ROS) or NYC, and Eleventh is a dichotomous indicator variable for whether a PPS i was
eligible for and selected the eleventh project compared to those that did not. The ROS and
Eleventh variables are not time-varying because each PPS’s value remains the same throughout
the study period. The coefficient β4 measures the difference in the values of PPS that have large
versus small sizes, after adjusting for pre/post DSRIP initiation and the other PPS characteristics
in the model. The coefficients β5, β6, and β7 have similar interpretations.
Extensions of this model included: three-way interaction terms between each characteristic and
the DSRIP variables and stratified models. For example, an addition of coefficients for
Month*Large Size, DSRIP*Large Size, and Trend*DSRIP*Large Size tests whether large PPS have
different pre-DSRIP initiation linear trends, post-DSRIP initiation level changes, or post-DSRIP
initiation slope changes compared to small PPS. For ease of interpretation, where these twoand three-way triple-interaction terms were significant, additional models stratified the PPS
into two groups (such as large versus small PPS). Separate models for each group allow for a
more intuitive understanding of how the pre- and post-DSRIP initiation performances differ
along these characteristics.
As a specification check, models with a heteroskedasticity- and autocorrelation-consistent
(HAC) estimator yielded similar findings.
3.3.3.1.4. Special Notes on the Potentially Preventable Emergency Room Visit Measures
As described above, the regression analyses based on monthly data have 37 months, yielding
37 observations for the interrupted time series analysis and 925 observations for the
comparative regression analysis (37 months for each of the 25 PPS). Two of the measures made
available to the Independent Evaluator at the time of the analysis, Potentially Preventable
Emergency Room Visits (PPV) and Potentially Preventable Emergency Room Visits among
Behavioral Health Members (PPVBH), only have 31 time points: 1 observation in the last month
of MY0, 12 monthly observations in MY1 and MY2, and 6 observations in MY3.
Therefore, analyses of these two measures, particularly the interrupted time series regression,
may be underpowered. In addition, findings may be biased if the months of with the missing
data have different trends. However, these variables were included as core metrics of the DSRIP
program. Results should therefore be interpreted with caution, and the final summative report
will use the complete set of monthly data.
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3.3.3.2. Analyses for Annual Performance Measures
For the annual measures, a regression analysis was inappropriate due to an insufficient
numbers of data points. They were summarized descriptively as values in each year, changes
over time, and differences across PPS. Analyses of two system transformation measures
(utilization of preventive care and emergency department (ED) services among the uninsured,
non-utilizing, and low-utilizing populations) were limited to PPS that opted to do the 11th
project (2.d.i., implementation of patient activation activities to engage, educate and integrate
the uninsured and low-utilizing and non-utilizing Medicaid populations into community based
care).

3.3.4. Cost Analysis
The last research question examines how the DSRIP program influenced health care costs. A
detailed cost assessment of the demonstration was not possible in time for the Interim Report
and would likely be limited in its findings due to the initial time period where PPS efforts were
focused on start-up activities and initiating implementation. For the Interim Report, the
Independent Evaluator examined where there might be other information regarding Medicaid
costs that would help inform the reader as to the state’s performance on cost trends. The state
reported on the Statewide Accountability Milestones (SWAM) for DY3 in its DSRIP, Year 3
Quarter 4 report to CMS.78 The SWAM measure 3 is the Medicaid spending milestone and New
York reports passing the DY3 milestone measure where costs for inpatient and emergency
room spending were below the target trend rate. DY4 SWAM information has not yet been
completed and made available. The final summative report will contain more detailed analyses
of how costs have shifted over time, and differences across PPS over the entire course of the
demonstration period.

3.4. Study Limitations
There are several limitations to the implementation and process study:
•
•

The implementation process data are subject to the standard interview and focus group
limitations, such as non-response bias and social desirability bias.
Key informant interviews were conducted in a small group via telephone. There is
potential that interviewees moderated their contributions to the discussion based on
the other people present.
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New York State Department of Health, Office of Health Insurance Programs (2018, May). New York DSRIP 115
Quarterly Report. January 1, 2018-March 31, 2018. Year 3, fourth quarter. Retrieved from:
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/quarterly_rpts/year3/q4/2018_janmar_report.htm
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•

•
•
•
•
•
•

While many of the PPS had members of the original team present for the interview,
there were a number of entities where there had been full turnover, and no respondent
was able to accurately provide historical data on start-up related questions.
Engaged partners who were invited to participate in the partner survey and focus
groups were identified by PPS, and a complete list may not have been provided.
Focus groups have not yet been conducted in Central or Western New York.
While qualitative conclusions are supported by stakeholder quotes, there is a possibility
that some experiences in the DSRIP program will not be represented by the findings.
The perspectives of patient care within the DSRIP program design may not yet be fully
informed. The Independent Evaluation team is evaluating the possibility to host future
data collection activities with patients through focus groups.
As data were retrospectively focused on DSRIP DY0 through part of DY4, there is a
possibility that some information was not recalled correctly.
Due to the data collection methodology for the CAHPS survey by the DOH vendor, the
patient surveys cannot be trended over multiple years.

The following limitations apply to the analysis of the DSRIP performance measures:
•

•
•

•

•

•

The analysis only includes data for New York. Although the comparative regression
framework explicitly controls for statewide trends, internal validity would be higher with
an external comparison group. Conceptually, it is difficult to identify an ideal “control”
state as comparison, given large inter-state variations in Medicaid implementation and
ongoing waivers. States that are typically used as comparisons for New York based on
program size or similar region (e.g., California, New Jersey, and Texas) already have
DSRIP waivers.
A small number of pre-DSRIP years limits the assessment of the DSRIP program’s effect
on statewide trends.
The current analysis assumes that pre- and post-DSRIP initiation trends are linear.
Additional specifications will be explored for the final summative report after additional
years of data and information about the implementation and process are available.
Future work might include distinguishing early and late implementation periods.
The monthly DSRIP performance measures are 12-month rolling average values, and
hence the full effect of the DSRIP program will show up on the performance with 12month lag. However, the inclusion of the first MY1 in the definition of pre-DSRIP
initiation period will mitigate this lagged effect to some extent.
The annual performance measures cannot be analyzed in a regression framework due to
an insufficient number of data points for a robust multivariate regression, limiting their
analysis to a more descriptive presentation.
During the study period, the billing codes changed from the International Classification
of Diseases (ICD) version 9, to ICD-10. Following consultation with NYS DOH, measures
affected by this change were not included in the Interim Report although they will be
considered for the final summative report.
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•
•

•

•

•

•

•

Most DSRIP performance measures are process outcomes rather than clinical outcomes,
due to the nature of the underlying data.
Potentially Preventable Readmissions are defined as 30-day readmissions in the total
attributed population, rather than 30-day admissions as a percentage of index
admissions. Changes in this measure could reflect higher or lower index admissions,
irrespective of readmissions.
There was a change in the health plan encounter intake system (EIS) that occurred in
October 2015 (between MY1 and MY2). This change led to differences in how
emergency room encounters were reported and could, in particular, affect assessment
of the level change immediately after DSRIP initiation (between MY1 and MY2) in the
regression analyses.
The monthly measures for Potentially Preventable Emergency Room
Visits and Potentially Preventable Emergency Room Visits among Behavioral Health
Members only have 31 time points due to missing data at the time of analysis.
Consequently, regression results may be underpowered and findings may be biased if
the months with missing data have different trends. Results should be interpreted with
caution, and the final summative report will use a complete set of monthly data.
The measures of initiation of and engagement in drug/alcohol abuse treatment are
defined as a percentage among index cases. The denominator is changing over time as a
result of the opioid crisis, and so no change or a worsening trend in this measure could
reflect increased index cases.
The DSRIP program is implemented concurrently with other important New York
initiatives to achieve the triple-aim, making it difficult to isolate its marginal effect on
system transformation. Due to its large size, it is presumed that much of the observed
difference is due to the DSRIP program although external policies and activities may also
play a role in facilitating changes in performance measures.
One of the DSRIP program’s overall goals is to enable broader system transformation,
beyond Medicaid. Enabling other aspects of the health care system to move towards the
triple-aim is an important outcome but is not fully captured in the performance
measures available in the DSRIP Dataset.

4. Findings and Conclusions
This section provides the findings and conclusions from the seven overarching research
questions. It starts with a general overview of characteristics of the Performing Provider
Systems (PPS) for general context (Section 4.1). Section 4.2 summarizes the main findings from
the analysis of the implementation and process (RQ-A), followed by preliminary findings for the
remaining six quantitative questions (RQ-B through RQ-G, described in sections 4.3 through
4.8).
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4.1. Characteristics of Performing Provider Systems
Summary At-A-Glance
The 25 Performing Provider Systems (PPS) varied substantially with respect to their size,
geographic reach, composition of members, project selection, type of system, and current
progress towards implementation. This is not unexpected, as there are substantial intrastate
differences in local communities’ population characteristics, health care infrastructure,
population health outcomes, and community health care needs. This was reflected in the
attributes of the PPS serving these areas, and the projects they selected based on their
community needs assessments.
These details on the PPS’s characteristics are important for contextualizing the successes and
challenges they have faced in their implementation and process (RQ-A, see Section 4.2) and
variations in their DSRIP performance metrics (RQ-B through RQ-F, see Sections 4.3-4.7). The
final summative evaluation will include a more comprehensive analysis of how these PPS
characteristics are associated with performance.

Exhibits 4.1, 4.2, and 4.3 summarize descriptive characteristics of the 25 PPS.
Regional distribution and PPS size: Ten PPS (40%) were in NYC, with the remaining 15 (60%)
distributed in the rest of state (ROS), comprised of Long Island and upstate. Their catchment
areas varied from 1 to 13 counties (median: 3 counties). They also varied in membership size,
from 31,600 to 637,300 attributed members (median: 144,300).79 Within geographic regions,
there was high variation in size: the smallest and largest PPS (NewYork-Presbyterian Queens
PPS and OneCity Health, respectively) were both located in NYC.
Member characteristics: Statewide across all PPS, 9.2%, 1.2%, and 2.2% of members were in
the behavioral health, developmental disabilities, and long-term care swim lanes, respectively.
The remaining 87.4% of members were assigned to the “all other” swim lane, the group
designated for individuals who were not assigned to the other three swim lanes. (See Section
2.3 for a detailed description of the attribution logic.) The largest differences in patient mix
across PPS were in behavioral health (ranging from 3.1% in NewYork-Presbyterian Queens PPS
to 15.3% in Montefiore Hudson Valley Collaborative) and long-term care (ranging from 0.7% in
SOMOS to 13.5% in NewYork-Presbyterian Queens PPS). The average age of all attributed
members was 31.2 years; among the PPS the average age ranged from 21.1 years (Refuah
Community Health Collaborative) to 38.8 years (Mount Sinai PPS). Overall, 21.4% of members
were black (PPS-level range: 1.7% (Adirondack Health Institute) to 37.1% (OneCity Health)) and
15.0% of members were Hispanic/Latino (PPS-level range: 0.7% (Adirondack Health Institute) to
34.1% (Bronx Health Access)). Most (79.9%) members were in Medicaid managed care plans
79

The number of attributed members changed over time. This count is from the last month of MY3, covering July
2016 through June 2017.
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(PPS-level range: 69.7% (Adirondack Health Institute) to 90.1% (NYU Langone Brooklyn)), 9.9%
were in health homes (PPS-level range: 1.3% (Refuah Community Health Collaborative) to
24.7% (Mount Sinai PPS)), and 12.6% were dually covered by both Medicaid and Medicare (PPSlevel range: 4.1% (Refuah Community Health Collaborative) to 21.1% (NewYork-Presbyterian
Queens)).
Project selection: The number of projects selected by each PPS ranged from 7 to 11. Twentytwo PPS (88%) selected a full menu of 10 projects, of which 14 were eligible for and selected
the optional eleventh patient activation project.
Type of System: Twenty-two (88%) of the lead entities are hospital-sponsored and the remainder

are led by other provider collaboratives. Among the hospital-based lead entities, 9 are
characterized as single hospital-led where the PPS efforts are primarily led by a single hospital
with its network that may include other hospitals; 5 PPS are led by hospital systems where
multiple hospitals are all under the same parent entity and involved in PPS activities; 8 PPS are
led by a collaborative of multiple unaffiliated hospitals. There are 3 PPS who are led by nonhospital provider organizations: community physicians, a health collaborative of multiple
unaffiliated providers, and an FQHC. Of the 25 lead entities, 11 (44%) elected to form separate
legal corporate entities ("Newcos") for the collaboration efforts of the PPS.
Current progress towards implementation: The PPS received a range of recommendations in
their midpoint assessment reports prepared by the Independent Assessor.80 The number of
recommendations related to organizational issues ranged from 0 to 7 (median: 2
recommendations), with 14 receiving a recommendation for partner engagement. Projectrelated recommendations ranged from 0 to 15 (median: 2 recommendations). Four PPS
(Community Care of Brooklyn, Montefiore Hudson Valley Collaborative, New York PresbyterianQueens, and Staten Island PPS) did not receive any recommendations.

80

These midpoint assessments were produced by the Independent Assessor, and available at
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/pps_map/midpoint/final_companion.htm
(accessed October 27, 2018, table "Independent Assessor (IA) Findings and Recommendations Table"). The
midpoint assessment comprises DY0, DY1, and DY2; details on the Independent Assessor’s methodology are in the
midpoint assessment reports. Following consultation with NYS DOH, the Independent Evaluation team focused on
aggregate measures of the number of recommendations related to organizational and partner engagement issues,
and separately the number of project-related recommendations.
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Exhibit 4.1. Summary characteristics of Performing Provider Systems
Preferred name

Projects
selected

Region

Midpoint
recommendations:
organizational and
partner engagement (PE)

Midpoint
recommendations:
project-related

NewCo versus
pre-existing
lead entity

Lead entity type

Counties
served

Adirondack Health
Institute
Alliance for Better
Health
Better Health for
Northeast New
York
Bronx Health
Access
Bronx Partners for
Healthy
Communities
Care Compass
Network
Central New York
Care Collaborative
Community Care of
Brooklyn
Community
Partners of
Western New York
Finger Lakes PPS

11

Rest of state

5

7

Pre-existing

9

11

Rest of state

7 (PE)

8

NewCo

11

Rest of state

4

4

Pre-existing

Multiple Unaffiliated
Providers
Multiple Unaffiliated
Hospitals
Single hospital

10

New York City

1 (PE)

1

NewCo

Single hospital

1

10

New York City

1 (PE)

2

Pre-existing

Single hospital

1

11

Rest of state

7 (PE)

15

NewCo

9

11

Rest of state

6

5

NewCo

10

New York City

0

0

Pre-existing

10

Rest of state

2 (PE)

6

Pre-existing

Multiple Unaffiliated
Hospitals
Multiple Unaffiliated
Hospitals
Multiple Unaffiliated
Hospitals
Single hospital

11

Rest of state

3 (PE)

3

NewCo

13

Leatherstocking
Collaborative
Health Partners
Millennium
Collaborative Care
Montefiore Hudson
Valley Collaborative
Mount Sinai PPS

11

Rest of state

4 (PE)

5

Pre-existing

Multiple Unaffiliated
Hospitals
Single hospital

11

Rest of state

3 (PE)

0

Pre-existing

Single hospital

8

10

Rest of state

0

0

Pre-existing

Hospital system

7

10

New York City

2 (PE)

1

NewCo

Hospital system

3

6
5

6
2
3

5
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Preferred name

Projects
selected

Region

Midpoint
recommendations:
organizational and
partner engagement (PE)

Midpoint
recommendations:
project-related

NewCo versus
pre-existing
lead entity

Lead entity type

Counties
served

Nassau Queens PPS

11

Rest of state

2 (PE)

7

NewCo

2

NewYorkPresbyterian PPS
NewYorkPresbyterian
Queens PPS
North Country
Initiative
NYU Langone
Brooklyn
OneCity Health

10

New York City

1

4

Pre-existing

Multiple Unaffiliated
Hospitals
Hospital system

9

New York City

0

0

Pre-existing

Single hospital

1

11

Rest of state

1

0

NewCo

Single hospital

3

9

New York City

3 (PE)

1

Pre-existing

Single hospital

1

11

New York City

2 (PE)

3

Pre-existing

Hospital system

4

Refuah Community
Health
Collaborative
SOMOS

7

Rest of state

1

0

Pre-existing

FQHC

2

10

New York City

1

2

NewCo

Community Physicians

4

Staten Island PPS

11

New York City

0

0

NewCo

1

Suffolk Care
Collaborative
WMCHealth

11

Rest of state

1 (PE)

0

NewCo

11

Rest of state

1 (PE)

3

Pre-existing

Multiple Unaffiliated
Hospitals
Multiple Unaffiliated
Hospitals
Hospital system

1

1
8

Source: Authors’ synthesis of DSRIP program materials.
Abbreviations: Federally Qualified Health Center (FQHC), New Corporation (NewCo)
Notes: The PPS lead entity type may have some categorization overlap. A PPS may have more than one hospital that supports the PPS performance.
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Exhibit 4.2. Demographic characteristics of attributed Medicaid members
Preferred Name

Average Age Female (%) Black (%) Hispanic (%) Managed Care (%) Health home (%) Dual (%)

Adirondack Health Institute

32.6

52.8

1.7

0.7

69.7

7.6

17.3

Alliance for Better Health

30.2

55.0

17.6

5.0

75.0

7.5

13.7

Better Health for Northeast New York

29.8

53.3

13.8

3.0

73.6

7.0

13.9

Bronx Health Access

31.1

55.2

32.7

34.1

83.6

14.5

11.2

Bronx Partners for Healthy Communities

31.2

55.7

32.1

29.2

79.5

7.8

13.2

Care Compass Network

29.1

52.8

8.4

2.9

71.9

9.4

13.9

Central New York Care Collaborative

30.5

54.1

14.9

3.6

75.7

14.2

12.8

Community Care of Brooklyn

30.0

52.9

22.2

11.2

84.9

4.6

11.2

Community Partners of Western New York

31.0

55.1

11.9

5.4

80.9

11.3

11.6

Finger Lakes PPS

29.5

53.8

20.9

6.3

75.7

12.4

13.0

Leatherstocking Collaborative Health Partners

30.6

53.8

2.1

1.1

75.6

7.8

13.3

Millennium Collaborative Care

29.2

53.3

25.6

6.5

77.0

18.9

12.9

Montefiore Hudson Valley Collaborative

32.4

55.9

19.1

10.8

75.4

18.7

15.7

Mount Sinai PPS

38.8

55.2

31.8

22.3

78.2

24.7

18.6

Nassau Queens PPS

33.2

54.7

19.1

14.2

80.2

6.1

12.9

NewYork-Presbyterian PPS

31.1

59.0

18.5

32.5

86.2

6.9

12.6

NewYork-Presbyterian Queens PPS

35.6

54.6

12.9

18.8

78.6

3.5

21.1

North Country Initiative

28.6

53.2

2.9

0.8

71.1

5.0

12.7

NYU Langone Brooklyn

23.7

51.8

10.0

16.4

90.1

2.7

6.2

OneCity Health

31.6

55.2

37.1

22.0

80.6

14.7

12.2

Refuah Community Health Collaborative

21.1

50.4

3.0

1.1

84.7

1.3

4.1

SOMOS

31.5

53.0

13.5

21.0

85.8

2.0

9.4

Staten Island PPS

31.8

53.1

19.9

16.0

75.2

5.2

14.0

Suffolk Care Collaborative

28.6

53.5

10.7

14.0

78.0

3.1

11.4

WMCHealth

27.5

54.0

12.8

7.3

77.8

2.8

11.1

Source: Authors’ analysis of the DSRIP Dataset. The numbers are from the last month of MY3; this rolling year covers July 2016 to June 2017.
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Exhibit 4.3. Attribution swim lanes for Medicaid members
Preferred Name

Total Attributed Member Count Behavioral Health Developmental Disabilities Long-term Care All Other

Adirondack Health Institute

84,463

12.0

4.0

3.7

80.3

Alliance for Better Health

119,564

13.0

2.1

3.0

81.8

Better Health for Northeast New York

90,796

9.7

3.2

2.0

85.1

Bronx Health Access

144,263

11.3

0.1

1.8

86.9

Bronx Partners for Healthy Communities

344,540

9.9

0.1

2.7

87.3

Care Compass Network

91,923

11.4

2.5

3.9

82.2

Central New York Care Collaborative

242,374

12.9

1.7

2.7

82.7

Community Care of Brooklyn

615,905

5.4

0.7

1.5

92.4

Community Partners of Western New York

83,031

10.7

0.8

2.6

86.0

Finger Lakes PPS

319,080

13.5

1.0

2.8

82.6

Leatherstocking Collaborative Health Partners

43,383

7.8

2.4

1.6

88.2

Millennium Collaborative Care

278,363

12.2

2.8

2.6

82.4

Montefiore Hudson Valley Collaborative

259,657

15.3

0.5

2.9

81.4

Mount Sinai PPS

411,037

14.0

1.1

1.7

83.3

Nassau Queens PPS

429,275

5.6

1.7

3.0

89.6

NewYork-Presbyterian PPS

82,483

6.9

0.0

0.9

92.2

NewYork-Presbyterian Queens PPS

31,645

3.1

0.3

13.5

83.1

North Country Initiative

39,900

11.9

3.8

3.3

81.0

NYU Langone Brooklyn

108,575

3.3

0.8

1.0

95.0

OneCity Health

637,293

10.6

1.2

1.1

87.1

Refuah Community Health Collaborative

51,408

3.1

1.2

0.9

94.9

SOMOS

617,598

3.4

0.1

0.7

95.8

Staten Island PPS

74,742

7.5

3.3

5.7

83.6

Suffolk Care Collaborative

201,721

6.6

1.0

4.5

87.9

WMCHealth

181,865

9.3

3.2

2.6

84.9

Source: Authors’ analysis of the DSRIP Dataset. The numbers are from the last month of MY3; this rolling year covers July 2016 to June 2017.
Notes: There were no PPS members attributed to the developmental disabilities swim lane for NewYork-Presbyterian PPS. The “all other” category represents the members that
were not assigned to the Behavioral Health, Developmental Disabilities, or Long-term Care swim lanes, and includes services such as engagement with a health home, any

connectivity with a Primary Care Provider, or other ambulatory care provider.
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4.2. Challenges and Successes of Implementation and Process
This section addresses RQ-A:
What were the successes and challenges with respect to PPS planning, implementation,
operation, and plans for program sustainability from the perspective of DSRIP program
planners, administrators, and providers; and why were they successful or challenging?
(CMS RQ7)

4.2.1. Start-up
This section presents the findings related to building the Performing Provider Systems (PPS) and
launching the DSRIP program from the perspectives of the PPS key informants and partners
engaged in projects.

4.2.1.1. PPS Formation
To receive DSRIP program funding, interested entities needed to form coalitions of partners to
create a PPS and submit an application to the NYS DOH. Depending on the pre-existing health
care systems in their regions, some PPS found this to be more of a challenge than others.
While many communities convened planning groups with newly formed coalitions, some PPS
leveraged existing relationships with partners to create collaborative applications. Many PPS
key informants indicated that the application process involved public meetings as well as
workgroups, where partners met several times per week to develop the application. While in
most cases, a broad-based coalition of planners was found to be beneficial, sometimes a large
and diverse group led to difficulty in consensus building.
We pulled together a workgroup or steering committee to write the application. It
included three FQHCs 81, four [community-based organizations], and [Hospital] as well as
other community providers. The whole process of building the application that way was
very painful because we had to have a lot of conversations earlier on that other PPS
didn't have to yet. – 2017 PPS key informant
In regions where many competitors were organized into a small number of PPS, key
informants often reported difficulties during the initial application development.
Challenges included alignment on key issues, allocation of resources, and leadership
structure.
It could really be described as “cooperatition,” or an amalgamation of cooperation
and competition, since these entities who came together were previously
competitors and remained that way to some extent. – 2017 PPS key informant
81

Federally Qualified Health Centers
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Sometimes these challenges were addressed and resolved, and the group evolved to develop
better functioning relationships by the final application phase.
The major things that turned the tide was integrating these two PPS. We re-selected all of
our projects together. We had 120 people in the meeting in small groups. Each table
worked with and reported out the projects selected…The willingness to stop, take a breath,
and let go of what we did independently to collectively pick our projects raised the
confidence of the PPS and their ability to hold their own in a larger PPS. – 2017 PPS key
informant
Several PPS, especially those which evolved from a unified health system, reported that their
existing structures enabled them to quickly pivot to the requirements of PPS formation and
related work.
Our overall governance and the speed with which we were able to get this launched
from ground zero was pretty incredible. – 2017 PPS key informant
With the medical home and the ACO82, we already had a lot of infrastructure there. –
2017 primary care/hospital regional focus group participant
Some PPS described building a PPS around their regional hospital. Through an advisory council,
they developed a consensus model and networked with major stakeholders, including local
government, behavioral health, social service organizations, and community hospitals. In one
example, this council merged successfully into a governance committee.
A small number of PPS reported that they had already started to make changes to their current
organizations prior to or around the time of PPS formation because of ongoing strategic
initiatives. They attributed these early actions as setting them up for success.
We started a transformation effort here about two years before DSRIP came in
terms of reducing unnecessary Emergency Department visits and moving toward
value based payments. We had a number of risk-based contracts and level-1
contracts prior to DSRIP. – 2017 PPS key informant
The lead agency, [health center], was DSRIP-ing before DSRIP. It seemed so logical
for us to continue what we were doing in a more formal structure. That was the
genesis. Rather than join another PPS, we did it on our own because we were
experienced in this area already. – 2017 PPS key informant
Before DSRIP, we had gotten a grant that allowed us to integrate behavioral health in
rural clinics. So, we had already gone down that road of trying to have a clinician sitting in

82

Accountable Care Organization
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a rural physical clinic, and trying to manage two billing systems, and two HR systems… –
2017 mental health and substance use regional focus group participant
The PPS that did not already have a pre-existing infrastructure reported additional early
challenges with project implementation and partner engagement. Key informants from these
New Corporation (NewCo) PPS explained that it was difficult to simultaneously build
infrastructure for a new organization, engage partners, and adhere to the breadth and pace of
DSRIP program project requirements.
We were concurrently organizing around the region, while also organizing around the
rollout of the projects. Those two things have two completely different needs and I think
that there’s a mismatch of pace compared to what it takes to effectively organize a
region, and ideally, then you roll out projects. The nature of DSRIP was that we needed
to do both of them at once and that presented a lot of operational challenges. – 2018
PPS key informant
Unlike many PPS with hospital-based infrastructure, we didn’t have anything when we
began. In order to implement and measure and do all of the things we needed to do, IT
platform was critical. We didn’t even have computers at first. Sort of like a startup, we
are building everything from the ground up. – 2017 PPS key informant
The NewCo creates an administrative structure that is kind of an impediment to
getting things done in our organization. – 2017 primary care regional focus group
participant

4.2.1.2. Project Selection
The PPS were required to select projects that demanded investment in technology and human
resources to better serve target populations consistent with DSRIP program goals. Each PPS was
required to submit a detailed plan for each of their selected projects. In that same application,
the PPS committed to speed (how fast they could meet their goals) and scale (how many
patients would be served, or how many partners would be included). This phase was
challenging for many PPS.
Nearly all PPS described utilizing the results of their community needs assessment to select
projects. The community needs assessment was a required component of the PPS application,
and was slated to be a “comprehensive assessment of health care resources, including
behavioral health, and community-based service resources currently available in the service
area and the demographics and health needs of the population to be served.”83
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New York State Department of Health. (2014). Guidance for conducting community needs assessment required
for DSRIP planning grants and final project plan applications. Retrieved from
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/community_needs_assessment.htm.
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Overall, the community needs assessment exercise was perceived as beneficial to inform
project selection.
The community needs assessment led to the selection of the right projects for us. All
selection was based on data and going through the exercise made us realize certain
areas where we already had high performance, wouldn’t have a gap to goal, or wouldn’t
be able to move the dial on that. Some of the analyses put behavioral health at the
forefront of our minds, where it wasn’t before. – 2017 PPS key informant
We also did a very comprehensive community needs assessment to figure out what gaps
there were to fill. We understood a few large needs, like behavioral health and primary
care, through this community needs assessment. Then we were working on [gaining]
stakeholder agreement. We had a PPS-wide conference in the beginning, and at that
time we discussed the community needs assessment with stakeholders. There were some
assumptions both proven and novel that came out of the community needs assessment.
– 2017 PPS key informant
Although most PPS key informants described positive outcomes of the community needs
assessment and project selection process, some reported that in hindsight, they should have
selected different projects. The reasons for this were varied and included changes in
partnership structure, project design flaws, emerging clinical needs in their community,
pressure from a dominant body, or lack of information.
We did not select the right projects. There's one that jumps out immediately, but the
[name] project has proven to be a significant hurdle for us because [partners have sold
the business or reduced capacity]. It's been a major struggle in trying to make progress
with this because the few places that do have capacity do not align with our hot spot
areas or our needs. – 2017 PPS key informant
One PPS had a particularly problematic experience with one project and had to reach out to
NYS DOH for assistance after the interpretation of the project changed.
One of the struggles with all project selection is that we had a limited time to absorb
what the project was and what it meant, and it was hard to see what the details were on
the project. We found a lot of issues with this particular project…The State or
Independent Assessor revised the wording on the project. It was a total game changer to
us, to the point that we had many discussions with the State and the Independent
Assessor, and got some relief on an alternative implementation plan. – 2017 PPS key
informant
Many key informants reported that they were generally pleased with their projects, but felt
that the “11th project” was problematic for their PPS.84
84

The optional 11th project focused efforts on uninsured patients and Medicaid low- or non-utilizers who may
benefit from additional primary care services. All of the uninsured patients in the region as well as a NYS
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We probably didn’t have all of the right information to understand the uninsured at that
point in time. The exchanges were barely up and running; it was hard to understand
what the uninsured population looked like. It made the PAM85 survey a nightmare in
terms of qualifying someone to meet the survey requirements. They reflected the
environment prior to the exchanges. The structuring of the 11th project didn’t get the
best footing because it didn’t have the right understanding of the size, scope, and
location of that population and how hard it would be to find the uninsured. Not that
we’d eliminate it, but we’d have to size and scale it differently if we knew what the
population would be like. – 2017 PPS key informant
After the fact, seeing how the State recalculated the other set of equity programs, I
wonder if the PPS would have been better off not selecting the 11th project for the
equity project. I’m not sure how well we were qualified for that. – 2017 PPS key
informant
Some PPS key informants expressed that in hindsight, they would have selected projects
differently given Pay for Performance considerations. They reported a lack of alignment
between the projects and the Pay for Performance measures on which they are being assessed.
We should have selected projects that would meet the Pay for Performance measures.
We lost sight of that in the list of the 44 projects. There is so little correlation between
the projects and the Pay for Performance measures. The projects are there to just checkthe-boxes and get dollars... If we had to do it over, I’d select new projects. I think a lot of
PPS didn’t realize that at the time. Meeting the milestones structured in terms of
building the organization was the big focus in the beginning, and we lost sight of the end
goal because of that. Speed and scale and actively engaged partners were the main
focus, and it detracted from the bigger picture. – 2017 PPS key informant

4.2.1.3. Project Milestones
The DSRIP program Project Requirements Milestones and Metrics centered around Domain 1,
PPS-led projects. Each quarter, PPS were required to submit reports to the Independent
Assessor through the Medicaid Analytics Performance Portal (MAPP), including project-level
reporting requirements (e.g. establishing monthly meetings with managed care organizations)
and provider-level reporting requirements (e.g., primary care practices achieving Level 3 PCMH

determined portion of non-utilizing and low-utilizing Medicaid members were attributed to project 2.d.i.
Ownership of this project and attribution for payment was determined by mechanics described in Attachment INYS DSRIP Program Funding and Mechanics Protocol
(https://www.health.ny.gov/health_care/medicaid/redesign/program_funding_and_mechanics.htm)
85
Patient Activation Measures or PAM is from project 2.d.i. The project is focused on increasing patient activation
related to health care paired with increased resources that can help the uninsured as well as non-utilizing and low
utilizing Medicaid populations gain access to and utilize the benefits associated with DSRIP PPS projects,
particularly primary and preventative services.
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certification). For each requirement, PPS committed to a target completion date which could
not exceed the prescribed speed and scale commitments made in their application.
Key informants from PPS reported significant challenges with committing to speed and scale
targets in Demonstration Year 0. They had trouble understanding the milestones and also
criticized continually changing requirements. These changes reverberated down to partners as
they described devoting time and staffing to meet requirements, only to have them change
again. Key informants said that guidance on the projects was often changing, there was not a
clear source of consistent information for PPS, and PPS had to make decisions without all the
information they needed to inform their commitments.
If we’re thinking about the history, I think the main, underlying problem that led to all of
these challenges was how the initial process went, where the state was asking us to
decide on a lot of things before they gave us the information that we would need to
make those decisions. Certainly, any kind of commitment…it seemed like those were very
premature. I know that the state was going as fast as they could, and then they were
pushing us to go as fast as we could, but it was a really hectic process that led to a lot of
weirdness that we’re still stuck with these years later. – 2018 PPS key informant
The challenge was just how quick everything was happening. The State was
figuring out what their requirements were; we didn’t get validation until after
things were due. We worked around it all; we have made 100% of our milestones
and goals that we set out to, but it really has come down to the State’s timeliness
(or lack thereof) on guidance. – 2017 PPS key informant
In the beginning, I think New York State was kind of making it up as they go, too. It was
difficult because we would receive multiple emails even per day on directions for many
things, from reporting, from metrics, from new plans. But over time, over the first year, I
think that finally sorted out and both sides got more organized. But, that was a bumpy
first year. – 2018 PPS key informant
Respondents felt there was inconsistency and a lack of clarity surrounding specific milestone
definitions, and did not believe the definitions aligned with project implementation and how
PPS would later be measured.
For me, there were issues in implementation around ambiguity and inconsistency in the
language. For example, the milestone and the metric or the metric and the data
requirements were essentially talking about the same thing, but if there were
inconsistencies in the language between those two, it could be very difficult to figure out
what was actually being required and asked for. There might be a list of things in
parenthesis, it was unclear if those were examples or if those were the only options that
were eligible. – 2018 PPS key informant
The scale and speed, we set those numbers before the definitions were even
complete…we didn’t even know what the actively engaged criteria was until after the
84

fact. The provider counts, we didn’t know what that meant until after the fact. Honestly,
that made things very difficult when the requirements were changing. – 2018 PPS key
informant
Because of this confusion, many PPS key informants reported that they set targets
unrealistically high, or that they did not understand the commitments they were making. They
cited challenges with not having the data they needed to assist them in making informed
decisions when setting their targets, and some felt they were pushed into making commitments
and only learned the ramifications of those decisions later. Without clear definitions related to
milestones, some PPS projected their targets based on what they anticipated the metrics would
be, and key informants said they would have made different projections if the requirements
were clear from the beginning.
The targets were set so high that we didn’t even have enough admissions to meet
the numbers set up. There was a push from DOH to set high marks for networks,
which became speed and scale commitments. It was after the numbers were handed
in that it became clear what we were committing. Essentially, the way speed and
scale commitments were set up was that we were instructed to give an
informational forecast we weren’t prepared to give yet. They said, “You’re either in
this pool or not…” Then, once you’re in the pool, they said, “Let me explain what it
means to you to be in this pool.” “Let me tell you ramifications of the numbers you
just gave us.” On the provider commitment side, one of the project requirements is
that we will have seven emergency rooms involved, and we only have six hospitals.
Those are examples of the nonsensical requirements. – 2017 PPS key informant
Part of the hurdles that we encountered and still are encountering is not having the data
to really estimate what our numbers really should be. In several projects, we might be
wedded to numbers that at the time, we didn’t have data to accurately estimate,
especially within the confines of the application. That also made it a bit difficult to go
forward. – 2018 PPS key informant
A number of key informants expressed that not knowing their PPS’s attribution in advance led
to particular difficulty with forecasting speed and scale targets. Attributions are the number of
Medicaid members assigned to each PPS, based on a NYS DOH algorithm applied to a PPS
partnered network. Many PPS regretted being stuck with inaccurate or unreachable service
targets.
Everybody was getting recalculated attributions for quite some time, so you didn't
even know who you were managing and if our projects even matched up with our
attribution – 2017 PPS key informant
It definitely has to do with making the projections before we even knew what our
attribution was going to be. It was a little bit of a blind projection and there was no ability
to really go back and edit those based on the reality of the situation going forward. I think
that was definitely a challenge. If we had re-forecasted based on the actual attribution
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and actual membership within the PPS, I think we would have gotten a lot closer to
achieving those targets on a prospective basis. – 2018 PPS key informant
When we started the application phase, we were focusing heavily on a 10-county
catchment area. As we went further along into the application period, we were
approved for a five-county region, which was still a good amount of coverage
geographically. Because everything we had been looking at for our application was
nine or 10 counties in terms of patient/provider engagement and community needs,
not being able to make changes to that after our size changed drastically continues
to be a huge challenge. The number of providers we have committed to and patient
numbers are totally wrong and unable to be changed. – 2017 PPS key informant
Engaged partners largely echoed these frustrations. Some focus groups participants felt
that project milestones were not realistic or tangible, which ultimately discouraged
partner participation. They often felt their own targets were out of sync with their work.
I think all of the participants are rational participants, and the way Albany is defining
metrics for the hospitals – the people in DSRIPs – they’re defined in some way that doesn’t
encourage participation and doesn’t encourage success. The benchmarks they’re looking
for really have nothing to do with improving care in the community. - 2018 hospital
regional focus group participant

4.2.1.4. Early Implementation Challenges
Key informants and partners identified several factors that slowed project implementation. Key
informants from both large and small PPS recalled the immense resources required to get
projects up and running. They described needing to reallocate staff from other departments,
hire talent externally, and create new office spaces. In some cases, initial reliance on
consultants led to a lack of staffed projects. The PPS and partners that needed to build more
infrastructure noted that it was even more challenging to do without capital funding.86
We doubled or tripled the size of our staff since the beginning of DSRIP. Trying to have
the resources to organize this program and get it up and running was a very significant
challenge. – 2017 PPS key informant
Key informants pointed out that as a system transformation demonstration project, the DSRIP
program required significant culture change. Groundwork needed to be established to prepare
the health care system for the transformative work that would ensue through DSRIP program
initiatives. Respondents expressed that simultaneously working to adjust administrative
systems, develop workflows for reporting requirements, formalize contractual agreements with

86

The Capital Restructuring Finance Program (CRFP) offered funds to PPS and partners to support capital projects
but the evaluation of the PPS sponsored site applications took longer than anticipated. Therefore, PPS and
partners had to move forward with the DSRIP program without knowing if they received a CRFP award.
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partners, and carry out DSRIP program project requirements to ready the system was an initial
challenge.
Formalizing agreements between different agencies in a different way was a unique
challenge because there are certain timelines related to these legal and contractual
documents which were sometimes outside of our hands, however were important to
establish. DSRIP initiatives are incredibly important but are a catalyst for change within
our service system, which predicates that the rest of the system is ready for that change. I
think that administratively aligning the different initiatives, so we could actually transform
the rest of the system, was also an administrative challenge. -2018 PPS key informant
The biggest challenge I had from the get-go is that we were not very top heavy. We were
a skeletal staff, and the reporting requirements were immense. …. We felt like we needed
a significant amount of manpower. I visited some other PPS, and they had giant office
spaces and huge armies of employees, which was intimidating. My initial reaction was
that we just didn’t have the infrastructure in place. – 2017 PPS key informant
One of the things that was a challenge was that award letters came out in May [2015] by
the time DSRIP had already started. The evolving requirements were difficult and continue
to be difficult. We weren’t working on the program until halfway through the first year. –
2017 PPS key informant
Key informants from several PPS reported that interim leadership at their PPS delayed all
aspects of start-up, and in some cases perceived that a lack of decision-making or conservative
approaches to project development by original leadership teams resulted in delayed outcomes.
Some study participants wished that the NYS DOH had saved the PPS time by defining some
structures for them.
There was zero structure. There was a group of projects and a bag of money. The
initially 50-some PPS that were combined into the 25 that we have now. And, each
had to go out and figure out structure. – 2017 mental health and substance use
regional focus group participant
Whether it was an EHR, connectivity consent form… Something. Give us some
foundational things so that we didn’t have to invent everything ourselves. Or, even
just some guidance how the PPS were going to be structured so that each PPS was
the same structure. – 2017 hospital regional focus group participant
There were probably ways that DOH could have maybe either guided some of those
efforts or at least on best practices… It almost seemed like the default was that you were
a PPS within a hospital system and already had those mechanisms in place. -2018 PPS key
informant
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4.2.1.5. Partner Engagement
Partner engagement also went slowly for some PPS. Given that some partner organizations
were competitors prior to the DSRIP program, obtaining buy-in and aligning different objectives
took time. Some respondents acknowledged that the nature of their PPS structure posed initial
challenges with partner communication and workflows. Others mentioned that while they
established large project workgroups to represent all provider types from their network, early
buy-in and consensus building was difficult to reach among so many participants.
We attempted to build a workgroup comprised of 35-40 individuals from 35-40 partners,
so all the different provider types that make up our network. Although there was a lot of
engagement from the group, it was very difficult to obtain appropriate buy-in and come
to conclusions with a group that large for some of the larger milestones… That was one
of the challenges from an engagement perspective, just ensuring we can get buy-in and
then coordinate toward one or two primary solutions that we can move forward with. –
2018 PPS key informant
Overall, the general consensus was that involving a broad-based group of partners early on was
vital to a well-functioning group and continued engagement. Key informants often attributed
early success to their partner engagement efforts, and emphasized the lengths to which they
had gone to gain buy-in from their partners. Some ways PPS engaged partners early on included
an advisory council with a consensus model or an active project advisory committee. In-person
meetings were generally described as an effective way of increasing partner buy-in and
camaraderie, despite scheduling difficulties. Other key informants reported that the project
selection process brought partners together. For example, they led PPS-wide conferences for
project selection, or used local agencies for the community needs assessment and then kept
them on as partners.
Some focus group participants felt that the PPS initially brought too many people to the table
which resulted in more confusion than action, and that it took PPS too long to fully roll out the
DSRIP program, but others felt that their PPS did a good job organizing partners and getting
work started in a timely manner.
At the onset of DSRIP, we were very fortunate to be partnered with [PPS], because we
had a lot of forward thinkers in the PPS. We took our opportunity to not spend so much
time thinking about how to perfectly manage this to get the outcomes that we want. In
health care, we really like to control our outcomes, right? We want to make sure we
have positive outcomes. With DSRIP, we had to make sure that we were moving. We
didn’t have five years to sit and talk about what we were going to do, we needed to put
boots on the ground. So I think that coming to that decision really positioned the [PPS]
and all of our organizations to move quickly and see results, and what we were able to
do was rather than plan out how we were going to come to these excellent outcomes,
we were learning as we went and tweaking the process as we went. I think that has been
why we’ve been successful as a PPS, because we did not hold back and we just moved
forward and corrected as we went. – 2018 hospital regional focus group participant
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I think that we wasted the first year paying all those consultants, and that money could
have gone to providers. The initial rolling out of it was a year behind before it even
caught up and started getting any real traction. Consultants were driving everything and
there was really a disconnect between PPS and consultants and providers. I think that
was the first misstep. – 2018 mental health and substance use regional focus group
participant
The DSRIP-engaged partners were critical of the PPS when they were not included in early
decision-making for defining network areas, project selection, and other formation issues.
What we found most frustrating about the process is that when we first became
involved, the projects were laid out. The PPS selected the projects that the PPS would be
involved in. – 2017 mental health and substance use regional focus group participant
Respondents noted that with the multitude of DSRIP projects, it was often difficult for partners
to fully understand the various project definitions, metrics, and patient populations. It was also
a challenge to ensure that the correct stakeholders were at the table to discuss specific
initiatives during the implementation phase, even within a single organization.
In the beginning, it wasn’t very well organized, it was very confusing. You go into
different group meetings and so many different boards were there and all these
stakeholders; everybody was on a different level of what they do. There was no
organization … They never went over things. It was almost like they were rushing, they
had all these deadlines and quick dates, so nobody gave a base in the beginning to have
a level platform for connectivity. – 2018 hospital regional focus group participant
Some of the other challenges…is that there are just so many initiatives with DSRIP and
what we found is that a lot of partners just really struggled with what is what? When
we’re looking at this process outcome or trying to hit this metric or this target, how are
we defining these things? What patient populations are we talking about? Even getting
the right people within an organization or within a site in the same room, the people
that would be working on the specific projects, was a challenge. -2018 PPS key
informant

4.2.1.6. Governance Structure
The PPS overwhelmingly found their governance and committee structures to be beneficial
from initial start-up.
We value a lot of the feedback that [committees] provide to us. For example, they
know how to create a registry within EHR. There’s always someone there to say
whether it will or won’t work. There is a high level of conceptual thinking that
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happens, and then there is also feedback about what happens daily at a given level.
– 2017 PPS key informant
A few reported changes to these structures over time, to foster continual improvement.
We had quarterly town hall meetings, which now have been moved to a less
frequent basis, but these included partners from all types across the network. The
discussions that occur within the clinical committee have transitioned as well. It
used to be very project-related, and now it’s related to discussing clinical
implementation and the strategies related to that. It’s now a forum for input from
members in terms of increasing approval for what we are doing and extending
projects to other partners to support our network. – 2017 PPS key informant
The IT committee, compliance, and clinical committees meet on an as-needed basis.
People have limited time, and committee meetings were taking up too much time.
They meet now when they need to, and the governing body takes the lead on these
issues. – 2017 PPS key informant
Key informants at three PPS reported more hostile relationships with committees at the
beginning of the DSRIP program, but described making structural changes that created
better working relationships.

4.2.2. Operations
This section presents stakeholder experiences regarding several of the DSRIP program
operations, including partnerships, performance measures, funds flow, PPS overlap, value
based payment, data access and reporting, and workforce issues.

4.2.2.1. Partnerships
4.2.2.1.1. Collaboration
The most frequently noted operations change due to the DSRIP program was increased
collaboration. This included collaboration between providers who were previously in
competition with each other, as well as collaboration between providers of different types of
services. Key informants reported that organizations that did not previously trust each other
had the opportunity to work together toward common goals, and formed positive relationships
that would not have occurred in the absence of the DSRIP program.
Because of DSRIP, we have accelerated the rate at which competing organizations work
well together. Competing hospitals, nursing homes, [and] physicians at different
practices are working together. It is unique and DSRIP helped make it possible. – 2018
PPS key informant
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I think the best part is that I sat at a table this size with all of our competitors in
[location], and they asked us to brainstorm. And we all were able to apply to do a
specific project. – 2018 hospital regional focus group participant
According to stakeholders, partners began working together more comprehensively and
cohesively. Key informants from several PPS described the formation of care collaboratives that
met regularly. Additionally, they reported an increase in hospitals partnering with communitybased organizations, and primary care practices collaborating with behavioral health providers.
Bringing different entities to the table that had not collaborated previously was said to lead to
new ideas and bring communities closer together.
We have made great strides with collaboration between organizations that without
DSRIP would never have collaborated. We really pride ourselves on this; that we brought
the community together. – 2018 PPS key informant
Study participants said that collaboration became a standard process and habit which they
expected to continue after DSRIP program funding ended.
We knew every provider within the community and they knew us, but we never sat at a
table with everyone. I’ve said at many PPS meetings where we are able to sit with
colleagues, that they really brought us together, and that was a very good thing. Those
conversations will continue now, long into the future. – 2018 community-based
organization regional focus group participant
I think DSRIP has shifted the way that our providers think about health care. Just from
the hospital side, our hospitals are thinking about social determinants of health. They’re
thinking about partnering with community-based organizations. They’re thinking about
food services, legal services, and they’re thinking about how all these things impact
someone’s health. They’re thinking about how they can partner with different types of
organizations and work with people beyond their own walls. These are things that will
have lasting impact beyond the five years of DSRIP. Beyond the projects we put in place,
they’ve learned how to partner with different types of organizations beyond traditional
health care organizations and think about health in a different way. – 2018 PPS key
informant
Shared provider accountability was singled out as a big step for the health care system. Key
informants said that previously, hospitals felt their responsibility ended when a patient was
discharged, but due to the DSRIP program, health care organizations developed connections
that encouraged them to work together to maintain responsibility for their patients. These
collaborations led to better care coordination between providers and improved care
transitions, which are discussed further in the patient care section (see Section 4.2.4.4).
These patients were [previously] handed discharge papers and shuffled out the door.
They were told to follow up with somebody and social factors were never really
something that was brought to the forefront. We have teams that are helping people get
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connections to places that can help them address these factors in a long-lasting
sustainable way. Helping them get connections to [disability] benefits, to food pantries,
to health homes, to legal services, to primary care practices and health coaches. They
are not just handing them a paper referral, they are actually making sure they get there;
they’re getting them connections to recovery peers. I think we’ve seen through the data
and through these interventions that this is having an impact. I think their quality of life
is improving and we’re seeing a drop in utilization for these people. – 2018 PPS key
informant
A majority of PPS key informants pointed to their new work with community-based
organizations as fundamental to their success, and cited these partnerships as a vital change to
the health care system. They said that development of more robust relationships with
community-based organizations led PPS to have more successful collaborations, break down
silos, and reduce hostility between medical and community providers. Community-based
organizations that had not previously considered their organizations to be part of the health
care system began seeing their roles a bit differently. Community-based organizations and
health care providers developed a common vocabulary and were starting to “look at the same
picture from almost the same perspective.”
One of our biggest successes has been our ability to work with, and integrate,
community-based organizations into the project. When it was first rolled out, we had
CBOs that were an integral part in developing the workflows, plans, and how the project
would look. That was really important, because it wasn’t just us saying, “This is how
we’re going to do it” and trying to find people who would want to do it our way. We
really sat down with the organizations that were going to be doing the work in the
community, with their staff, and valued their input. As a result of that, we’ve been able
to grow it, we’ve been able to add a lot of other types of CB0 partners to the project, and
that has allowed us to reach a much bigger section of the population than we would
have been able to do on our own. – 2018 PPS key informant
We had a lot of pressure to give money to Tier 187, and we even got remediation on
the mid-point assessment because we are working with the [community-based
organizations] who need help in capacity building. It takes time. We finally are
seeing them blossom… This is the beginning of doing transformational work in
developing a community practice where we are sharing goals and ways of doing
care. – 2017 PPS key informant
CBOs don’t necessarily know the clinical piece, so when we began to really have open
discussions, those were successes. Really being able to see how we can learn and work
together – it probably now is pushing us to look at how we can have collective impact
and collective engagement. – 2018 community-based organization regional focus group
participant
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Non-Medicaid billing community-based organizations are considered Tier 1.
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Most partners from community-based organizations were pleased with the expanded project
scope they had been able to develop with DSRIP program funding. They reported increased
service provision in some of their toughest service areas and gratitude for the ability to expand
the scope of their health care workforce.
This has opened the doors for us to engage new clinical partners, develop relationships
within those organizations, and get our services out to patients whose doctors would not
know about it. We are reaching a new group of people in our own community. – 2018
community-based organization regional focus group participant
Some community-based organizations did struggle with figuring out how their organization
fit into the DSRIP program. For example, the exposure to risk was new for many of them:
I know some of the initial bumps in the road and to be honest, that we still face
today, is the amount of risk that this endeavor carries. We had to ramp up our HIPAA
and our compliance end of things and it’s still a work in progress. That was a major
investment that we made on our own. We didn’t write a funding request for anything
from the [PPS]. So there’s been a lot of investment, to get to us to this place. …They
really put us on the hook for everything. I mean, God forbid something were to
happen. We are a three or four-million-dollar organization. I mean, everything can
get wiped out in a heartbeat. Now, the payoff on our end is obviously that we can
create new jobs, that we can grow and expand our mission beyond what it ever had
been before. And, it gives us a place at the table that we have never been at before
too. So, there is some payoff to that risk. Hopefully, that continues. –2017
community-based organization regional focus group participant
4.2.2.1.2. Partner Engagement Challenges
While collaboration was viewed as a success by a significant majority of study participants,
partner engagement challenges were also reported by about two-thirds of PPS. Challenges
were most often experienced during the initial implementation phase, but some continued
beyond that to a lesser degree.
Many noted that partners were already overloaded with their own tasks, and the additional
DSRIP program-related responsibilities required further dedication of time.
On the partner side, it’s been challenging because they have their businesses to run and
we’re trying to get in there and be disrupters of their day-to-day business. –2018 PPS
key informant
It has turned into a game of Health Home coordinators chasing primary care providers to
get information, and primary care providers not really knowing who we are or what we
do... And they just don’t have the time, so we are still chasing them around and trying to
get information, and trying to get a case conference in. It was like that before DSRIP and
it is like that now. – 2018 primary care regional focus group participant
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Although some suggested that participation in the DSRIP program was more difficult for larger
organizations with multiple sites where more staffing was required, other key informants noted
that smaller organizations were also significantly challenged. With more constrained staffing,
DSRIP program engagement could be financially harmful to smaller practices.
Engaging our smaller partners, not necessarily CBOs, even smaller PCPs, was extremely
challenging. They do not even have the resources to engage. The cost of engagement is
the cost of seeing patients in their practice. Even taking an hour out of their day to talk
about project implementation can be financially detrimental to their practice. It made us
think about how much more effort we need to put forth to understanding the unique
needs of those partners and how to tailor support to them based on their ability. – 2018
PPS key informant
Several PPS had trouble obtaining buy-in from partners they considered particularly important
to engage.
As we get along to implementing our projects, we have very influential partners who are
making decisions on whether to engage in projects based on whether the money they’d
get from DSRIP is equal or more than the effort they will put into the work. It’s a
transformational effort, and the DSRIP dollars are a bridge to get them to a VBP world.
They aren’t buying into the system. These partners are looking very short-term to figure
out next quarter gains, and if they spend more than they make, they won’t do the
activity. – 2017 PPS key informant
Partners, meanwhile, did not always see the benefit of participating in DSRIP projects, and were
frustrated when offered contracts that were not financially feasible.
We were offered an opportunity for transitions of care at [PPS], and it was going to be a
money loser from the word “Go.” There’s been more than one project that we had to
walk away from, and it’s not like we pay people gazillions of dollars. But there was no
appreciation for the cost of delivering care or services, and we just had to say it was
amazing that they wanted to work with us, but we couldn’t afford to do that. Who is in a
position where they can lose money from day one? So that was a real frustration. – 2018
hospital regional focus group participant
Sometimes partners found that larger organizations were unwilling to work with them
collaboratively.
It just seems that historically, the large practices don’t know how to work with the
[substance use disorder] patients. They don’t know how to develop good connections.
One of the roles I had was outreaching every FQHC, and only a handful actually got back
and wanted to meet… Somebody is going to provide these services for [substance use
disorder], and what we found is some of them try to provide it themselves. It usually
looks good for patients, because it ends up being a very minimal touch. I am not sure
what their outcomes are, but generally, when the client continues to use and is unable to
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maintain, then they end up trying to refer them to us when the patient is more severe.
Maybe if we could have gotten them earlier and actually provided the appropriate level
of treatment.– 2018 mental health and substance use regional focus group participant
A number of study participants noted that partners were not accustomed to the level of
reporting or oversight that projects demanded, and this led to frustration on both sides.
[Partners are] struggling with understanding that we’re asking them to implement an
evidence-based intervention related to the project, and integrate some form of quality
improvement to ensure they are reviewing what they are doing, and that they are doing
it within acceptable standards. I think a lot of partners were used to being able to say, ‘I
did something,’ but not having to demonstrate that they did it with any rigor. – 2018 PPS
key informant
If we want to become integrated, the paperwork that needs to happen for us to be able
to provide medical care in our mental health clinics is crazy. –2018 mental health and
substance use regional focus group participant
A lot of partners felt that PPS took too long to engage them initially, and that lag continued into
the first years of the DSRIP program. They expressed frustrations about contracts taking too
long to take effect and PPS committing to work that never actually got off the ground.
We have a project with a PPS where they’re going to be putting nurse practitioner
physician assistants in some of our programs and we’re going to put social workers in
some of the PCP offices in the community. That contract has taken over a year, not on
our side, on their side, the PPS side, to formalize and sign. It also seems that the mental
health providers are the ones that have to make all the changes, not so much the
providers on the health side, the physical side of the PCPs. –2018 mental health and
substance use regional focus group participant
I feel like it’s Groundhog Day we keep having. It’s been a year and we keep having the
same conversation over and over again. You sit at the table – I won’t mention the
hospital – but you say you’re going to work with us and this is where we need to go, and
nothing happens – so are you just doing this for show? It’s very frustrating because we
do make so many changes. The CBOs make such efforts so they really want this work
and they really want to form the partnerships, and the PPS come in and say, “Yes, we’re
going to do this,” and nothing happens. – 2018 mental health and substance use
regional focus group participant
4.2.2.1.3. Educational Resources and Training
All PPS provided educational resources and training to partners, including education to improve
organizational capacity to provide services and to participate in the DSRIP program as well as
trainings for partners’ service provision staff. Nearly all PPS key informants and a majority of
focus group participants reported that the resources and training PPS provided to partners
resulted in higher levels of engagement and participation. They believed that materials such as
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community resource guides and project toolkits helped partners not only implement projects
but think “outside the box” in their approaches. Partner staff trainings, which may not have
been accessible to smaller organizations if they were not offered by the PPS, were said to
improve service quality (for example, through cultural competency trainings) and capacity (for
example, by training tobacco treatment specialists).
And training and education has been a very big thing – we’ve been able to get access to
training that we would never have access to before, at a very high level. – 2018
community-based organization regional focus group participant
A number of PPS were successful with helping their partners achieve National Committee for
Quality Assurance (NCQA) Patient-Centered Medical Home (PCMH) 2014 Level 3 Recognition.
Key informants attributed this success to the additional resources and training that they were
able to provide with DSRIP program funding, particularity for smaller practices which would not
have been able to accomplish this otherwise.
The work getting primary care practices PCMH recognized, we ended up being able to
touch a lot of practices especially the small ones that wouldn’t have been able to do it on
their own…close to 100 sites getting Level 3 recognition due to help and resources PPS
was able to provide. - 2018 PPS key informant
Although many regional focus group participants reported positive thoughts on the education
and training offered by PPS, some believed that the trainings could have been expanded to
cover a wider array of topics and could have been targeted at specific organizations and
positions. Additionally, several partners would have appreciated trainings on the services other
partners provided so that everyone was familiar with each other’s work and could make
appropriate referrals.
So we’re going to build these teams of care coordinators, but we’re not going to let
providers or primary care physicians know that there are these people that are not case
managers, that are mainly focused on medical and mental health, are out there and can
be a support and an ally in the community. That information was never shared, or
maybe to the extent that it should have been. - 2018 primary care regional focus group
participant

4.2.2.2. Performance Measures
In Demonstration Year 2, clinical improvement (Domain 3) Pay for Performance measures
began, and in Demonstration Year 3, all system transformation (Domain 2) Pay for
Performance measures shifted to Pay for Performance. As the DSRIP program continued,
funding progressively shifted from Payment for Reporting to Payment for Performance.
By the end of DSRIP Demonstration Year 4, Domains 2 and 3 would be completely Pay for
Performance.
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Key informants from PPS reported being unsure where to direct their efforts as Pay for
Performance measurement began. They noted that many PPS focused so heavily on meeting
the project milestone requirements early on, it was difficult to later shift focus toward meeting
performance measures.
Part of my concern with that is that we are moving into Pay for Performance, but we
are spending a lot of time in our practices working with EHRs88 and changing
workflows when really, we have to be focused on the outcome or performance
measures. With so much of the focus now on performance, we are still spending a
lot of time trying to build the EHR screen and the workflows around getting this
done. My concern is that we aren’t spending enough time on more of the
performance-related requirements. – 2017 PPS key informant
The way the program requirements were laid out initially, it really drew our attention to
the details around meeting project requirements and checking some boxes (I hate to say
that, but there was a lot of box checking that went on to satisfy those project
requirements). The other thing was the emphasis on that, as opposed to some of the
performance aspects early in the formation of the program, really sent a lot of the PPS
down the path for both an incentivization model for the partners and a focus on the
activities and resources that we brought on board to execute on the project requirements,
but they were worth a relatively small amount of money and I think just took a
disproportionate amount of resources. It was also the clearest path we had initially, we
knew what was expected and we could march in that direction, where the performance
improvement pieces were a little more ambiguous, especially given the data challenges. –
2018 PPS key informant
Respondents expressed that the initial emphasis on project milestones did not align with
subsequent performance measures, which had the unintended consequence of diverting focus
away from building a meaningful infrastructure and completing projects.
Of the [number] projects that we chose, some of the requirements of those projects,
process milestones, had no relation to how you were later judged in DSRIP as far as pay
for performance. There were some things that were sort of contrary to actual pay for
performance measures. You may have spent your time hiring nutritionists to meet a
requirement, but you’re later going to get judged on medication adherence. We spent two
years setting up projects that were valuable to impact patient care but might not have the
impacts that we’re being evaluated on in the latter years. – 2018 PPS key informant
There’s been a tremendous focus on getting project requirements met, but what we
are finding is that it doesn’t necessarily translate to performance on outcome
measures unless other innovative things are done. – 2017 PPS key informant

88 Electronic Health Records
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We spent the first 18 months of DSRIP working on the projects and the milestones
required by them, and now we’ve made what we fondly refer to as the pivot, where
those projects are operational and being managed, but we are almost doing wholly
separate work on the specific goals. We had a DSRIP phase 1 and a phase 2, and
we’ve had to flex our resources between the two. A lot of the early milestones had
nothing to do with the performance measures, but now we are working on the
performance measures. – 2017 PPS key informant
A number of partners were concerned that this shift toward Pay for Performance might
leave them behind.
I think some of those infrastructure issues that have hampered our participation, I
think of this junction as they move into performance-based payment is just leaving
us behind, and the medical folks are going to move forward. Because we don't have
that capacity, when interestingly the biggest effect on the scores are going to occur
by our participation. – 2017 mental health and substance use regional focus group
participant
4.2.2.2.1. Challenges with Domain 4: New York’s Prevention Agenda
Each PPS selected and committed to at least one (and up to two) projects from Domain 4,
which focused on priorities in New York State’s Prevention Agenda and were designed to
impact population-wide health. Performing Provider Systems could select project categories
that corresponded to, but did not duplicate, efforts related to their Domain 3 projects in the
following topic areas: promote mental health and prevent substance abuse, prevent chronic
disease, prevent HIV and STDs, and promote healthy women, infants and children.
Under Domain 4, while PPS appreciated the flexibility that came with developing their own
milestones in the sense that they could focus more directly on their work, the lack of
predefined targets sometimes created confusion during project implementation. Respondents
stated it was difficult to develop and guide projects without clear, pre-established deliverables.
With the [Domain 4 project], it appeared like the group was struggling because there
weren’t direct targets to go after, or direct metrics. It seemed that they had been
floundering for a little while deciding what it was they actually wanted to do. I think that
was a different sort of set of challenges as opposed to having metrics that were hard to
decipher in some way or were sort of ambiguous. Not having output metrics to guide
project development was kind of equally confusing for people. – 2018 PPS key informant
When the group came together, there was a lot of enthusiasm, but it was like, “What
exactly are we supposed to do?” We’ll define what we are going to try to accomplish and
make our own milestones, but each step of the way there was a sense of, “Are we doing
what we are supposed to? Are we doing the right thing?” Lack of definition in Domain 4
was sort of a curse in that respect, but also a blessing in that people were relieved to
have the freedom to identify the goals they thought were the most important, and not
be spending a great deal of time trying to configure reports to meet some specific
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reporting metric that had been defined by DOH. It was a relief not to be caught in that
bureaucratic exercise, and to focus on the work. – 2018 PPS key informant
Some key informants also stated that the lack of strong requirements and flexibility within
Domain 4 had the unintended effect of making it difficult to prioritize those efforts.
I think all the Domain 4 projects are so vague…sometimes the things that are vague or
don’t have strong deliverables can take a back burner. It would almost have been unwise
to prioritize that over things that were actually due. If I were doing it again, I don’t know
that I could recommend a ‘blank slate’ that was the Domain 4 projects. – 2018 PPS key
informant
Way back in the beginning (probably even while we were still in Year 0) for Domain 4,
coming from DOH, these projects were referred to as “free money,” as basically Pay for
Reporting. That made it very challenging to make them priorities and really get them as
much attention as some of the other projects. In some ways that was justified, but the
whole thing where they were referred to as “free money” was really not helpful in
getting some momentum behind them. – 2018 PPS key informant
4.2.2.2.2. Criticism of the Projects Approach
Some respondents felt that the projects reinforced the health care delivery system’s siloed
approach and distracted them from reaching the broader DSRIP program transformational
goals.
The emphasis on the projects in the beginning may have been the wrong emphasis if the
state were hoping for mass systems change. It may have been a little too specific, and
while resulted in sort of really good microsystems of care, it may have not resulted in the
“health care systems of the future” that they were looking for. It may have only moved us
more incrementally in that direction. – 2018 PPS key informant
I woke up one day and realized we weren’t providing patient care. We did an
excellent job along the way checking off the boxes on our projects, but I can’t say
whether that has made a change for patients. We’ve been extremely successful
wasting dollars on the projects. We’ve gotten the marks for getting the boxes all
ticked. Once you get out there bringing these community neighborhoods together,
you realize the transformation is not about specific projects. It’s about bringing
people together, determining what the goals and objectives of the referral
relationships [are], and connecting people with each other through IT systems in
some form or fashion. Care management from the simplest form of it to the most
complicated is the key to the whole thing, but it’s care management from people
who are not organizationally related except through referral relationships. That’s
where transformation takes place. The biggest problem with the projects is that
they have interfered with the meaningful transformation. Our challenge has been,
“How do we do something meaningful while checking the boxes?” We have had
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some success doing that, but all the boxes we’ve had to tick have gotten in the way,
and we could have done more, faster, at less cost if we didn’t have to do that other
stuff. – 2017 PPS key informant
I would like to see them become focused on tangible, meaningful goals, not arbitrary
metrics. The goal is to save money for the health system. The goal is to reduce
hospitalizations. I would like them to engage in projects that have near-term, tangible,
measurable results that do those things as opposed to these pie-in-the-sky ideas, which
likely will never come to fruition. - 2018 hospital regional focus group participant
From the very beginning, we thought it was very ironic that the purpose of DSRIP was to
break down the silos in the delivery system, and then it was designed to do so through
siloed projects. – 2018 PPS key informant
The collaboration we have seen among our partners in the last year or so has really
been gratifying and amazing, but if we were able to focus on the activities with our
partners that we feel will have the biggest impact and decrease the focus on some
of the specific requirements of those projects, I think we could probably advance this
thing better and faster. – 2017 PPS key informant

4.2.2.3. Funds Flow
The amount of time it took PPS to distribute funds to their partners varied. In some cases,
partners’ experiences with funding differed based upon the level of PPS infrastructure that
existed prior to the DSRIP program. New Corporation (NewCo) PPS, without established
infrastructures, more often struggled with delays and lapses in the flow of funds. However,
some partners preferred the direct payment model of the new entities, rather than the hospital
or health-systems based PPS, which they described as having more indirect payment models.
Many PPS were successful in quickly moving the funds out to partners, and felt they were
rewarded for those efforts.
One of our successes is that we’ve received 97% of the available funds to date. We
are a small, lean-running PPS, so we don’t put a lot of money into building capital.
More than 85% is put back into our partners, and all of that has gone to our
partners successfully. We are very transparent with our funds flow and how it works
and how funds cycle back to them. We try to maximize all available funds, and it’s
been a great success. – 2017 PPS key informant
We were able to get money quickly out to partners, which helped us out in the long
run. We created educational documents and webinars for the partners to teach
them why we were doing things in a certain manner. It allowed us to have an
opportunity to flow our funds quickly, and the required documentation and
information was submitted timely and accurately, so it made our jobs easier when
these partners were on board and up to date. We knew exactly what we needed, so
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our partners were on the ball in terms of providing things to us. – 2017 PPS key
informant
Other PPS described why they dispensed funds more slowly.
We had challenges with funds flow. This whole idea of getting funds out to partners
as quickly as we can, but having some accountability for what they do with those
funds without having mature reporting structures, expectations, and deliverables...
It concerns us to this day. We were trying to be very conservative, cautious, and
accountable in what we were doing, but we were also trying to meet the demand
that our state and our partners had in trying to get funds out the door. – 2017 PPS
key informant
Funds flow was difficult for us at the beginning. We had to flow dollars to
organizations that would make meaningful changes, while also flowing dollars to
the CBOs. In addition, we have a 5% cap on CBOs for safety net providers. We got
called out on the funds we were flowing, and we had to justify why funds weren’t
flowing to the CBOs, but it was difficult to figure out how to do it in a meaningful
way. – 2017 PPS key informant
Several PPS key informants perceived that the Independent Assessor’s reports did not
accurately reflect the progress they had made in pushing out the funds, especially to
community-based organizations.
I’m proud of that and the fact that we’ve done a really good job as financial
stewards of the funds we’ve received. The pushback, then, that none of the money
was flowing down to the CBOs, much of that was an artifact of how we had to
report. We spent a lot of money that was going to care providers, and it went to the
hospitals first, but a great majority of it was going to people providing flow. It was a
categorization problem as well as a reporting problem. We’ve started to switch the
way we report so that it’s more of an accurate report of the way we spend. – 2017
PPS key informant
A number of partners and key informants said that the 5% funding limitation89 to nonsafety net providers versus the 95% to safety net providers had alienated key partners
that were fundamental to the DSRIP program’s success.
We are a private practice in a rural county and see about 17% Medicaid but do not
meet the criteria as a safety net provider. The resource sharing seems too heavily
weighted towards safety net providers who are not typically as efficient or as
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nimble in the market place as we have to be in private practice. – 2017 partner
survey respondent
The 95/5 rule has been a great challenge for us, because we have been supporting our
Tier 1 CBOs throughout our region, but getting hung up on that we’re being held to we
can only support them with only 5% of that funding. Keeping in mind that CBOs support
nearly every other non-preventative project with regards to the social determinants of
health, basically retraining and training our workforce partners and also with the patient
engagement project, so that’s been a definite challenge. – 2018 PPS key informant
Many partners reported a desire to see the NYS DOH monitor whether funds flow was
indeed making its way to non-hospital participants, including community-based
organizations and clinical practitioners.
The State should more closely monitor the funds flow between PPS and the
community-based partners. The community partners are engaged but are not
sufficiently compensated for their time/effort. – 2017 partner survey respondent
Unquestionably to get appropriate and effective funding to CBOs, CMS and the
State will have to "carve out” real funds for CBOs to implement projects. Since the
CBOs have had so little opportunity within DSRIP to demonstrate what their
programs can do---many of which may not fit into the "siloed" official DSRIP
projects but do bring down hospital use---they will be in an even worse position for
VBP. – 2017 partner survey respondent
I think one of the challenges has been to actually get the funds. My understanding is that
the hospitals are holding onto the money and they’re not really releasing it to the CBOs
that really need it to do the work and are helping the hospitals meet their targets.
There’s a lot more being put on the CBOs – more responsibility in treating clients and
keeping them out of the hospital, but without the necessary funding that we really need.
– 2018 mental health and substance use regional focus group participant
[Hospital] has got the money from the state; they have not distributed that money to
practices. They have not. They have kept their money in their pocket. I know because I
have been to practices on behalf of [hospital], and they don’t even pay me, let alone the
practices. – 2018 primary care regional focus group participant
We’re not really getting the money that we need to do this work, and you don’t want to
get yourself so in the red that you need to close a program. You have to be very smart
about how you balance that. We got a lot of mixed messages. You started with how it
affected behavioral health and SUD90. Most of the PPS wasted the first two years before
they even thought about behavioral health and SUD. Our services are the ones that
really impact emergency room costs, also there are other ones that could help achieve
90
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most of the goals on 2.a.i., 3.a.i., and most of the integration projects. Of the nine [PPS]
that we are in, seven of them stood on the sidelines scratching their heads and collecting
money. Most of them never paid DY1, DY2 incentive dollars to behavioral health and
SUD providers. Despite lengthy emails and exchanges that they are going to include us,
three and four years later, “You never executed an agreement, all you executed was an
attestation.” I am not a lawyer; send me an agreement. – 2018 mental health and
substance use regional focus group participant
Meanwhile, partners from hospitals reported that the funds were not significant enough
to make meaningful change to the health care system.
The funds flow to partners, especially hospitals, has not been significant enough to
propel change that will transform the way we provide services. Rather, DY0-2 has
felt like an exercise in “checking boxes” to meet goals on paper. Until VBP is here
across all payers hospitals still need to operate within the FFS 91system. Until funds
flow to hospitals to truly offset the cost of a volume decrease of 25%, there won’t
be incentive to change. – 2017 partner survey respondent
I would increase PPS reimbursement rates for hospital partners. Prior to DY3,
hospital systems were reimbursed for the coordination of services for Medicaid
discharges. However, current funds flow models reimburse hospital systems simply
for a report of the Medicaid discharges monthly. – 2017 partner survey
respondent
Partners also reported challenges with delays related to funding and other contractual
hurdles to their work with the PPS. For example:
[PPS] has presented its contracts to us both years at least six months late, creating
tremendous cash flow problems for us. In fact, this year's contract just arrived last
week; they changed key provisions without even asking us… – 2017 partner survey
respondent
My organization still does not have a contract for this year...so we have no funds
flow. I know how much we've earned and I know how much we've gotten paid and
there's a very big discrepancy between the two because the payment doesn't
happen until there's a contract and of course that’s way above my pay level, but
that concerns me. – 2017 primary care regional focus group respondent
But in terms of us as an organization -- what we also do, we what really do – this, there’s
nothing there. Luckily enough, we had income to fund ourselves until we could receive
payment for the project that we were doing. We didn’t break even for almost a year, in
terms of the salaries for the workers, the training that we provided, the day-to-day of
providing the service. – 2018 hospital regional focus group participant
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4.2.2.4. PPS Overlap
In New York, 33 of the state’s 62 counties had only one PPS entity, while the remaining 29
counties had an overlap of between two and six PPS. In regions with PPS overlap, some
providers worked with multiple PPS on DSRIP projects.
Partners were often frustrated with conflicting interpretations of DSRIP program rules by
different PPS. For example, a partner in two different PPS sometimes received different
guidance on how to handle a rule change or project guidelines. Partners sometimes felt
overwhelmed by working with multiple PPS administrations, and struggled to meet DSRIP
project reporting requirements.
A number of our high attribution partners are spread across/participating in more than
one PPS, and each PPS has their own strategy, tactics to carry out, the DSRIP required
work, and long-term required strategies that differ. A lot of our partners seem to try to
find a common denominator among all the PPS, and sometimes that is the minimal type
of work you can expect back from partners, when our PPS may be asking for a little more
aggressive-type work. – 2018 PPS key informant
These partners want more alignment across PPS so they aren’t doing things three
different ways for three different PPS. It’s hard for us to change course later on. We’ve
had to collaborate with partners after the fact, which has been immensely challenging. It
would have made sense not to have 10 PPS in the NYC area, but at this point, it is what it
is. Some partners complete four different surveys for four different PPS. – 2017 PPS key
informant
Being a part of nine different PPS, they all have their own intricacies and things.
Sometimes it was difficult to work with the staff because, depending on what PPS was
involved in that particular area, it was working on different projects. So where one project
may be working on peer services, another may be working on integration, another may be
working on integrating medical services. – 2018 mental health and substance use
regional focus group participant
When partners first learned about DSRIP, they signed up to participate with multiple PPS,
and along the way became fatigued and either did not comply with the contractual
obligations or simply said, “I want to remain a partner, but I can’t get anything done this
year because I’m busy with my other PPS obligations.” Fatigue impacted their ability to
implement projects and to demonstrate their implementation of those projects through
reporting. – 2018 PPS key informant
Respondents described challenges with keeping track of which patients were attributed to
which PPS, and felt that the need to focus only on “their” patients was sometimes a distraction
from their work or encouraged other PPS to transfer patients to their own partners.
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We may be affecting outcomes of patients that are attributed to a different PPS
than our own. How well our outcomes improve are not only related to our own
efforts, but to the efforts of the other PPS downstate, which made it a benefit for us
to align projects together. – 2017 PPS key informant
When they go into the hospital, the first thing they try to do is move you over to their
doctors, even though you are happy with your primary, because this hospital’s [PPS]
doesn’t have enough patients yet. – 2018 hospital regional focus group participant
I love that answer. “You weren’t in our attributed lives.” What is so crazy is we are living
where we are, we all impact each other, and that elderly person moves now to their
daughter’s house in a different place; it’s a moving target. If we are going to impact
change, allow us to impact change and don’t worry about your specific attributed lives. 2018 hospital regional focus group participant
I think we are challenged in this area more than some because of the way our PPS overlap
and also with our shifting attribution. At the last all-PPS meeting they referenced that
attribution didn’t shift that much, but I think there’s a handful of PPS that really had a lot
of attribution shifts, and I don’t know if that’s because of our overlapping nature. – 2018
PPS key informant
Some PPS key informants said that attribution shifts made it more difficult to provide feedback
to providers, resulting in missed opportunities to engage clinicians and illustrate their efforts
and results.
With that attribution problem, it’s really hard for us to, again, go back to the clinicians
and make it real to say, “These are definitely the patients that you are caring for that are
driving these measures,” and making that linkage so that they can understand that. So
that has been, from a data standpoint, the biggest challenge is really being able to give
that feedback loop back to the providers to say, “Okay, you implemented this project or
this program and this is the effect it had on your patients,” and making that real from a
reporting standpoint. -2018 PPS key informant
Most respondents in overlapping PPS said that it would have been preferable if there was only
one PPS per region. They said this would prevent confusion and fatigue among PPS partners, as
well as reduce inefficiencies in the investment of time and resources in areas where other PPS
were established. Key informants from PPS noted that they had not originally built their service
models to be collaborative; thus, they found overlap difficult.
I hope the state sees this as a lesson learned to not have multiple PPS in one region. We
have a problem with attributed membership going back and forth between multiple PPS.
This causes a lot of confusion for the CBO partners being part of multiple PPS, deciding
which PPS to align with, but you still have attributed membership that is part of all of the
organizations. Multiple PPS in one county is a problem. – 2018 PPS key informant
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I think there’s been a lot of issues derived from mixing counties across PPS. It’s incredibly
impractical for us to dedicate resources to patients in a county that we do very little
business, in a county that already has infrastructure set up at the PPS level and is already
doing this work. It’s at best an inconvenience and I just think it’s very inefficient. I guess
the question for me would be “why?” – 2018 PPS key informant
There should not have been overlap on projects. In hindsight, maybe it sounded
wonderful when they were designing it, but with all of this effort to work together,
things are still not operating at 100%; the providers and partners are getting
different things from each PPS. A lot of providers were doing multiple surveys on the
same topics, and we couldn’t coordinate fast enough. There has to be a better way
next time. – 2017 PPS key informant
Finally, while PPS key informants acknowledged challenges with overlapping PPS at the design
and initial implementation phase, some felt they had overcome these challenges by
collaborating with other PPS to develop similar reporting requirements and alignment of other
procedures.
We deal with a lot of overlapping providers, and we had to discuss early on as to
how to divide and conquer the work. It was a challenge, but we had some elegant
solutions to that. The PCPs only had one PPS to work [with] within this agreement,
which was really helpful for us in the end. Behavioral health providers are involved
in both PPS and are committed to shared outcomes and shared goals. It is a real
commitment regionally. – 2017 PPS key informant
We’ve gotten challenges with providers in two or three of our sister PPS, but on the
other hand, we’ve placed more emphasis on collaborating to try to overcome those
challenges with an “all must rise” philosophy. The medical directors have tried to
come up with similar sets of reports that would be easier for our participating
partners to fill out one set of forms, rather than multiple different sets. They’ve
really worked hard to try to coordinate the efforts, and we did one community needs
assessment for the entire region. – 2017 PPS key informant
The other thing I think for partners is that they had multiple potential sources of support.
One PPS was offering technical assistance for the PCMH, the other one was offering
funding for the RHIO connection, meaning that whatever you as a partner needed, there
was three stores you could go shop at, not just one. So I’m hopeful that it made them
actually able to close their gaps more easily. – 2018 PPS key informant
We have developed pretty good systems for working together. In the beginning, there was
not a lot of understanding of what it meant to sign up for a PPS, so I think letters and
information were sent out to many providers within the community and people signed up
for multiple PPS… so from the attribution methodology, could be in both PPS. We have
worked very collaboratively with [other PPS] leadership and have developed ways of
“we’re only going to reach out to these providers, they’re only going to reach out to
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those” and we have developed ways of working around that but also collaborating
especially in the behavioral health area and a few other areas…and partnered 100% on
those and we do joint funding to all of our partners in that area. – 2018 PPS key
informant
4.2.2.5. Value Based Payment Preparedness
Partners and PPS reported devoting a lot of attention to preparing for value based payment
(VBP). While several PPS key informants stated that all DSRIP program activities were preparing
partners for the move towards value based payment, they believed that the trainings and
resources provided to their partners were particularly helpful. Almost all PPS provided
significant partner education activities for the shift to value based payment, including trainings,
videos, webinars, workshops, conferences, and symposiums, and the NYS DOH offered “VBP
Bootcamp” and “VBP University” programs as well. Key informants felt that the trainings were
well-received and helpful in educating partners about how to operate in a value based payment
environment.
A lot of what we do is tied to the shift to value based payment. We had some VBP
educational series ourselves that we launched to our partner organizations in
conjunction with our overlapping PPS. We’ve created an account management team
that focuses on going out to visit partner sites to educate on how the work they do as it
relates to DSRIP ties to VBP and how they can align themselves with VBP. – 2018 PPS key
informant
Focus group participants had mixed responses about the value based payment education they
received. While many partners felt that the value based payment trainings they participated in
were well done and helpful, others did not like the format of the trainings, did not believe
useful information was provided, or did not feel they gained enough knowledge to enter the
value based payment landscape confidently.
Best practices and things like that have not been shared broadly, or have only been
shared in a finance-directed way, and not so much in a general administration way.
What needs to be done to support the contracts? Not how do you write the contract or
negotiate the contract? All of the VBP boot camps I have gone to have been very
finance-driven or contract management-driven, where it’s about how to negotiate
contracts -- not from the health care administrator perspective, which is how to develop
the organization to support these contracts, or poise the organization to be successful in
these contracts. – 2018 hospital regional focus group participant
One thing I would like to change is the VBP training. I had to take the VBP training92
because that was a requirement. When I clicked the YouTube link, I laughed. Everyone,
all the staff who had taken the training, they laughed because it was really a total waste
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of money. I don’t know, did they pay to create that thing? – 2018 community-based
organization regional focus group participant
Each PPS had partners that started from different points of value based payment preparedness,
and many PPS launched surveys and listening tours to learn more about their partners’ needs. A
number of PPS key informants reported targeting some support specifically towards
community-based organizations, since they were often less prepared for the shift to a value
based payment environment than medical providers.
As we move towards the VBP model, we’re working with each of those [CBO] partners to
determine, “Well, if we’re going to contract with an MCO, what is your contribution?
What should you be measuring? What should you be saying is your value statement?” so
that when we get into potentially risk-based or capitated models, that they can say,
“Okay, this is the part I contributed to the overall success and I get paid on that.” That’s
a very challenging formula for a primary care office; it’s a near impossible formula for a
CBO. We’re really trying to tackle that…we’re actually hosting roundtables and stuff like
that with the CBOs to work through some of those questions. – 2018 PPS key informant
Because we recognized early on that many of our social service providers did not have
the infrastructure or the capacity to successfully compete in a VBP-arena, we realized we
needed to do some of the work to be able to guide them along the road. We offered the
capacity-building assessment to 90 of our providers and 62 picked up the offer and went
through an elaborate assessment process, which then had learning collaboratives
specifically for social service providers. Our CBO partners were extremely grateful that
we were paying attention to their sector in particular, because most of the work has
focused on health care providers. We want them to be able to have conversations with
MCOs about how their services impact the social determinants of health and increase
health outcomes. - 2018 PPS key informant
Despite these efforts, focus group participants voiced frustrations about the value based
payment system excluding community-based organizations. Even when trainings were aimed at
bolstering their strengths, they believed that the model was not set up to include them.
The value based payment system still was only clinical and medical, it was not based or
built on CBO. - 2018 community-based organization regional focus group participant
In addition to education activities, PPS invested in infrastructure to prepare for value based
payment. Specifically, PPS used DSRIP program funds to increase information technology
connectivity and data analytics capabilities to better prepared their partners to operate in a
value based payment environment.
[Information technology] connectivity, the ability to subscribe to activity happening
outside of their organization, prepares [partners] for VBP so they don’t order repetitive
tests; we’re helping them set up systems so they can see outside of their organization. –
2018 PPS key informant
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Several PPS key informants also increased engagement of managed care organizations, which
they saw as key for a successful transition to value based payment. Having managed care
organizations at the table was viewed as crucial since they will be negotiating contracts with
partners in a value based payment environment. In addition, a number of PPS key informants
reported hiring consultants to help them with the transition to value based payment.
Partner survey results suggested that these activities were fairly successful at educating
partners about value based payment. More than three-quarters of respondents characterized
themselves as “very knowledgeable” or “somewhat knowledgeable” about value based
payments (82.2% in 2017; 78.9% in 2018). About three-fourths of respondents’ organizations
had made changes to prepare for value based payment (73.7% in 2017; 78.9% in 2018).
However, most still said they required more resources to facilitate the shift to value based
payment (83.7% in 2017; 80.4% in 2018). In 2018, over 90% of respondents at clinics and
behavioral health organizations said they required more resources, while fewer than 75% of
respondents working at skilled nursing facilities, hospice/palliative care, government offices,
non-primary care practitioner offices, and pharmacies required additional resources.
Partner survey respondents who said they needed more resources to facilitate the shift to value
based payment were asked which resource would be most helpful. Almost half (46.9%) said
they most needed additional funding for infrastructure changes, and almost one-fifth requested
one-on-one consulting. About 10% listed improved access to performance data, additional
training, or peer training and support (see Exhibit 4.4).
There was some variation in these resource needs by organization type. More than two-thirds
of respondents from hospitals and more than half of community-based organizations cited
additional funding as most helpful. One-on-one consulting was chosen by at least one-quarter
of respondents from non-primary care providers, clinics, and government offices. At least onefifth of respondents from substance use treatment organizations, clinics, and health home/care
management programs selected improved access to performance data. Peer training and
support was most common among respondents from skilled nursing facilities and
hospice/palliative care centers.
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Exhibit 4.4. Which of these resources would be MOST helpful to your organization’s shift to
value based payment? (N=688)
itional funding for inftastructure changes

46.9%

On...cn-ooecons"lting -

18.3%

Improved access to perforrmnce d•t•

-

10.5%

Additional training

-

10.3%

Peer training and support -

10.0%

Oth!r

1 3.9%

Source: Authors’ analysis of the 2018 statewide partner survey.
Note: Responses do not total 100% due to rounding.

Within the framework of value based payments, many PPS described tensions that they were
facing before the full transition to a value based payment environment. Key informants at PPS
and partners noted that as they had early successes in meeting performance measures like
avoidable emergency department visits, they were losing financially, as their hospital
admissions went down:
There has been a constant tension in this program that we are moving to VBP,
because the more we reduce avoidable visits, the less we get paid. If we do our job
and have success, we lose pay. That doesn’t mean we aren’t moving to VBP. This
group is really tuned into that. It makes reimbursement precarious in some respects,
though. – 2017 PPS key informant
We went from 24% to 13% of emergency department patients being admitted. It
has had an impact on us in terms of reimbursements. There is a disconnect at the
State level because the money hasn’t caught up to what the State needs us to do
(i.e., reduce hospital visits). They should be giving grants to those who are making
the change. We are losing money by implementing. – 2017 PPS key informant
When asked if value based payment would help sustain DSRIP program projects, PPS key
informants provided mixed responses. Some believed that the projects were not important in
the end, but were primarily a means for the PPS to organize and identify what they would need
to proceed with value based payment. Others felt that since value based payments were not
aligned with the work being done through the projects, they would not be sustainable beyond
the DSRIP program. Many of these respondents believed that collaboration with managed care
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organizations was integral to sustainability, and that DOH should have facilitated these
collaborations as part of the DSRIP program. However, several PPS key informants said that if
negotiations with managed care organizations were fair, their projects would be sustainable.
Additionally, a few reported that although they were less optimistic about sustaining projects in
the short-term after the DSRIP program ended, they believed that in the long-term, after more
health care transformation took place, projects would be sustainable.
Focus group participants voiced concerns about being able to demonstrate their value for value
based payment contracts. Many partners reported they lacked the data access and capabilities
to show managed care organizations the value they provided, which made them fear they
would not be able to sustain their work.
If we had data from the payers, we would know when our patients were rehospitalized,
because we don’t see claims. I don’t know how that would all work, but it’s hard to know
what kind of value we are producing or creating because we don’t see the whole picture.
That’s a challenge. - 2018 hospital regional focus group participant
It’s very hard for community-based organizations to understand how you fit in, how you
can price your services, because we don’t have data that isolates what our value is. After
all this time, we understand that’s what we need, but there really hasn’t been much
emphasis on trying to tease that out to see what we contribute to the overall picture
because we don’t have directly billable services in many cases that you can look at
claims to see. We’re part of the value based purchasing world. Probably almost all of our
organizations are involved in one form of network or another that’s forming
[independent practice associations] so that we don’t lose our place, but again, it’s very
hard to understand how to price out our services within that, put a value on them. Even
though we all kind of know it, we don’t have the hard data. – 2018 community-based
organization regional focus group participant

4.2.2.6. Data Access and Sharing
Data access and sharing was a significant issue throughout DSRIP program implementation. The
PPS and partners were frustrated by difficulties accessing data provided by NYS DOH, and PPS
were not always able to access the data their partners were collecting. Respondents described
substantial challenges with data lag, data access, and data sharing.
4.2.2.6.1. Accessing Data from NYS DOH
The PPS did not have full access to NYS DOH electronic data during Demonstration Years 0-2,
which made it difficult to obtain the information they needed to develop projects and track
progress. Performing Provider System key informants were frustrated by the delays in gaining
access to the full spectrum of needed data.
Once data access was obtained, ongoing reporting lags remained a significant challenge that
prevented PPS from knowing their current performance level and adjusting interventions as
necessary. Key informants from PPS found the Salient Interactive Miner (SIM) and the Medicaid
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Analytics Performance Portal (MAPP) to be useful, but less actionable than it could be for PPS
and partners. Without real-time data, it was not clear whether efforts were influencing
outcomes, and it was a challenge to provide effective guidance to partners.
It would have been helpful to lessen the lag with the outcomes data so that partners can
see their investment, and how their investment is or is not paying off. Either way, it is a
challenge to say, “you’re still not getting it right, because the data is showing that,” or,
“you’re hitting it out of the park and doing great,” or, “you’re supposed to be hitting it
out of the park, so adjust your efforts a little bit and try to make it happen.” By the time
they get data it is so long after they put in the effort. –2018 PPS key informant
Partners echoed frustrations with their inability to measure real-time impacts due to the data
lag time.
We are doing the work, but we just don’t know what the outcomes are. We rely on
PSYCKES93, which is great, but it doesn’t really have up-to-date data. It’s Medicaid
generated, so things are not seen for three months. We don’t know if a client did go for
their test or not, or did they pick up their meds? All the data that we need, we can’t
really extract real-time data. -2018 mental health and substance use regional focus
group participant
PPS key informants also reported that certain types of data they expected were not available.
Overwhelmingly, PPS and partners struggled to obtain data from managed care organizations,
noting the importance of managed care organization data and collaboration to system
transformation. Some key informants expressed they lacked necessary claims data for Pay for
Performance measures, and explained that data on cost associated with care would have been
helpful for partners to understand their financial impacts in preparation for value based
payment opportunities. Other respondents felt limited in their ability to provide care for
patients with substance use issues without access to patient substance use data.
I was at several meetings at several different PPS, and people around the table would
say, “We need someone from managed care here. Why isn’t there anyone from
managed care here?” That was two years ago, and finally, they just gave up asking. I
don’t know if they couldn’t get them to the table, I don’t know what the reason was, but
a lot hinges on them and them giving us claims data so that we can see how we can
make an impact. If we want to do a before and after study on asthma, for example, we
need to know if this child has had multiple hospitalizations, and what was the cost
before the intervention so that we can show that it made a difference. – 2018 hospital
regional focus group participant
I don’t think anyone sufficiently considered at the launch of DSRIP the fact that the PPS,
as a PPS, are not legally entitled to contract for care; and absent the contract for care,
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most of the MCOs would not and will not share data directly with the PPS. –2018 PPS
key informant
It would be great to know the cost associated with the care so we can have a better
sense of what we’re trying to do with value based care. We don’t know the value if we
don’t know the dollar signs. We have great statistics that show over 50% reductions in
emergency room visits, but we really don’t have the sense of what the financial impact
of that reduction is. –2018 PPS key informant
4.2.2.6.2. Sharing Data with Partners
Patient privacy regulations also prevented PPS from sharing some types of data with partners,
which reduced its utility.
Here we are in Measurement Year 5 and even if we had all the data at our fingertips, the
reality is that we are very limited as a PPS with what we can share downstream. There’s
been a tremendous amount of confusion and dialogue and limited documentation; and
even with documentation, confusion about comingling of data (“what does that mean?”),
what we can share with our partners downstream, even what defines a partner relative to
attribution. We do talk to our PPS colleagues, everybody seems to interpret it very
differently…we err on caution on things because we are obviously very concerned. We
share minimum information with partners downstream, we have not really shared much
with the CBOs. Where we’ve wanted to implement some interesting interventions and
activities, particularly around patient engagement and unengaged patients, if you can’t
give a partner (particularly a CBO) a patient’s address, for example (because that is not
allowed, at least in our interpretation), it’s meaningless. –2018 PPS key informant
The State knows who the super-utilizers are, and they’ve provided PPS with the
patient data. I’ve been saying it for three years, if they just provide the patient data
to us, we could tell you exactly how we can impact this, and we probably could have
been doing it two years sooner. – 2017 mental health and substance use regional
focus group participant
What we attempted to do to get around [patient privacy regulations] was to use
claims data to identify which providers had touched those patients so that we could
send the information to those providers. The State has now said that we can’t put
the data in that RAM94 environment and use it externally. Even though we aren’t
taking any of the claims data outside of that environment, we are only taking the
data we put into it and the data we created that cannot be put into the state’s file—
they said it’s contaminated now, and that we are not allowed to share it. They give
us access, but then put handcuffs on so we aren’t allowed to share it. – 2017 PPS
key informant
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The PPS key informants wished they had more assistance from NYS DOH with data sharing
issues.
All PPS continue to struggle with patient consent component. There is not much
guidance from DOH in terms of data sharing…they pretty much said “figure it out, it’s
your own legal responsibility.” Each PPS has approached it a little bit different, and when
you have PPS overlapping in the community, it is challenging to work with partners in
multiple PPS to gain an understanding. –2018 PPS key informant
4.2.2.6.3. Data Systems Developed by PPS
Because of data lag, data sharing barriers, and data security and privacy protocols, many PPS
developed their own internal data systems to provide more real-time feedback. The majority of
PPS key informants reported that they built dashboards or other platforms which largely made
use of online partner portals to gather partner data. Some PPS data analytics teams were able
to use partners’ electronic health record data along with state-provided data to share
aggregate results and guide efforts to close gaps in patient care and meet performance targets.
We’ve really defaulted more to our internal reports and building the HEDIS95 measures
using our internal [EMR] data, so that we have complete and real-time and actionable
reports that the teams can use. I would say prioritizing those reports has been the most
important work we’ve done in terms of driving improvement but has also come with
challenges… We share the measurement year reports from the state. Teams are
frustrated that they’re old, so we share them, but the team really spends the most time
looking at the internal reports we’ve created. The PPS has done a really good job
working with each of the reporting teams to talk though the logic and understand that
we’re all on the same page about what’s being reported, but it has been a huge effort to
get us to this place. –2018 PPS key informant
Real-time information, as it relates to most of the 43 Pay for Performance
measures, is critically important. We have been able to take that data to evolve
dashboards where users can look up their status on any given day and respond.
PCP practices can respond. You can only do that with real-time information—not
with claims data. For Pay for Performance, we’ve had to rely on new systems for
this. –2017 PPS key informant
We listened to our partners early on in DSRIP and began having the discussion with them
a little over a year ago around implementation and improvement work to drive
improvement/performance measures, and they needed actual data opposed to
snapshot/outdated information that the state typically has provided to us with an 8month lag. We began collecting [data] on a monthly basis from our highest attribution
partners. We placed it in a dashboard that is a little more user-friendly to understand
their patient population, which patients have care gaps, and specific to each of our
performance measures we want them to focus on. –2018 PPS key informant
95

Healthcare Effectiveness Data and Information Set
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From a data collection perspective for managing our clinical outcomes, we are
finally in a position where we are not relying on the State’s data. We have gotten
data from our two lead hospital systems that are feeding pre-adjudicated claims. –
2017 PPS key informant
Several respondents saw these systems as a waste of resources, and believed that NYS DOH
could have provided better support to avoid the need to create so many separate data systems
statewide.
I wish they had figured out the IT thing before they had started DSRIP. Every PPS has a
different vision, they have a different platform, they use different RHIOs, they’re creating
their own thing, and as an organization – and most of us are in a bunch of different PPS
– how do you do that? You can’t. We can’t, anyway. – 2018 hospital regional focus
group participant
I happen to know how much was spent on IT here, in a big bucket way, and if you
multiply that number time 25 across the state, that money could have invested in the
SHIN-NY96 – even a part of it. So we’re allowing each PPS to decide what they need in
terms of IT and spend as much as they want to spend. Who are you benefiting at the end
of this? When you watch systems get developed that are so costly and have no real value
in the long haul, except getting your portion of the 8.4 billion dollars, it’s really obvious. –
2018 primary care regional focus group participant
4.2.2.6.4. Accessing Data from Partners
While PPS-developed data systems were useful, they generally required partners to provide
data directly to PPS, which was also a challenge. Partners used a wide variety of electronic
health records systems, and some partners (particularly community-based organizations) did
not have electronic health records at all. The lack of integrated systems created challenges with
project implementation, data sharing, and reporting. Information technology development and
ongoing support were required, and this was new to some partners.
One of our biggest challenges has been technology for PPS partners. There is still a
struggle to create an integrated IT system and there is a lot of fragmentation. Partners
have challenges in terms of knowledge, staffing, and finances. –2018 PPS key informant
One of the barriers are the various EHR systems and interoperability challenges that we
face. Since we’re not a single health system with one EHR (we probably have over 40
EHRs in use and that may not include [all partners]), that presents some challenges,
especially when some of the project components weave in use of EHRs and registries and
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The Statewide Health Information Network for New York (SHIN-NY) allows the electronic exchange of clinical
information statewide and is described in more detail in Section 4.2.2.6.5.
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it requires IT onboarding and things of that nature with smaller practices not familiar
with having to do this type of technological work. –2018 PPS key informant
Nearly all respondents reported challenges with health records data infrastructure, but some
felt their solutions to those challenges were a success. Some PPS set up their partners with new
electronic health records systems or provided support to enhance the ones they already had.
Key informants from PPS felt that they came a long way with data connectivity, and that the
DSRIP program was the impetus for that.
We’ve definitely given many providers support with their EHRs, support with the RHIO97,
to be able to start running reports so they can find the metrics that are meaningful to
them and use that information, and are working to do that more in real time. –2018 PPS
key informant
4.2.2.6.5. Connecting with Qualified Entities
To facilitate the shift towards improved care coordination and value based care, the DSRIP
program served as a mechanism to promote clinical data exchange among providers. Providers
that offered clinical services or had electronic health records were required to connect to their
Qualified Entities (QEs), previously known as Regional Health Information Organizations
(RHIOs), by March 201898. Qualified Entities are regional networks where electronic health
information is stored and shared; there are eight in New York State.
In some cases, this connection was successful:
Very early on, we had our partners connect to [the Qualified Entity], sign agreements, and
then we were able to work with [the Qualified Entity] to create what we call a population
health gateway server. That collects our clinical information based on one-to-one
agreements and connects to our analytics platform so we’re able to have clinical data to
support our claims data that we have from the state. We’re just implementing this now, but
the connectivity requirement of 2.a.i. really helped us energize our partners to sign
agreements and get connected. – 2018 PPS key informant
While some PPS key informants reported success with providers ultimately connecting to the
Qualified Entities, many felt the NYS DOH should have taken a stronger role in emphasizing and
leading the process of connectivity to lay a foundation for later transformative work.
The challenge is their ability to physically get connected. There’s some interface issues,
the RHIOs not being able to be responsive, but the partners themselves truly want to be
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Regional Health Information Organization (RHIO), further described in Section 4.2.2.6.5.
Domain 1 Project Requirements Metrics and Milestones; Project 2.a.i – Requirement 4
https://www.health.ny.gov/health_care/medicaid/redesign/docs/dsrip_domain1_project_requirements_mileston
es_metrics.pdf
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able to get that information and they want that information flowing to them. It’s just the
challenge of making that a smooth transition for them. –2018 PPS key informant
There are QE connectivity requirements prescribed by the DOH, but they require PPS to
engage as a vendor. This has not been encouraged by DOH. The QE has been slow in
responding to our area and understanding what our needs are. –2017 PPS key
informant
But as just happened recently, we’ve passed now the March 31st timeline where all the
safety nets who need to be connected, should be connected, and I suspect our PPS, as
many PPS, were not able to meet that deadline. Obviously, that work still needs to be
ongoing, but after this year there is no further incentive from the state for that to occur.
–2018 PPS key informant
Patient privacy regulations were noted to be an additional barrier to effective use of Qualified
Entity data. The Statewide Health Information Network for New York (SHIN-NY) was created to
permit electronic health record information exchange between clinical professionals across the
state. Because patient data is protected by the Health Insurance Portability and Accountability
Act (HIPAA), Qualified Entity participants were only able to access patient information if a
patient signed a written consent form. PPS reported struggles with this process, noting it
hindered the ability to access and review comprehensive patient health information for
coordinated clinical work.
The rules and regulations regarding sharing information with the Regional Health
Information Organization were barriers because you have to get consent every single
time a patient interacts with a new provider, so each new provider has to get their own
consent. It would have been much better if the RHIOs were run on an opt-out model as
opposed to an opt-in. –2018 PPS key informant

4.2.2.7. Workforce
The PPS reported both successes and challenges in workforce development. Key informants
relayed that they hired hundreds of people and trained thousands in their efforts to get the PPS
and its projects operational. Additional positions were created and introduced new people to
the health care industry.
In general, what DSRIP has highlighted, I think, for a lot of people, is we need more
people in the workforce that are trying to reduce the total acute care utilization of our
patients. And that is something that is relatively new. People that fall under that are
care managers, navigators, project managers and the DSRIP team, there’s a lot of
people. – 2018 PPS key informant
Key informants from PPS specifically mentioned successes in the following areas:
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•
•
•
•

Training health workers in care coordination, motivational interviewing, and LGBTQ
health care competency.
Recruiting and training emergency department staff to significantly reduce potentially
preventable admissions.
Bringing their workforce into historically underserved areas; one respondent said the
changes that were happening in their community through workforce deployed through
the projects were “mindboggling.”
Developing scholarship and apprentice programs to increase staffing in needed fields,
including certified nursing assistants, community health workers, and social workers.

However, the struggle to recruit and retain staff, specialty providers, was widely noted to be a
barrier to getting projects up and running.
A lot of our challenges from my project was the hiring of staff. A lot of what we wanted
to do, and what we had in place to do, was hard to get it going because it was slow
going with getting our teams staffed up to where they needed to be. – 2018 PPS key
informant
So there’s a workforce shortage in the field right now, particularly Article 31 clinics99. The
work demand now, especially because of a lot of the DSRIP work that we’re doing and all
of the added documentation, has led to experienced staff not really applying for jobs at
Article 31 clinics. We’re getting students who are literally right out of school. So the
staffing has become an issue…It’s problematic to do the work with less staff and green
staff. We definitely needed to identify a coordinator. We had someone, and
unfortunately, that person left the organization. We’re plagued with quite a bit of
turnover. – 2018 mental health and substance use regional focus group participant
Recruitment in general took a while because when all the PPS were starting, there was a
recruitment spree across New York State for qualified providers and front-line staff. IT
development was not always in sync with the speed at which you were able to set up
your project. Either you recruited 5 NPs100 and they were live one day and their IT was
not ready for two months, or you had your IT but no staff to use it. That was an issue in
the first two years. – 2018 PPS key informant
Since smaller organizations did not have the capabilities to hire additional staff upfront in hopes
that DSRIP program funding will cover the costs, partners reported workforce shortages that
placed DSRIP program responsibilities on staff who were already contributing a lot of their time
and effort, often causing employee exhaustion.
I don’t think there was any understanding or appreciation for the fact that most
organizations cannot upfront hire staff. – 2018 hospital regional focus group participant

99

Office of Mental Health licensed mental health clinic
Nurse practitioners

100
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I think at the community-based organizations, where we don’t have additional people to
do this work, it just was work that was added on to the senior management to really be
involved because we couldn’t keep putting more onto other people... We’re really small,
compared to some of these organizations; we have a $12 million budget, and we’re not
the smallest CBO. However, we knew DSRIP was really important, so we participated, we
volunteered on more committees. It was very important to do and we’re happy we did it,
and we really believe in it. We have done everything we can to keep it going. However,
our days are long. A 12-hour day turns into a 16-hour day, and that’s the reality of it. The
workload has just poured on top of existing stuff to carry out. – 2018 community-based
organization regional focus group participant

4.2.3. Support Systems and Accountability Structures
The PPS provided feedback regarding the Account Support Team, the Independent Assessor,
KPMG’s Medicaid Accelerated eXchange (MAX) facilitation, data tools, and communication
from NYS DOH.

4.2.3.1. Account Support Team
The Account Support Team (AST) role is provided by an independent contractor to fulfill
programmatic needs for the NYS DOH and the PPS. The Account Support Team’s main functions
are to informally check in on PPS progress one-on-one on a monthly basis, provide technical
support to the PPS, facilitate policy and protocol questions and answers between PPS and NYS
DOH, and promote cross-PPS collaboration and learning. The Account Support Team meets with
each PPS monthly (usually via conference calls) and conducts site visits annually. Each PPS has a
single point of contact (the relationship lead) and additional support from the performance
facilitators and team analysts. The Account Support Team role was originally performed by
KPMG beginning with the PPS DSRIP application phase in 2014 but shifted to the Public
Consulting Group (PCG) in March of 2016. The PPS were critical of the support provided by
KPMG during the beginning of the DSRIP program and said that high turnover and
inexperienced staff impacted their ability to be supportive at a critical time of PPS start up.
KPMG faced challenges in this role because the DSRIP program was just being launched and
program operational requirements were being further refined. Several PPS key informants
believed that they were provided with incorrect information, causing them to commit to
milestones and targets that were ultimately unattainable.
After PCG assumed the role of the Account Support Team as KPMG contracted staff rolled off,
PPS reported slightly higher levels of satisfaction with responsiveness, helpfulness, and clarity.
They noted that PCG was particularly helpful to project leads around cultural competency and
health literacy:
PCG was really instrumental in helping project leads around cultural competency and
health literacy. They convened meetings across the state with project leads and helped
us process/understand what was being asked of us…and put us in touch with
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appropriate folks at various PPS who were working on a similar strategy. -2018 PPS key
informant
Our PCG consultants are really valuable and really responsive and we appreciate their
guidance and connection to the state. They are very thorough in their responses. -2018
PPS key informant
However, many PPS key informants felt that the Account Support Team was often unable to
answer their questions and directed them to either the Independent Assessor team or NYS DOH
instead:
On the AST side…that side is much more responsive, wants to be much more helpful, but
I feel like they almost can’t be just because it’s the nature of what their paths can do.
They’re supposed to be getting the updates, they answer questions that they can
answer, but then a lot of times they’re directed to direct us back to the IA…so we get put
in this strange loop of ‘we can’t get things resolved or answered.’ – 2018 PPS key
informant
The name “Account Support Team” is a little deceiving because they are
incapacitated in their ability to provide support. They are not the authority to give
guidance, and we tend to find ourselves in waiting queues for answers, and some
of those answers might not be accurate or come to pass. They’re in a difficult spot.
They’re largely communication facilitators, and we don’t always see or appreciate
the message. – 2017 PPS key informant
Many PPS reported that answers from the Account Support Team, NYS DOH, and the
Independent Assessor were not always consistent. Different interpretations across PPS were
challenging and they wished for a repository of responses for more transparent implementation
and operation of the DSRIP program.
The Account Support Team also assists to organize the DSRIP program annual Learning
Symposium as required by the STC. There was a consensus that the Learning Symposia are very
rich in content and information. PPS key informants reported that the speakers at the Learning
Symposia were high quality, and that the face-to-face interactions with other PPS
representatives and colleagues were valuable for creating comradery and learning from each
other.

4.2.3.2. Independent Assessor
The Independent Assessor (IA) has three primary functions throughout the DSRIP program: (1)
project plan application reviews, (2) a mid-point assessment, and (3) regular monitoring of PPS
progress. Monitoring occurs through quarterly reports and determines the semi-annual
performance payments. Independent Assessor responsibilities are also contracted to PCG, but a
firewall was created between the Independent Assessor and the Account Support Team to
reduce the likelihood of any conflicts of interest related to the Independent Assessor’s official
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duties. Key informants from the PPS had mixed reactions to working with the Independent
Assessor. Some PPS felt that the Independent Assessor was supportive and responsive:
The IA is more open than others to having discussions and is responsive to questions and
comments. – 2018 PPS key informant
I think it’s been wonderful. Our questions that go to the Independent Assessor do
get answered, and over the course of time, our understanding has been clarified in
certain areas we were really dependent on. – 2017 PPS key informant
Other PPS described challenges working with the Independent Assessor. Several PPS key
informants felt that the Independent Assessor was unable to provide them with meaningful
answers to their questions.
Regarding the IA and the grading of the quarterly reports, we had very specific questions
and sometimes the answers were vague. It was kind of like the professor who doesn’t
want to give away the answer to the question before the test, yet we were struggling
just to “get our ducks in a row” and report the way we were expected to be reporting. –
2018 PPS key informant
4.2.3.3. Medicaid Accelerated eXchange (MAX) Facilitation
The Medicaid Accelerated eXchange (MAX) Series, facilitated by KPMG into early
Demonstration Year 4, was focused on improving care for high utilizers and sustaining that
change. It consisted of three full-day structured and dynamic workshops, followed by fasttracked action periods to implement change over a 5-6 month period. Several of the PPS
reported that the MAX Series was helpful and they were seeing positive outcomes in patient
care and reduction of emergency department visits. Many PPS key informants attended the
train-the-trainer series through MAX and felt that it provided valuable information. The PPS key
informants credited the MAX Series for a greater awareness of the social determinants of
health, the creation of “daily huddles” to identify high utilizers, the development of behavioral
health innovations, and for serving as a resource for collaboration, workforce development, and
educational purposes. Additionally, PPS reported that MAX was useful in developing
partnerships and workflows that were sustainable even after they had completed the Series:
I think overall, it was really helpful to have that sort of focused attention on super
utilizers and to be given the training and framework for addressing the needs of that
population…We actually adopted MAX methodology: the concept of the action teams
and focusing on high utilizers, and incorporated that into all our contracts with all our
network hospitals within the PPS. – 2018 PPS key informant
The MAX has been helpful to network and learn what other PPS partners are doing
across- projects and projects we have in common. It’s great to see some of the
accomplishments and challenges they’ve had. – 2018 PPS key informant
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One thing I can point out that I thought was a huge success and really highlighted ways
the health department thought about these projects is what [name] did with the MAX
series. It was very clear- identifying the problem and actually put hands-on help in
getting people to change and help them maintain that change…I just want to point the
eye to a real success of lasting change and getting everybody on board was that MAX
series. I thank the project workgroups for doing that because it incorporated all of those
critical elements in on that change and it was very high incentive. – 2018 PPS key
informant
Regarding MAX, [we participated in that series], and it was one of the best exercises we
have undertaken. It jump-started our focus on care management and coordination.
KPMG facilitators have been extraordinary. That’s been a remarkable process. We are in
the process of rebuilding our operation here in network development and provider
relations – we are in a rebuild and reset mode. – 2017 PPS key informant

4.2.3.4. Data Tools
The PPS key informants reported that the Salient Interactive Miner, which provides in-depth
access to the state’s Medicaid claims and encounter data, and the Medicaid Analytics
Performance Portal (MAPP), which houses DSRIP program performance tools, were useful.
The support around Salient is great. They are very responsive to questions that are
coming up. It’s not an easy tool, and there’s a lot of understanding in trying to teach how
to use it. – 2017 PPS key informant
However, while the data provided through these tools was noted to be timelier as the DSRIP
program progressed, the ongoing data lag since DSRIP’s inception remained a significant
challenge and prevented that data from being as actionable as it could be for PPS and partners.
Things have progressively gotten better with the tools that the state is providing us but
we’re nearing the end of the road here…we’ve basically taken advantage of any tool that
the state will offer us, but it’s been challenging not only with getting access to those
tools but understanding the requirements that you need to achieve to get access for
those tools. The lag in MAPP and Salient has made it very challenging for real-time
population health management. – 2018 PPS key informant
Further discussion of data issues is included in the section on data access and sharing (Section
4.2.2.6).

4.2.3.5. New York State Department of Health Communication and Support
Key informants from PPS reported mixed feedback on the support they receive directly from
the NYS DOH. Support from NYS DOH included sending out weekly emails to keep PPS
informed, hosting webinars for project and program area clarity, retaining guidance documents
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in the PPS-specific Digital Library, maintaining an up-to-date DSRIP program website, hosting
all-PPS meetings, and facilitating regular enhanced oversight check ins with specific PPS that
need more support and guidance. Several PPS key informants believed that NYS DOH was
responsive and was able to provide answers to questions and resources that neither the
Account Support Team nor Independent Assessor were able to:
The DOH team is really responsive and helpful. They understand what is going on, on the
ground. We are in a different place than we were a few years ago. Initially it was very
frustrating, but our contacts now seem responsive and able to provide us with answers.
– 2018 PPS key informant
Other PPS key informants reported that the communication and support they received from
NYS DOH was poor to nonexistent. They explained that NYS DOH was unable to provide clarity
on expectations and made little effort to engage with the PPS aside from the regularly
scheduled check-in meetings, which put them at risk of missing measures and being financially
penalized.
Key informants from PPS also reported mixed feedback on the in-person all-PPS meetings
hosted by NYS DOH throughout the year. While some PPS key informants believed that the allPPS meetings were helpful, many reported that they did not feel that they required travel
across the state since most of the information presented could be shared electronically. Several
PPS suggested that the all-PPS meetings should be less of an “information dump” by NYS DOH,
and more of an opportunity for PPS to collaborate and share their best practices.
Annual Learning Symposiums are super valuable. All-PPS meetings are sometimes
helpful, sometimes not. – 2018 PPS key informant
The nature of some of the topics at the all-PPS meetings doesn’t necessarily require all of
the PPS to come in-person to one location. We just had a meeting in New York City, and
that was tough for some PPS outside of the city. The agenda could have been balanced
over a webinar for a lot of the content. More thought could have gone into what’s
important to get people together for. In the space we were in, there wasn’t room for
networking or other benefits of getting folks together. – 2017 PPS key informant

4.2.4. Perceived Outcomes and Observations
This section presents perceived outcomes from Performing Provider System (PPS) key
informants who participated in interviews and project partners that participated in the partner
survey or focus groups.

4.2.4.1. Findings from the Statewide Partner Survey
As noted in the Study Design section (see Section 3.3.4), an electronic survey was administered
to project-associated partners from all PPS in September 2017 and September 2018. A total of
123

897 partners in 2017 and 1,071 partners in 2018 provided usable responses to the survey. The
total number of respondents in the exhibits vary because response rates varied for individual
survey questions.
4.2.4.1.1. Perceived Effectiveness of the DSRIP program
Most respondents (74.7% in 2017; 70.3% in 2018) reported the DSRIP program to be extremely,
very, or moderately effective (see Exhibit 4.5). Between 20.4% and 23.2% perceived it as slightly
effective, and between 4.8% and 6.5% as not effective at all.
Exhibit 4.5. How effective do you perceive the DSRIP program to be overall?

40.3"

100%

N=764

2018

36.1"

100%

N=942

• Not at all effective

• Slightly effective

Moderately effedive

• Very effective

• Extremely effective

Source: Authors’ analysis of the 2017 and 2018 statewide partner survey.
Note: Responses do not total 100% due to rounding.

Most (54.5% in 2017; 73.3% in 2018) also believed that the DSRIP program had positively
affected population health in their service area (see Exhibit 4.6).
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Exhibit 4.6. Do you believe the DSRIP program has changed any aspect of population health
within your service area?
0.3"

2017

7A

23.3"

21.9%

100%

N=771

0.6"

20]8

7.6"

17.7"

100%

N:946

0.7"

• I don't know

• No, very negatl\/o chang•

• No, some negatl\lo dlange

No dlango

•

v.., some po<ltlvo change

•

v.., vory po<ltlve chang•

Source: Authors’ analysis of the 2017 and 2018 statewide partner survey.
Notes: Responses do not total 100% due to rounding.

In the 2018 partner survey, 81.4% of respondents reported that the services or clinical care at
their organization had changed for the better since the DSRIP program was initiated (see Exhibit
4.7).101
Exhibit 4.7. How have the services or clinical care at your organization changed since the DSRIP
program was initiated?

0 .6%

2018

16.9%

100%

N=978

1.1%

• Very negative change

• Some negative change

No change

• Some positive change

• Very positive change

Source: Authors’ analysis of the 2018 statewide partner survey.

101

Direct comparison to the 2017 statewide partner survey is not possible for this survey item due to some
wording changes to improve clarity.
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Partner survey participants in 2018 were asked what type of organization they worked for
(Exhibit 4.8). Over one-quarter of respondents worked for community-based organizations, and
22.4% of respondents worked in primary care.
Exhibit 4.8. Partner survey respondents by organization type
Type of Organization
Community-based organization
Primary care provider
Skilled nursing facility/ nursing home
Hospital
Clinic
Behavioral health organization
Home care agency
Government office
Substance use treatment organization
Health home/ care management
Non-primary care practitioner
Hospice/ palliative care center
Pharmacy
Other

N
280
239
119
100
63
59
43
35
32
29
13
12
4
38

Percent
26.3
22.4
11.2
9.4
5.9
5.5
4.0
3.3
3.0
2.7
1.2
1.1
0.4
3.5

Source: Authors’ analysis of the 2018 statewide partner survey.
Note: Five participants did not select an organization type. Respondents were able to self-select their organization
type. The survey did not define each organization type for respondents (see Appendix 6 for survey instrument).

Perceptions of the DSRIP program varied somewhat by organization type (see Exhibit 4.9).
Respondents working at hospitals were more likely to report that the DSRIP program was
effective (79.8%), changed population health for the better (84.3%), and changed services or
clinical care at their organization for the better (92.6%). Approximately two-thirds of
respondents working at community-based organizations perceived the DSRIP program to be at
least moderately effective (65.9%), and almost three-fourths of these respondents believed
that the DSRIP program changed population health for the better (73.1%) or led to positive
changes at their organizations (72.7%).
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Exhibit 4.9. Effectiveness measures by organization type

Organization type

Hospital
Behavioral health or substance use treatment
organization
Skilled nursing facility/ nursing home
Primary care provider, non-primary care provider,
or clinic
Community-based organization
All other organization types

Percent
perceived
DSRIP
program to
be at least
moderately
effective

Percent
believed
DSRIP
program
changed
population
health for
the better

Percent
reported
services at their
organization or
clinical care
changed for the
better

79.8

84.3

92.6

73.5
72.5

79.5
60.9

87.2
82.7

71.8
65.9
64.2

75.5
73.1
68.1

88.3
72.7
71.4

Source: Authors’ analysis of the 2018 statewide partner survey.
Note: All other organization types includes those that selected hospice/palliative care center, home care agency,
government office, pharmacy, health home/care management program, or “other” as their organization type.
Respondents were able to self-select their organization type. The survey did not define each organization type for
respondents (see Appendix 6 for survey instrument).

4.2.4.1.2. Benefits Attributed to the DSRIP Program
Survey participants were asked if they observed any of the following benefits from the DSRIP
program (see Exhibit 4.10). In 2018, more than half perceived more coordinated care. Over 40%
observed improved understanding of patient needs and reduced avoidable hospital utilization.
Approximately 29% reported improved clinical outcomes, increased primary care provider use
of behavioral health intervention, and improved recognition of mental health disorders. About
one-fifth saw improved patient satisfaction, and about one-eighth observed reduced medical
costs.
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Exhibit 4.10. Benefits attributed to the DSRIP program (N=971)

coordl~ted care
43.7%

ln1)roved unde-rstandlns of patient needs

Reduced .wold.able hospital vtllzation

41.l"

lmp,owd din.Cal outc0ttlie$

29.4"

Improved recognition of mental heahhdlsorders
lftl)roYt-d p,Jtient uiti,far;tiOn

20.1"

-

Reduced me-ditc1I costs Noneoftheabove -

11.S%

17-°"

Source: Authors’ analysis of the 2018 statewide partner survey.
Note: Percentages do not total 100% because respondents could select more than one item.

In the 2018 partner survey, for each of the above benefits they selected, respondents were
asked whether they expected that benefit to continue after DSRIP program funding ended.
About three-quarters believed that the benefits would continue, ranging from 71.4% of those
selecting “reduced medical costs” to 82.4% of those selecting “improved recognition of mental
health disorders” and “increased primary care provider use of behavioral health intervention.”
These responses were affected by organization type (see Exhibit 4.11). Respondents from
hospitals and behavioral health or substance use treatment organizations were more likely to
observe improvements to care coordination. Those employed at skilled nursing facilities and
hospitals were especially likely to perceive reductions in avoidable hospital utilization.
Respondents from primary care provider or non-primary care provider offices, clinics, or skilled
nursing facilities were more likely to see improvements in clinical outcomes. Increased primary
care provider use of behavioral health interventions and improved recognition of mental health
disorders were most often perceived by respondents from hospitals, primary care provider or
non-primary care provider offices, clinics, or behavioral health or substance use treatment
organizations.
Respondents from community-based organizations and skilled nursing facilities were less likely
to perceive most benefits, and more likely to say they had seen none of the above benefits.
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Exhibit 4.11. Benefits attributed to the DSRIP program by organization type

Coordinated
care
74.5%

Patient
needs
47.9%

Reduced
avoidable
hospital
use
55.3%

64.7%

29.4%

49.4%

27.1%

40.0%

34.1%

22.4%

12.9%

10.6%

57.0%

50.2%

32.1%

41.2%

44.8%

35.7%

29.2%

14.4%

13.0%

Communitybased
organization

43.3%

40.6%

30.7%

17.3%

13.0%

23.2%

13.8%

8.3%

26.0%

Skilled nursing
facility/
nursing home

42.3%

37.8%

64.0%

36.9%

9.0%

10.8%

19.8%

8.1%

17.1%

Hospital
Behavioral
health or
substance use
treatment
organization
Primary care
provider, nonprimary care
provider, or
clinic

Improved
clinical
outcomes
30.9%

PCP use of
behavioral
health
52.1%

Recognition
of MH
43.6%

Patient
satisfaction
23.4%

Reduced
costs
19.1%

None
of the
above
9.6%

All other
51.4%
45.9%
43.8%
22.6%
21.9%
25.3%
13.7%
8.2%
19.9%
organization
types
Source: Authors’ analysis of the 2018 statewide partner survey.
Abbreviations: Primary Care Provider (PCP), Mental Health (MH)
Notes: All other organization types includes those that selected hospice/palliative care center, home care agency,
government office, pharmacy, home health/care management program, or “other” as their organization type.
Respondents were able to self-select their organization type. The survey did not define each organization type for
respondents (see Appendix 6 for survey instrument).

4.2.4.1.3. Project Satisfaction and Effectiveness
The partner survey asked providers about their experiences with individual projects as well as
their experiences with the DSRIP program overall. In 2017, respondents had the opportunity to
provide feedback about up to three projects they worked on, and 1,689 project-specific
responses were collected. In 2018, respondents could provide feedback about all of their
projects, and 3,621 project-specific responses were collected.
Partners’ satisfaction ratings of projects are shown in Exhibit 4.12. In 2017, survey participants
were asked about their satisfaction with project implementation, operations during
Demonstration Years 0-2, and current operations (Demonstration Year 3 at the time of the
survey). In 2018, participants were asked about their satisfaction with operations of the project
over the past 12 months (Demonstration Year 4 at the time of the survey). About two-thirds of
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respondents were satisfied or very satisfied with project implementation (66.4%), operation in
Demonstration Years 0-2 (69.9%), Demonstration Year 3 operation (66.1%), and Demonstration
Year 4 operation (71.0%).
Exhibit 4.12. Project satisfaction ratings
with Project Implementation (N=l,628)

---n.a

~!..lti~flcd

,co%

s.,tisfoction with riro·cct O crations Dcmonstrntion Yc.:irs O 2

100%

Satistaction with Project Operations Demonstration 'i'ear 3 (N=l ,622)

- ---5.ft

\',y

24.a

100%

Dissatisfied

Satisfaction with Pro'ect O erations Demonst ration Vear 4 (N=3,147)
100%

Source: Authors’ analysis of the 2017 and 2018 statewide partner survey.
Notes: The results shown in the top three bars are based on the 2017 statewide partner survey. The results shown
in the bottom bar are based on the 2018 statewide partner survey.

In both years, participants were asked how effective they currently perceived the project to be
at meeting its intended goals. About three-quarters (73.6% in 2017; 79.0% in 2018) viewed
projects to be extremely, very or moderately effective (see Exhibit 4.13).
Exhibit 4.13. Project effectiveness ratings

2017
N=l,456

100%

33.3%

19.1"

35.9%

2018
N=3,177

• Not at all Effective

• Slig htly Effective

100%

Moderately Effective

• Very Effective

• Extremely Effective

Source: Authors’ analysis of the 2017 and 2018 statewide partner survey.
Note: Responses do not total 100% due to rounding.
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The 2018 satisfaction and perceived effectiveness responses were also evaluated by project, to
determine whether some projects were evaluated more positively than others. As some
projects received only a few evaluations, a minimum of 20 total responses across PPS was set as
a floor for inclusion. The possible score range was between 1 and 5, with smaller numbers
indicating greater satisfaction or effectiveness. Among the 24 projects with a sufficient number
of satisfaction evaluations, mean satisfaction ratings ranged from 1.68 to 2.36. Projects 2.c.i
(Development of community-based health navigation services) and 3.c.i (Evidence-based
strategies for disease management in high risk/affected populations) had the highest
satisfaction ratings (both 1.68), and projects 4.d.i (Reduce premature births), 2.a.iii (Health
home at-risk intervention program), and 4.a.iii (Strengthen mental health and substance abuse
infrastructure across systems) had the lowest (2.36, 2.32, and 2.32).
Among the 24 projects with a sufficient number of effectiveness evaluations, mean
effectiveness ratings ranged from 2.09 to 3.25. Projects 2.a.ii (Increase certification of primary
care practitioners with PCMH certification and/or Advanced Primary Care Models), 2.b.vii
(Implementing the INTERACT project), and 3.c.i (Evidence-based strategies for disease
management in high risk/affected populations) had the highest effectiveness ratings (2.09,
2.25, and 2.25), and projects 4.d.i (Reduce premature births), 2.a.iii (Health home at-risk
intervention program), and 2.d.i (Implementation of patient activation activities to engage,
educate and integrate the uninsured and low/non-utilizing Medicaid populations into
community based care ) had the lowest (3.25, 2.96, and 2.96).

4.2.4.2. Positive Perceptions of the DSRIP Program from Interviews and Focus Groups
Key informants from PPS and focus group participants were also asked about their perceptions
of DSRIP program outcomes. Consistent with the partner survey, most felt that the DSRIP
program had laid a foundation for changes to the health care system. Care transitions, the
integration of primary care and behavioral health, and encouragement of innovation were most
often specifically cited as positive outcomes of the DSRIP program.
4.2.4.2.1. Care Transitions
Care transitions between inpatient and outpatient and clinical and community settings
improved during the DSRIP program, according to study participants. Increased partner
communication and collaboration led to easier care transitions since partners were more aware
of appropriate referral tracks. The addition of community health workers and transitional care
managers resulted in a better understanding of patients’ needs and higher rates of patient
engagement, which improved care transitions and reduced the rate of emergency department
utilizations.
What we did early on is bring together inpatient and outpatient substance abuse
providers to think about the transition from inpatient to outpatient. They had never
really talked before. When people were being discharged, the inpatient provider was not
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confident that they were releasing to the appropriate outpatient…We have identified
and worked to correct many of these issues. – 2018 PPS key informant
Before DSRIP…hospitals didn’t do that much to keep people out of the hospital. Here, you
have all of the administration of the hospital trying to figure out how to keep people out.
It’s interesting, where they’re investing in care transition staff to get people out,
investing in initiatives to keep people out of the emergency room. I think without DSRIP,
you wouldn’t have had this huge push from the hospital staff to do this. – 2018 PPS key
informant
We noticed that there was this drop-off from hospital utilization to follow-up, and one of
the solutions was to have the community health group spend one day a week at the
hospital and be able to provide a warm handoff. Sure enough, just the face time with the
health providers helped increase referrals that way. This is a small hospital [in location],
so I don’t know how functional or easy that would be to translate to the really busy
places. But that was something that we realized – when you have a warm handoff, you
are less likely to fall through the cracks. – 2018 hospital regional focus group
participant
Anytime anybody entered the emergency room with a behavioral health or SUD issue,
after triage, my peers were called in to work with those folks to see if we could get them
out of the emergency room and into either an inpatient detox, inpatient rehab, an
outpatient detox, or an outpatient facility, based on their clinical needs to properly
service them, so that they weren’t constantly coming back to the emergency room for
expensive care that they didn’t need. – 2018 mental health and substance use regional
focus group participant
4.2.4.2.2. Integration of Primary Care with Behavioral Health
A majority of PPS key informants described successes with the integration of primary care and
behavioral health. They noted an increased focus on behavioral health in primary care
practices, including a significant increase in depression screenings. Respondents referred to this
integration as the breaking down of a silo, and while some primary care providers were
reluctant at first, many became committed to funding the integration of behavioral health after
the DSRIP program ends. Primary care providers obtained better resources to care for
behavioral health patients, and there was increased awareness of the connections between
physical and behavioral health and a realization that these systems should not be segregated.
Behavioral health has been one of the greatest successes for our DSRIP implementation. In
the primary care space, we have been able to integrate behavioral health into a number of
primary care practices. When we started that journey, many PCPs were pretty reluctant, and
they have now really embraced the program. Practices that don’t have behavioral health
resources are really eager to get started with the programs. Primary care providers are
committed to helping find funding for these individuals once DSRIP ends, so that’s been
really great. As part of that initiative, we also saw a dramatic increase in depression
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screenings in primary care practices. Our PHQ102 screenings went from about 20 percent to
almost 80 percent at most of our sites, and that was a real credit to medicine’s support and
willingness to get on board with the initiative. – 2018 PPS key informant
The mental health staff are learning a lot more about primary care and the importance of
primary care. We are learning about chronic diseases, so it’s opening up realms of new
discovery for staff. And I do agree that integrated approach isn’t really new, and it didn’t
have this term before, but creating systems for that is a great idea. – 2018 mental health
and substance use regional focus group participant
We have co-located behavioral health services in our primary care facilities who can do
treatment for the patient right then and there with a warm handoff. Similarly, in the
behavioral health setting, there is a primary care screen done on every single patient on
every single visit, and if they have a primary care need, they can do a warm handoff to the
primary care provider in that setting. This is occurring across all of our clinics, in all of our
outpatient clinics for behavioral and primary care, and that is a big impact. In that setting, I
think it helped to reduce stigma for behavioral health, and also capitalized in meeting the
patients where they are. – 2018 hospital regional focus group participant
4.2.4.2.3. Innovation
Some PPS key informants said that the DSRIP program encouraged partners to work on
innovative programs, permitting them to experiment and pilot programs which may not have
been attempted otherwise. The funding provided more flexibility and creativity than budgets
typically allowed. While these programs were not necessarily transforming the entire delivery
system, they were filling important gaps.
Overall, we’ve seen a number of our partners take up innovative efforts that hadn’t been
in place before. – 2018 PPS key informant
What DSRIP allowed us to do was create a remarkable model program. For [this type of
intervention] across the country, academic medical centers and community-based
organizations have been frustrated. DSRIP really enabled us to do all the things we had
been talking about but never could actually pull all together. – 2018 PPS key informant
4.2.4.2.4. Other Positive Outcomes
Participants cited increased awareness of social determinants of health, best practices, new
interventions, care coordination tools, and population health management as further
transformative effects of the DSRIP program.
[DSRIP] has created an awareness of different interventions that can be applied to
different populations of patients. It also has created an awareness of people who are
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high utilizers and social factors that are driving high utilization. It has created an
awareness of IT tools that can be applied. It has created an awareness around effective
peer-coordination processes. From a clinical perspective, the providers are more aware
of the different tools that can support better care coordination and better patient
outcomes. More importantly, DSRIP has created an awareness as a whole: where
everybody who either works in a hospital or is a part of the network knows there are
these different tools, strategies, and different populations of patients who need to be
treated with different methods in our region. – 2018 PPS key informant
Just in terms of moving everybody from thinking about individuals to thinking
about populations. It has forced in a positive way this mind shift to working with
CBOs to a degree. – 2017 PPS key informant
I had gone to a [PPS] training session, and they were talking about they were doing the
deep dive on the ER hospitalizations, which is a main focus of DSRIP. They found a
patient had gone to the ER 94 times because they wanted food, so they got him hooked
up with the food bank. Another patient likes the hospital beds, so he had 50-60 stays in
the hospital because he likes the hospital bed. So [hospital] got him a hospital bed
purchase for his home. The thing is, the PPS looked at the data and defined what they
can do to reduce their ER hospitalizations, because some of these things the practice
cannot do at their end, and they have to solve for those. – 2018 primary care regional
focus group participant
Also, in some PPS, hospitals began devoting resources to reduce admissions, which was a
significant paradigm change.
Before DSRIP…hospitals didn’t do that much to keep people out of the hospital. Here, you
have all of the administration of the hospital trying to figure out how to keep people out.
It’s interesting, where they’re investing in care transition staff to get people out,
investing in initiatives to keep people out of the emergency room. I think without DSRIP,
you wouldn’t have had this huge push from the hospital staff to do this. – 2018 PPS key
informant

4.2.4.3. Less Positive Perspectives of the DSRIP Program from Interviews and Focus
Groups
Not all key informants and focus group participants felt that the DSRIP program was changing
the health care system.
Many study participants did not think that five years was enough time to make a substantial
difference in health care delivery because of all the system-level changes that needed to take
place.
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Much of this change is cultural, it’s a culture shift. Five years, given that at the beginning
we had to set up our own infrastructure, does not allow for much time left to get the
work rolling and change made. This is a lot of significant change in terms of things
outside our control: transportation, housing, regulatory bodies with different sets of
rules and ideas, so that becomes very challenging for us. – 2018 PPS key informant
I do not think that in five years we are going to change all of the behavior, cultural and
environmental constructs, political constructs, and financial constructs that enabled the
way we have been delivering care for the last thirty years. – 2018 PPS key informant
Some believed that rather than making fundamental changes to their service models, a subset
of providers was waiting for systems to go back to “business as usual” at the end of the DSRIP
program.
One of the ways that we are trying to change mindsets about DSRIP is as a project that
will begin and end. They [some partners] think that once it ends, it’s back to business as
usual. – 2018 PPS key informant
Partners participating in focus groups often said that hospitals should not have had as much
control over PPS, and a few PPS key informants agreed. They said that hospitals remained
incentivized to admit patients, and in some cases, hospitals used DSRIP funds to build their own
capacity rather than distribute funds to other organizations that were already providing
services.
Early on, several years ago, they were talking about how a lot of the hospital systems
were increasing their beds. They were taking the funds that were supposed to be
reducing avoidable emergency room visits, and they were expanding their bed capacity.
– 2018 mental health and substance use regional focus group participant
Whenever there was a gap, the hospitals were higher staffed and put it [a referral] in the
hospital instead of putting it out in the community. If you want the hospitals to only have
patients that they should really see, then you don’t want to always be putting the
resources in the hospital when they really should be a community type of resource. –
2018 community-based organization regional focus group participant
To fundamentally change how health care is delivered, you’ve got to take the hospitals
out of control a little bit and move the center of gravity more towards non-hospital care.
– 2018 PPS key informant
Get rid of hospitals…I know they have ulterior motives, but they won’t come out and say
it and they won’t see it because they are holding the purse strings. You have actually
given the keys to the kingdom to the people who you don’t want to give it to. – 2018
hospital regional focus group participant
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The shift from an inpatient to outpatient care focus became a new way of thinking for many
clinical sector professionals, and the DSRIP program’s goal to reduce potentially preventable
emergency department visits and potentially preventable hospital readmissions was noted to
conflict with the current payment and reimbursement structure:
Across all the partners, especially some of the larger institutional partners, it was very
challenging to engage their current culture and push through systems and expectations
in a very aggressive way. The DSRIP Year 0 came and went and DSRIP Year 1 came and
we started building very quickly….but there are cultural norms and cultural expectations
that exist for many years with our partners. Pushing through some of that to get them to
grasp new ideas and want to change the way they’ve done work for a while was very
challenging. Many have moved in a way that they’re able to accept the new systems and
workflows, but the cultural settings need to be engaged and maybe a bit slower next
time. Shifting resources and shifting the thinking from an in-patient focus to ambulatory
is a huge move for many in the hospital field. Also, the insurance companies and state
DOH still pay for in-patient care more than they do for ambulatory care and ambulatory
behavioral health. Obstacles still in the way are billing, and managed-care
infrastructures are what we get paid for in the industry. – 2018 PPS key informant
An overarching challenge is convincing providers, hospitals, partners, etcetera, to do
work in a way that is very different from how they’ve done it and is sometimes at odds
with the way they are reimbursed. We definitely share the message and speak the
language that VBP is coming and quality is going to drive payments and fee for service
won’t be here anymore. It’s hard though (even with all of that, because I think they’ve
heard that for a long time and fee for service is still very much here), to convince
providers they should start acting in a way that doesn’t necessarily generate more
money for them and in some cases generates less money for them. I think here now in
DY4, there are VBP contracts that are happening and we are making moves in that
direction, but it doesn’t seem at the end of DSRIP that fee for service will be anywhere
close to completely gone. I think that’s been, at a high level, one of the challenges with
trying to get providers on board with what we’re overall trying to accomplish through
DSRIP. – 2018 PPS key informant
Key informants explained that it has been a struggle to get hospitals on board with reducing
emergency department visits because of the consistent source of revenue. Without value based
contracts in place, there was no incentive, in a fee-for-service system, to keep patients out:
We’ve gotten a lot of pushback from the hospitals because of the loss of value that has
to do with decreasing the ED visits. That part wasn’t very well thought out. We wanted
to do it, we wanted to do it right, we knew it was the right thing to do…but it created
kind of like a division within the hospital. – 2018 PPS key informant
We do not want these patients coming to the emergency room but when paramedics
pick up a patient, they are not paid unless they bring the patient to the emergency room.
– 2018 PPS key informant
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Some partners were already implementing projects before the DSRIP program was
implemented and found it to be a duplication of efforts. Others saw state regulations as
hampering transformation efforts. Several didn’t think significant change would be seen until
payment models were aligned with transformation goals. A few pointed out that communitybased organizations didn’t always have capacity for referrals.
Our program has always had an integrated model where our community health workers
actually come in with equipment and supplies to address the asthma triggers in a very
hands-on way, and teach the caregivers how to do it alongside them. This model
excluded that. The model that was decided was to outsource the remediation to a third
party, an outside company, so effectively changing our model and forcing us to figure
out, on a case by case basis, if we should deny a more comprehensive service to one
patient when we are providing a comprehensive service to another patient that’s
attached to a different funding stream. – 2018 community-based organization regional
focus group participant
I don’t know that DSRIP itself has been transformative for me as a substance use
provider, in terms of how I do business. I wouldn’t use the word “transformative” to
describe any relationship between DSRIP and the clinic having a transformative response
in how they are operating. – 2018 mental health and substance use regional focus
group participant
The very interesting dilemma with DSRIP is we were given funds to transform healthcare
until the payors got there. At the end of the day, until the payment model truly changes
so you are compensated for a “total person care,” there are limitations, in my sense, on
how much it is going to truly change the patient. The MAX103 process, a lot of providers
like it, but their payment model hasn’t necessarily changed to compensate for the work
they are doing. In the sense of really making the full swing to improving care for
patients, now we need the payment models to reflect the changes in work. – 2018 PPS
key informant
I think that there were some partners that were already implementing these projects
before DSRIP started, so in that case, it hasn’t changed the health care system because
there was already a move towards it to begin with. – 2018 PPS key informant
While most PPS key informants and focus group participants cited improvements in care
transitions as a positive outcome, several focus group participants did not agree and believed
that the DSRIP program missed the opportunity to make a lasting positive impact on care
transitions.
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But in the spirit of engagement, I believe if we don’t fix care transitions, none of this
works... I haven’t seen a bit of that come to reality, sadly, and I don’t see that there’s a
real desire to fix that – that is at the core of reducing avoidable hospitalizations in our
patients. We know all the reasons why we get the bounce back, and many times maybe
it’s because nobody wanted to talk to anybody else, or share information, or whatever
that is. We’re so close to the end of DSRIP now that I don’t see it changing in any
significant way. – 2018 primary care regional focus group participant
I think they think they’re changing, but if you’re not engaging the people touching those
patients – I said, “How are you teaching your residents and fellows about the courtesy of
a phone call, or some kind of communication with the primary care provider who is
going to receive that patient on the outside?” I get, “Oh no, they’re not in this.” When
you ask a resident, they have heard of DSRIP, but they don’t know anything more than
that – “Delivery System Redesign. Isn’t that what that means?” - 2018 primary care
regional focus group participant

4.2.4.4. Patient Experience
4.2.4.4.1. Patient Survey
The Clinician & Group Consumer Assessment of Healthcare Providers and Systems (version 3.0)
(CG-CAHPS) surveys completed in Demonstration Years 1, 2, and 3 (DY1, DY2, and DY3) showed
that overall, patients were satisfied with their health care providers (see Exhibit 4.14). On a
scale of 0 to 10, where 0 was “Worst provider possible” and 10 was “Best provider possible,”
between 82.2% and 84.4% rated their provider eight or above each year. Over 90% felt their
provider was a good communicator, and between 82.9% and 90.5% reported that they received
good care coordination; received timely appointments, care, and information; and experienced
helpful, courteous, and respectful office staff. Given the high level of satisfaction in DY1, large
improvements in satisfaction would not be expected to be seen in subsequent years (i.e., it is
difficult to make substantial improvements when satisfaction levels are already very high).
Rather, it is notable that patient satisfaction was high in DY1 and remained high in DY2 and
DY3. Appendix 8 contains responses to the items comprising these composite scores.
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Exhibit 4.14. Patient satisfaction with providers, Demonstration Years 1, 2, and 3

84.1%
82.2%
84.4%

Rate provider 8 or above

92.3%
91.1%
92.7%

How Well Doctors Communicate with Patients

83.9%
82.9%
84.0%

Care Coordination

85.1%
83.3%
86.0%

Getting Timely Appointment, Care, and Information

Helpful, Courteous, and Respectful Office Staff

89.6%
88.9%
90.5%

•DY1 •DY2 •DY3
Source: Authors’ analysis of the Clinician & Group CAHPS 3.0 survey.

An established relationship with a primary care provider has been shown to improve health
outcomes, reduce the cost of care overall by providing preventive interventions, facilitate
access to the rest of the health care system, and reduce preventable hospital visits.104 Thus, the
CG-CAHPS survey included items about continuity of care.
For more than three-quarters of respondents (78.6% in DY1; 80.9% in DY2; 86.9% in DY3), the
provider from whom they received care was the provider they usually saw if they needed a
check-up, wanted advice about a health problem, or got sick or hurt (see Exhibit 4.15). Nearly
as many (73.6% in DY1; 76.1% in DY2; 77.9% in DY3) had been seeing this provider for at least
one year. The percentage of respondents reporting a usual source of care and that they had
been seeing the same provider for a least one year increased somewhat between DY1 and DY3,
although data were not available to assess whether these trends were statistically significant.
These observed increases may suggest that the DSRIP program was more effectively connecting
and maintaining patient access to primary care, but it is not possible to say whether this change
is meaningful until more years of data have been collected.
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Starfield, B., Shi, L., & Macinko, J. (2005). Contribution of primary care to health systems and health. The
Milbank Quarterly, 83(3), 457–502. http://doi.org/10.1111/j.1468-0009.2005.00409.

139

Exhibit 4.15. Patient relationship with provider, Demonstration Years 1, 2, and 3

78.6%
Patient saw usual provider

80.9%
86.9%

73.6%
Patient had been seeing provider for at least one year

76.1%
77.9%

• DY1 • DY2 • DY3
Source: Authors’ analysis of the Clinician & Group CAHPS 3.0 survey.

4.2.4.4.2. Partner and Key Informant Perspectives on Patient Care
Most partner survey respondents reported that patient care had changed for the better since
the launch of the DSRIP program. A total of 62.7% survey respondents in 2017 and 75.4% in
2018 said that patients were experiencing some positive change or very positive change in care
(see Exhibit 4.16).
Exhibit 4.16. In your view, are patients experiencing better care since the launch of the DSRIP
program?
0.5"

100%
18.2"
N=772

1.3"

100%

2018
N~52

0.4"

I don' t know

• No, very negative change

• No, some negative change

No change

• Yes, some positive change

• Yes, very positive change

Source: Authors’ analysis of the 2017 and 2018 statewide partner survey.
Notes: Percentages do not total 100 due to rounding. The 2018 Statewide Annual Report did not include the “No
change” and “I don’t know” responses for this item.
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Partners were also asked to rate the degree to which they perceived each of their projects were
changing patient care. (Survey respondents were able to answer separately for each project in
which they participated.) About three-quarters of responses indicated that projects were
leading to some positive change or very positive change; 74.1% in 2017 and 79.0% in 2018. (see
Exhibit 4.17)
Exhibit 4.17. Please indicate the degree to which you perceive the project is changing patient
care

0.3%

25.6%

100%

N=l,573

0.4%

2018
N=3, 189

19.3%

100%

1.3%

• Very negat ive change

• Some negative change

No change

• Some positive change

• Very positive change

Source: 2017 and 2018 statewide partner survey.

Supporting the survey results, a significant majority of the partners and administrators who
participated in the focus groups and key informant interviews emphasized improvements in
patient care coordination as a result of the DSRIP program. Respondents shared that patients
were connected to health homes, received more appropriate referrals to both specialists and
community-based organizations, received more integrated behavioral health services, and
experienced more support after hospital discharge.
A lot of patients when they are discharged are not compliant and don’t go to their
follow-up visits. So we follow the patients. We make sure that they have a follow-up
visit, and if they’re not consistent or they don’t go, we send a [provider] home to them
for a one-time transitional visit so they don’t lose their insurance, they don’t lose their
primary physician. – 2018 hospital regional focus group participant
At the patient level, our patients don’t know about DSRIP per se, but have they felt it
locally? I would say yes, absolutely. The fact that they can go to the emergency room…
and engage with a navigator, have a community health worker support them in the
community, have a care manager who is helping them coordinate logistics of
appointments in their home and insurance. All of these are things that the local system
was very challenged with pre-DSRIP and just completely under-resourced. So at the
patient level, they have absolutely felt it. – 2018 PPS key informant
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It has helped us uncover new ways to go to business and take care of the patient. And it
has helped us focus more on a holistic approach to a patient than just a hospital or
primary care approach. – 2017 mental health and substance use regional focus group
participant
The providers are now looking to treat patients in terms of making referrals. If they are
screening a patient, they understand this patient may have social, behavioral health, or
substance abuse issues. Providers are using resources available through DSRIP to make
appropriate referrals. Patients are being tracked now and have better engagement
because of DSRIP initiatives and tools. – 2018 PPS key informant
The financial incentives of the DSRIP program raised awareness of the social determinants of
health and led to increased efforts to address them. A more holistic view of patients allowed
better connections to social services such as housing assistance.
Hospitals, from a traditional perspective for our vulnerable patients…these patients were
handed discharge papers and shuffled out the door. They were told to follow up with
somebody and social factors were never really something that was brought to the
forefront…We now have teams that are helping people get connections to places that
can help them address these factors in a long-lasting sustainable way. Helping them get
connections to [disability] benefits, to food pantries, to health homes, to legal services,
to primary care practices and health coaches. They are not just handing them a paper
referral, they are actually making sure they get there; they’re getting them connections
to recovery peers. I think we’ve seen through the data and through these interventions
that this is having an impact. I think their quality of life is improving and we’re seeing a
drop in utilization for these people. – 2018 PPS key informant
I do think it is helping, to some degree, with some of the “silo-ing” that had happened
and realizing that we may be touching the same lives, just in different ways.” – 2017
primary care regional focus group participant
Patient engagement efforts were a significant part of this improvement in coordination.
Educational outreach taught patients proper medication administration, provided instruction
about when it was appropriate to go to the emergency department rather than making an
appointment with their primary care provider, and empowered patients to take better care of
themselves in their own homes. Care navigators were utilized to provide the appropriate level
of care in the way patients wanted to receive it; meeting people where they were through
integration services, home visits, and assistance with system navigation.
We’ve been able to educate patients on a deeper level in their home than we otherwise
would have ever, so I think that has been the biggest benefit of DSRIP for us. – 2018
hospital regional focus group participant
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Being able to go in and improve quality of life, empowering the families to know how to
administer their medication, just making them a little more aware of what they need to
be doing; I feel like that has been a wonderful aspect of this. – 2018 hospital regional
focus group participant
For other folks, a lot of it is, how do you tap into outreach services? Part of what we do
under the health home is outreach, which is actually going out and trying to find people
based on lists or your own connections in the community. I think that that is important.
Community events are important. – 2018 primary care regional focus group participant
The DSRIP program provided the ability for participating organizations and providers to pay for
items beyond direct medical services, such as community health offerings (e.g., yoga classes)
and home-use products (e.g., air purifiers for asthma patients). Providing transportation to
health care providers and pharmacies was said to increase compliance with specialist and
mental health care services. Partners also reported that the DSRIP program supported in-home
paraprofessional services (e.g., food delivery, shoveled walkways), which were seen as reducing
the need for emergency services.
A minority of study participants did not perceive positive changes in patient care. Some felt that
bureaucratic requirements had increased for patients; for example, they had more forms to
read and sign. Others saw money being spent in ways that improved their performance
measures, but they felt it was not the best use of funds overall for innovation or patientcentered care. Although the majority of participants reported patient engagement successes
even though patients were unaware of the DSRIP program, a few believed that patient
engagement and education were lacking. Some stated that if the DSRIP program failed to
educate the consumers of services about the transformation efforts and include their
perspectives, then no real systemic change could occur.105
A lot of the stuff that we’ve implemented or that we’ve done has been more on the
provider and institution side and not considering the voice of the patient, what they need
and what’s not working for them. If you ask me if it’s changed, I’d probably say no, it
hasn’t. Until we change that perspective and allow the patient to actually have a voice in
what is happening in the health care system, I think in some aspects it’s going to remain
the same. -- 2018 PPS key informant

4.2.5. Stakeholder Input
This section synthesizes stakeholder input for future implementations of health care reform
programs.
105

The DSRIP program’s STC require a consumer education campaign to be conducted statewide to help educate
Medicaid and uninsured populations about the benefits of health care transformation. The workstream of the
patient focus groups was launched in DY3, the recommended educational strategy is to be concluded in DY4, and
rollout for the recommended educational messaging and consumer campaign is to be launched in DY5 and
beyond.
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4.2.5.1. Communication
Stakeholders’ ability to receive clear information on all aspects of the DSRIP program was
important, as it affected daily tasks, coordination of in-house and between-provider services,
and overarching implementation decisions. Despite a wide range of communication platforms
utilized by all stakeholders (e.g., newsletters, email blasts, webinars, and in-person meetings), a
lack of communication was reported across many entities: NYS DOH-to-PPS, PPS-to-PPS, PPS-topartner, and partner-to-partner. Stakeholder themes included:
● Continue to target communications and reach out to DSRIP stakeholders. While NYS
DOH made significant improvements to its communication protocols since the start of
the DSRIP program, stakeholders still reported a desire for additional targeted
communications, especially around the topics of value based payment, funds flow, and
sustainability planning.
● Revise annual meeting structures. Stakeholders reported interest in additional
opportunities for PPS and partners to meet with other PPS and partners to discuss
challenges and successes. Suggested topics included treatment of at-risk populations;
ways to overcome obstacles to patient engagement; effective data strategies; and
community outreach and buy-in.
● Raise awareness of information repositories. Although the NYS DOH created a
centralized FAQ and webinar repository, PPS key informants continued to report belief
that different PPS received different guidance. They requested more transparency in
answers to questions from stakeholders so that all PPS were informed of clarifications.
● Continue to increase communication between partners. While collaboration between
partners grew, partners hoped to see real-time communication improve when their
patients sought care from other providers, so that they could engage those patients and
avoid potential re-hospitalizations.
● Improve referral tracks from partner-to-partner. Although partners became more
aware of each other, some reported disappointment with the number of referrals they
received from within their PPS network. Partners wished to see referral platforms (such
as NowPow, a referral platform which allows health care providers to refer patients to
community-based organizations) more highly utilized and felt that partners should focus
on referring patients to other partners in their PPS.
● Develop transparency for upcoming value based payment contracting. Partners were
eager to hear about the decisions managed care organizations would make in regard to
value based payment contracting.

4.2.5.2. Training
Training and education of partners were critical components of ongoing implementation.
Partners appreciated the training provided on DSRIP objectives, implementation, and
accomplishments. Their feedback included:
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● Continue providing value based payment resources. Despite provider-based
assessments that they were largely knowledgeable of value based payment, many
stakeholders requested additional educational resources to aid implementation, such
as one-on-one consultations.
● Tailor training for partner types. Trainings that were not relevant to all partners were
frustrating and demoralizing. For example, non-Medicaid-billing community-based
organizations reported that some trainings were not relevant to their situations and
that they remained unsure of how to move toward value based payment.
● Include the right people in DSRIP program training. While partners felt that
management staff who were on board since the start of the DSRIP program received
adequate education about the program and its goals, they believed that frontline staff
should have received more training about the changes that were occurring, since they
were the ones who had direct impact on patients. Partners also wanted new employees
to receive training.
● Revisit training types and locations. Partners requested in-person and hands-on
training that fostered more dialogue than the distance training (such as webinars) most
often provided currently. In-person training could also facilitate intergroup discussions
to understand how various providers were transforming their practices.

4.2.5.3. Data and Information Technology Infrastructure and Support
The following feedback focused on critical data infrastructure needs that were necessary to
support continued system transformation efforts and produce efficient patient record
management.
•

•

•

Provide more timely data. While acknowledging that claims data would always be
reported with a lag, stakeholders continued to request more real-time comprehensive
clinical data in order to track performance and provide more robust patient care.
Obtain data from managed care organizations. Stakeholders explained that
cooperation from managed care organizations related to data access was essential to
health care transformation, but was lacking throughout the DSRIP program. More
support from NYS DOH was requested to help facilitate collaboration in accessing
essential data.
Obtain additional sources of data: cost data, substance use data, and data related to
patient experience.
o Cost data. In preparation for value based payment opportunities, stakeholders
expressed that data on the costs associated with care were key to understanding
the financial impacts of their efforts. While stakeholders sometimes had
statistics to show reductions in emergency room visits, for example, they could
145

•

not determine the financial impact of that reduction from a total cost
perspective without these data.
o Substance use data. Key informants from PPS explained that data could be
obtained from participating entities covered under a Business Associate
Agreement (BAA) which fit the definition of the Organized Health Care
Arrangement (OHCA). This allowed them to create patient lists, analyze data, and
provide reports for partners so they could make informed decisions and
prioritize resources. However, even with BAAs in place, stakeholders reported
that federal regulations restricted access to data related to patients being
treated for a substance use disorder. They requested that substance use data be
made more easily available to them, as these patients tended to be high utilizers
of the emergency room and substance use disorders had an impact across the
entire health spectrum.
o Data related to patient experience. Some key informants and partners believed
that until patient perspectives were incorporated into all health care efforts, true
system transformation could not occur. Stakeholders said that the Consumer
Assessment of Healthcare Providers and Systems (CAHPS) surveys captured data
related to patient experience at the primary care level, but did not adequately
assess patient experience in other health care sectors. Additional data collection
to obtain additional patient perspectives was suggested.
Ensure that all stakeholders are clear on current interoperability progress. As each
clinical system in New York State was unique, partners voiced frustration with the
interoperability of electronic health records. While acknowledging that NYS DOH
provided substantial resources to improve information sharing and that there were
ongoing federal/business initiatives regarding interoperability, partners reported
significant challenges to sharing patient information among themselves, due to the lack
of standardization in information sharing platforms. Partners requested more support
from the NYS DOH in promoting better Qualified Entity partnerships or leveraging other
data sharing capabilities.

4.2.5.4. DSRIP Program Payment Models
The DSRIP program’s financial model was complex and changed over time as goals move from
Payment for Reporting to Payment for Performance. Many of the PPS were successful at
distributing funds to partners, but some partners reported that they did not perceive fair funds
flow. A consensus in the non-hospital focus groups was that non-hospital partners felt that
funds were directed much more generously to hospitals over other partners. Stakeholder
feedback included:
● Review payment model fairness. Stakeholders reported inequities in how funds were
distributed to partners. Many partners’ viewpoint was that hospital-based PPS kept
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funds internal to hospitals. They believed that if that was the preferred model and
unlikely to change, then the PPS that maintained a more internal funding model should
have been transparent about this with their partners, who may have developed
different expectations at earlier stages of the project.
● Include community-based organizations more fully. Stakeholders requested an
increase in the involvement of community-based organizations in funding decisions.
Community-based organizations had the ability to increase community engagement and
patient buy-in beyond health care partners’ capabilities and were a key component of
DSRIP program success. However, community-based organizations reported that their
involvement was hindered by lack of infrastructure and resources to make those
linkages. They requested additional opportunities to demonstrate value, more capacity
building assistance, and increased funds flow.
● Update billing codes and payment regulations. A number of stakeholders reported that
for the activities of the DSRIP program to be sustainable, billing and regulation practices
needed updating. Current billing codes were not sufficient to support the projects,
especially the integration of primary care and behavioral health. Several PPS key
informants pointed out telepsychiatry and telehealth as services that should be more
broadly billable in order to sustain their integration work.106 Stakeholders were worried
that projects that could not currently bill for services would disappear at the end of the
DSRIP program. Additionally, stakeholders described regulatory challenges to
sustainability, such as Article 28, which prevented billing for behavioral health services
provided by social workers unless it was for pregnant mothers or children under age 18,
and Article 30, which dictated EMT staffing standards for voluntary ambulance services
and did not allow EMTs to provide certain services outside of the emergency room.

4.2.5.5. Programmatic Changes
Several suggestions related to the programmatic scope of the DSRIP program emerged:
● Broaden focus on non-Medicaid populations. Partners reported that guidelines for
serving both Medicaid and non-Medicaid patients would be helpful. The focus was
on Medicaid populations, without as much guidance for those with no insurance or
those dually eligible for Medicaid and Medicare. Stakeholders reported that while
groups such as individuals with intellectual and developmental disabilities may not
have fit directly under the DSRIP program, they were affected by project
implementation and should be considered.
● Eliminate PPS overlap. Stakeholders voiced frustrations regarding inefficiencies in
the investment of time and resources caused by PPS overlapping geographically.
They recommended designating only one PPS per county.
106

Changes have since taken place that allow more telemedicine services to be billed to Medicaid in New York
State.
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● Consider an extension of the DSRIP program timeline to effect systems-level
change. A majority of PPS key informants and partners reported uncertainty about
what was going to happen after DSRIP program funding ended. Stakeholders wanted
to see DSRIP program funding continue after the initial five years, and feared that if
funding abruptly stopped their progress would regress. Many felt that five years was
not long enough to achieve the systemic change the DSRIP program was intended to
develop, and would like to see an extension to finish the work that they started.
● Encourage collaboration with managed care organizations. Because stakeholders
considered collaboration with managed care organizations to be fundamental to
project sustainability, they believed that the DSRIP program should have encouraged
managed care organizations to engage with PPS. Many stakeholders viewed lack of
engagement with managed care organizations as a missed opportunity for the DSRIP
program.

4.3. Assessment of Changes in Health Care Quality
This section addresses RQ-B:
Did health care quality improve as a result of clinical improvements in the treatment of
selected diseases and conditions? (CMS RQ2)

Summary At-A-Glance
The Interim Report focused on two common measures of health care quality: (1) the asthma
medication ratio, and (2) medication management for people aged 5-64 with asthma. The
asthma medication ratio assesses appropriate medication prescribing to members with
persistent asthma, with a ratio of controller medications to total asthma medication of 0.50 or
greater indicating high quality clinical care.107 The asthma medication management measure
assesses adherence, and it is defined as the percentage of members with persistent asthma who
were dispensed appropriate asthma medication and remained on their prescribed asthma
controller medications for at least 75% of the treatment period. Preliminary results among the
PPS that selected the asthma project revealed that the asthma medication ratio displayed
worsening performance in the pre-DSRIP period, but following DSRIP initiation the trajectory
subsequently changed and the PPS are now improving. In addition, the level of asthma
controller medication management has remained steady overall.
107

These measures use Healthcare Effectiveness Data and Information Set (HEDIS) measure specifications by the
National Committee for Quality Assurance (NCQA) for health plans and other health care organizations. For more
information, see: NCQA. (n.d.). Medication management for people with asthma and asthma medication ratio
(MMA, AMR). Retrieved from https://www.ncqa.org/hedis/measures/medication-management-for-people-withasthma-and-asthma-medication-ratio/
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At the statewide level, at baseline 60.5% of members with persistent asthma had an asthma
medication ratio of 0.5 or higher, and 32.1% of members who were on a controller had 75% or
more of their treatment days covered. The asthma medication ratio declined in the pre-DSRIP
period and in the early portion of the post-DSRIP period. Thereafter, the trend shifted and
performance improved with a positive rate of increase in the asthma medication ratio
performance. The level of asthma medication management among members who were
prescribed a controller remained constant throughout the period. It is not unexpected that the
asthma medication ratio showed improvement while the medication management measure did
not, as it takes longer to improve long-term adherence.
There are several important cautions for interpreting these findings, which will be explored in
more detail for the final summative report. First, the Interim Report does not contain a
comparative analysis for these measures, as only 13 PPS selected the project. Additional work
to compare these PPS, as well as other time trends will be considered in the final summative
report. There is a limited study time period, so the Interim Report only examines changes in the
early phases of DSRIP implementation; these trends will evolve over time and thus findings in
the final summative report may differ. It is not uncommon to see initial drops in performance
when implementing a new program, followed by improvements; the additional time points will
allow for more detailed exploration in the final summative report. There was considerable
variability in the asthma medication measure which may have contributed to inconclusive
findings, and the final summative report will consider alternative measures to fully understand
differences across PPS and time. The Interim Report focused on asthma measures among the
13 PPS that selected that project. Additional quality outcomes, including those relevant to other
PPS, will be explored for the final summative report.

4.3.1. Statewide Trends in Quality of Care Measures
Exhibits 4.18 and 4.19 illustrate the monthly statewide trends in the Asthma Medication Ratio
(5-64 Years) among attributed members and the Medication Management for People with
Asthma (5-64 Years) – 75% of Treatment Days Covered, two common quality of clinical care
indicators. The asthma medication ratio assesses appropriate medication prescribing to
attributed members with asthma, whereas the asthma medication management measure
focuses on access and adherence to care among those prescribed a controller medication. The
Asthma Medication Ratio (5-64 Years) measure quantifies the percentage of members with a
controller-to-total asthma medication ratio of 0.5 or higher, among attributed members aged 5
to 64 years with persistent asthma who received at least one asthma medication (either
controller or reliever). A controller-to-total asthma medication ratio of 0.50 denotes high
quality clinical care.108 The Medication Management for People with Asthma (5-64 Years) – 75%

108

These measures use Healthcare Effectiveness Data and Information Set (HEDIS) measure specifications by the
National Committee for Quality Assurance (NCQA) for health plans and other health care organizations. For more
information, see: NCQA. (n.d.). Medication management for people with asthma and asthma medication ratio
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of Treatment Days Covered assesses the percentage of members who filled prescriptions for
asthma controller medications during at least 75% of their treatment period, among attributed
members aged 5 to 64 years with persistent asthma and who received at least one controller
medication. Both measures have values from 0% to 100%, and higher values indicate better
quality of care.
These plots have fitted linear trend lines to illustrate changes in performance at the statewide
level during the study period, from the start of MY1 through the end of MY3. The interrupted
time series model, described in more detail below, tests whether there is a level and/or slope
change in the post-DSRIP initiation period. That corresponds to the study hypotheses and
research questions regarding whether these measures improved following the DSRIP program’s
initiation. To be consistent with the regression specification, these plots have a disjuncture at
the start of the post-DSRIP initiation period to illustrate early differences after the initiation of
the DSRIP program. The pre- and post-DSRIP initiation periods have separate fitted lines to
show whether there are slope changes after the DSRIP program’s initiation. The immediate
drop following the initiation corresponds with the level change.
The asthma medication ratio had a slight decline in the pre-DSRIP period followed by an
improvement. At the end of MY0, the baseline value, 60.5% of members with persistent asthma
had an asthma medication ratio of 0.5 or higher. This declined by 4.1% to 58.1% at the end of
MY1. Immediately following DSRIP initiation, there was no level change but there was a
perceptible slope change and thereafter the trend had a positive trajectory signaling an
improvement in this measure.
Although the asthma medication management measure fluctuates slightly across the period,
overall the pre- and post-DSRIP trend lines are similar indicating a level trend and limited
change across time. At the end of MY0, the baseline value, 32.1% of members aged 5 to 64 with
persistent asthma had 75% or more of their treatment days covered. The fitted linear trend in
the pre-DSRIP period appears flat, indicating there is no change in this percentage by the end of
MY1. After the initiation of the DSRIP program, there is a no meaningful increase or decrease in
the level of this outcome (level change) and the post-DSRIP initiation slope appears flat similar
to the pre-DSRIP period.

(MMA, AMR). Retrieved from https://www.ncqa.org/hedis/measures/medication-management-for-people-withasthma-and-asthma-medication-ratio/
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Exhibit 4.18. Monthly changes in asthma medication ratio
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: Asthma medication ratio is measured as the percentage of members with a controller-to-total asthma
medication ratio of 0.5 or higher, among attributed members aged 5 to 64 years with persistent asthma who
received at least one asthma medication. June 2014 through June 2015 (MY0 and MY1) is pre-DSRIP, and July 2015
through July 2017 (MY2 and MY3) are post-DSRIP. Results are restricted to the 13 PPS that selected the asthma
project.

Exhibit 4.19. Monthly changes in the asthma medication management
45

C

40

<I)

E
35
<I)
QO

n,
C
n,

~
C

-

.Q

1

•

30

······---· ··········
••

25

ee

..... ..
•

• , e•

n,

.!= 20

.:,
<I)

~ 15
n,

E 10

~

t;;

<(

Post-DSRIP

5
0
I.I")

<.O

8
N

8
N

Source: Authors’ analysis of the DSRIP Dataset.
Notes: Asthma medication management is measured as the percentage of members who filled prescriptions for
asthma controller medications during at least 75% of their treatment period, among attributed members aged 564 with persistent asthma who received at least one controller medication. June 2014 through June 2015 (MY0
and MY1) are pre-DSRIP, and July 2015 through July 2017 (MY2 and MY3) are post-DSRIP. Results are restricted to
the 13 PPS that selected the asthma project.
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The statewide interrupted time series (see Exhibit 4.20) quantified the magnitude and statistical
significance of post-DSRIP initiation changes in asthma medication management and the
asthma medication ratio across the 37-month study period. There are three sets of coefficients
because a separate regression model was developed for each outcome measure. For each
outcome, the interrupted time series has three main coefficients: (1) a Trend that captures the
slope in the pre-DSRIP period, (2) a DSRIP dummy variable that is coded as 1 in the post-DSRIP
initiation period and 0 in the pre-DSRIP period to estimate the level change in the post-DSRIP
initiation period, and (3) a Trend*DSRIP coefficient that assesses whether the slope changed in
the post-DSRIP initiation period. The Constant term refers to the baseline level at the start of
the study period (last month of MY0). For the coefficients, a p-value of p<0.01 is considered
strong evidence, p<0.05 is considered moderate evidence, and p<0.1 is not statistically
significant but provides suggestive evidence for a possible relationship with the outcome
variable.
Exhibit 4.20. State-level time series regression model

Variable
Trend
DSRIP
Trend*DSRIP
Constant
Observations
Adjusted R2

Asthma Medication
Ratio
b (SE)
-0.218***
(0.054)
-4.535***
(0.713)
0.379***
(0.058)
60.805***
(0.430)
37
0.710

Asthma Medication
Management
b (SE)
0.004
(0.036)
-0.929*
(0.472)
0.052
(0.039)
31.242***
(0.285)
37
0.362

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. Results are restricted to the 13 PPS that selected the asthma project.

For the asthma medication ratio measure, the regression model showed a worsening trend
prior to the DSRIP program, and thereafter the trend reversed and the measure improved. The
Trend coefficient was negative and statistically significant (b= -0.218, p<0.01), indicating that
each month prior to the DSRIP initiation is associated with a 0.2 percentage-point decline in the
percent of patients with an asthma medication ratio that meets quality of care standards.
Following DSRIP initiation, the Trend*DSRIP interaction term, which quantifies the slope change
in the post-DSRIP initiation period, was positive and statistically significant (b= 0.379, p<0.01).
This is strong evidence that the trend improved in the post-DSRIP initiation period and confirms
the visual plot that shows a positive trajectory after DSRIP initiation.109
109

Although the DSRIP dummy variable is negative and statistically significant (b= -4.535), the decline between the
end of MY1 and the start of MY2 is not meaningful. The immediate post-DSRIP initiation change is calculated using
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For the asthma medication management measure, the regression model confirmed the visual
plots that this outcome has remained at a steady value throughout the study period, and there
was no significant change in the level or trend following the initiation of the DSRIP program.
The Trend coefficient (b= 0.004) was not statistically significant, providing no evidence that
these values changed in the pre-DSRIP period. The DSRIP coefficient (b= -0.929) and
Trend*DSRIP interaction term (b= 0.052) were both insignificant at the p<0.05 level, suggesting
that the percentage of patients who filled their asthma prescriptions for at least 75% of their
treatment days has remained at a constant level.

4.3.2. Comparative Analysis of Quality of Care Measures among Performing
Provider Systems
Exhibits 4.21 and 4.22 display the two measures in MY0, MY1, MY2, and MY3, by PPS. Findings
are limited to the 13 PPS that selected the asthma project. Each PPS has one bar per MY.
Although monthly data are available, these graphs only present the last observation in each MY
for ease of interpretation. The performance outcomes in the DSRIP Dataset are 12-month
rolling averages, so the last value of the MY captures the prior year’s average performance.
Across PPS which selected the asthma project, there was variability in the percentage of
members meeting the asthma medication ratio benchmark (MY0: from 56.8% to 67.8%, MY1:
from 52.7% to 65.2%, MY2: from 56.8% to 67.4%, MY3: from 57.2% to 70.6%). All but one PPS
had an improvement from MY0 to MY3, consistent with the statewide trend that showed
improvements following DSRIP initiation (see Section 4.3.1).
Across PPS which selected the asthma project, there was variability in the percent of members
meeting the asthma medication management benchmark (MY0: from 25.0% to 35.1%, MY1:
from 26.1% to 40.6%, MY2: from 24.6% to 36.1% in MY2, MY3: from 24.6% to 37.0%). In
contrast to the asthma medication ratio measure, the 13 PPS exhibited variations in their
trends over time. For example, Better Health for Northeast New York (BHNNY) had a steady
rate around 34% in all years, and Bronx Partners for Healthy Communities (BPHC) had a steady
rate in MY0, MY1, and MY2 (32.1%, 32.0%, and 32.7%, respectively) and an increase in MY3
(35.7%). Leatherstocking Collaborative Health Partners (LCHP) has a notable improvement in
the pre-DSRIP initiation period (MY0: 33.5%, MY1: 40.6%), and thereafter the levels lowered
but were still an improvement from the initial MY0 value (MY2: 36.1%, MY3: 37.0%). SOMOS
had a decline in performance over the study time period (MY0: 32.0%, MY3: 30.5%). This
variability in performance trends warrants further analysis in the final summative report.

the predicted values, using t=13 and DSRIP=0 for the last month of MY1, and t=14 and DSRIP=1 for the first month
of MY2. The predicted values for these months are 58.0 and 58.5, and there is no substantial level change.
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Exhibit 4.21. Annual changes in asthma medication ratio from MY0 to MY3, by PPS participating
in an asthma project
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: Asthma medication ratio is measured as the percentage of members with a controller-to-total asthma
medication ratio of 0.5 or higher, among attributed members aged 5 to 64 years with persistent asthma who
received at least one asthma medication. July 2014 through June 2015 (MY1) is pre-DSRIP, and July 2015 through
July 2017 (MY2 and MY3) are post-DSRIP. Results are restricted to the 13 PPS that selected the asthma project.
Each PPS has four bars, one per MY, with values based on the last month in the MY. Within each PPS cluster, MY0
has the left bar position followed to the right by MY1, MY2, and MY3.

Exhibit 4.22. Annual changes in controller-to-total asthma medication management from MY0
to MY3, by PPS participating in an asthma project
45. 0%
40.0%
35. 0%
30.0%
25. 0%
20.0%
15.0%
10.0%
5.0%
0 .0%

• Asthma Medication Management

Source: Authors’ analysis of the DSRIP Dataset.
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Notes: Asthma medication management is measured as the percentage of members who filled prescriptions for
asthma controller medications during at least 75% of their treatment period, among attributed members aged 564 with persistent asthma who received at least one controller medication. July 2014 through June 2015 (MY1) are
pre-DSRIP, and July 2015 through July 2017 (MY2 and MY3) are post-DSRIP. Results are restricted to the 13 PPS
that selected the asthma project. Each PPS has four bars, one bar per MY, with values based on the last month in
the MY. Within each PPS cluster, MY0 has the left bar position followed to the right by MY1, MY2, and MY3.

4.4. Assessment of Changes in Population Health
This section addresses RQ-C:
Did population health improve as a result of implementation of New York’s DSRIP
initiative? (Sub-question: Were racial and ethnic disparities on specific population
measures reduced following the DSRIP program?) (CMS RQ3)

Summary At-A-Glance
The Interim Report focused on population health measures in four areas: (1) mental health and
substance abuse, (2) chronic disease prevention, (3) HIV, and (4) racial/ethnic disparities in
chronic disease prevention and HIV. The DSRIP program’s Domain 4 measures and PPS projects
are closely aligned with the New York State Prevention Agenda 2013-2018, and the population
health measures presented here are consistent with the Prevention Agenda measures and
relevant to projects that were selected by the PPS. If the DSRIP program were successful in
achieving system transformation and shifting towards increased use of preventive services,
population health measures should also improve. It is anticipated that there would be a larger
lag time between the implementation of the DSRIP program and changes in population health
measures. Consequently, the interim report aims to provide a snapshot of New York’s recent
trends from MY0 to MY3, and current performance compared to the state’s Prevention Agenda
and national indicators. Additionally, many of the data sources used for population health
measures involve the larger statewide populations beyond Medicaid members. Currently, the
statewide population is 19.5 million and the Medicaid population is 6 million.
Several population health measures improved during the first few years of the DSRIP program’s
initiation (i.e., reduced if an unwanted event, or increased if a desired event): prevalence of
poor mental health, prevalence of current cigarette smoking, newly diagnosed HIV cases,
racial/ethnic disparities in premature deaths, and racial/ethnic disparities in newly diagnosed
HIV cases. Among these measures that improved, the newly diagnosed HIV cases and
racial/ethnic disparities in newly diagnosed HIV cases also exceeded the statewide Prevention
Agenda targets. In addition, the prevalence of binge drinking among adults exceeded the
statewide Prevention Agenda target, although it did not decline during the time period
examined in this interim report.
Other population health measures have room for improvement. The suicide death rate,
percentage of premature deaths, and percentage of adults with up-to-date colorectal cancer
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screenings remained steady throughout the study period and did not yet meet the Prevention
Agenda targets. Although the prevalence of cigarette smoking and racial/ethnic disparities in
premature deaths declined, these measures did not yet meet the Prevention Agenda goals by
the end of MY3.
There are several cautions in interpreting these interim findings. The population health
measures were collected through existing public health surveillance data systems, and so their
years do not align precisely with MY. The small number of data points for these annual
measures, with two years pre-DSRIP and two years post-DSRIP initiation, make it difficult to
isolate changes that occurred due to the DSRIP program. Without additional information on
these measures over a longer period of time, it is not possible to quantify the degree to which
their trajectories were altered following the DSRIP program’s implementation. More
importantly, as discussed in more detail in Section 6, the Prevention Agenda launched in 2011
and has been a large focus for New York, NYC, and local health departments. Concurrently, New
York initiated in 2014 the nation’s first Ending the Epidemic initiative to achieve a first-ever
decline in HIV prevalence, including a focus on reducing health disparities. The DSRIP program is
aligned with these important population health initiatives and has served as an accelerant for
their activities. Given the limited number of data points and the close alignment between New
York’s DSRIP program and other state initiatives, it is difficult to isolate the contribution that is
solely attributable to the DSRIP program.

As described in Section 2.2.4, the DSRIP program’s Domain 4 measures align closely with the
New York State Prevention Agenda 2013-2018 and projects in this domain are an accelerant to
other statewide population health initiatives. These are reported publicly at the statewide and
county levels, to allow communities to assess their performance and improvements over time.
If the DSRIP program were successful in achieving system transformation and shifting towards
increased use of preventive services, then population health outcomes should also improve. It
is anticipated that there would be a larger lag time between the implementation of the DSRIP
program and changes in population health measures. Consequently, the interim report focuses
on providing a snapshot of New York’s recent trends and current performance compared to the
state’s Prevention Agenda and national indicators.
Exhibit 4.23. summarizes the baseline values and goals for the Prevention Agenda indicators
that are most relevant to the DSRIP program, categorized by focus area. These are referenced
in the following sections, to contextualize the findings from the DSRIP program’s statewide
performance measures. The Domain 4 measures come from multiple existing public health data
surveillance systems, and they reflect calendar years rather than DSRIP measurement years
(MY). For the purposes of DSRIP reporting and evaluation, they are converted to MY. For
consistency with the other Interim Report findings, the population health measures are
presented in MY and are derived from the DSRIP Dataset.
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Exhibit 4.23. Baseline values and goals for New York State Prevention Agenda indicators
Focus Area

Indicators and Data Sources

Mental health
and substance
abuse
population
health
outcomes
(Section 4.4.1)

Age-adjusted percentage of adult
binge drinking during the past
month (Data source: Behavioral
Risk Factor Surveillance System
(BRFSS) and Expanded BRFSS)
Age-adjusted percentage of adults
with poor mental health for 14 or
more days in the past month
(Data source: Behavioral Risk
Factor Surveillance System
(BRFSS) and Expanded BRFSS)
Age-adjusted suicide death rate
per 100,000 (Data source: Bureau
of Biometrics)

Chronic disease
prevention
population
health
outcomes
(Section 4.4.2)

Percentage of adults aged 50-75
years who received a colorectal
cancer screening based on the
most recent guidelines (Data
source: NYS BRFSS)
Percent of cigarette smoking
among adults aged 18 and above
(Data source: NYS BRFSS)

HIV population
health
outcomes
(Section 4.4.3)

Percentage of premature deaths,
defined as deaths before age 65
(Data source: NYS Vital Statistics)
Newly diagnosed HIV case rate
per 100,000 (Data source: HIV
Surveillance System)

Percentage of premature death,
ratio of black non-Hispanic to

New York State Prevention Agenda
Statewide Objectives
Reduce binge drinking by 10%, to
≤18.4%. (Baseline: 20.4% in 2011.)

Reduce the reported poor mental
health (14 or more days in the last
month) by 10%, to ≤10.1%. (Baseline:
11.2% in 2011)

Reduce the age-adjusted suicide rate
by 10%, to ≤5.9 per 100,000.
(Baseline: 6.6 per 100,000 in years
2007-2009.)
Increase the percentage of adults
who receive up-to-date colorectal
cancer screening by 5%, to ≥71.4%. In
November 2015, a revised target of
80% was set for 2018. (Baseline:
68.0% in 2010)
Decrease the prevalence of cigarette
smoking by adults by 17%, to ≤15.0%.
In November 2015, a revised target of
12.3% was set for 2018. (Baseline:
18.1% in 2011)
Reduce the percentage of premature
deaths (before age 65 years) by 10%,
to ≤21.8%. (Baseline: 24.2% in 2010)
Reduce the newly diagnosed HIV case
rate by 25%, to ≤14.7 new diagnoses
per 100,000. In July 2015, indicator
baseline and trend data were updated
and a revised target of ≤16.1 new
diagnoses per 100,000 population
was set for 2018. (Baseline: 19.6 per
100,000 in 2010; updated baseline:
21.5 per 100,000 in 2010)
Reduce disparities by 10%, to ≤1.87.
(Baseline: 2.08 in 2010)
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Focus Area

Indicators and Data Sources

Population
health
disparities
(Section 4.4.4)

white non-Hispanic (Data source:
NYS Vital Statistics)
Percentage of premature death,
ratio of Hispanic to white nonHispanic (Data source: NYS Vital
Statistics)
Newly diagnosed HIV case rate
per 100,000, difference in rates of
new HIV diagnoses between black
non-Hispanic and white nonHispanic

Newly diagnosed HIV case rate
per 100,000, difference in rates of
new HIV diagnoses between nonHispanic and white non-Hispanic

New York State Prevention Agenda
Statewide Objectives

Reduce disparities by 10%, to ≤1.86.
(Baseline: 2.07 in 2010)

Reduce disparities by 25%, to a rate
difference of ≤45.7 per 100,000. In
July 2015, the indicator baseline and
trend data were updated, and a
revised target of ≤46.8 per 100,000
was set for 2018. (Baseline: 60.9 per
100,000 in years 2006-2010; revised
baseline: 62.4 per 100,000)
Reduce disparities by 25%, to a rate
difference of ≤22.3 per 100,000. In
July 2015, the indicator baseline and
trend data were updated, and a
revised target of ≤26.6 per 100,000
was set for 2018. (Baseline: 29.8 in
years 2006-2010; revised baseline:
35.5 per 100,000)

Source: New York State Department of Health Prevention Agenda website. 110
Notes: Values are for the New York State Health Improvement Plan associated with the Prevention Agenda 20132018.

4.4.1. Statewide Trends in Mental Health and Substance Abuse Population
Health Outcomes
Exhibit 4.24 displays annual values of the age-adjusted percentage of adults reporting binge
drinking in the past month (blue bars) and the age-adjusted percentage of adults reporting poor
mental health for 14 or more days in the last month (orange bars). Exhibit 4.25 displays annual
values of the age-adjusted suicide death rate per 100,000. In both exhibits, lower values are
desirable.
Across the four MY, the population health outcomes of binge drinking among adults and the
suicide death rate remained at a steady level, while the percent of adults with poor mental
health declined slightly between MY2 and MY3. Across the four MY, between 17.8% and 18.3%
110

New York State Department of Health. (2015, March 16). New York State Prevention Agenda 2013-2018:
priorities, focus areas, goal and objectives, 1/25/2013 (revised March 16, 2015). Retrieved from
https://www.health.ny.gov/prevention/prevention_agenda/2013-2017/tracking_indicators.htm
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of adults reported binge drinking, which is slightly higher than the national reported average of
16.3% (in 2015) but meets the statewide Prevention Agenda target of 18.4%. 111 In the study
period, the percentage of adults reporting poor mental health increased slightly from 11.2% in
MY0 and MY1 to 11.7% in MY2. Thereafter, it declined by one percentage-point between MY2
and MY3, to 10.7% in MY3. This is slightly lower than the national reported average of 12.5% (in
2012) but does not yet meet the Prevention Agenda target of 10.1%.112 The suicide death rate
from MY0 to MY3 was relatively steady with values from 7.9 per 100,000 to 8.0 per 100,000
across the measurement years. That is lower than the national average of 13.3 per 100,000 (in
2015) but does not yet meet the Prevention Agenda target of 5.9 per 100,000.113
Exhibit 4.24. Statewide annual trends in binge drinking and poor mental health from MY0 to
MY3
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Source: Authors’ analysis of the population health data available in the DSRIP Dataset.
Notes: Binge drinking and poor mental health are measured as the age-adjusted percentage of adult binge drinking
in the past month, and age-adjusted percentage of adults with poor mental health for 14 or more days in the last
month. The coverage is the NYS general population and not limited to Medicaid members.

111

Centers for Disease Control and Prevention. (n.d.). BRFSS prevalence & trends data. Retrieved from
https://www.cdc.gov/brfss/brfssprevalence/index.html
112
Dwyer-Lindgren, L., Mackenbach, J.P., Van Lenthe, F.J., & Mokdad, A.H. (2017). Self-reported general health,
physical distress, mental distress, and activity limitation by US county, 1995-2012. Population Health Metrics, 15,
16.
113
National Institutes of Mental Health. (n.d.). Suicide. Retrieved from
https://www.nimh.nih.gov/health/statistics/suicide.shtml
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Exhibit 4.25. Statewide annual trends in suicide death rate from MY0 to MY3
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Source: Authors’ analysis of the population health data available in the DSRIP Dataset.
Notes: The suicide death rate is measured as the age-adjusted suicide death rate per 100,000. The coverage is the
NYS general population and not limited to Medicaid members.

4.4.2. Statewide Trends in Chronic Disease Prevention Population Health
Outcomes
Exhibit 4.26 displays annual values in two chronic disease prevention population health
outcomes: the percentage of adults aged 18 and older who report currently smoking cigarettes
(blue bars); and percentage of premature deaths, defined as deaths among individuals aged 64
and younger (orange bars). Lower values are desirable. Exhibit 4.27 displays a third chronic
disease prevention population health outcome, the percentage of adults aged 50-75 years who
received a colorectal cancer screening based on the most recent screening guidelines. Higher
values of colorectal cancer screening are desirable.
The smoking outcome improved over the period, while the premature death and colorectal
cancer screening outcomes fluctuated but did not decline. The prevalence of smoking among
adults declined steadily each year, from 15.6% in MY0 to 14.2% in MY3. This outcome did not
yet meet the statewide Prevention Agenda target of 12.3%,114 but it was lower than the
national average of 15.5% in 2016.115 The percentage of deaths that were premature had a
relatively steady trend with annual values ranging from 23.2% to 24.0% during the period,
which did not yet meet the statewide Prevention Agenda target of 21.8% but was lower than
114

The Prevention Agenda target was updated following a change in the indicator baseline and trend; the value
here reflects the updated target.
115
Centers for Disease Control and Prevention. (2018, September 24). Current cigarette smoking among adults in
the United States. Retrieved from
https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm
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the national average of 27.0% in 2016.116 The percentage of adults aged 50-75 who received
up-to-date colorectal cancer screening ranged from 68.5% to 70.5% during the period. That is
about 2 to 3 percentage points higher than the national average (66.2% and 63.7% in 2014 and
2016, respectively),117 although it did not yet meet the Prevention Agenda target of 71.4%.

Exhibit 4.26. Statewide annual trends in cigarette smoking and premature deaths from MY0 to
MY3
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Source: Authors’ analysis of the population health data available in the DSRIP Dataset.
Notes: Cigarette smoking is measured as the percentage of people aged 18 or older who report currently smoking
cigarettes. Premature death is measured as the percentage of deaths that occurred among individuals aged 64
years and younger. The coverage is the NYS general population and not limited to Medicaid members.

116

This was calculated by the NYS DOH Public Health Information Group using CDC Wonder queries for the total
count of deaths among individuals aged 0-64 (https://wonder.cdc.gov/controller/saved/D76/D49F996) and the
total counts of deaths among all age groups (https://wonder.cdc.gov/controller/saved/D76/D49F997).
117
Centers for Disease Control and Prevention. (n.d.). Quick facts. Colorectal cancer screening in U.S. Behavioral
Risk Factor Surveillance System – 2016. Retrieved from https://www.cdc.gov/cancer/colorectal/pdf/QuickFactsBRFSS-2016-CRC-Screening-508.pdf
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Exhibit 4.27. Statewide annual trends in colorectal cancer screening from MY0 to MY3
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Source: Authors’ analysis of the population health data available in the DSRIP Dataset.
Notes: Colorectal cancer screening is measured as the percentage of adults aged 50-75 years who received a
colorectal cancer screening based on the most recent guidelines. The coverage is the NYS general population and
not limited to Medicaid members.

4.4.3. Statewide Trends in HIV Population Health Outcomes
Exhibit 4.28 displays annual trends in the rate of newly diagnosed HIV cases per 100,000. The
diagnosis rate declined steadily throughout the period, from 19.1 per 100,000 in MY0 to 16.0
per 100,000 in MY3. This meets the statewide Prevention Agenda target of 16.1 new diagnoses
per 100,000.118 Despite New York’s improvements in diagnosis rates, its rate is still above the
national average.119 Some caution is warranted in comparing rates across states; as an
infectious disease, rates are higher in large urban areas such as New York City compared to
rural regions and New York was an early epicenter.

118

The Prevention Agenda target was updated as a result of a change in the indicator baseline and trend; the value
here reflects the updated target.
119
Centers for Disease Control and Prevention. (2017). HIV surveillance report, 2017; vol. 29, Table 26. Retrieved
from https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2017-vol-29.pdf
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Exhibit 4.28. Statewide annual trends in HIV population health outcomes from MY0 to MY3
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Source: Authors’ analysis of the population health data available in the DSRIP Dataset.
Notes: The HIV case rate is measured as new diagnoses per 100,000. The coverage is the NYS general population
and not limited to Medicaid members.

4.4.4. Statewide Trends in Population Health Disparities
Exhibit 4.29 displays annual trends in disparities in premature deaths, measured as the ratio of
the percentage of deaths among individuals aged 64 years and younger between black nonHispanic versus white non-Hispanic persons (blue line), and the ratio between Hispanic versus
white non-Hispanic persons (orange line). A ratio of one would indicate no disparities. Both
disparities declined during the period, although the decline was more notable for Hispanics.
The ratio for black non-Hispanics declined from 2.01 in MY0 to 1.95 in MY3, which did not yet
meet the Prevention Agenda target of 1.87. The ratio for Hispanics declined from 1.98 in MY0
to 1.87 in MY3, which approached but did not yet exceed the Prevention Agenda target of 1.86.

163

Exhibit 4.29. Statewide annual trends in disparities in premature deaths from MY0 to MY3
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Source: Authors’ analysis of the population health data available in the DSRIP Dataset.
Notes: Premature death is measured as the percentage of deaths that occurred among individuals aged 64 years
and younger. Disparities are measured as the ratio of premature deaths between groups, with 1.0 representing no
differences by race/ethnicity. The coverage is the NYS general population and not limited to Medicaid members.

Exhibit 4.30 displays annual trends in disparities in the rate of HIV cases per 100,000 between
black non-Hispanic versus white non-Hispanic persons (blue line), and between Hispanic versus
white non-Hispanic persons (orange line). The values represent the absolute differences in the
case rates between populations, with a value of zero indicating no disparities. Both disparities
declined during the period. The decline was more notable for black non-Hispanics, although the
magnitude of that disparity started at a higher level so there was more room for improvement.
The rate difference for black non-Hispanics declined from 44.4 per 100,000 in MY0 to 35.2 per
100,000 in MY3, which surpasses the statewide Prevention Agenda target of 46.8 per 100,000.
The rate difference for Hispanics declined from 26.7 per 100,000 to 22.9 per 100,000, which
surpasses the statewide Prevention Agenda target of 26.6 per 100,000.120

120

The Prevention Agenda target was updated as a result of a change in the indicator baseline and trend; the
values here reflect the updated targets.
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Exhibit 4.30. Statewide annual trends in disparities in HIV cases per 100,000 from MY0 to MY3
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Source: Authors’ analysis of the population health data available in the DSRIP Dataset.
Notes: The HIV case rate is measured as new diagnoses per 100,000. Disparities are measured by subtracting each
group’s absolute value of case rates per 100,000, with 0.0 representing no differences by race/ethnicity. The
coverage is the NYS general population and not limited to Medicaid members.

4.5. Assessment of Changes in Behavioral Health Care Utilization
This section addresses RQ-D:
Did utilization of behavioral health care services increase as a result of the DSRIP
program? (CMS RQ4)

Summary At-A-Glance
The Interim Report focused on two substance use treatment measures and two mental health
treatment measures: (1) initiation of alcohol and other drug dependence treatment among
persons aged 13 and older, (2) engagement in alcohol and other drug dependence treatment
among persons aged 13 and older, (3) adherence to antipsychotics among adults aged 19 to 64
with schizophrenia, and (4) follow-up within 30 days of hospitalization for mental illness. The
analysis included all PPS, as each was required to select a behavioral health project. Preliminary
results revealed an initial worsening of these measures following the initiation of the DSRIP
program, but thereafter their trends were higher than those in the pre-DSRIP period allowing
their levels to return towards their pre-DSRIP levels. The initial declines for most measures were
less pronounced in PPS located in the rest of state (ROS) compared to those in NYC, although the
differences between ROS and NYC PPS lessened in the post-DSRIP initiation period. For the
initiation of treatment for alcohol and other drug dependence, a similar pattern emerged by
size, with large PPS having a more pronounced initial worsening compared to post-DSRIP
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initiation changes among small PPS. However, the differences between large and small PPS
attenuated in the following years.
At the statewide level, at baseline 49.9% and 21.4% of persons with new episodes of alcohol or
other drug dependence initiated and engaged in treatment, respectively. Immediately following
DSRIP initiation, there was a slight but only marginally significant decline in the level of
initiation in treatment and a statistically significant 1.2 percentage-point decline in the level of
engagement in treatment. The post-DSRIP initiation trend in initiation of drug treatment was
similar to the pre-DSRIP trend, but for engagement in care there was a small and only
marginally significant improvement in the post-DSRIP initiation trend compared to the preDSRIP period. However, it is important to note that New York is experiencing an opioid
epidemic and many PPS had increases in the number of individuals presenting to treatment.
For the two mental health measures examined, at baseline, 61.1% of patients with
schizophrenia were adherent to their medication therapy and 59.4% of discharges of mental
illness hospitalization had a follow-up visit within 30 days. Immediately following DSRIP
implementation, the level of antipsychotic adherence declined by 3.3 percentage points,
although thereafter the post-DSRIP initiation trend was higher than the pre-DSRIP trend with
medication adherence reverting to its pre-DSRIP baseline level. The 30-day follow-up measure
improved throughout the period to 66.8% by the end of MY3, with the largest improvement
gains during the end of the study time period.
In the comparative analysis, two of the PPS characteristics examined in the Interim Report were
associated with different levels of these measures and different post-DSRIP initiation
performance changes. The two substance use measures and the antipsychotic adherence
measure differed by geography, which is consistent with NYS DOH practice to separate
population-level findings by rest of state (ROS) versus NYC. In addition, the two measures for
initiation of alcohol and other drug treatment measure, and 30-day follow-up after mental
illness hospitalization, differed by PPS size. The 30-day follow-up measure also differed among
PPS that selected the eleventh project (patient activation).
When comparing PPS located in different regions, there were performance improvements in
the two substance use measures and the antipsychotic adherence measure following the DSRIP
program’s initiation in NYC, but among the PPS located in ROS the results varied depending on
the measure. For both the initiation of and engagement in alcohol and other drug treatment
measures, the PPS located in NYC had worsening pre-DSRIP trends. Immediately following the
DSRIP program’s initiation, they experienced an initial performance drop but thereafter their
post-DSRIP initiation trends improved. For those two measures, the PPS located in ROS had
steady levels of performance pre-DSRIP but their trends worsened post-DSRIP initiation. For the
adherence to antipsychotics measure, the PPS in NYC and ROS both experienced improvements
in the post-DSRIP initiation period, with the NYC PPS having a larger improvement.
PPS size was associated with post-DSRIP initiation performance changes in the initiation of
alcohol and other drug treatment. Large PPS had an initial drop in performance on this measure
after the DSRIP program’s initiation, but thereafter their post-DSRIP initiation trends were
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similar to their pre-DSRIP trends. Small PPS exhibited a slight decline immediately following
DSRIP initiation and thereafter a steeper rate of decline (worsening trend) following DSRIP
initiation.
Eligibility for and selection of the eleventh project (patient activation) was associated with
different post-DSRIP initiation trends for the mental illness hospitalization 30-day follow-up
measure. The PPS that did not select the eleventh project had larger post-DSRIP initiation
performance gains, compared to the PPS that did select this project.
There are several important cautions for interpreting these findings, which will be explored in
more detail for the final summative report. First, the Interim Report only considered four PPS
characteristics. Additional factors and functional forms for the variables representing PPS
characteristics and time trends will be considered in the final summative report. For example, it
is not uncommon to see initial drops in performance when implementing a new program
followed by improvements. There is a limited study time period, so the Interim Report only
examines early changes; these trends will evolve over time and thus findings in the final
summative report may differ. While it is interesting that the initial post-DSRIP initiation
performances differed according to size and geography, there is high volatility in the measures
that needs to be explored in more detail in the final summative report. Finally, findings need to
be interpreted within the larger context of New York’s opioid epidemic and a concerted opioid
overdose prevention response from multiple state agencies which includes: programs to
improve linkage to and retention care; the provision of harm reduction services for persons
who use drugs; a comprehensive set of naloxone training and distribution programs for law
enforcement officers and other first responders, community laypersons, and people who use
drugs. These changes influence the number of individuals presenting to care with an index case
(denominator change) and the number of available drug treatment slots, and the initiation of
and engagement in alcohol and other drug treatment measures used in this Interim Report do
not allow for a more refined understanding of improvements over time. These considerations
will be explored in more detail in the final summative report.

4.5.1. Statewide Trends in Behavioral Health Care Utilization
Exhibits 4.31, 4.32, 4.33, and 4.34 illustrate the monthly statewide trends in the Initiation of
Alcohol and Other Drug Dependence Treatment (1 Visit within 14 Days), Engagement of Alcohol
and Other Drug Dependence Treatment (Initiation and 2 Visits within 44 Days), Adherence to
Antipsychotic Medications for People with Schizophrenia, and Follow Up within 30 days after
Hospitalization for Mental Illness. Each measure is expressed in percentages at the statewide
level. The Y-axis scales of these graphs do not cover the entire range of 0% to 100%, to make it
easier to visualize patterns and the changes being assessed with the regression analyses.
The first two measures (initiation of and engagement in treatment for alcohol and other drugs)
relate to substance use, and their denominator is the number of persons aged 13 and older
presenting to care with a new episode of alcohol or other drug dependence. Initiation is
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defined as having an inpatient admission, intensive outpatient encounter, or partial
hospitalization related to alcohol or other drug dependence within 14 days of the index
episode. Engagement is defined as both initiating treatment and having two or more additional
services within 30 days of the initial visit. Comparing the two substance use measures, it is
expected that the values for initiation of alcohol and other drug treatment dependence will be
higher than the values for engagement, as the latter measure requires both initiation and
attending multiple follow-up visits.
The third and fourth measures are related to mental health. For the schizophrenia measure, the
denominator is the number of persons aged 19 to 64 years with a schizophrenia diagnosis who
were provided with antipsychotic medications at least twice during the measurement year.
Adherence to medications is defined as remaining on an antipsychotic medication for at least
80% of the treatment period. For the mental illness hospitalization measure, the denominator
is the number of discharge events among persons aged 6 and older who were hospitalized for
treatment of selected mental health disorders, and the numerator is the number of those
discharge events where the patient was seen on an ambulatory basis or in intermediate
treatment with a mental health provider within 30 days of discharge. For all four behavioral
health measures, a higher value is desirable.
These plots have fitted linear trend lines to illustrate changes in performance at the statewide
level during the study period, from the end of MY0 through the end of MY3. The interrupted
time series model, described in more detail below, tests whether there is a level and/or slope
change in the post-DSRIP initiation period. That corresponds to the study hypotheses and
research questions regarding whether these measures improved following the DSRIP program’s
implementation. To be consistent with the regression specification, these plots have a
disjuncture at the start of the post-DSRIP initiation period to illustrate early differences after
the initiation of the DSRIP program. The pre- and post-DSRIP initiation periods have separate
fitted lines to show whether there are slope changes after the DSRIP program’s
implementation. The immediate drop following the implementation corresponds with the level
change.
Both measures of alcohol and drug dependence treatment show a very small decline in the preDSRIP period, although these changes are small in magnitude and not numerically meaningful
(see Exhibits 4.31 and 4.32). From the end of MY0 to the end of MY1, these values changed
from 49.9% to 49.3% for initiation and from 21.4% to 20.9% for engagement. The higher values
for initiation reflect the more stringent requirements to be classified as engaged in care, which
comprises both initiating treatment within 14 days of the index episode as well as at least two
additional follow-up visits within the subsequent month. Both measures had a small initial drop
(level change) immediately following the DSRIP program’s initiation. For the initiation measure,
after the initial drop the post-DSRIP initiation slope was similar to that of the pre-DSRIP period.
For the engagement measure, there was a more perceptible slope change in the post-DSRIP
initiation period, with the trend changing from a slight downward trajectory in the pre-DSRIP
period to a positive trend in the post-DSRIP initiation period.
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Exhibit 4.31. Monthly changes in the initiation of alcohol and other drug dependence treatment
I

60

I
I
I
I

...
...E 50 ••••••••••••• , •e e• ••••••••••• I •••••••
C:
<lJ
C'O

<lJ

~ 40
2

Cl

~

_g

30

0

u

~
._
0 20
C:

...
.!!:!

Post-DSRIP

.Q
.<.:

10

C:

0
L.t")

1.0

.-I
0

8
N

N

Source: Authors’ analysis of the DSRIP Dataset.
Notes: Initiation is measured as a percentage of persons aged 13 and older with one visit within 14 days of
presenting to care with a new episode of alcohol or other drug dependence. June 2014 through June 2015 (MY0
and MY1) are pre-DSRIP, and July 2015 through July 2017 (MY2 and MY3) are post-DSRIP initiation.

Exhibit 4.32. Monthly changes in engagement in alcohol and other drug dependence treatment
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: Engagement is measured as a percentage of persons aged 13 and older with a new episode of alcohol or
other drug dependence that have an initial treatment visit within 14 days and two additional treatment visits
within 30 days of the initial visit. June 2014 through June 2015 (MY0 and MY1) are pre-DSRIP, and July 2015
through July 2017 (MY2 and MY3) are post-DSRIP initiation.
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Changes in trends in the pre- and post-DSRIP initiation periods were more striking for the two
mental illness indicators (see Exhibits 4.33 and 4.34). For the antipsychotic medications
adherence measure, there was a small decline in the pre-DSRIP period. From the end of MY0 to
the end of MY1, this value declined from 61.1% to 57.8%. The monthly values showed a steeper
rate of decline in the first part of the post-DSRIP initiation period indicating a level change, but
thereafter it increased and the post-DSRIP initiation slope was overall positive. For the mental
illness 30-day hospitalization follow-up measure, there was a slight improvement in the preDSRIP period. From the end of MY0 to the end of MY1, this value increased from 59.4% to
61.2%. The rate of improvement increased in the post-DSRIP initiation period, rising to 66.8%
by the end of MY3.
Exhibit 4.33. Monthly changes in adherence to antipsychotic medications for people with
schizophrenia
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: Adherence is defined as the proportion of persons who remained on an antipsychotic medication for at
least 80% of their treatment period, among persons aged 19 to 64 years with diagnosed schizophrenia who were
dispensed at least two antipsychotic medications during the measurement year. June 2014 through June 2015
(MY0 and MY1) are pre-DSRIP, and July 2015 through July 2017 (MY2 and MY3) are post-DSRIP initiation.
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Exhibit 4.34. Monthly changes in 30-day follow-up after mental health hospitalizations
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: Follow-up is defined as the proportion of discharges of persons aged 6 and older who were seen on an
ambulatory basis or who were in intermediate treatment with a mental health provider within 30 days of their
discharge for hospitalization related to selected mental health disorders. June 2014 through June 2015 (MY0 and
MY1) are pre-DSRIP, and July 2015 through June 2017 (MY2 and MY3) are post-DSRIP initiation.

The statewide interrupted time series (see Exhibit 4.35) quantified the magnitude and statistical
significance of post-DSRIP initiation changes in alcohol and drug treatment initiation and
engagement, and adherence to antipsychotic medications across the 37-month study period.
There are four sets of coefficients because a separate regression model was developed for each
outcome measure. For each outcome, the interrupted time series has three main coefficients:
(1) a Trend that captures the slope in the pre-DSRIP period, (2) a DSRIP dummy variable that is
coded as 1 in the post-DSRIP initiation period and 0 in the pre-DSRIP period to estimate the
level change in the post-DSRIP initiation period, and (3) a Trend*DSRIP coefficient that assesses
whether the slope changed in the post-DSRIP initiation period. The Constant term refers to the
baseline level at the start of the study period (last month of MY0). For the coefficients, a pvalue of p<0.01 is considered strong evidence, p<0.05 is considered moderate evidence, and
p<0.1 is not statistically significant but provides suggestive evidence.

Exhibit 4.35. State-level time series regression model

Variable
Trend
DSRIP

Initiation of Drug
Treatment
b (SE)
-0.063
(0.042)
-1.183**

Engagement in
Drug Treatment
b (SE)
-0.045
(0.033)
-2.254***

Adherence to
Antipsychotic
Medications
b (SE)
-0.174
(0.118)
-9.413***

Mental Illness
Hospitalization 30-Day
Follow-up
b (SE)
0.068
(0.075)
-4.241***
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Trend*DSRIP
Constant
Observations
Adjusted R2

(0.551)
-0.009
(0.045)
50.059***
(0.332)
37
0.8423

(0.432)
0.0783**
(0.035)
21.684***
(0.261)
37
0.6098

(1.553)
0.448***
(0.127)
61.357***
(0.936)
37
0.5146

(0.993)
0.187**
(0.081)
59.287***
(0.598)
37
0.7268

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01

For the initiation of drug treatment measure, the regression model results indicate that the
levels and trends were similar in the pre- and post-initiation periods, and that this performance
measure remained steady throughout the study time period. The Trend coefficient (b= -0.063)
was negative but not statistically significant. That is consistent with the visual plot (see Exhibit
4.31), which indicated a very small but not numerically meaningful decline in the pre-DSRIP
period. The DSRIP coefficient (b= -1.183) was negative and statistically significant at the level of
p<0.05, although the Trend*DSRIP interaction term coefficient (b= -0.009) was not statistically
significant. This indicates a slight level change following DSRIP initiation but no slope change
that would lead to worsening trends.
For the engagement in drug treatment measure, the regression model findings indicate a
statistically significant reduction (level change) in the post-DSRIP initiation period and a
significant increase in the post-DSRIP initiation trend (slope change) compared to the baseline
pre-DSRIP trend. This can be interpreted as suggestive evidence that although there was an
initial drop-off in this measure immediately following the DSRIP program’s initiation,
engagement may be improving in the post-DSRIP initiation period. The Trend coefficient (b= 0.045) was negative but not statistically significant. That is consistent with the visual plot (see
Exhibit 4.32), which indicated a small but not numerically meaningful decline in the pre-DSRIP
period. After the initiation of the DSRIP program, there was a level change and the percentage
of cases that were engaged declined by 1.2 percentage points.121 The Trend*DSRIP interaction
term (b= 0.0783), which quantifies the slope change in the post-DSRIP initiation period, was
positive and statistically significant at the p<0.05 level. This can be interpreted as evidence for a
potentially small improvement in the post-DSRIP initiation trend.
An appropriate interpretation of the trends in the initiation of and engagement in alcohol and
drug treatment requires understanding the broader context of trends in substance abuse in
New York. The limited improvement in the two substance abuse measures examined here likely
reflect an increase in the denominator of people presenting to care, rather than reduced or
stable performance in meeting care needs. Similar to other states, New York is experiencing an
epidemic in opioid addiction and overdose. From 2012 to 2014, the number of emergency
department visits involving any drug overdose increased from 20,676 per 100,000 to 22,317 per
121

The immediate post-DSRIP initiation change is calculated using the predicted values from the equation using
t=13 and DSRIP=0 for the last month of MY1, and t=14 and DSRIP=1 for the first month of MY2.
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100,000.122 Diverse state agencies have implemented various programs to improve outreach to
individuals with addictions and link them to care, including but not limited to naloxone trainings
and distribution, drug user health hubs, mandatory education for health care providers on
appropriate prescribing of controlled substances, comprehensive prevention programming in
schools, promoting public awareness, enacting the 911 Good Samaritan Law to allow the public
to call 911 without fear of arrest if they experience or witness a drug or alcohol overdose, pilot
programs for new points of access for buprenorphine prescribing, streamlining processes to
enroll clients in state-run drug treatment centers, and changing insurance regulations to
improve access to drug treatment. The opioid epidemic and its coordinated statewide response
has thus led to an increase in the number of index cases presenting to alcohol and drug
treatment.
For the adherence to antipsychotic medications measure, the regression model findings
indicate a statistically significant reduction (level change) in the post-DSRIP initiation period and
a statistically significant increase in the post-DSRIP initiation trend (slope change) compared to
the baseline pre-DSRIP trend. This provides early evidence that although there was an initial
drop-off in this measure immediately following the DSRIP program’s initiation, this outcome
subsequently improved in the post-DSRIP initiation period. The Trend coefficient (b= -0.174)
was negative but not statistically significant, indicating a small but insignificant decline in the
pre-DSRIP period. After the initiation of the DSRIP program, there was a level change and the
level of adherence declined by 3.3 percentage points.123 The Trend*DSRIP interaction term (b=
0.448), which quantifies the slope change in the post-DSRIP initiation period, was positive and
statistically significant at the p<0.01 level. This provides evidence that the post-DSRIP initiation
trend improved, which is consistent with Exhibit 4.33 which showed different slopes in the preand post-DSRIP initiation periods.
For the 30-day follow up after mental illness hospitalization measure, the regression findings
indicate a statistically significant reduction (level change) in the post-DSRIP initiation period and
a statistically significant increase (p<0.05 level) signaling in the post-DSRIP trend. These
regression findings suggest that post-DSRIP initiation improvements may be modest. However,
when looking at the original monthly values (Exhibit 4.34), there is some fluctuation during the
first 12 months following DSRIP initiation and thereafter in MY3 there is visually a notable
uptick and positive trajectory. This improvement will be explored in more detail in the final
summative report, when more data are available for detailed analysis including using additional
functional forms for the time trend.

122

New York State Department of Health. (November 2017). Outpatient emergency department visits involving any
drug overdose, rate per 100,000 population. Retrieved from
https://www.health.ny.gov/statistics/opioid/data/e1.htm
123
The immediate post-DSRIP initiation change is calculated using the predicted values from the equation using
t=13 and DSRIP=0 for the last month of MY1, and t=14 and DSRIP=1 for the first month of MY2.
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4.5.2. Comparative Analysis of Behavioral Health Care Utilization among
Performing Provider Systems
The following exhibits display the three measures in MY0, MY1, MY2, and MY3, by PPS. Each
PPS has one bar per MY. Although monthly data are available, these graphs only present the
last observation in each MY for ease of interpretation. The performance outcomes in the DSRIP
Dataset are 12-month rolling averages, so the last value of the MY captures the prior year’s
average performance.
Across PPS, there was variability in the initiation of alcohol and other drug dependence
treatment measure (MY0: from 42.1% to 57.3%, MY1: from 37.1% to 60.1%, MY2: from 40.0%
to 52.5% in MY2, MY3: from 31.5% to 52.9%). (see Exhibit 4.36) There were also variations in
trends over time; for example, Central New York Care Collaborative (CNYCC) and Staten Island
PPS (SIPPS) had steady levels across years, Adirondack Health Institute (AHI) and New YorkPresbyterian Queens (NYPQ) had sudden drops in MY2, with New York-Presbyterian Queens
(NYPQ) showing notable improvement from 48.82% in MY0 to 52.94% in MY3 despite the drop
in MY2. Refuah Community Health Collaborative (RCHC) and New York-Presbyterian PPS (NYP)
showed declining performance on the measure from MY0 to MY3 (-16.9 and -10.5 percentage
point declines, respectively).
There was also variability in the engagement in drug treatment measure (MY0: from 14.5% to
30.5%, MY1: from 12.7% to 30.7%, MY2: from 13.1% to 29.8%, MY3: from 13.3% to 30.0%). (see
Exhibit 4.37) Compared to the initiation of alcohol and other drug dependence treatment
measure, the overall values are lower and the differences in values across PPS were narrower
for the engagement in drug treatment measure. Similar to the initiation measure, Central New
York Care Collaborative (CNYCC) had steady levels across years. Several PPS, including Bronx
Health Access (BHA) and North Country Initiative (NCI), showed decreases in performance on
the engagement in drug treatment measure from MY0 to MY2. Staten Island PPS (SIPPS) and
Suffolk Care Collaborative (SCC) exhibited increases in their performances on the engagement
in drug treatment measure from MY0 to MY3.
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Exhibit 4.36. Annual changes in the initiation of alcohol and other drug dependence treatment
from MY0 to MY3, by PPS
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: Engagement is measured as a percentage of persons aged 13 and older with a new episode of alcohol or
other drug dependence that have an initiation of treatment within 14 days and two visits within 30 days of the
initiation visit. Each PPS has four bars, one per MY, with values based on the last month in the MY. Within each PPS
cluster, MY0 has the left bar position followed to the right by MY1, MY2, and MY3.
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Exhibit 4.37. Annual changes in engagement in alcohol and other drug dependence treatment
from MY0 to MY3, by PPS

Source: Authors’ analysis of the DSRIP Dataset.
Notes: Initiation is measured as a percentage of persons aged 13 and older with one visit within 14 days of
presenting to care with a new episode of alcohol or other drug dependence. Each PPS has four bars, one per MY,
with values based on the last month in the MY. Within each PPS cluster, MY0 has the left bar position, followed to
the right by MY1, MY2, and MY3.
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Consistent with the previously described underlying context of rising opioid dependency and
state programs to increase initiation of treatment, several PPS had notable increases in the
number of index cases (see Exhibit 4.38). For example, Central New York Care Collaborative
(CNYCC), Community Care of Brooklyn (CCB), and Mount Sinai PPS (MSPPS) had notable
increases in the number of episode cases over time. At the same time, their performance on
the initiation in alcohol and other drug treatment measure declined slightly during the study
time period. Their performance declines are likely attributable to the increase in the number of
individuals presenting to care for alcohol and other drug dependencies.
Exhibit 4.38. Annual changes in the number of new episodes of alcohol or other drug
dependence from MY0 to MY3, by PPS
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: This chart reflects the changes in the volume of the denominator for the initiation of and engagement in
care measures. Each PPS has one bar per MY, with values based on the last month in the MY. Within each PPS
cluster, MY0 is the left-most bar position followed to the right by MY1, MY2 and MY3 in the right-most position.

There was substantial variability in adherence to antipsychotic medications for people with
schizophrenia measure across PPS (MY0: from 54.3% to 75.8%, MY1: from 48.2% to 79.8%,
MY2: from 51.6% to 82.1%, MY3: from 53.6% to 88.9%). (See Exhibit 4.39.) There were also
variations in trends over time; for example, Central New York Care Collaborative (CNYCC) and
Millennium Collaborative Care (MCC) had steady levels across years, New York-Presbyterian
Queens (NYPQ) and Leatherstocking Collaborative Health Partners (LCHP) exhibited sudden
declines between MY0 and MY1. Several PPS experienced stable gains from MY0 to MY3,
including Refuah Community Health Collaborative (RCHC) (from 75.42% in MY0 to 88.89% in
MY3), Bronx Partners for Health Communities (BPHC), and WMCHealth (WMC).
Similar to the other behavioral health measures, there was variability in 30-day follow-up for
mental health hospitalization across PPS (MY0: from 46.6% to 72.7%, MY1: from 47.3% to
76.1%, MY2: from 51.7% to 76.0%, MY3: from 50.7% to 75.4%). Most PPS (N=22) had
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improvements from MY0 to MY3. (see Exhibit 4.40.) Among the PPS that improved, the average
improvement was 8.2 percentage points, with improvements ranging from 1.8 percentage
points (Finger Lakes PPS (FLPPS)) to 17.5 percentage points (Refuah Community Health
Collaborative (RCHC)). Seven PPS had overall improvements from MY0 to MY3 that exceeded 10
percentage points: Bronx Health Access (BHA), Community Care of Brooklyn (CCB), Millennium
Collaborative Care (MCC), NewYork-Presbyterian PPS (NYP), NewYork-Presbyterian Queens PPS
(NYPQ), Refuah Community Health Collaborative (RCHC), and Suffolk Care Collaborative (SCC).
Among the three PPS that did not improve, Alliance for Better Health (ABHC) and Better Health
for Northeastern New York (BHNNY) had an initial gain but subsequently declined in the postDSRIP implementation period, and Care Compass Network (CCN) had an initial decline but
improvements in the post-DSRIP implementation period.

Exhibit 4.39. Annual changes in adherence to antipsychotic medications for people with
schizophrenia from MY0 to MY3, by PPS
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: Adherence is defined as the proportion of persons who remained on an antipsychotic medication for at
least 80% of their treatment period, among persons aged 19 to 64 years with diagnosed schizophrenia who were
dispensed at least two antipsychotic medications during the measurement year. Each PPS has four bars, one per
MY, with values based on the last month in the MY. Within each PPS cluster, MY0 has the left bar position followed
to the right by MY1, MY2, and MY3.
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Exhibit 4.40. Annual changes in 30-day follow-up after mental health hospitalization from MY0
to MY3, by PPS.
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: Follow-up is defined as the proportion of discharges for persons aged 6 and older who were seen on an
ambulatory basis or who were in intermediate treatment with a mental health provider within 30 days of their
discharge for hospitalization related to selected mental health disorders. Each PPS has four bars, one per MY, with
values based on the last month in the MY. Within each PPS cluster, MY0 has the left bar position followed to the
right by MY1, MY2, and MY3.

The comparative regression models quantified the magnitude and statistical significance of
post-DSRIP initiation changes in alcohol and drug treatment initiation and engagement, and
adherence to antipsychotic medications across the 37-month period. Unlike the statewide
interrupted time series, these comparative models are at the PPS-level and allow for an
assessment of how various PPS characteristics are associated with values of the performance
indicators. The four characteristics considered in the Interim Report are: having an attributed
member population that is higher or lower than the median PPS value (Large Size), having a
percentage of attributed members in the behavioral health swim lane that is higher or lower
than the median PPS value (High BH), geographic location in the rest of state compared to New
York City (ROS), and being eligible for and selecting the eleventh project (11th). Each measure is
a dichotomous indicator.
Each outcome has five regression models. Each model contains the same Trend, DSRIP,
Trend*DSRIP, and Constant coefficients as described in the statewide interrupted time series.
The first model, denoted by the (1) heading, contains coefficients for Large Size, High BH, ROS,
and 11th to assess whether PPS with these characteristics had higher or lower levels of the
outcome compared to PPS that did not have these features. Model (2) adds triple-interaction
terms (Trend*Large Size, DSRIP*Large Size, and Trend*DSRIP*Large Size) to assess whether
large PPS had different level and slope changes in the post-DSRIP initiation period, compared to
the level and slope changes among small PPS. This tests the hypothesis that PPS with a
178

particular characteristic had differential improvements in performance. Models (3), (4), and (5)
introduce other triple-interaction terms to test for differential level and slope changes in the
post-DSRIP initiation periods for PPS with a higher percentage of members in the behavioral
health swim lane (High BH), location in ROS compared to NYC (ROS), and eligibility for and
selection of the eleventh project (11th), respectively.
For the initiation of alcohol or other drug dependence treatment measure (see Exhibit 4.41),
none of the four PPS characteristics examined in this Interim Report had observed differences
in the level of this outcome on average across the time period, after adjusting for other PPS
characteristics. However, post-DSRIP initiation changes differed among PPS with different sizes
and between those located in NYC versus ROS.
In model (1), none of the coefficients for Large Size, High BH, ROS, or 11th were statistically
significant which indicates that on average throughout the study period, PPS with these
characteristics did not have an observable difference in their levels compared to PPS without
these characteristics. However, model (2) has statistically significant two- and three-way
interaction terms, signaling different performance changes by PPS size. To illustrate this
difference in more detail, Exhibit 4.42 presents stratified, or “split sample,” regressions to show
how the level and slope changes differed between large versus small PPS. In Exhibit 4.42, model
(1) is for the full sample, and similar to model (1) in Exhibit 4.41 except that it does not have the
Large Size coefficient. The other columns show these regressions when they are limited to subpopulations of large PPS and small PPS (models (2) and (3), respectively). Large PPS had an
initial drop in their performance on this measure after the initiation of the DSRIP program, but
thereafter their post-DSRIP initiation trends were similar to their pre-DSRIP trends. Small PPS
had a slight decline immediately following DSRIP initiation and thereafter a steeper rate of
decline (worsening of the trend) following DSRIP initiation.124
The other significant PPS characteristic in Exhibit 4.41 is for model (4), which assesses
differences in post-DSRIP initiation outcomes for PPS in ROS versus NYC. The interpretation of
the ROS interaction terms is the same as that of the Large Size interaction terms. For ease of
interpretation, Exhibit 4.43 presents the stratified models, with model (2) limited to the subpopulation of PPS in NYC and model (3) limited to the sub-population of PPS in ROS. The PPS
located in NYC had a worsening pre-DSRIP trend. Immediately following DSRIP initiation, their
performance dropped but thereafter the post-DSRIP initiation trend reversed and improved.
The PPS located in ROS had steady levels pre-DSRIP, but their trends worsened post-DSRIP
initiation.

124

These trends were calculated using the predicted values from the regression equations. The immediate postDSRIP initiation change is calculated using t=13 and DSRIP=0 for the last month of MY1, and t=14 and DSRIP=1 for
the first month of MY2.
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Exhibit 4.41. PPS-level comparative analysis regression for initiation of alcohol and other drug
dependence treatment
Initiation of Drug Treatment
Basic
Model
(1)

Time Trend
DSRIP
Large Size
High BH
ROS
11th
Trend*DSRIP
Trend*Large Size
DSRIP*Large Size
Trend*DSRIP*Large
Size
Trend*High BH
DSRIP*High BH
Trend*DSRIP*High
BH
Trend*ROS
DSRIP*ROS
Trend*DSRIP*ROS
Trend*11th

-0.035
(0.038)
0.166
(0.499)
0.247
(0.705)
0.369
(0.424)
-0.214
(1.797)
-0.153
(1.766)
-0.078*
(0.041)

Size
Interaction
Terms
(2)
-0.004
(0.053)
1.674**
(0.691)

Behavioral
Health
Interaction
Terms
(3)
0.003 (0.052)
0.368 (0.692)

Geography
Interaction
Terms
(4)
-0.160***
(0.057)
-5.221***
(0.753)

Eleventh
Project
Interaction
Terms
(5)
-0.079 (0.057)
-0.596 (0.752)

0.532 (0.853) -0.300 (0.717) -0.145 (0.695) -0.299 (0.720)
0.320 (0.423) 2.000*** (0.739) 0.238 (0.406)
-0.197
(1.797)
-0.151
(1.766)
-0.164***
(0.057)
-0.065
(0.077)
-3.141***
(1.005)
0.179**
(0.082)

0.364 (0.423)

-0.281 (1.794) -1.797 (1.891) -0.273 (1.801)
-0.113 (1.763) -0.123 (1.767) -1.574 (1.861)
-0.086 (0.056)

0.219***
(0.062)

-0.047 (0.061)

-0.080 (0.076)
-0.411 (1.013)
0.016 (0.082)
0.207***
(0.074)
8.980***
(0.977)
-0.494***
(0.080)
0.078 (0.077)
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DSRIP*11th
Trend*DSRIP*11th
Constant
Observations

49.704***
(1.260)

49.579***
(1.281)

49.202***
(1.274)

50.888***
(1.323)

1.362 (1.012)
-0.055 (0.083)
50.800***
(1.325)

925

925

925

925

925

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01

Exhibit 4.42. PPS-level comparative analysis regression for initiation of alcohol and other drug
dependence treatment, comparing large versus small PPS
Initiation of Drug Treatment

Trend
DSRIP
BH
ROS
11th
Trend*DSRIP
Constant
Observations

-Full sample Large Size
(1)
(2)

Small Size
(3)

-0.035
(0.038)
0.166
(0.499)
0.369
(0.424)
-0.214
(1.797)
-0.153
(1.766)
-0.078*
(0.041)
49.704***
(1.260)

-0.060*
(0.032)
-1.313***
(0.425)
0.866**
(0.350)
0.777
(2.775)
-1.721
(2.774)
0.005
(0.035)
50.313***
(1.571)

0.003
(0.067)
1.803**
(0.883)
-0.231
(0.762)
-1.115
(2.544)
0.815
(2.449)
-0.172**
(0.072)
49.981***
(1.835)

925

444

481

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. Model (1) is identical to model (1) in Exhibit 4.41 but the Large Size
coefficient is not displayed here.
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Exhibit 4.43. PPS-level comparative analysis regression for initiation of alcohol and other drug
dependence treatment, comparing PPS in NYC versus Rest of State
Initiation of Drug Treatment

Trend
DSRIP
Large Size
High BH
11th
Trend*DSRIP
Constant
Observations

--

Full sample
(1)

NYC
(2)

-0.035
(0.038)
0.166
(0.499)
0.247
(0.705)
0.369
(0.424)
-0.153
(1.766)
-0.078*
(0.041)
49.704***
(1.260)

-0.154***
(0.053)
-5.084***
(0.693)
0.521
(0.944)
0.914
(0.580)
3.279
(2.904)
0.212***
(0.057)
49.595***
(1.492)

925

370

--

ROS
(3)

0.049
(0.049)
3.816***
(0.649)
-0.450
(0.964)
-0.286
(0.552)
-2.335
(2.065)
-0.278***
(0.053)
51.296***
(1.926)
555

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. Model (1) is identical to model (1) in Exhibit 4.41 but the ROS coefficient is
not displayed here.

For the engagement in alcohol or other drug treatment measure (see Exhibit 4.44), the major
differences occurred by size and geography, with large PPS and those located in ROS having
higher engagement in treatment on average throughout the period. However, after DSRIP
initiation, the PPS in ROS had a slight worsening while the PPS in NYC had a notable
improvement in their trends.
The interpretation of these models is similar to that of the initiation in treatment models. In
Exhibit 4.44, the Large Size coefficient (b= 1.608, p<0.01) is positive and statistically significant
in model (1), indicating that PPS with a higher number of members had, on average throughout
the study time period, a 1.6 percentage-point higher level compared to those with a smaller
number of members. The ROS coefficient (b= 4.405, p<0.05) is positive and statistically
significant in model (1), indicating that PPS located in ROS had, on average, a 4.4 percentagepoint higher level compared to PPS located in NYC. Model (4) indicates that PPS located in ROS
had different pre- and post-DSRIP initiation changes. For ease of interpretation, Exhibit 4.45
shows the stratified models comparing PPS in NYC (model (2)) to PPS in ROS (model (3)). The
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PPS in ROS had a steady level of engagement in the pre-DSRIP period but their trends worsened
in the post-DSRIP initiation period. In contrast, the PPS in NYC had worsening trends in the preDSRIP period. Immediately following DSRIP initiation, they experienced an initial drop in their
level of engagement, but thereafter their trends reversed direction and they improved.125

Exhibit 4.44. PPS-level comparative analysis regression for engagement in alcohol and other
drug dependence treatment
Engagement in Drug Treatment
Behavioral
Size
Health
Basic Model Interaction
Interaction
(1)
Terms
Terms
(2)
(3)
Time Trend
DSRIP
Large Size
High BH
ROS
11th
Trend*DSRIP
Trend*Large Size
DSRIP*Large Size
Trend*DSRIP*Large Size
Trend*High BH

-0.028
(0.027)
-1.609***
(0.358)
1.608***
(0.535)
0.159
(0.309)
4.405**
(1.728)
-1.329
(1.701)
0.028
(0.029)

-0.009
(0.038)
-1.147**
(0.495)
1.471**
(0.630)
0.226
(0.308)
4.389**
(1.734)
-1.347
(1.707)
-0.020
(0.040)
-0.040
(0.055)
-0.963
(0.721)
0.101*
(0.059)

-0.005
(0.038)
-1.978***
(0.497)
1.254**
(0.545)
1.154**
(0.534)
4.341**
(1.723)
-1.286
(1.696)
0.042
(0.040)

Geography
Interaction
Terms
(4)

Eleventh
Project
Interaction
Terms
(5)

-0.110***
(0.042)
-4.935***
(0.545)
1.462***
(0.530)
0.133
(0.298)
3.613*
(1.774)
-1.318
(1.695)
0.225***
(0.045)

-0.041
(0.041)
-1.521***
(0.543)
1.345**
(0.549)
0.115
(0.309)
4.393**
(1.719)
-1.911
(1.743)
0.019
(0.044)

-0.049
(0.055)

125

These trends were calculated using the predicted values from the regression equations. The immediate postDSRIP initiation change is calculated using t=13 and DSRIP=0 for the last month of MY1, and t=14 and DSRIP=1 for
the first month of MY2.
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0.777
(0.727)
-0.029
(0.059)

DSRIP*High BH
Trend*DSRIP*High BH

0.137**
(0.054)
5.545***
(0.708)
-0.327***
(0.058)

Trend*ROS
DSRIP*ROS
Trend*DSRIP*ROS

19.301***
(1.180)

19.354***
(1.194)

19.008***
(1.184)

19.852***
(1.214)

0.023
(0.056)
-0.156
(0.730)
0.016
(0.060)
19.781***
(1.212)

925

925

925

925

925

Trend*11th
DSRIP*11th
Trend*DSRIP*11th
Constant
Observations

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01

Exhibit 4.45. PPS-level comparative analysis regression for engagement in alcohol and other
drug dependence treatment, comparing PPS in NYC versus Rest of State
Engagement in Drug Treatment

Trend
DSRIP
Large Size
High BH
11th

Full sample
(1)

NYC
(2)

ROS
(3)

-0.028
(0.027)
-1.609***
(0.358)
1.608***
(0.535)
0.159
(0.309)
-1.329
(1.701)

-0.095**
(0.043)
-4.729***
(0.560)
2.900***
(0.788)
0.436
(0.473)
1.166
(3.050)

0.035
(0.033)
0.721
(0.438)
0.267
(0.722)
-0.046
(0.382)
-2.770
(2.155)
184

Trend*DSRIP
Constant
Observations

0.028
(0.029)
19.301***
(1.180)

0.208***
(0.046)
18.366***
(1.493)

-0.112***
(0.036)
25.192***
(1.964)

925

370

555

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. Model (1) is identical to model (1) in Exhibit 4.44 but the ROS coefficient is
not displayed here.

Similar to the engagement in drug treatment measure, the major changes in adherence to
antipsychotics for people with schizophrenia occurred in PPS located in ROS compared to NYC.
On average throughout the study period, none of the PPS characteristics were associated with
different levels of adherence to antipsychotics after adjusting for other PPS characteristics.
When examining differential changes, the PPS in NYC and ROS both experienced improvements
in the post-DSRIP initiation period but the PPS in NYC had a larger improvement.
In Exhibit 4.46, none of the PPS characteristics in model (1) are statistically significant,
indicating that on average throughout the period, PPS did not differ according to these
characteristics. However, model (4) has statistically significant triple-interaction terms,
suggesting that PPS located in ROS versus NYC experienced different changes in the post-DSRIP
initiation periods. The stratified models are presented in Exhibit 4.47. Both categories of PPS
have declining levels of adherence in the pre-DSRIP period with a slightly more rapid decline
among NYC PPS (Trend; NYC: b= -0.297, p<0.01; ROS: b= -0.144, p<0.05). Both categories of PPS
experienced an immediate decline in the post-DSRIP initiation period, but thereafter their
trends reversed and their performance improved. While both experienced increases in their
levels of adherence to antipsychotic medications in the post-DSRIP initiation period, the
performance improvement was higher among NYC PPS (Trend*DSRIP; NYC: b= 0.658, p<0.01;
ROS: b= 0.370, p<0.01).
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Exhibit 4.46. PPS-level comparative analysis regression for adherence to antipsychotic
medications for people with schizophrenia
Adherence to Antipsychotic Medications

Size
Basic Model Interaction
(1)
Terms
(2)
Time Trend
DSRIP
Large Size
High BH
ROS
11th
Trend*DSRIP
Trend*Large Size
DSRIP*Large Size
Trend*DSRIP*Large Size
Trend*High BH
DSRIP*High BH
Trend*DSRIP*High BH
Trend*ROS
DSRIP*ROS

-0.189***
(0.044)
-9.424***
(0.585)
0.189
(0.880)
-0.617
(0.505)
4.667
(2.983)
-2.571
(2.938)
0.468***
(0.048)

-0.200***
(0.062)
-9.369***
(0.818)
0.271
(1.043)
-0.680
(0.509)
4.685
(2.971)
-2.560
(2.926)
0.484***
(0.067)
0.025
(0.091)
-0.115
(1.189)
-0.034
(0.097)

Behavioral
Health
Interaction
Terms
(3)

Geography
Interaction
Terms
(4)

Eleventh
Project
Interaction
Terms
(5)

-0.188***
(0.062)
-9.695***
(0.816)
-0.230
(0.902)
0.358
(0.878)
4.610
(2.980)
-2.533
(2.934)
0.503***
(0.066)

-0.278***
(0.070)
-11.090***
(0.916)
0.506
(0.896)
-0.383
(0.501)
4.684
(3.121)
-2.591
(2.991)
0.639***
(0.075)

-0.158**
(0.066)
-10.648***
(0.875)
0.807
(0.897)
-0.393
(0.500)
4.652
(3.055)
-1.269
(3.083)
0.527***
(0.071)

-0.002
(0.090)
0.573
(1.195)
-0.073
(0.097)
0.149*
(0.091)
2.774**
(1.190)
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-0.285***
(0.097)

Trend*DSRIP*ROS

62.175***
(2.029)

62.150***
(2.039)

61.923***
(2.040)

61.912***
(2.128)

-0.054
(0.090)
2.182*
(1.178)
-0.105
(0.096)
61.052***
(2.129)

925

925

925

925

925

Trend*11th
DSRIP*11th
Trend*DSRIP*11th
Constant
Observations

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01

Exhibit 4.47. PPS-level comparative analysis regression for adherence to antipsychotic
medications for people with schizophrenia, comparing PPS in NYC versus Rest of State
Adherence to Antipsychotic Medications

Full sample
(1)
Trend
DSRIP
Large Size
High BH
11th
Trend*DSRIP
Constant
Observations

-0.189***
(0.044)
-9.424***
(0.585)
0.189
(0.880)
-0.617
(0.505)
-2.571
(2.938)
0.468***
(0.048)
62.175***
(2.029)
925

--

NYC
(2)

ROS
(3)

-0.297***
(0.069)
-11.295***
(0.899)
-1.138
(1.145)
-0.333
(0.741)
2.205
(2.697)
0.658***
(0.074)
61.970***
(1.511)

-0.144**
(0.058)
-8.476***
(0.760)
2.485*
(1.292)
-0.507
(0.668)
-6.116
(4.714)
0.370***
(0.062)
68.736***
(4.267)

370

555

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. Model (1) is identical to model (1) in Exhibit 4.46 but the ROS coefficient is
not displayed here.
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Consistent with the other behavioral health measures, the major difference in performance on
30-day follow-up after mental illness hospitalization occurred by size. On average throughout
the period, large PPS had lower 30-day follow-up. After DSRIP initiation, the PPS that did not
select the eleventh project (patient activation) had a faster rate of improvement in the postDSRIP initiation period compared to the PPS that did select the project.
The interpretation of the models is similar to the other behavioral health measures. In Exhibit
4.48, the Large Size coefficient (b= -2.200, p<0.01) is negative and statistically significant in
model (1), indicating that PPS with a higher number of members had, on average throughout
the study time period, a 2.2 percentage-point lower level compared to those with a smaller
number of members. The interaction terms in Model (5) indicate that PPS that selected the
eleventh project had different post-DSRIP initiation trends. Exhibit 4.49 shows the stratified
models comparing PPS that selected the eleventh project (model (2)) to PPS that did not do the
eleventh project (model (3)). Comparing the Trend*DSRIP interactions between the two groups
of PPS, the PPS that did not select the eleventh project had a faster rate of improvement in the
post-DSRIP initiation period.

Exhibit 4.48. PPS-level comparative analysis regression for 30-day follow-up after mental health
hospitalization
Mental Illness Hospitalization 30-Day Follow-Up

Basic
Model
(1)

Size
Interaction
Terms
(2)

Behavioral
Health
Interaction
Terms
(3)

Geography
Interaction
Terms
(4)

Eleventh
Project
Interaction
Terms
(5)

Trend

0.054
(0.042)

0.006
(0.059)

0.061
(0.058)

0.030
(0.064)

0.030
(0.063)

DSRIP

-4.647***
(0.554)

-4.980***
(0.773)

-6.019***
(0.763)

-5.454***
(0.846)

-6.611***
(0.825)

Large Size

-2.200***
(0.830)

-2.483**
(0.984)

-2.629***
(0.841)

-1.278
(0.826)

-1.839**
(0.841)

High BH

0.473
(0.478)

0.399
(0.480)

1.570*
(0.821)

0.847*
(0.463)

0.721
(0.471)

ROS

2.597
(2.750)

2.623
(2.748)

2.492
(2.734)

4.216
(2.858)

2.545
(2.761)

11th

-1.733
(2.707)

-1.731
(2.706)

-1.655
(2.692)

-1.801
(2.738)

-1.186
(2.791)
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Trend*DSRIP

0.214***
(0.045)

0.275***
(0.063)

DSRIP*Large Size

0.694
(1.124)

Trend*Large Size

0.100
(0.086)

Trend*DSRIP*Large
Size

0.287***
(0.062)

0.333***
(0.069)

0.337***
(0.067)

-0.127
(0.092)

DSRIP*High BH

2.876**
(1.118)

Trend*High BH

-0.015
(0.084)

Trend*DSRIP*High
BH

-0.154*
(0.091)

DSRIP*ROS

1.343
(1.098)

Trend*ROS

0.040
(0.084)

Trend*DSRIP*ROS

-0.199**
(0.090)

DSRIP*11th

3.506***
(1.111)

Trend*11th

0.043
(0.084)

Trend*DSRIP*11th

-0.221**
(0.091)

Constant

Observations

61.568***
(1.874)

61.723***
(1.890)

61.267***
(1.875)

60.013***
(1.950)

61.001***
(1.933)

925

925

925

925

925

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01
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Exhibit 4.49. PPS-level comparative analysis regression for 30-day follow-up after mental health
hospitalization, comparing PPS that did and did not select the eleventh project
Mental Illness Hospitalization 30-Day Follow-Up
Full Sample
(1)

11th Project
(2)

No 11th Project
(3)

Trend

0.054
(0.042)

0.082
(0.053)

0.037
(0.068)

DSRIP

-4.647***
(0.554)

-3.022***
(0.690)

-6.588***
(0.894)

Large Size

-2.200***
(0.830)

-2.999***
(1.145)

-1.128
(1.097)

High BH

0.473
(0.478)

0.482
(0.508)

1.198
(0.954)

ROS

2.597
(2.750)

0.971
(5.290)

3.796*
(1.975)

Trend*DSRIP

0.214***
(0.045)

0.108*
(0.056)

0.333***
(0.073)

Constant

61.568***
(1.874)

61.777***
(4.934)

60.085***
(1.330)

925

518

407

Observations

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. Model (1) is identical to model (1) in Exhibit 4.48 but the ROS coefficient is
not displayed here.
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4.6. Assessment of Changes in Hospital Utilization
This section addresses RQ-E:
Was avoidable hospital utilization reduced as a result of the DSRIP program? (CMS RQ5)

Summary At-A-Glance
The Interim Report focused on early changes in potentially preventable readmissions (PPR)
and two measures of potentially preventable emergency room visits: (1) among the full
attributed population (PPV) and (2) among the population diagnosed with a behavioral health
condition (PPVBH). Overall, rates of PPR and PPVBH exhibited a significantly steady decline in
the pre-DSRIP initiation periods and a significant drop immediately following DSRIP initiation.
The pre-DSRIP trend in PPR did not significantly change post-DSRIP initiation, but the postDSRIP trend for PPVBH reversed and the rate increased. The rate of PPV did not change
significantly in either the pre- or post-DSRIP initiation periods. There was substantial
variability in performances across PPS for all three hospital utilization measures. The PPS with
large size, higher percentages of members with behavioral health needs, and located in NYC
had higher rates of PPR for both pre- and post-DSRIP initiation periods. Large PPS had lower
rates of PPV and PPVBH for both pre- and post-DSRIP initiation periods. The PPS that were
eligible for and selected the eleventh project had higher rates of PPV and PPVBH during the
pre- and post-DSRIP period.
At the statewide level, the rate of PPR declined by 3.6% in the pre-DSRIP period from a
baseline level of 678.7 readmissions per 100,000 members to 654.0 readmissions per
100,000 at the end of MY1. Following the initiation of the DSRIP program, this level dropped
by 39.5 readmissions per 100,000 members and thereafter the post-DSRIP initiation slope
was similar to the pre-DSRIP slope. The rate of PPV and PPVBH declined by 0.5% and 2.7% in
the pre-DSRIP period from a baseline level of 37.8 and 109.7 visits per 100 members to 37.6
and 106.7 visits per 100 members at the end of MY1, respectively. Following the initiation of
the DSRIP program, the rate of PPV remained steady in the post-DSRIP initiation period.
However, for PPVBH there was a significant level drop of 1.4 visits per 100 members but
thereafter the rate increased to the pre-DSRIP level.
In the comparative analysis, there were substantial differences in the rates of PPR across PPS.
Three of the PPS characteristics examined in the Interim Report were associated with
different levels of PPR. In the multivariate models, large PPS had on average 44.1 more
readmissions per 100,000 members, PPS with a high percentage of members in the
behavioral health swim lane had 29.7 more readmissions per 100,000 members, and PPS
located in ROS had 350.3 fewer readmissions per 100,000 members compared to PPS in NYC.
Size was also associated with differences in post-DSRIP initiation performance changes:
following initiation, large PPS had a reduction in their number of readmissions while small
PPS had a small increase in their readmissions rate. Thereafter, the large PPS had a post191

DSRIP initiation trend that was similar to the pre-DSRIP trend while small PPS had a steeper
decline in potentially preventable readmissions resulting in a convergence back to the preDSRIP differences between these categories of PPS.
The comparative analysis also showed substantial differences in the rates of PPV and PPVBH.
Two of the PPS characteristics examined were associated with different levels of these
measures. In the multivariate models, large PPS had on average 2.1 and 5.6 fewer potentially
preventable emergency room visits per 100 members in the full attributed population and
the behavioral health population, respectively. The PPS that were eligible for and selected
the eleventh project had 12.1 and 28.9 more visits per 100 members in the full attributed and
behavioral health population, respectively.
All four PPS characteristics examined in the Interim Report were significantly associated with
post-DSRIP initiation trends in PPV rates that differed from pre-DSRIP initiation trends.
Compared to their pre-DSRIP initiation trends, post-DSRIP initiation trends significantly
decreased for large PPS, and significantly increased for PPS with a high percentage of
members in the behavioral health swim lane, PPS located in the ROS, and PPS that selected
the 11th project.
Geographic location was associated with differences in post-DSRIP initiation PPVBH
performance changes (level change): following DSRIP initiation, PPS in ROS had a greater
reduction in their PPVBH rates. Thereafter, the PPS in ROS had a post-initiation trend that
significantly increased.
There are several important cautions for interpreting these findings, which will be explored in
more detail in the final summative report. First, for the PPV and PPVBH measures, not all
monthly data points were available for MY3 at the time of the analysis, resulting in more
weight being placed on MY2 and the first half of MY3 for the post-DSRIP initiation period.
Additionally, there was a change in the health plan encounter intake system (EIS) that
occurred in October 2015 (between MY1 and MY2). This change led to differences in how
emergency room encounters were reported. The level drop in PPV rates from MY1 to MY2
may be in part due to this change. The Interim Report only considered four PPS
characteristics using simple measures. Additional factors and functional forms will be
considered in the final summative report. There is a limited time period, so the Interim
Report only examines early changes; these trends will evolve over time and thus findings in
the final summative report may differ. The final summative report will also consider
alternative specifications of the post-DSRIP initiation trend beyond the linear trends
presented in the Interim Report. Finally, these measures had a particularly high amount of
variability across PPS, which will continue to be explored in the final summative report.
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4.6.1. Statewide Trends in Hospital Utilization
Exhibit 4.50 illustrates the monthly statewide trend in PPR rates among attributed members.
This measure is expressed as the number of readmissions per 100,000 members, and is
calculated using the proprietary “preventables” software algorithm developed by 3M.126 The
3M algorithm is a widely-used, prevalidated measure.
These plots have fitted linear trend lines to illustrate changes in performance at the statewide
level during the study period, from the end of MY0 through the end of MY3. The interrupted
time series model, described in more detail below, tests whether there is a level and/or slope
change in the post-DSRIP initiation period. That corresponds to the study hypotheses and
research questions regarding whether these measures improved following the DSRIP program’s
initiation. To be consistent with the regression specification, these plots have a disjuncture at
the start of the post-DSRIP initiation period to illustrate early differences after the
implementation of the DSRIP program. The pre- and post-DSRIP initiation periods have separate
fitted lines to show whether there are slope changes after the DSRIP program’s initiation. The
immediate drop following the implementation corresponds with the level change.
The PPR rate follows a decline in the pre-DSRIP period, from a baseline level of 678.7
readmissions per 100,000 members at the end of MY0 to 654.0 readmissions per 100,000
members by the end of MY1 (3.6% reduction). There is an initial level change after the
implementation of the DSRIP program, with a rapid drop in the rate of readmissions.
Thereafter, the post-DSRIP initiation trend appears to have a similar slope to the pre-DSRIP
trend.

126

3M. (nd). 3M solutions for potentially preventable readmissions. Retrieved from
https://www.3m.com/3M/en_US/company-us/all-3m-products/~/3M-Solutions-for-Potentially-PreventableEvents/?N=5002385+3290603246&rt=rud
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Exhibit 4.50. Monthly changes in potentially preventable readmissions
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Notes: Potentially preventable readmissions is measured per 100,000 members. June 2014 through June 2015
(MY0 and MY1) are pre-DSRIP, and July 2015 through July 2017 (MY2 and MY3) are post-DSRIP initiation.

Exhibits 4.51 and 4.52 illustrate the monthly statewide trend in PPV and PPVBH rates. Similar to
the PPR measure, these were calculated using the 3M algorithm.
In the full population of all attributed members (see Exhibit 4.51), the PPV rate remained at a
somewhat similar level throughout the period with some oscillations. There was a small decline
in the pre-DSRIP period, from a baseline level of 37.8 visits per 100 members at the end of MY0
to 37.6 visits per 100 members by the end of MY1 (0.5% reduction), although in the pre-DSRIP
period there was an initial small increase followed by a decline. In the post-DSRIP
implementation period, this rate increased to 37.7 per 100 members from the end of MY1 to
MY2 (0.2% increase) and then leveled off with 37.3 per 100 members in the end of MY3.
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Exhibit 4.51. Monthly changes in potentially preventable emergency room visits, full population
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Notes: Potentially preventable emergency room visits is measured per 100 members. The pre-DSRIP period
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includes MY2 (July 2015 through June 2016) and part of MY3, due to data availability for this measure at the time
of the analysis. Specifically, MY3 includes the first five months and last month of MY3, corresponding with July
2016 through November 2016 and June 2017.

The PPVBH rate decreased in the pre-DSRIP period, from a baseline level of 109.7 visits per 100
members at the end of MY0 to 106.7 visits per 100 members by the end of MY1 (2.7%
decrease) (see Exhibit 4.52). In the post-DSRIP implementation period, this rate increased to
111.0 visits per 100 members from the end of MY1 to MY2 (4.0% increase) and approximately
leveled off with 110.6 visit per 100 members at the end of MY3.
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Exhibit 4.52. Monthly changes in potentially preventable emergency room visits, behavioral
health population
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The statewide interrupted time series (see Exhibit 4.53) quantified the magnitude and statistical
significance of post-DSRIP initiation changes in rates of PPR, PPV, and PPVBH across the 37month study period duration.127 There is one column per outcome variable. The interrupted
time series has three main coefficients: (1) a Trend that captures the slope in the pre-DSRIP
period, (2) a DSRIP dummy variable that is coded as 1 in the post-DSRIP initiation period and 0
in the pre-DSRIP period to estimate the level change in the post-DSRIP initiation period, and (3)
a Trend*DSRIP coefficient that assesses whether the slope changed in the post-DSRIP initiation
period. The Constant term refers to the baseline level at the start of the study period (last
month of MY0). For the coefficients, a p-value of p<0.01 is considered strong evidence, p<0.05
is considered moderate evidence, and p<0.1 is not statistically significant but provides
suggestive evidence.

127

For the PPV and PPVBH two potentially preventable emergency room visit measures, there are 31 time points
as data for months 6-11 of MY3 were not available at the time of analysis.
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Exhibit 4.53. State-level time series regression model for potentially preventable readmissions
and emergency room visits

Variable
Trend
DSRIP
Trend*DSRIP
Constant
Observations
Adjusted R2

Potentially
Preventable
Readmissions
b (SE)
-2.167**
(1.054)
-34.408**
(13.884)
-0.211
(1.134)
675.341***
(8.367)
37
0.855

Potentially Preventable
Emergency Room Visits,
Full Population
b (SE)
0.004
(0.026)
-0.649
(0.390)

Potentially Preventable
Emergency Room Visits,
Behavioral Health Population
b (SE)
-0.249***

-0.006
(0.029)

0.557***
(0.095)
110.546***

38.075***
(0.206)
31
0.490

(0.084)
-8.931***
(1.261)

(0.666)
31
0.635

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. The number of observations for preventable emergency room visits is lower
because MY3 only includes 6 time points (months 1, 2, 3, 4, 5, and 12). Data for the other time points in the second
half of MY3 were not available at the time of analysis.

For the PPR measure, the model indicates that throughout the period there was a steady trend
of declining rates of readmissions; post-DSRIP initiation, there was a level change signaling an
immediate decline in readmissions rates but there was no evidence that the post-DSRIP
initiation trend differed from the pre-DSRIP trend. In the pre-DSRIP period, the rate of
readmissions declined by 2.2 readmissions per 100,000 members each month (Trend, b= -2.167,
p<0.05). After the initiation of the DSRIP program, there was a level change and the rate of
readmissions dropped by 39.5 per 100,000 members (p<0.05).128 However, in the post-DSRIP
initiation period there was no evidence that the trend in readmissions differed from the preDSRIP slope (Trend*DSRIP, not significant).
For the PPV measure, the model provides no evidence for substantial changes during the
period. In the pre-DSRIP initiation period, there was no statistically significant increase or
decrease (Trend, not significant), and in the post-DSRIP initiation period there was neither an
initial level change (DSRIP, not significant) nor evidence for a statistically significant slope
change (Trend*DSRIP, not significant).
For the PPVBH measure, the model indicates that in the pre-DSRIP initiation period potentially
preventable emergency room visits were significantly declining by 0.249 visits per 100 members
each month (Trend, b= -0.249, p<0.01). After the initiation of the DSRIP program, there was a
128

The immediate post-DSRIP initiation level changes for the PPR, PPV, and PPVBH measures are calculated using
the predicted values from the equation using t=13 and DSRIP=0 for the last month of MY1, and t=14 and DSRIP=1
for the first month of MY2.
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significant level change, and the rate of potentially preventable emergency room visits declined
by 1.4 visits per 100 members per month. The Trend*DSRIP interaction term (b= 0.557), which
quantifies the slope change in the post-DSRIP initiation period, was positive and statistically
significant at the p<0.01 level. This suggests there was an initial improvement but then a
subsequent increase back to the pre-DSRIP level.
The findings for the PPV and PPVBH visits measures should be interpreted cautiously, as not all
monthly data points were available at the time of analysis. The missing data in the second half
of MY3 places more weight on MY2 and the first half of MY3. There was a change in the health
plan encounter intake system (EIS) that occurred in October 2015 (between MY1 and MY2).
This change led to differences in how emergency department encounters were reported. The
level drop in potentially preventable emergency room visits from MY1 to MY2 may be in part
due to this change. Health plans were specifically directed to change the way they reported
emergency department encounter claim lines. The final summative report will contain a more
robust analysis when all DSRIP performance data are available.

4.6.2. Comparative Analysis of Hospital Utilization among Performing
Provider Systems
Exhibit 4.54 displays the PPR rate in MY0, MY1, M2, and MY3, by PPS. Each PPS has one bar per
MY. Although monthly data are available, this graph only presents the last observation in each
MY for ease of interpretation. The performance outcomes in the DSRIP Dataset are 12-month
rolling averages, so the last value of the MY captures the prior year’s average performance.
Across PPS, there was variability in the PPR rate (MY0: from 225.8 to 1,388.9, MY1: from 233.1
to 1353.0, MY2: from 152.9 to 1,217.0, MY3: from 122.8 to 1269.5). There were also variations
in trends over time, with Finger Lakes PPS (FLPPS) and Refuah Community Health Collaborative
(RCHC) showing stable improvements from MY0 to MY3. The majority of PPS showed
substantial decreases in PPR rates, including Bronx Health Access (BHA), Bronx Partners for
Healthy Communities (BPHC), Staten Island PPS (SIPPS), WMCHealth (WMC), Central New York
Care Collaborative (CNYCC), NYU Langone-Brooklyn (NYUL), and OneCity Health (HHC). Only
three PPS experienced increases in the readmission measure from MY0 to MY3: Alliance for
Better Health (ABHC), Montefiore Hudson Valley Collaborative (MHVC), and Mount Sinai PPS
(MSPPS).
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Exhibit 4.54. Annual changes in the rate of potentially preventable readmissions from MY0 to
MY3, by PPS
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: Potentially preventable readmissions is measured per 100,000 members. Each PPS has four bars, one per
MY, with values based on the last month in the MY. Within each PPS cluster, MY0 has the left bar position followed
to the right by MY1, MY2, and MY3.

Exhibits 4.55 and 4.56 display the PPV and PPVBH rates in MY0, MY1, MY2, and MY3, by PPS.
Across PPS, there was variability in the PPV rate per 100 members (MY0: 8.1 to 60.9, MY1: 6.8
to 59.8, MY2: 6.8 to 61.3, MY3: 6.2 to 56.9). There were also variations in trends over time, with
about one-quarter of PPS showing stable decreases in PPV rates from MY1 to MY3 and about
one-quarter of PPS showing increases. Many of the PPS exhibited variations in their trends over
time. For example, Better Health for Northeast New York (BHNNY) had higher PPV rates in MY0
and MY2 (49.4 and 50.2) than MY 1 and MY3 (44.1 and 44.4). This variability in performance
trends warrants further analysis in the final summative report.
There was also variability in the PPVBH rate per 100 members, across PPS (MY0: 49.5 to 132.7,
MY1: 32.6 to 133.0, MY2: 36.7 to 140.0, MY3: 34.4 to 150.2). Compared to PPV rates, the
overall values of PPVBH rates are higher. Similar to the PPV rates, there were also variations in
trends over time; for example, Bronx Partners for Healthy Communities (BPHC) had steady
levels across all years except for a 2.9% decrease in MY1, Bronx Health Access (BHA) had
decreasing levels in all years, with a more noticeable drop in MY3. Several PPS, including
Alliance for Better Health Care (ABHC) and OneCity (HHC), showed a decrease in rates in MY1,
but increases in MY2 and MY3, with rates at the end of MY3 higher than the rates in MY0.
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Exhibit 4.55. Annual changes in the rate of potentially preventable emergency room visits, full
population, from MY0 to MY3, by PPS
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: Potentially preventable emergency room visits is measured per 100 members. Each PPS has four bars, one
per MY, with values based on the last month in the MY. Within each PPS cluster, MY0 has the left bar position
followed to the right by MY1, MY2, and MY3. Data for MY3 only includes 6 time points (months 1, 2, 3, 4, 5, and
12). Data for the other time points in the second half of MY3 were not available at the time of analysis.
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Exhibit 4.56. Annual changes in the rate of potentially preventable emergency room visits,
behavioral health population, from MY0 to MY3, by PPS
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Source: Authors’ analysis of the DSRIP Dataset.
Notes: Potentially preventable emergency room visits among the behavioral health population is measured per
100 members. Each PPS has four bars, one per MY, with values based on the last month in the MY. Within each
PPS cluster, MY0 has the left bar position followed to the right by MY1, MY2, and MY3. Data for MY3 only includes
6 time points (months 1, 2, 3, 4, 5, and 12). Data for the other time points in the second half of MY3 were not
available at the time of analysis.

The comparative regression models quantified the magnitude and statistical significance of
post-DSRIP initiation changes in PPR, PPV, and PPVBH rates across the 37-month period.129
Unlike the statewide interrupted time series, the comparative models are at the PPS-level and
allow for an assessment of how various PPS characteristics are associated with values of the
performance indicator. The four characteristics considered in the Interim Report are: having an
attributed member population that is higher or lower than the median PPS value (Large Size),
having a percentage of attributed members in the behavioral health swim lane that is higher or
lower than the median PPS value (High BH), geographic location in the rest of state compared
to New York City (ROS), and being eligible for and selecting the eleventh project (11th). Each
measure is a dichotomous indicator.
Each outcome has five regression models (see Exhibit 4.57, Exhibit 4.59, and Exhibit 4.64) and
each model contains the same Trend, DSRIP, Trend*DSRIP, and Constant coefficients as
described in the statewide interrupted time series. The first model, denoted by the (1) heading,
129

As noted earlier, for the two potentially preventable emergency room visit measures, there are 31 time points
as data for months 6-11 of MY3 were not available at the time of analysis.
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contains coefficients for Large Size, High BH, ROS, and 11th to assess whether PPS with these
characteristics had higher or lower levels of the outcome compared to PPS that did not have
these features. Models (2) through (5) test the hypotheses that PPS with a particular
characteristic had differential improvements in performance. Model (2) adds triple-interaction
terms (Trend*Large Size, DSRIP*Large Size, and Trend*DSRIP*Large Size) to assess whether
large PPS had different level and slope changes in the post-DSRIP initiation period, compared to
the level and slope changes among small PPS. Models (3), (4), and (5) introduce other tripleinteraction terms to test for differential level and slope changes in the post-DSRIP initiation
periods for PPS with a higher percentage of members in the behavioral health swim lane (High
BH), location in ROS compared to NYC (ROS), and eligibility for and selection of the eleventh
project (11th), respectively.
For the PPR measure (see Exhibit 4.57), there were notable differences in the levels of PPR
rates: PPS with large sizes, a high percentage of members in the behavioral health swim lane,
and NYC location all had higher PPR rates. Each of these coefficients in Model (1) was
statistically significant and had a large magnitude, indicating that differences were numerically
meaningful, and these findings were consistent across the other models in Exhibit 4.57. After
adjusting for the time trend and the other characteristics, large PPS had on average 44.1 more
potentially preventable readmissions per 100,000 members (Large Size, b= 44.115, p<0.01)
throughout the study period compared to small PPS, PPS with a high percentage of members in
the behavioral health swim lane had 29.7 more readmissions per 100,000 (High BH, b= 29.700,
p<0.01) than PPS with a low percentage of behavioral health swim lane, and PPS located in ROS
had 350.3 fewer readmissions per 100,000 members compared to PPS in NYC (ROS, b= 350.261, p<0.05).
Size was also associated with differences in post-DSRIP initiation performance changes: large
PPS had a larger post-DSRIP initiation decrease in their levels, but thereafter large and small
PPS had different post-DSRIP initiation trends and the two categories of PPS converged back
towards their differences in the pre-DSRIP initiation period. In model (2), the statistically
significant DSRIP*Large Size and DSRIP*Trend*Large Size interaction terms indicate that large
PPS had differences in their post-DSRIP implementation levels and trends after adjusting for the
other PPS characteristics. The large PPS had larger declines in their PPR rate immediately
following DSRIP initiation (decline of 48.4 per 100,000), compared to post-DSRIP initiation
changes among small PPS (increase of 21.8 per 100,000).130 The positive Trend*DSRIP*Large
Size triple-interaction term (b= 4.498, p<0.05) signals that large and small PPS had different
post-DSRIP initiation trends resulting in the two types of PPS reverting back towards their preDSRIP differences by the end of MY3. For ease of interpretation, Exhibit 4.58 presents the
stratified models, with model (2) limited to the sub-population of large PPS and model (3)
limited to the sub-population of small PPS. After the DSRIP program’s initiation, large PPS had
48.8 fewer readmissions per 100,000 members while small PPS had 21.3 more readmissions per

130

The immediate post-DSRIP initiation change is calculated using the predicted values from the equation for
model (2), using t=13 and DSRIP=0 for the last month of MY1, t=14 and DSRIP=1 for the first month of MY2, and
Large Size=1 or 0.
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100,000 members.131 Following initiation, there was no evidence that large PPS had a different
post-DSRIP initiation trend (Trend*DSRIP, non-significant) but small PPS had a steeper negative
post-DSRIP initiation trend which suggests convergence back to its pre-DSRIP values.
Compared to the other measures examined, there was high variability in the PPR rate across
PPS and over time. However, most PPS experienced a downward trend in those rates regardless
of their starting point. Caution is warranted in interpreting these findings. The current models
provide suggestive evidence of early changes, but the final summative report will explore
additional model specifications when more years of data are available to develop a more robust
understanding of changes in potentially preventable readmissions.

Exhibit 4.57. PPS-level comparative analysis regression for potentially preventable readmissions
Potentially Preventable Readmissions

Basic Model
(1)

Trend
DSRIP
Large Size
High BH
ROS
11th
Trend*DSRIP
Trend*Large Size
DSRIP*Large Size

-1.824**
(0.833)
13.002
(10.966)
44.115**
(17.472)
29.700***
(9.606)
-350.261**
(128.610)
170.394
(126.872)
-1.649*
(0.896)

Size
Interaction
Terms
(2)
-1.757
(1.135)
76.865***
(14.921)
53.580***
(19.688)
23.768**
(9.414)
-348.375**
(128.957)
170.901
(127.218)
-3.809***
(1.220)
-0.140
(1.655)
-132.986***
(21.714)

Behavioral
Health
Interaction
Terms
(3)

Geography
Interaction
Terms
(4)

Eleventh
Project
Interaction
Terms
(5)

-2.188*
(1.145)
25.047*
(15.121)
58.537***
(17.735)
-2.560
(16.377)
-347.977**
(129.476)
168.880
(127.729)
-2.541**
(1.232)

-4.457***
(1.257)
8.862
(16.508)
10.558
(17.089)
21.979**
(9.145)
-425.215***
(129.523)
173.018
(127.133)
-1.150
(1.351)

-2.754**
(1.270)
5.796
(16.716)
37.134**
(18.089)
29.606***
(9.664)
-350.999**
(128.484)
153.118
(127.392)
-0.902
(1.366)

131

The immediate post-DSRIP initiation change is calculated using the predicted values from the equation using
t=13 and DSRIP=0 for the last month of MY1, and t=14 and DSRIP=1 for the first month of MY2.

203

4.498**
(1.776)

Trend*DSRIP*Large
Size

0.759
(1.671)
-25.398
(22.167)
1.874
(1.800)

Trend*High BH
DSRIP*High BH
Trend*DSRIP*High
BH

4.389***
(1.637)
6.964
(21.450)
-0.834
(1.756)

Trend*ROS
DSRIP*ROS
Trend*DSRIP*ROS

746.946***
(84.871)

743.835***
(85.197)

754.986***
(85.511)

810.263***
(85.528)

1.662
(1.712)
12.869
(22.517)
-1.334
(1.841)
760.460***
(85.327)

925

925

925

925

925

Trend*11th
DSRIP*11th
Trend*DSRIP*11th
Constant
Observations

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01
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Exhibit 4.58. PPS-level comparative analysis regression for potentially
preventable readmissions, comparing large versus small PPS
Potentially Preventable Readmissions

Trend
DSRIP
BH
ROS
11th
Trend*DSRIP
Constant
Observations

Full sample
(1)

Large Size
(2)

Small Size
(3)

-1.824**
(0.833)
13.002
(10.966)
29.700***
(9.606)
-350.261**
(128.610)
170.394
(126.872)
-1.649*
(0.896)
746.946***
(84.871)

-1.440
(0.956)
-50.496***
(12.545)
30.410***
(10.438)
-202.933
(202.425)
37.263
(202.413)
0.222
(1.026)
796.022***
(112.953)

-1.346
(1.316)
81.871***
(17.267)
18.572
(15.646)
-510.792**
(183.086)
223.249
(177.192)
-4.231***
(1.412)
839.213***
(127.139)

925

444

481

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. Model (1) is identical to model (1) in Exhibit 4.57 but the Large Size
coefficient is not displayed here.

Comparative regression analyses also showed there were notable differences in the levels of
PPV rates: PPS with large sizes had lower rates, and PPS that were eligible for and selected the
eleventh project had higher rates (see Exhibit 4.59). After adjusting for the time trend and other
PPS characteristics, large PPS had on average 2.1 fewer potentially preventable emergency
room visits per 100 members throughout the study period in the full attributed population
(Large Size, b= -2.108, p<0.01). The PPS that were eligible for and selected the eleventh project
had 12.1 higher visits per 100 members in the full attributed population, (full population: 11th,
b= 12.130, p<0.05).

Exhibit 4.59. PPS-level comparative analysis regression for potentially preventable emergency
room visits, full population
205

I

I

Potentially Preventable Emergency Room Visits, Full Population
-

-

-

-

Basic Model
(1)

Size
Interaction
Terms
(2)

Behavioral
Health
Interaction
Terms
(3)

Geography
Interaction
Terms
(4)

Eleventh Project
Interaction
Terms
(5)

Trend

-0.045*
(0.027)

-0.123***
(0.038)

-0.018
(0.036)

0.00005
(0.042)

-0.006
(0.041)

DSRIP

-1.269***
(0.410)

-1.903***
(0.569)

0.051
(0.547)

1.293**
(0.634)

0.530
(0.619)

Large Size

-2.108***
(0.587)

-2.930***
(0.673)

-1.744***
(0.578)

-2.115***
(0.591)

-1.847***
(0.603)

High BH

0.605
(0.370)

0.533
(0.372)

-0.094
(0.553)

0.336
(0.366)

0.443
(0.369)

ROS

-3.252
(5.594)

-3.214
(5.612)

-3.251
(5.630)

-2.935
(5.659)

-3.159
(5.628)

11th

12.130**
(5.518)

12.106**
(5.537)

12.129**
(5.554)

12.118**
(5.567)

12.748**
(5.567)

Trend*DSRIP

0.066**
(0.031)

0.154***
(0.043)

-0.046
(0.041)

-0.092*
(0.048)

-0.033
(0.047)

Trend*Large Size
DSRIP*Large Size
Trend*DSRIP*Large
Size

0.163***
(0.055)
1.322
(0.826)
-0.183***
(0.063)

Trend*High BH
DSRIP*High BH
Trend*DSRIP*High
BH

-0.057
(0.053)
-2.750***
(0.799)
0.233***
(0.060)

Trend*ROS

-0.075
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(0.055)
-4.269***
(0.822)

DSRIP*ROS

0.263***
(0.063)

Trend*DSRIP*ROS
Trend*11th

-0.069
(0.056)
-3.211***
(0.833)

DSRIP*11th

0.176***
(0.063)

Trend*DSRIP*11th
Constant
Observations

36.546***
(3.679)

36.967***
(3.695)

36.707***
(3.703)

36.496***
(3.725)

36.097***
(3.714)

775

775

775

775

775

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, *p<0.05, ***p<0.01. The number of observations for preventable emergency room visits is lower
because MY3 only includes 6 time points (months 1, 2, 3, 4, 5, and 12). Data for the other time points in the second
half of MY3 were not available at the time of analysis.

All four PPS characteristics were associated with differences in post-DSRIP initiation
performance in PPV rates. In model (2) in Exhibit 4.59 the statistically significant
Trend*DSRIP*Large Size interaction term indicates that large and small PPS had different postDSRIP initiation trends after adjusting for the other PPS characteristics. The negative
Trend*DSRIP*Large Size triple interaction term (b= -0.183, p<0.01) indicates that that the
difference between large and small PPS increased during the post-DSRIP initiation period (as
shown in Model (1) large PPS had lower PPV rates). For ease of interpretation, Exhibit 4.60
presents the stratified models, with model (2) limited to the sub-population of large PPS and
model (3) limited to the sub-population of small PPS. Large PPS had steady PPV rates in the preDSRIP period. In contrast, small PPS had a significantly decreasing trend. Immediately following
DSRIP initiation, small PPS experienced a statistically significant initial decrease in their PPV
rate, but thereafter their trends reversed direction and significantly increased.
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Exhibit 4.60. PPS-level comparative analysis regression for potentially preventable emergency
room visits, full population, comparing large versus small PPS
Potentially Preventable Emergency Room Visits, Full Population
Full Sample
(1)

Large Size
(2)

Small Size
(3)

Trend

-0.045*
(0.027)

0.039
(0.040)

-0.123***
(0.038)

DSRIP

-1.269***
(0.410)

-0.607
(0.598)

-1.928***
(0.572)

Large Size

-2.108***
(0.587)

High BH

0.605
(0.370)

0.301
(0.465)

0.962
(0.625)

ROS

-3.252
(5.594)

-2.787
(7.970)

-4.607
(8.288)

11th

12.130**
(5.518)

6.680
(7.969)

14.890*
(8.021)

Trend*DSRIP

0.066**
(0.031)

-0.028
(0.045)

0.154***
(0.043)

36.546***
(3.679)

36.740***
(4.449)

36.414***
(5.744)

775

372

403

Constant
Observations

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. The number of observations for preventable emergency room visits is lower
because MY3 only includes 6 time points (months 1, 2, 3, 4, 5, and 12). Data for the other time points in the second
half of MY3 were not available at the time of analysis.

Model (3) of Exhibit 4.59 shows that the percent of attributed members in the behavioral
health swim lane was also associated with differences in post-DSRIP initiation performance
changes in PPV rates: PPS with a high percentage of attributed members in the behavioral
health swim lane had a larger post-DSRIP initiation decrease in their levels, but thereafter PPV
rates increased for PPS with a high percentage of attributed members in the behavioral health
swim lane. In model (3), the statistically significant DSRIP*High BH and Trend*DSRIP*High BH
interaction terms indicate that PPS with a high percentage of attributed members in the
behavioral health swim lane had differences in their post-DSRIP initiation levels and trends after
adjusting for other PPS characteristics. The PPS with a high percentage of attributed members
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in the behavioral health swim lane had larger declines in their levels immediately following
DSRIP initiation compared to post-DSRIP level changes among PPS with a low percentage of
behavioral health swim lane members (b = -2.750, p<0.01). The positive Trend*DSRIP*High BH
interaction term (b= 0.233, p<0.01) indicates that PPS with high and low percentages of
attributed members in the behavioral health swim lane had different post-DSRIP initiation
trends resulting in the PPS with a high percentage of attributed members in the behavioral
health swim lane reverting back towards its pre-DSRIP trend.
For ease of interpretation, Exhibit 4.61 presents the stratified models, with model (2) limited to
the sub-population of PPS with a high percentage of attributed members in the behavioral
health swim lane and model (3) limited to the sub-population of PPS with a low percentage.
Both PPS with a high and low percentage of behavioral health swim lane members had steady
PPV rates in the pre-DSRIP period (Trend coefficient not significant for either type of PPS).
Immediately following DSRIP initiation, PPS with a high percentage of DSRIP members
attributed in the behavioral health swim lane had a significant initial decrease in the level of
potentially preventable emergency room visits (DSRIP, b= -2.879, p<0.01), but thereafter the
trend reversed direction and the rates increased (Trend*DSRIP, b= 0.199, p<0.01). In contrast,
PPS with a low percentage of members attributed in the behavioral health swim lane showed
no statistically significant level change after DSRIP-initiation and the post-DSRIP trend
coefficient was only marginally significant, suggesting there was only modest change in the
post-DSRIP initiation trend.

Exhibit 4.61. PPS-level comparative analysis regression for potentially preventable emergency
room visits, full population, comparing high versus low percentage of members attributed in the
behavioral health swim lane

Potentially Preventable Emergency Room Visits, Full Population
Full Sample
(1)

High BH
(2)

Low BH
(3)

Trend

-0.045*
(0.027)

-0.081
(0.050)

-0.016
(0.022)

DSRIP

-1.269***
(0.410)

-2.879***
(0.760)

-0.007
(0.327)

Large Size

-2.108***
(0.587)

-2.048**
(1.024)

-1.494***
(0.490)

-2.285
(4.045)

-7.298
(6.261)

High BH

0.605
(0.370)

ROS

-3.252
(5.594)
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11th

12.130**
(5.518)

4.521
(3.776)

13.384*
(6.260)

Trend*DSRIP

0.066**
(0.031)

0.199***
(0.057)

-0.046*
(0.025)

36.546***
(3.679)

46.885***
(3.222)

33.334***
(4.144)

775

372

403

Constant

Observations

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. The number of observations for preventable emergency room visits is lower
because MY3 only includes 6 time points (months 1, 2, 3, 4, 5, and 12). Data for the other time points in the second
half of MY3 were not available at the time of analysis.

The other significant PPS characteristics in Exhibit 4.59 were geographic location and eligibility
for and selection of the eleventh project. In model (4) in Exhibit 4.59, the statistically significant
DSRIP*ROS and Trend*DSRIP*ROS interaction terms indicate that PPS in ROS had differences in
their post-DSRIP initiation levels and trends on the PPV measure after adjusting for other PPS
characteristics. The PPS located in ROS had larger declines in their levels immediately following
DSRIP initiation compared to post-DSRIP level changes among PPS in New York City (b = -4.269,
p<0.01). The positive Trend*DSRIP*ROS interaction term (b= 0.263, p<0.01) indicates that PPS
in ROS and those in New York City had different post-DSRIP initiation trends resulting in the PPS
in ROS reverting back towards its pre-DSRIP trend. For ease of interpretation, Exhibit 4.62
presents the stratified models, with model (2) limited to the sub-population of PPS located in
New York City and model (3) limited to the sub-population of PPS located in ROS. The PPS
located in ROS and New York City had stable rates of preventable emergency visits in the preDSRIP period, the Trend coefficient was not significant for PPS in New York City and only
marginally significant at p<0.1 for PPS in ROS. Immediately following DSRIP initiation, PPS in
ROS and New York City had a statistically significant decrease in their level of potentially
preventable emergency room visits, but the decrease was greater for PPS in ROS (DSRIP
coefficient for ROS, b= -2.980, p<0.01; DSRIP coefficient for New York City, b= 1.280, p<0.01).
Thereafter, the post-DSRIP trends for ROS reversed direction and preventable emergency room
visit rates significantly increased (Trend*DSRIP, b= 0.171, p<0.01) whereas rates in New York
City significantly decreased (Trend*DSRIP, b= -0.091, p<0.01).
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Exhibit 4.62. PPS-level comparative analysis regression for potentially preventable emergency
room visits, full population, comparing rest of state to New York City

--

Potentially Preventable Emergency Room Visits, Full Population
Full Sample
(1)

NYC
(2)

ROS
(3)

Trend

-0.045*
(0.027)

-0.001
(0.025)

-0.075*
(0.042)

DSRIP

-1.269***
(0.410)

1.280***
(0.368)

-2.980***
(0.624)

Large Size

-2.108***
(0.587)

-2.213***
(0.487)

-2.074**
(0.996)

High BH

0.605
(0.370)

0.216
(0.299)

0.460
(0.624)

ROS

-3.252
(5.594)

11th

12.130**
(5.518)

10.173
(8.689)

13.406*
(7.480)

Trend*DSRIP

0.066**
(0.031)

-0.091***
(0.028)

0.171***
(0.047)

36.546***
(3.679)

36.981***
(3.904)

32.439***
(6.712)

775

310

465

Constant

Observations

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. The number of observations for preventable emergency room visits is lower
because MY3 only includes 6 time points (months 1, 2, 3, 4, 5, and 12). Data for the other time points in the second
half of MY3 were not available at the time of analysis.

The final significant characteristic in Exhibit 4.59 is for model (5) which assesses differences in
post-DSRIP initiation PPV outcomes for PPS that were eligible for and selected the eleventh
project versus those that did not. The interpretation of the 11th project interaction terms is the
same as that of the ROS interaction terms and the other PPS characteristics. For ease of
interpretation, Exhibit 4.63 presents the stratified models, with model (2) limited to PPS that
were eligible for and selected the eleventh project and model (3) limited to PPS that did not
select the eleventh project. Immediately following DSRIP initiation, PPS that selected the
eleventh project experienced a level decrease in the PPV rate, but thereafter the post-DSRIP
initiation trend reversed and the PPV rate increased (DSRIP, b= -2.685, p<0.01; Trend*DSRIP,
b=0.143, p<0.01). There was no level change immediately following DSRIP initiation for PPS that
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did not select the 11th project and no change in trend during the post-DSRIP initiation period
(the DSRIP and Trend*DSRIP coefficients were not statistically significant).

Exhibit 4.63. PPS-level comparative analysis regression for potentially preventable emergency
room visits, full population, comparing the PPS that selected the 11th project to those that did
not

--

Potentially Preventable Emergency Room Visits, Full Population
Full Sample
(1)

11th Project
(2)

No 11th Project
(3)

Trend

-0.045*
(0.027)

-0.075*
(0.040)

-0.007
(0.037)

DSRIP

-1.269***
(0.410)

-2.685***
(0.597)

0.474
(0.555)

Large Size

-2.108***
(0.587)

-1.924**
(0.913)

-1.878**
(0.758)

High BH

0.605
(0.370)

0.341
(0.458)

0.861
(0.675)

ROS

-3.252
(5.594)

-1.341
(6.510)

-4.721
(9.581)

11th

12.130**
(5.518)

Trend*DSRIP

0.066**
(0.031)

0.143***
(0.045)

-0.030
(0.042)

36.546***
(3.679)

47.377***
(6.045)

36.391***
(5.033)

775

434

341

Constant

Observations

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01

Exhibit 4.64 presents the comparative regression analysis regression results for the PPVBH
measure. There were notable differences in the levels of PPVBH: PPS with large sizes had
significantly lower PPVBH rates, and PPS that were eligible for and selected the eleventh project
had significantly higher rates. After adjusting for the time trend and other PPS characteristics,
large PPS had on average 5.6 fewer potentially preventable emergency room visits per 100
members through the study period (Large Size, b= -5.603, p<0.01). The PPS that were eligible
for and selected the eleventh project had on average 28.9 higher visits per 100 members
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throughout the study period (11th, b= 28.947, p<0.01). These findings are similar to those for
the PPV measure (see Exhibit 4.59).
Exhibit 4.64. PPS-level comparative analysis regression for potentially preventable emergency
room visits, behavioral health population
Potentially Preventable Emergency Room Visits,
Behavioral Health Population
Basic
Model
(1)

Size
Interaction
Terms
(2)

Behavioral
Health
Interaction
Terms
(3)

Geography
Interaction
Terms
(4)

Eleventh
Project
Interaction
Terms
(5)

Trend

-0.250***
(0.086)

-0.289**
(0.119)

-0.288**
(0.116)

-0.098
(0.133)

-0.279**
(0.130)

DSRIP

-8.860***
(1.290)

-10.308***
(1.783)

-7.039***
(1.751)

-1.856
(1.989)

-6.240***
(1.948)

Large Size

-5.603***
(1.817)

-5.026**
(2.090)

-4.049**
(1.818)

-6.081***
(1.824)

-6.339***
(1.866)

High BH

0.540
(1.160)

0.029
(1.161)

-3.264*
(1.764)

-0.620
(1.143)

0.280
(1.158)

ROS

-14.569
(10.101)

-14.393
(10.215)

-14.499
(10.073)

-14.146
(10.425)

-14.551
(10.204)

11th

28.947***
(9.957)

28.984***
(10.070)

28.924***
(9.931)

28.929***
(10.190)

27.565**
(10.142)

Trend*DSRIP

0.577***
(0.098)

0.725***
(0.135)

0.421***
(0.132)

0.087
(0.151)

0.438***
(0.147)

Trend*Large Size
DSRIP*Large Size
Trend*DSRIP*Large
Size

0.080
(0.174)
3.018
(2.590)
-0.308
(0.197)

Trend*High BH

0.079
(0.170)
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DSRIP*High BH

-3.793
(2.559)

Trend*DSRIP*High
BH

0.327*
(0.193)

Trend*ROS

-0.253
(0.173)
-11.672***
(2.579)

DSRIP*ROS

0.818***
(0.196)

Trend*DSRIP*ROS
DSRIP*11th

-4.677*
(2.622)

Trend*11th

0.052
(0.175)

Trend*DSRIP*11th

0.249
(0.199)

Constant
Observations

99.894***
(6.704)

99.736***
(6.795)

100.945***
(6.694)

100.436***
(6.928)

101.135***
(6.838)

775

775

775

775

775

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. The number of observations for preventable emergency room visits is lower
because MY3 only includes 6 time points (months 1, 2, 3, 4, 5, and 12). Data for the other time points in the second
half of MY3 were not available at the time of analysis.

Exhibit 4.64 shows that geographic location was associated with differences in post-DSRIP
performance changes in PPVBH rates. The PPS located in ROS had larger declines in their levels
immediately following DSRIP initiation compared to post-DSRIP level changes among PPS in
New York City (DSRIP*ROS, b = -11.672, p<0.01). The positive Trend*DSRIP*ROS interaction
term (b= 0.818, p<0.01) indicates that PPS in ROS and those in New York City had different postDSRIP initiation trends resulting in the PPS in ROS reverting back towards their pre-DSRIP trend.
For ease of interpretation, Exhibit 4.65 presents the stratified models, with model (2) limited to
the sub-population of PPS located in New York City and model (3) limited to the sub-population
of PPS located in ROS. The PPS located in ROS had a significantly decreasing trend in the PPVBH
rate in the pre-DSRIP period (Trend, b= -0.312, p<0.01) whereas rates were stable for NYC PPS
(Trend not significant). Immediately following DSRIP initiation, PPS in ROS had a statistically
significant decrease in their level of PPVBH rates (DSRIP, b= -13.101, p<0.01); there was no level
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change in NYC PPS. Thereafter, the post-DSRIP trends for ROS PPS reversed direction and
PPVBH rates significantly increased (Trend*DSRIP, b= 0.865, p<0.01); there was no statistically
significant post-DSRIP trend change for NYC PPS.
Exhibit 4.65. PPS-level comparative analysis regression for potentially preventable emergency
room visits, behavioral health population, comparing the PPS in ROS to those in NYC

Potentially Preventable Emergency Room Visits,
Behavioral Health Population
Full Sample
(1)

NYC
(2)

ROS
(3)

Trend

-0.250***
(0.086)

-0.040
(0.122)

-0.312***
(0.115)

DSRIP

-8.860***
(1.290)

-1.210
(1.808)

-13.101***
(1.713)

Large Size

-5.603***
(1.817)

-0.994
(2.349)

-11.140***
(2.704)

High BH

0.540
(1.160)

-0.465
(1.462)

-0.490
(1.706)

ROS

-14.569
(10.101)

11th

28.947***
(9.957)

23.112
(13.447)

33.662**
(15.201)

Trend*DSRIP

0.577***
(0.098)

0.029
(0.138)

0.865***
(0.130)

Constant

99.894***
(6.704)

98.366***
(6.276)

84.357***
(13.675)

775

310

465

Observations

Source: Authors’ analysis of the DSRIP Dataset.
Notes: *p<0.1, **p<0.05, ***p<0.01. The number of observations for preventable emergency room visits is lower
because MY3 only includes 6 time points (months 1, 2, 3, 4, 5, and 12). Data for the other time points in the second
half of MY3 were not available at the time of analysis.

The findings for the PPV and PPVBH measures should be interpreted cautiously, as not all
monthly data points were available at the time of analysis. The missing data in the second half
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of MY3 places more weight on MY2 and the first half of MY3 and also results in lower statistical
power. Additionally, there was a change in the health plan encounter intake system (EIS) that
occurred in October 2015 (between MY1 and MY2). This change led to differences in how
emergency department encounters were reported. The level drop in PPV rates from MY1 to
MY2 may be in part due to this change. The final summative report will contain a more robust
analysis when all DSRIP performance data are available.

4.7. Assessment of Changes in Health Care System Transformation
This section addresses RQ-F:
To what extend did PPS achieve health care system transformation, including increasing
the availability of behavioral health care? (CMS RQ1)

Summary At-A-Glance
The Interim Report focused on system transformation measures in three areas: (1) health care
service delivery integration; (2) health care coordination; (3) utilization among the uninsured,
non-utilizing, and low-utilizing populations (with a focus on non-use of preventive care
services among the Medicaid members, and emergency department (ED) services among the
uninsured population. The findings in the third area were limited to the 14 PPS that selected
the eleventh “patient activation” project. These are relevant to projects in Domains 2A, 2B,
and 2D, respectively. Integration and coordination are foundational to improved health care
quality, which may in turn prevent avoidable hospitalizations and ED visits thereby saving
costs. The third area is also relevant to cost-savings, as increasing preventive care, especially
among non-utilizing and low-utilizing Medicaid members should reduce downstream tertiary
care. Efforts to connect the uninsured to community resources, thereby diverting the
uninsured from the ED, could also reduce costs through increased primary care and reduced
use of expensive ED services.
At the statewide level, the percentage of providers meeting Meaningful Use criteria who
conduct bidirectional exchange improved from 57.5% in MY2 to 70.4% in MY3.
Approximately 94% of patients had positive experiences with their health care transition
plans after hospital discharges, and approximately 84% of patients had positive experiences
with up-to-date coordination in clinical settings. These positive experiences were consistent
throughout the period. There was an 8.3 percentage-point increase in the percent of patients
reporting a provider as their usual source of care, from 78.6% in MY1 to 86.9% in MY3.
Between MY0 (2014) and MY1 (2015), there was a small increase in the percentage of
attributed Medicaid members with non-use of preventive services (from 10.4% to 11.6%),
although thereafter it remained at a relatively constant level of 11.0% and 11.3% in MY2 and
MY3, respectively. The percentage of ED visits that were from self-pay patients, presumed to
be uninsured, decreased overall from 15.2% in MY0 to 11.2% in MY3.
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Across PPS, the highest variability occurred in health information technology capabilities. In
MY2, the percentage of providers in PPS that conducted bidirectional exchange or had
participating agreements varied from 18.3% to 87.9%, and from 38.3% to 98.7%, respectively.
These ranges narrowed in MY3 to 39.9% to 90.5% in bidirectional exchange, and 45.3% to
99.5% in participating agreements. These differences are consistent with early findings from
the implementation and process study, with some PPS having larger start-up challenges due
to their level of HIT infrastructure.
Among the 14 PPS that selected the eleventh project, there was high variability across PPS
with respect to the measure of non-use of preventive services among attributed Medicaid
members, and also the measure of ED visits comprised of self-pay patients (presumed to be
the uninsured). Differences across PPS were particularly striking for the ED visit measure, and
these differences persisted across the study time period, ranging from 7.9% to 29.6% in MY0,
and from 2.3% to 24.1% in MY3. This measure should be interpreted cautiously, as it reflects
a combination of differential utilization between insured and uninsured populations within
PPS, and differences across PPS in the underlying level of insurance coverage among their
patient populations. Although the DSRIP program aims to influence ED utilization among both
Medicaid members and uninsured populations, expansion of health insurance is not within its
scope. Furthermore, the public hospitals and safety net providers that qualified for the
eleventh project may have limited ability to influence these measures in a short time frame
because their patient populations are particularly vulnerable.
There are several cautions in interpreting these interim findings. First, because there are only
two or three observations for the first two sets of measures and four observations for the
third set of measures, it is difficult to isolate changes that occurred due to the DSRIP
program. Without additional information on these measures over a longer time period, it is
not possible to quantify the degree to which their trajectories changed following the DSRIP
program’s implementation. Second, PPS had annual opportunities to add partners. Variability
in the first two measures may reflect differences in partners, although they are nonetheless
useful indicators of the state of PPS over time. Third, changes in self-pay ED utilization
(presumably the uninsured population) could reflect changes in utilization of uninsured
versus insured patients, declines in the percentage of uninsured individuals due to
implementation of the Affordable Care Act’s Medicaid expansion and health insurance
marketplace, or a combination. Finally, an important achievement has been progression to
the statewide milestone for primary care medical home (PCMH) certification. That was not
included in the Interim Report because this analysis focuses on data through the end of MY3,
which preceded the 2018 statewide milestone.
These findings provide context for the current state of HIT infrastructure, progress towards
integration of primary care services, health care coordination and patient experiences, and
utilization among individuals who are uninsured or less connected to the health care system.
The final summative report will examine changes across the full DSRIP program period;
compare characteristics of PPS with different outcomes and project selections; examine
changes in PCMH certification to encompass the full period including the 2018 statewide
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milestone; and explore alternative measures of health care utilization among the uninsured,
non-utilizing, and low-utilizing populations.

4.7.1. Statewide Trends and Comparative Analysis of Health Care Service
Delivery Integration
Exhibit 4.55 displays annual measures for two HIT outcomes: the percentage of providers
meeting Meaningful Use criteria who conduct bidirectional exchange (blue bars) or have
participating agreements (orange bars) with Qualified Entities. These are relevant to successful
implementation of DSRIP projects, and system transformation more generally. In the DSRIP
program, PPS receive data on their attributed members to create “chase lists” of individuals
who are flagged as out of care, identify areas for quality improvement, and other uses. More
broadly, despite claims period lags, New York has invested considerable resources to promote
health information exchange and interoperability across clinics to improve care coordination,
improve patient safety, and other outcomes.132
Most providers meeting Meaningful Use criteria engage in bidirectional exchange with
Qualified Entities, and this increased from 57.5% (MY2) to 70.4% (MY3). Slightly over threequarters of these providers had participating agreements with Qualified Entities in both
measurement years. The increase in bidirectional exchange is consistent with the DSRIP
program’s large emphasis on HIT, and is applicable to many DSRIP projects.

132

Vest, J.R. & Martin, E.G. (2016). Creating a 21 st century health information technology infrastructure: New
York’s Health Care Efficiency and Affordability Law for New Yorkers capital grant program. In: Dixon, B.E. (ed.)
Health Information Exchange: Navigating and Managing a Network of Health Information Systems. San Diego, CA:
Elsevier Inc., pp. 295-312.
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Exhibit 4.55. Annual measures of health information technology among eligible providers
meeting Meaningful Use criteria from MY2 to MY3
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Source: Authors’ analysis of the DSRIP Dataset. “Bidirectional Exchange” and “Participating Agreements” is the
percent of providers meeting Meaningful Use criteria who conduct bidirectional exchange or have participating
agreements with Qualified Entities.

The following two exhibits display the HIT measures in MY2 and MY3, by PPS. Each PPS has one
bar per MY. Consistent with Exhibit 4.55, the blue bars in Exhibit 4.56 represent bidirectional
exchange and the orange bars in Exhibit 4.57 represent participating agreements.
Many PPS demonstrated improvements in conducting bidirectional exchange. There was
considerable variability across PPS. This ranged from 18.3% to 87.9% in MY2, and from 39.9% to
90.5% in MY3. Several PPS with high initial starting values (such as Adirondack Health Institute
(AHI) and NewYork-Presbyterian PPS (NYP)) had little change because their starting values were
much higher than that of other PPS, and thus there was less room for improvement. In
contrast, there were notable improvements among PPS that had low starting values; for
example, Millennium Collaborative Care (MCC) improved from 18.3% to 39.9% and Refuah
Community Health Care Collaborative (RCHC) improved from 42.4% to 78.7%.
Many PPS also had increased numbers of providers with participating agreements, but these
changes were not as striking as the bidirectional exchange measure. Across the PPS, the
percentage of eligible providers with participating agreements ranged from 38.3% to 98.7% in
MY2, and from 45.3% to 99.5% in MY3. Several PPS had nearly all providers meeting this
benchmark; for example, Central New York Care Collaborative (CNYCC) and Finger Lakes PPS
(FLPPS) had starting values of 98.3% and 98.7% in MY2, respectively. Consequently, they had
little room for improvement. The most notable improvement occurred in North County
Initiative (NCI), which increased by 23.5 percentage-points from 73.7% in MY2 to 97.2% in MY3.
Some PPS declined, with the largest decrease occurring in OneCity Health (HHC) from 77.5% in
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MY2 to 70.5% in MY3. This might reflect a recent change in the Qualified Entities serving the
NYC area.
Exhibit 4.56. Percent of eligible providers meeting Meaningful Use criteria who conduct
bidirectional exchange with qualified entities from MY2 to MY3, by PPS
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Source: Authors’ analysis of the DSRIP Dataset. “Bidirectional Exchange” is the percent of providers meeting
Meaningful Use criteria who conduct bidirectional exchange with Qualified Entities.
Notes: Each PPS has one bar per DSRIP measurement year (MY). The midpoint of the corresponding calendar years
are January 2016 (MY2) and January 2017 (MY3). Within each PPS cluster, MY2 is the left bar and MY3 the right
bar.
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Exhibit 4.57. Percent of eligible providers meeting Meaningful Use criteria who have
participating agreements with qualified entities from MY2 to MY3, by PPS
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Source: Authors’ analysis of the DSRIP Dataset. “Participating Agreements” is the percent of providers meeting
Meaningful Use criteria who have participating agreements with Qualified Entities.
Notes: Each PPS has one bar per DSRIP measurement year (MY). The midpoint of the corresponding calendar years
are January 2016 (MY2) and January 2017 (MY3). Within each PPS cluster, MY2 is the left bar and MY3 the right
bar.

4.7.2. Statewide Trends and Comparative Analysis of Health Care Coordination
Exhibit 4.58 displays annual measures for three health care coordination measures derived
from the Consumer Assessment of Health Care Providers and Systems (CAHPS) family of patient
experience surveys: care transition (blue bars), usual source of care (orange bars), and up-todate coordination (gray bars). The CAHPS surveys are pre-validated, standardized instruments
used across health care settings. They focus on patient reports and ratings of experiences
rather than satisfaction, which could be confounded by attitudes towards caregivers. Patient
experiences align with patient-centered care, and positive patient experiences can help achieve
trust and strengthened provider-patient relationships, improved continuity of care and
adherence to treatment plans, and improved health care outcomes.133
A vendor (DataStat) surveyed Medicaid members within each PPS for the Clinician & Group
CAHPS (CG-CAHPS).134 The Adult Hospital CAHPS (HCAHPS)are submitted by hospitals, and the

133

Cleary, P.D. & Elliott, M.N. (2015, October 5). Sorting fact from fiction: the value of patient experience
measurement. Retrieved from https://www.ahrq.gov/cahps/news-and-events/events/ahrq-conference2015/sorting-fact-fiction-slides.html
134
The PPS that were eligible for and selected the eleventh project also fielded their own CG-CAHPS for the
uninsured non-Medicaid population. These are not reported here because they are neither centrally administered
by a vendor nor case-mix adjusted.
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values in the DSRIP Dataset are based on information accessed from the CMS website. The PPS
results are case-mix adjusted, which limits the ability to trend PPS performance across years.
Exhibit 4.58. Annual measures of health care coordination from MY1 to MY3
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Source: Authors’ analysis of the DSRIP Dataset. “Care Transition” is the average of results for “strongly agree” and
“agree” responses for three HCAHPS survey questions related to understanding their hospital discharge
instructions. “Usual Source of Care” is a dichotomous measure from the CG-CAHPS survey on whether respondents
considered the provider they were rating to be their usual source of care. “Up-to-Date Coordination” is the
average of results from “usually” and “always” responses of three CG-CAHPS survey questions related to whether
providers were up-to-date about care received from other providers.

The care transition measure (blue bars) is a composite of questions 23, 24, and 25 from the
Hospital CAHPS (HCAHPS), reproduced below. Each question contains a four-point Likert scale,
from “strongly disagree” to “strongly agree.” The DSRIP measure is on a 0 to 100 percentagepoint scale, and takes an average of the percentage of surveys from hospitals within each PPS
with “strongly agree” and “agree” responses. The composite score is an average of the three
measures.
• “During this hospital stay, staff took my preferences and those of my family/caregiver
into account in deciding what my health care needs would be when I left.”
• “When I left the hospital, I had a good understanding of the things I was responsible for
in managing my health."
• “When I left the hospital, I clearly understood the purpose of taking each of my
medications.”
The usual source of care measure (orange bars) is from the Clinician & Group CAHPS (CGCAHPS) Survey. The first question asks patients to identify the provider they visited in the last
six months. The second question (used in the DSRIP usual source of care measure) asks patients
to indicate whether they received care from, “the provider you usually see if you need a checkup, want advice about a health problem, or get sick or hurt.” The DSRIP measure is on a 0 to
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100 percentage-point scale, with 100% indicating that all patients reported that provider as
their usual source of care.
The up-to-date coordination measure (gray bars) is a composite of questions 13, 17, and 20
from the CG-CAHPS, reproduced below. Each question contains a four-point Likert scale, from
“never” to “always.” The DSRIP measure is on a 0 to 100 percentage-point scale, and takes an
average of the percentage of surveys within each PPS with “usually” and “always” responses.
The composite score is an average of the three measures.
•
•

•

“In the last 6 months, how often did this provider seem to know the important
information about your medical history?”
“In the last 6 months, when this provider ordered a blood test, x-ray, or other test for
you, how often did someone from this provider’s office follow up to give you those
results?”
“In the last 6 months, how often did you and someone from this provider’s office talk
about all the prescription medicines you were taking?”

Most patients agreed they had a good understanding of their hospital discharge plans and that
their preferences were taken into account, and this level of agreement was consistent across
the three years (MY1: 93.9%, MY2: 93.9%, MY3: 93.8%). Across the three years, there was an
increase in the percentage of patients identifying their provider as a usual source of care, from
78.6% in MY1 to 86.9% in MY3. Agreement about whether their providers had up-to-date was
consistent across the three years (MY1: 83.9%, MY2: 82.9%, MY3: 84.0%).
The following three exhibits display these measures in MY1, MY2, and MY3, by PPS. Each PPS
has one bar per MY. Consistent with Exhibit 4.58, the blue bars in Exhibit 4.59 represent the
health care transition measures, the orange bars in Exhibit 4.60 represent identifying the
provider as a usual source of care, and the gray bars in Exhibit 4.61 represent up-to-date care
coordination.
Similar to what is seen on the statewide plots (see Exhibit 4.58), within PPS there was limited
variation in care transition experiences over time, and many PPS had similar values (Exhibit
4.59). They ranged from 90.7% to 96.8% in MY1, from 91.0% to 96.3% in MY2, and from 90.0%
to 96.1% in MY3. This reflects how the PPS had high values at the start of the time period,
leaving less room for improvement compared to other measures.
For the usual source of care, the variability between PPS lessened over time (Exhibit 4.60). At
the PPS level, the percentage of patients indicating the provider was their usual source of care
ranged from 53.6% to 90.6% in MY1, from 72.2% to 90.7% in MY2, and from 79.5% to 92.7% in
MY3. All PPS had increases in this measure between MY1 to M3, with some having particularly
notable improvements. For example, Refuah Community Health Collaborative (RCHC) and the
Adirondack Health Institute (AHI) had 31.3 and 13.6 percentage point improvements,
respectively.
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Compared to the care transition experiences, there was more variation between PPS in
patients’ experiences with up-to-date care coordination (Exhibit 4.61). However, unlike the
usual source of care measure, within PPS these values remained relatively constant across the
three years. The up-to-date care coordination experiences ranged from 77.8% to 89.9% in MY1,
from 78.8% to 87.1% in MY2, and from 78.9% to 87.6% in MY3.
Exhibit 4.59. Health care transition measure from MY1 to MY3, by PPS
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Source: Authors’ analysis of the DSRIP Dataset. “Care Transition” is the average of results for “strongly agree” and
“agree” responses for three HCAHPS survey questions related to understanding their hospital discharge
instructions.
Notes: Each PPS has three bars, one per DSRIP measurement year (MY). The midpoints of the corresponding
calendar years are January 2015 (MY1), January 2016 (MY2), and January 2017 (MY3). Within each PPS cluster,
MY1 in the left position, followed to the right by MY2 and MY3.
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Exhibit 4.60. Whether health care provider is a usual source of care from MY1 to MY3, by PPS
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Source: Authors’ analysis of the DSRIP Dataset. “Usual Source of Care” is a dichotomous measure from the CGCAHPS survey on whether respondents considered the provider they were rating to be their usual source of care.
Notes: Each PPS has three bars, one per DSRIP measurement year (MY). The midpoints of the corresponding
calendar years are January 2015 (MY1), January 2016 (MY2), and January 2017 (MY3). Within each PPS cluster,
MY1 is in the left position, followed to the right by MY2 and MY3.

Exhibit 4.61. Whether provider is up-to-date about care received from other providers from MY1
to MY3, by PPS
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Source: Authors’ analysis of the DSRIP Dataset. “Up-to-Date Coordination” is the average of results from “strongly
agree” and “agree” responses of three CG-CAHPS survey questions related to whether providers were up-to-date
about care received from other providers.
Notes: Each PPS has three bars, one per DSRIP measurement year (MY). The midpoints of the corresponding
calendar years are January 2015 (MY1), January 2016 (MY2), and January 2017 (MY3). Within each PPS cluster,
MY1 in is the left position, followed to the right by MY2 and MY3.
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4.7.3. Statewide Trends and Comparative Analysis of Utilization among the
Uninsured, Non-Utilizing, and Low-Utilizing Populations
Exhibit 4.62 displays annual measures for two outcomes related to utilization among the
uninsured, non-utilizing, and low-utilizing populations. These findings are limited to the 14 PPS
that selected the eleventh project (patient activation). The blue bars represent the percent of
attributed members who did not have at least one claim with a preventative services code
during the year. If the DSRIP program shifts costs upstream and increases the use of preventive
services, this measure of “non-use” should decline. The orange bars represent the percentage
of all emergency department (ED) visits to hospitals in the PPS network during the year that had
a payer typology of “self-pay.” A value of zero would indicate that all individuals presenting to
care at the ED had public or private insurance. Positive values would reflect a high volume of ED
use among the uninsured compared to the insured population, a high percentage of the
population that is uninsured, or a combination of these factors.

Exhibit 4.62. Annual measures of utilization among the uninsured, non-utilizing, and lowutilizing populations from MY0 to MY3 for those PPS that chose Project 2.d.i
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Source: Authors’ analysis of the DSRIP Dataset. “No Preventive Services” is the percent of attributed Medicaid
members who did not have at least one claim with a preventative services code during the year. “Self-Pay ED
Visits” is the percent of all emergency department visits to hospitals in the PPS network during the year that had a
payer typology of self-pay. Results are limited to the 14 PPS that selected the eleventh project (patient activation).

Throughout the period, the percent of attributed members with non-use of preventive services
remained relatively steady around 11%. There was a slight increase in the pre-DSRIP period,
between MY0 (10.4%) to MY1 (11.6%), although thereafter it remained at a constant level of
11.0% and 11.3% in MY2 and MY3, respectively. During this period, there was a decline in self226

pay ED visits. During the pre-DSRIP period, there was a 2.8 percentage-point decline from
15.2% in MY0 to 12.5% in MY1, followed by a slight increase to 13.4% in MY2 and subsequent
decline to 11.2% in MY3. One possible explanation for the decrease in self-pay ED visits
between MY0 and MY1 is the coincidence with the implementation of the Medicaid expansion
under the Affordable Care Act and the launch of NY State of Health, New York’s health
insurance exchange. A decline in the number of uninsured individuals would result in a smaller
percentage of self-pay ED visits, even if the ratio of the volume of visits between the uninsured
and insured populations remained the same.
The final summative report will use the hospital discharge data to explore in more detail the
utilization of ED and inpatient services among low-utilizing, non-utilizing, and uninsured
populations. It will also consider additional specifications such as the volume of visits rather
than a dichotomous measure of the delivery of any preventive services.
The following two exhibits display these measures in MY0, MY1, MY2, and MY3, by PPS. This is
also limited to the 14 PPS that selected the eleventh project (patient activation). Each PPS has
one bar per MY. Consistent with Exhibit 4.62, the blue bars in Exhibit 4.63 represent non-use of
preventive services and the orange bars in Exhibit 4.64 represent the percentage ED visits
comprised of self-pay patients.
There was notable variability in the percentage of non-use of preventive services. Across PPS,
this measure ranged from 7.9% to 12.1% in MY0, from 8.9% to 13.7% in MY1, from 8.8% to
12.8% in MY2, and from 9.1% to 14.6% in MY3. Most of the PPS selecting the eleventh project
experienced increased percentages of non-use or else constant levels across years.
Although the percentage of ED visits comprised of self-pay patients varied considerably across
PPS, most of the PPS selecting the eleventh project had similar trends of declining percentages
over time. Across PPS, this measure ranged from 7.9% to 29.6% in MY0, 5.3% to 26.0% in MY1,
from 4.2% to 31.8% in MY2, and from 2.3% to 24.1% in MY3. A challenge of comparing PPS
performance on this measure is that its value reflects several factors including the prevalence
of insurance, the rate of ED utilization among the uninsured, and the rate of ED utilization
among each PPS’s attributed populations which differ across PPS (see Section 4.1 for details on
inter-PPS variation in attributed members). For example, OneCity Health (HHC) has values that
are substantially higher than other PPS, but its lead entity (New York City Health and Hospital
Corporation) is the state’s largest public hospital system and likely receives a disproportionate
share of uninsured patients. Differences across PPS and over time should be interpreted
cautiously.
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Exhibit 4.63. Percent of attributed Medicaid members with no use of preventive care services
from MY0 to MY3 for those PPS that chose Project 2di.
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Source: Authors’ analysis of the DSRIP Dataset. “No Preventive Services” is the percent of attributed Medicaid
members who did not have at least one claim with a preventative services code during the year.
Notes: Each PPS has four bars, one per DSRIP measurement year (MY). Within each PPS cluster, MY0 has the left
position, followed by M1, MY, and MY3. The midpoints of the corresponding calendar years are January 2014
(MY0), January 2015 (MY1), January 2016 (MY2), and January 2017 (MY3). Results are limited to the 14 PPS that
selected the eleventh project (patient activation).
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Exhibit 4.64. Percent of emergency department visits comprised of self-pay patients, from MY0
to MY3, by PPS participating in Project 2di
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• Self-Pay ED Visits

Source: Authors’ analysis of the DSRIP Dataset. “Self-Pay ED Visits” is the percent of all emergency department
visits to hospitals in the PPS network during the year that had a payer typology of self-pay.
Notes: Each PPS has four bars, one per DSRIP measurement year (MY). Within each PPS cluster, MY0 has the left
position, followed by MY1, MY2, and MY3. The midpoints of the corresponding calendar years are January 2014
(MY0), January 2015 (MY1), January 2016 (MY2), and January 2017 (MY3). Results are limited to the 14 PPS that
selected the eleventh project (patient activation).

4.8. Assessment of Changes in Health Care Costs
This section addresses RQ-G:
Did the DSRIP program reduce health care costs? (Sub-question: Was the DSRIP program
cost effective in terms of New York and federal governments receiving adequate value
for their investments?)
A detailed cost assessment of the demonstration was not possible in time for the Interim
Report and would likely be limited in its findings due to the initial time period where PPS efforts
were focused on start-up activities and initiating implementation. For the Interim Report, the
Independent Evaluator examined where there might be other information regarding Medicaid
costs that would help inform the reader as to the state’s performance on cost trends. The state
reported on the Statewide Accountability Milestones (SWAM) for DY3 in its DSRIP, Year 3
Quarter 4 report to CMS.135 The SWAM measure 3 is the Medicaid spending milestone and New
York reports passing the DY3 milestone measure where costs for inpatient and emergency
135
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room spending were below the target trend rate. The DY4 SWAM information has not yet been
made available. The final summative report will contain more detailed analyses of how costs
have shifted over time, and differences across PPS over the entire course of the demonstration
period.

5. Policy and Practice Implications
The New York DSRIP program seeks to achieve the triple-aim by fundamentally restructuring
New York’s health care delivery systems through investments in the Medicaid program and
participating providers. This Interim Evaluation examined the DSRIP program’s early
implementation through part of Demonstration Year 4 and outcomes through Measurement
Year 3 using mixed methods.
New York DSRIP program participants provided insights into the early years of the DSRIP
program, through key informant interviews, focus groups, and surveys. The early years of the
DSRIP program were important for capacity building and laying the foundation for improving
clinical and population outcomes. Preliminary outcomes on several performance measures
were also examined using administrative data. Because the DSRIP program is still ongoing and
the data available on performance measures was limited to a small number of years before and
after initiation of the program, it is too early for the Independent Evaluation to draw
conclusions about the impact of the DSRIP program on quality, cost, service utilization, and
overall system transformation.
Although it is premature to draw major conclusions about the impact of the DSRIP program on
health outcomes and cost based on the Interim Evaluation, New York’s performance on
statewide accountability milestones suggest that New York is starting to make progress on its
DSRIP performance goals. As described in Section 2.2, the DSRIP program’s STC identifies four
milestones for which statewide performance is evaluated annually, beginning in Demonstration
Year 3. Failure to meet performance goals on any of the four milestones results in a financial
penalty that increases over time. In its first and only year of assessment to date, New York
exceeded targets on all four of its statewide milestones.136 Notably, performance either
improved or was maintained on 12 of the 16 measures used to assess statewide measure
performance in DY3 (e.g., potentially preventable readmissions), nearly 60% of project-specific
and population-wide measures were met statewide, total statewide inpatient and emergency
room spending was below the target rate, and 34.6% of all managed care organization
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The specific performance goals for the four milestones in DY3 were: (1) at least 50% of statewide performance
measures must be determined to be improving/maintaining, versus worsening (minimum of 9 of 16 measures in
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target ($206.24 per member per month in DY3); and (4) at least 10% of total managed care organization
expenditures must be captured in Level 1 or above value based payment contracts.
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expenditures were in Level 1 or above value based payment contracts.137 The purpose of
evaluating performance on the statewide accountability milestones and the method for
determining if performance met milestones agreed to by New York and CMS differ somewhat
from the purpose and methods of the Independent Evaluation of the DSRIP program.
Nevertheless, New York’s achievement on the statewide milestones in their first year of
assessment provides some additional evidence that health care outcomes are trending in a
positive direction.
Recognizing the importance of patient-centered care to system transformation, all primary care
practices in PPS were expected to meet National Committee for Quality Assurance (NCQA)
Level 3 patient-centered medical home (PCMH) standards by the end of DY3 (March 31, 2018).
Because the interim evaluation addresses performance outcomes up to the end of MY3 (June
30, 2017), it would not adequately capture the DY3 PCMH milestone. Therefore, PCMH
measures will be examined in more detail in the summative evaluation and are not included in
this interim report. However, internal analyses by the NYS DOH using data up to June 30, 2018
suggest that the DSRIP program has had a positive impact on increasing the number of new
PCMH providers and providers who moved up to Level 3, especially compared to providers who
are not partnered with a PPS.
Because it is still early to draw conclusions based on the evaluation of performance measures,
this section will focus on early observations and implications for practice from the
implementation and process component of the evaluation, including both success and
challenges. The final summative report will include findings on the overall outcomes of the
program, using additional performance measures and data from all DSRIP Demonstration Years
and more extensively triangulate implementation and process results with performance
measure results. The summative report will also provide more extensive analysis of PPS level
performance, including comparing performance on specific DSRIP program projects. The
additional analyses included in the summative report will provide a more complete
understanding of the New York DSRIP program and will, therefore, present a more detailed
synthesis of implications for state and federal policy.

5.1. Successes of the DSRIP Program to Date
5.1.1. Collaboration and Breaking Down “Silos”
The New York DSRIP program takes a comprehensive, multi-stakeholder approach to system
transformation. The structure of the program, with coalitions of partners forming PPS to work
on a specific set of projects, necessitates collaboration and the breaking down of “silos”
between a broad range of provider types, and investments in infrastructure development and
capacity building (e.g., governance, technology, human resources). Although this is challenging
137
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and takes time for the full results of these efforts to be realized, data collected from PPS key
informants and engaged-partners indicate that the DSRIP program has been a catalyst for
changing the way many providers and organizations think about and provide care to Medicaid
members and to the population as a whole. This was seen early on during the start-up phase
when PPS were forming, selecting projects, and setting “speed and scale targets” in
Demonstration Year 0, and has continued through implementation and the early years of
operations. Many stakeholders reported that the DSRIP program increased collaboration
between providers and organizations and allowed stakeholders to work together towards
common goals. Notably, new collaborations were established between providers and
organizations that had never worked together before, considered themselves competitors, or
who were previously mistrustful of each other. In the beginning, this was not always easy and
obtaining buy-in and aligning different objectives took time. The general consensus was that
involving a broad-based group of partners early on was vital to a well-functioning group and
continued engagement. Stakeholders also reported that increased collaboration and shared
goals led to new ideas and brought communities closer together. As one PPS key informant
noted, “We have made great strides with collaboration between organizations that without
DSRIP would have never collaborated. We really pride ourselves on this; that we brought the
community together.” This collaboration has become a standard process which many PPS and
engaged-partners expect to continue after the DSRIP program has ended.
The DSRIP program has further helped break down silos between providers and organizations
through shared accountability. Shared accountability, which many stakeholders view as a major
step for the health care system, has encouraged providers and organizations to develop
connections that encourage them to work together to maintain responsibilities for their
patients. In particular, a majority of PPS key informants interviewed saw their new work with
community-based organizations as a vital change to the health care system. Community-based
organizations that had not previously considered their organizations to be part of the health
care system also began seeing their roles differently. In many cases, community-based
organizations and health care providers developed a common vocabulary and were starting to
“look at the same picture from almost the same perspective.”

5.1.2. Observed Positive Changes in the Delivery of Care
Overall, PPS key informants, focus group participants, and partner survey respondents
observed that the DSRIP program, to date, has contributed to many positive changes in the way
care is provided, including movement towards patient-centered, continuous, and coordinated
care.
Consistent with increased collaboration and shared accountability, PPS key informants and
focus group participants most often cited improved care transitions, the integration of primary
care with behavioral health care, and encouragement of innovation as specific positive
outcomes of the DSRIP program so far. These are all goals of the DSRIP program, and prerequisites for a high-performing health care system.
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The results of the partner survey provide further evidence that providers have observed
positive changes in the way care is being delivered since the initiation of the DSRIP program.
The majority of partner survey respondents in 2018 reported that services at their organization
have changed for the better since the initiation of the DSRIP program. Findings did vary
somewhat by organization type, with respondents working at hospitals most likely to report
having observed positive changes and respondents working at community-based organizations
among those least likely. Similar to key informants and focus group participants, the most
commonly cited benefit from the DSRIP program observed by 2018 partner survey participants
was coordinated care. These findings also varied somewhat by provider type.
It is also important to include patient experiences when evaluating the impact of the DSRIP
program on changes to the delivery of care. Surveys of Medicaid attributed members showed
that overall in New York, members were already at a high level of satisfaction with their health
care providers.

5.1.3. Increased Understanding of and Preparation for Value Based Payment
Value based payment is a key component of the DSRIP program and overall Medicaid redesign
in New York. In 2015 CMS approved the NYS DOH Value Based Payment Roadmap, a five-year
plan for comprehensive Medicaid payment reform.138 New York’s Medicaid payment reform
requires all Medicaid managed care organizations to shift 80-90% of provider payments from
fee-for-service to value based payment arrangements by the end of the DSRIP program in
2020.139 The overall goal is to ensure that payment systems reward and promote the
sustainability of the integrated delivery system that the DSRIP program aims to create.
Changing health systems in an environment where both fee-for-service and value based
payment operate simultaneously is challenging, and requires organizational focus and capital.
In addition to educational resources provided by the NYS DOH, most PPS have provided
significant partner education activities for the shift to value based payment, and many PPS
launched surveys and listening tours to learn more about their partner’s needs. Most PPS key
informants felt that these were important activities and were helpful in educating partners
about how to operate in a value based payment environment. Partner survey results suggest
that these activities have been fairly successful at educating partners about value based
payment, with the majority of partners reporting that they were at least somewhat
knowledgeable about value based payment and that their organization had made changes to
prepare for value based payment. In addition to education and training, some PPS reported
they have invested in infrastructure using DSRIP funds to prepare for value based payment,
particularly in the area of health information technology connectivity and data analytics to
better prepare their partners to operate in a value based payment environment. Several PPS
138
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key informants also increased engagement of managed care organizations, which they viewed
as crucial since they will be negotiating contracts with partners in a value based payment
system.
Although there is a better understanding of value based payment and preparations are being
made to move in this direction, challenges remain for PPS and partners. These challenges are
described in more detail in Section 5.2.

5.2. Challenges of the DSRIP Programs to Date
The New York DSRIP program is an ambitious program to fundamentally transform New York’s
health system into a “financially viable, high-performing health system.”140 Any large, complex
program is likely to encounter challenges when trying to reform a health care system that is
equally complex, especially in the context of a five-year demonstration program. Although
these challenges need to be recognized, it is also important to note that many DSRIP program
participants have been able to overcome early challenges and move forward in their efforts.
Identifying program challenges can also provide valuable lessons for CMS and states that are
considering DSRIP programs.

5.2.1. PPS Formation and Start-Up
The New York DSRIP program has required considerable time and resources on the part of
participants, including investment in relationship-building, governance, staff, technical
expertise, education, and technology resources. Most DSRIP program structures had to be
created anew, including the formation of PPS, in a very short time frame. Each PPS consists of a
lead entity that forms partnerships with community providers, leads strategies and efforts, and
is responsible for collective performance. Challenges were sometimes encountered during PPS
formation and application development, including alignment on key issues, allocation of
resources, and leadership structure. This was particularly the case in regions where many
competitors were organized into a small number of PPS. These challenges were often
addressed and resolved, allowing the group to develop a better functioning relationship by the
final application phase, but this took time and effort. Overall, PPS that already had some
existing structures in place, such as those evolving from a unified health system or those that
had previously begun DSRIP-like initiatives, were able to quickly pivot to the requirements of
PPS formation and related work. Other PPS with no existing infrastructure in place faced
additional early challenges with project implementation and partner engagement. It was
difficult for them to simultaneously build infrastructure for a new organization, engage
partners, and adhere to the breadth and pace of DSRIP program project requirements.
Some PPS encountered other challenges with start-up and the early stages of implementation,
including understanding Domain 1 project milestones, difficulty setting appropriate targets
based on the information available, and not knowing their PPS’s attribution in advance, making
140
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it difficult to set speed and scale targets. These particular challenges occurred at the beginning
of the DSRIP program when all entities, including the NYS DOH, were working on multiple startup tasks simultaneously, resulting in what many PPS perceived to be continually changing
requirements and a lack of clear and consistent information.

5.2.2. Operations
Operational challenges mainly occurred in the areas of PPS overlap, value based payment
preparation, funds flow, and data and information technology.
PPS Overlap: In regions with PPS overlap, some providers worked with multiple PPS on DSRIP
program projects. Partners working with multiple PPS were sometimes frustrated by differing
interpretations of DSRIP program rules by each PPS, overwhelmed by working with multiple PPS
administrations, and struggled to meet DSRIP project reporting requirements. Most PPS key
informants noted that they had not originally built their service models to be collaborative with
other PPS and therefore found overlap difficult. However, while PPS key informants
acknowledged challenges with overlapping PPS at the design and initial implementation phase,
some felt they had overcome these challenges by collaborating with other PPS to develop
similar reporting requirements and alignment of other procedures.
Value Based Payment: Although many of the efforts by PPS and the NYS DOH to prepare for
the shift to value based payment have been well received and resulted in improved
understanding and infrastructure investments on the part of PPS and their partners, challenges
remain. Several partner focus-group participants felt that educational programs did not provide
useful information, or they did not feel that they gained enough information to enter the value
based payment landscape confidently. For example, one 2018 hospital regional focus group
participant noted that they would have liked to have learned more about “how to develop the
organization to support [value based] contracts or poise the organization to be successful in
these contracts rather than just how to write or negotiate the contract.”
A number of PPS key informants reported targeting some support specifically towards
community-based organizations, since they were often less prepared for the shift to value
based payment than medical providers. Despite these efforts, focus group participants from
community-based organizations felt that value based payment models were not structured to
include them and expressed concern about the sustainability of their work if they did not have
the ability to demonstrate their value for value based payment contracts, a concern shared by
multiple types of focus group participants.
The results of the partner survey also reflect the concern that some providers and organizations
have about the shift to value based payment. The majority of survey respondents said they
needed more resources to facilitate the shift to value based payment, including additional
funding, one-on-one consulting, improved access to performance data, additional training, or
peer training and support. The types of resources needed varied by provider and organization
type. Overall, continued efforts and resources may be needed to prepare providers for value
based payment, and these should reflect the specific needs of different organization types.
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Funds Flow: The PPS Lead is responsible for distributing funds to participating providers based
upon the budget and funding distribution plan they developed and submitted in their DSRIP
application. The New York DSRIP program’s Special Terms and Conditions (STC) specify that 95%
of a project’s total valuation must go to safety net providers; non-safety net providers are
eligible to receive, in aggregate, no more than 5% of a project’s total valuation. The amount of
time it took for PPS to establish contracts with individual providers and organizations, and
ultimately distribute funds, varied. Many PPS were able to move funds to partners quickly and
felt that this improved relationships, while others took a more deliberate approach. The time it
took to distribute funds was often based on the level of PPS infrastructure that existed before
the DSRIP program began. New Corporation PPS (“NewCos”) without established
infrastructures tended to struggle more often with delays and lapses in the flow of funds.
Several partners and PPS key informants mentioned that the 5% funding limitation to nonsafety net providers created challenges by alienating key partners that were fundamental to the
DSRIP program’s success. Likewise, several partner organizations, particularly non-hospital
participants, expressed concerns about the time it took for them to receive funds. Several
organizations also reported that the level of funding was not commensurate with the effort
they were putting in to the DSRIP projects. Many partners reported a desire to see the NYS DOH
monitor whether funds were making their way to non-hospital participants, including
community-based organizations and clinical practitioners.
Data Access and Sharing: Data access and sharing was a significant issue throughout DSRIP
program implementation and could affect operations. Transformation to a coordinated,
patient-centered system of care requires ready access to clinical, administrative, and financial
data. Both PPS and partners were often frustrated by difficulties accessing data provided by the
NYS DOH, and PPS were not always able to access the data their partners were collecting.
Respondents reported substantial challenges with data lag, data access, and data sharing. The
PPS did not have access to NYS DOH electronic data during Demonstration Years 0-2, making it
difficult to obtain the information they needed to develop projects and track progress. Even
when entities were able to access data, reporting lags made it difficult for PPS and partners to
know their current performance level and adjust interventions accordingly. The need for realtime data to measure real-time impacts was a common theme across PPS key informants and
partners. Many PPS and partners also found it difficult to access certain types of data that
would be useful, particularly managed care data. Challenges were also encountered by PPS in
their attempt to share data with their partners, due to patient privacy regulations or
uncertainty about privacy regulations. Many PPS key informants thought that it would be
helpful to have additional guidance from the NYS DOH on data sharing issues in order to
maximize the utility of data.
Many PPS developed their own internal data systems to address data lags and barriers to data
sharing. In some cases, accessing needed data from their partners was difficult because of the
wide variety of electronic health records systems used by partners, and the fact that some
partners did not have electronic health records (particularly community-based organizations).
This required some PPS to assist their partners with new electronic health systems or to provide
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support to enhance the ones they already had. Although these systems were important to
guide efforts to close gaps in patient care and meet performance targets, several respondents
believed that steps should have been taken early on in the DSRIP program to avoid the need to
create so many separate systems statewide.

5.3. Implications for Practice from Early Findings
The New York DSRIP program is a potential model for other states interested in systemwide
transformation of their Medicaid program. Although it is still too early to fully assess DSRIP
program delivery system changes and their impact on performance outcomes, early findings on
DSRIP implementation and processes can provide insights for practice. This section briefly
presents some of the practical considerations for states and CMS when planning
comprehensive health care system transformation efforts. The final summative report will more
fully consider implications for state and federal health policy and the potential for New York’s
DSRIP program to be replicated in other states.
•

Collaboration: Improved collaboration between a broad spectrum of providers and
organizations necessary to provide the continuum of care for Medicaid members and to
address health care holistically is possible, but it takes time and effort to align priorities,
build trust, and change culture. Efforts to improve collaboration and break down silos
should start early, engage diverse stakeholders, and will require continued effort to
maintain productive relationships.

•

Funds Flow: Transparency of funds flow is important so that providers know what to
expect before they agree to participate. If a goal is to increase the utilization of
providers outside of hospital systems, state oversight of funds flow may be needed to
ensure that it is taking place. If community-based organizations are relied on heavily for
patient outreach and to impact the social determinants of health, their budgets may
need to be increased or additional access to training or funding may be needed.

•

Geographic Overlap: Overlapping administrative entities (e.g., PPS in New York) can
potentially result in unintended complexities and possible inefficiencies. Minimizing or
avoiding overlap in geographic health care referral regions can make it clearer which
entities are responsible for what population, which allows for better program design
and increased efficiency. It can also simplify reporting requirements for providers
affiliated with multiple administrative entities.

•

Data Systems: Data systems that allow providers and administrative entities to access
and securely share up-to-date performance data is central to system transformation.
Providers’ electronic health records systems should be developed and linked as quickly
as possible through health information exchange so other providers and administrative
entities can access them to better coordinate projects and patient care. This may
require careful thinking regarding how population health management may be done
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securely while providing actionable data that meet HIPAA and interoperability
requirements among diverse partners.
•

Managed Care Organizations: Managed care organization decisions will have a large
impact on provider payments moving forward, so they should be further engaged in
programs intended to reduce hospitalizations, share data, and promote value based
payment.

6. Interaction with Other State Initiatives
6.1. Overview
This section includes a discussion of New York’s DSRIP program within an overall Medicaid
context, interrelations of the DSRIP program with other aspects of the state’s Medicaid
program, and interactions with other Medicaid waivers and federal awards affecting service
delivery, health outcomes and the cost of care under Medicaid.
As described in Section 2.1, New York’s DSRIP program is the main mechanism by which the
state is implementing its health care transformation Section 1115 Medicaid Redesign Team
(MRT) Demonstration Waiver Amendment. The DSRIP program complements, builds on, and, in
some cases, accelerates, many of the other MRT initiatives and efforts in New York to align its
health care system with the triple-aim by improving care, improving health, and reducing costs.

6.2. Improving Care and Improving Health
Making fully integrated care management available for all Medicaid beneficiaries is a core
tenant under the “Improving Care” domain of the triple-aim. The MRT defines care
management as provided either by health care providers, or health plans. At the time of the
MRT launch the state had a mixture of care management organizations run by both managed
care plans, and health care providers including hospitals, and primary care providers.
Traditionally, more managed care plans and hospitals provide care management services, than
do primary care providers due to the cost, however, the development of public and private
accountable care organizations (ACOs) and ACO-like arrangements has resulted in more care
management in primary care.141,142
The MRT expects all Medicaid beneficiaries to be enrolled in a care management organization.
Each care management organization must incorporate best practices and functions of patient141
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centered medical homes, health homes, health plans, and special needs health plans where
relevant to the population. Care management organizations are expected to evolve and
increase in numbers as a result of MRT efforts. New York’s DSRIP program has resulted in many
projects focused on care management and accelerated the use of care management
statewide.143
Several PPS have created new organizations focused on care management and other
population health management functions such as health data analytics, and workflow
transformation consulting. In particular, these new care management organizations focus on
activities such as improving care coordination and transitional care, which are central to
reducing hospital utilization and associated costs. Clinical data exchange is also critical to
coordinating care, enabled by the State Health Information Network of New York (SHIN-NY).
Care management activities are designed to improve health outcomes as measured by the
Healthcare Effectiveness Data and Information Set (HEDIS) and Consumer Assessment of
Healthcare Providers and Systems (CAHPS) measures, common among state Medicaid
initiatives.144
The creation of new care management organizations is consistent with the MRT goal of making
integrated care management available to all Medicaid beneficiaries. It is unclear whether there
are now (as a result of DSRIP) a sufficient number of care management organizations available
for all beneficiaries, and whether the scope of these organizations is sufficient in that they
provide for all patient needs including complete health, social needs, behavioral health, and
long-term care (where appropriate). New York’s DSRIP program has begun to lay the
foundation and create the environment for integrated care management options to be more
broadly available and, perhaps, for some PPS to sustainably transition, or transform into truly
integrated organizations such as clinically integrated networks, ACOs, or evolved managed care
organizations.145
Care management is a key part of re-designing primary care. The MRT sought to ensure
universal access to high quality primary care by focusing on patient-centered medical homes
(PCMH). Goals under the MRT were to expand access to Level 3 PCMHs to all Medicaid patients.
New York identified several steps that needed to be taken (and the state has been working on)
to achieve this goal, including the provision of financial incentives and technical assistance to
provider practices to support PCMH adoption and recognition; the recruitment and retention of
primary care providers; and the expansion of physical infrastructure.146 Greater emphasize on
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adopting PCMHs was placed on providers by DSRIP program requirements, and by community
stakeholders relying on structures for coordinated care.
Health homes, under the Affordable Care Act, are similar to PCMHs, but specifically focus on
Medicaid members with chronic medical and behavioral conditions, and emphasize diverse
stakeholder integration and care management. The MRT objective was to embrace the federal
Health Home program, building on PCMHs and PCMH-like demonstration projects, and
substantial statewide health information technology investments, in order to effectively
manage the overall health of high need and the most vulnerable populations. Through this
focus on a person’s overall health, community-based organizations (CBOs) became a key
stakeholder both leading and participating in Health Homes supporting a populations’ medical
and social wellness. New York’s DSRIP program has continued the work of Health Homes by
seeding and supporting critical community infrastructure led by CBOs. Without these
community supports it is challenging to improve health outcomes.

6.3. Reducing Costs
New York is targeting initiatives to make its Medicaid program sustainable. The MRT focused on
measures like the global spending cap, capitation, and Accountable Care Organizations (ACOs)
and Advanced Health Homes to control Medicaid spending. Many of these measures are in the
early stages of provider acceptance. The global spending cap requires that any new program
expenditure be analyzed in terms of its ability to optimize value by improving quality and
lowering the total cost of care. Medicaid spending in New York has remained within the global
cap since the cap’s initiation, while Medicaid coverage has expanded.
Another aspect of New York’s cost reduction strategy is payment reform and transitioning away
from Medicaid fee-for-service (FFS) to value based payment. Medicare ACOs are looked to for a
shared savings model for Medicaid providers. Effective coordination between Medicaid,
Medicare and other large payers is key to designing a financial risk model that is accepted by
providers with the goal of aligning financial incentives and reducing adoption barriers. The
existing PCMH and Advanced Primary Care incentive is an important foundational start that
should evolve into a greater emphasis on performance data, ultimately supporting increased
provider risk, and greater patient empowerment and responsibility. Claims data sharing by
Medicaid to PPS (and from PPS to providers), as part of DSRIP, begins to create the financial
awareness necessary to manage the total cost of care. Payment that aligns with care
management service delivery provides for the time and focus needed to improve health
outcomes. Initiatives under New York’s DSRIP program are positioning and preparing
community health service and medical providers to structurally organize their care teams and
optimize health outcomes under accountable and global payment models.
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Appendix 1. Projects Selected by Each Performing Provider
System
Exhibit A1.1. List of projects by Performing Provider System
PPS and Number of
Projects

Adirondack Health
Institute
(11 projects)

Alliance for Better
Health Care
(11 projects)

Projects Selected
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management
2. 2.a.ii Increase certification of primary care practitioners with
PCMH certification and/or Advanced Primary Care Models
3. 2.a.iv Create a medical village using existing hospital
infrastructure
4. 2.b.viii Hospital-Home Care Collaboration Solutions
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.ii Behavioral health community crisis stabilization services
3. 3.a.iv Development of Withdrawal Management (e.g.,
ambulatory detoxification, ancillary withdrawal services) and
abstinence services
4. 3.g.i Integration of palliative care into the PCMH Model
Domain 4
1. 4.a.iii Strengthen Mental Health and Substance Use
Infrastructure across Systems
2. 4.b.ii Increase Access to High Quality Chronic Disease
Preventive Care and Management in Both Clinical and
Community Settings
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management
2. 2.b.iii ED care triage for at-risk populations
3. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
4. 2.b.viii Hospital-Home Care Collaboration Solutions
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
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PPS and Number of
Projects

Better Health for
Northeast New York
(11 projects)

Bronx Health Access
(10 projects)

Projects Selected
2. 3.a.iv Development of Withdrawal Management (e.g.,
ambulatory detoxification, ancillary withdrawal services) and
abstinence services
3. 3.d.ii Expansion of asthma home-based self-management
program
4. 3.g.i Integration of palliative care into the PCMH Model
Domain 4:
1. 4.a.iii Strengthen Mental Health and Substance Use
Infrastructure across Systems
2. 4.b.i Promote tobacco use cessation, especially among low SES
populations and those with poor mental health
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management
2. 2.a.iii Health Home At-Risk Intervention Program: Proactive
management of higher risk patients not currently eligible for
Health Homes
3. 2.a.v. Create a medical village/alternative housing using
existing nursing home infrastructure
4. 2.b.iii ED care triage for at-risk populations
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.ii Behavioral health community crisis stabilization services
3. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.d.iii Implementation of evidence-based medicine guidelines
for asthma management
Domain 4:
1. 4.b.i Promote tobacco use cessation, especially among low SES
populations and those with poor mental health
2. 4.b.ii Increase Access to High Quality Chronic Disease
Preventive Care and Management in Both Clinical and
Community Settings
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management
2. 2.a.iii Health Home At-Risk Intervention Program: Proactive
management of higher risk patients not currently eligible for
Health Homes
3. 2.b.i. Ambulatory intensive care units (ICUs)
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PPS and Number of
Projects

Bronx Partners for
Healthy
Communities
(10 projects)

Care Compass
Network
(11 projects)

Projects Selected
4. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.c.i Evidence-based strategies for disease management in
high risk/affected populations
3. 3.d.ii Expansion of asthma home-based self-management
program
4. 3.f.i. Increase support for maternal & child health (including
high risk pregnancies)
Domain 4:
1. 4.a.iii. Strengthen mental health and substance abuse
infrastructure across systems
2. 4.c.ii Increase early access to, and retention in, HIV care
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management
2. 2.a.iii Health Home At-Risk Intervention Program: Proactive
management of higher risk patients not currently eligible for
Health Homes
3. 2.b.iii ED care triage for at-risk populations
4. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.b.i. Evidence-based strategies for disease management in
high risk/affected populations (adult only)
3. 3.c.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.d.ii Expansion of asthma home-based self-management
program
Domain 4:
1. 4.a.iii Strengthen Mental Health and Substance Use
Infrastructure across Systems
2. 4.c.ii. Increase early access to, and retention in, HIV care
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management
2. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
3. 2.b.vii Implementing the INTERACT project (inpatient transfer
avoidance program for SNF)
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PPS and Number of
Projects

Central New York
Care Collaborative
(11 projects)

Community Care of
Brooklyn

Projects Selected
4. 2.c.i Development of community-based health navigation
services
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.ii Behavioral health community crisis stabilization services
3. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.g.i Integration of palliative care into the PCMH Model
Domain 4:
1. 4.a.iii Strengthen Mental Health and Substance Use
Infrastructure across Systems
2. 4.b.ii. Increase access to high quality chronic disease
prevention care and management in both clinical and
community settings
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management
2. 2.a.iii Health Home At-Risk Intervention Program: Proactive
management of higher risk patients not currently eligible for
Health Homes
3. 2.b.iii ED care triage for at-risk populations
4. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.ii Behavioral health community crisis stabilization services
3. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.g.i Integration of palliative care into the PCMH Model
Domain 4:
1. 4.a.iii Strengthen Mental Health and Substance Use
Infrastructure across Systems
2. 4.d.i Reduce premature births
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management

(10 projects)
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PPS and Number of
Projects

Community Partners
of Western New
York
(10 projects)

Finger Lakes PPS
(11 projects)

Projects Selected
2. 2.a.iii Health Home At-Risk Intervention Program: Proactive
management of higher risk patients not currently eligible for
Health Homes
3. 2.b.iii ED care triage for at-risk populations
4. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
3. 3.d.ii Expansion of asthma home-based self-management
program
4. 3.g.i Integration of palliative care into the PCMH Model
Domain 4:
1. 4.a.iii Strengthen Mental Health and Substance Use
Infrastructure across Systems
2. 4.c.ii. Increase early access to, and retention in, HIV care
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management
2. 2.b.iii ED care triage for at-risk populations
3. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
4. 2.c.ii Expand usage of telemedicine in underserved areas to
provide access to otherwise scarce services
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
3. 3.f.i Increase support programs for maternal & child health
(including high risk pregnancies)
4. 3.g.i Integration of palliative care into the PCMH Model
Domain 4:
1. 4.a.i Promote mental, emotional and behavioral (MEB) wellbeing in communities
2. 4.b.i Promote tobacco use cessation, especially among low SES
populations and those with poor mental health
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management
2. 2.b.iii ED care triage for at-risk populations
3. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
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PPS and Number of
Projects

Leatherstocking
Collaborative Health
Partners
(11 projects)

Projects Selected
4. 2.b.vi Transitional supportive housing services
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.ii Behavioral health community crisis stabilization services
3. 3.a.v Behavioral Interventions Paradigm (BIP) in Nursing
Homes
4. 3.f.i Increase support programs for maternal & child health
(including high risk pregnancies)
Domain 4:
1. 4.a.iii Strengthen Mental Health and Substance Use
Infrastructure across Systems
2. 4.b.ii. Increase access to high quality chronic disease
prevention care and management in both clinical and
community settings
Domain 2:
1. 2.a.ii Increase certification of primary care practitioners with
PCMH certification and/or Advanced Primary Care Models
2. 2.b.vii Implementing the INTERACT project (inpatient transfer
avoidance program for SNF)
3. 2.b.viii Hospital-Home Care Collaboration Solutions
4. 2.c.i Development of community-based health navigation
services
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.iv Development of Withdrawal Management (e.g.,
ambulatory detoxification, ancillary withdrawal services) and
abstinence services
3. 3.d.iii Implementation of evidence-based medicine guidelines
for asthma management
4. 3.g.i Integration of palliative care into the PCMH Model
Domain 4:
1. 4.a.iii Strengthen Mental Health and Substance Use
Infrastructure across Systems
2. 4.b.i Promote tobacco use cessation, especially among low SES
populations and those with poor mental health
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PPS and Number of
Projects

Millennium
Collaborative Care
(11 projects)

Montefiore Hudson
Valley Collaborative
(10 projects)

Projects Selected
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management
2. 2.b.iii ED care triage for at-risk populations
3. 2.b.vii Implementing the INTERACT project (inpatient transfer
avoidance program for SNF)
4. 2.b.viii Hospital-Home Care Collaboration Solutions
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.ii Behavioral health community crisis stabilization services
3. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.f.i Increase support programs for maternal & child health
(including high risk pregnancies)
Domain 4:
1. 4.a.i Promote mental, emotional and behavioral (MEB) wellbeing in communities
2. 4.d.i Reduce premature births
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine/ Population Health Management
2. 2.a.iii Health Home At-Risk Intervention Program: Proactive
management of higher risk patients not currently eligible for
Health Homes
3. 2.a.iv Create a medical village using existing hospital
infrastructure
4. 2.b.iii ED care triage for at-risk populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.ii Behavioral health community crisis stabilization services
3. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.d.iii Implementation of evidence-based medicine guidelines
for asthma management
Domain 4:
1. 4.b.i Promote tobacco use cessation, especially among low SES
populations and those with poor mental health
2. 4.b.ii. Increase access to high quality chronic disease
prevention care and management in both clinical and
community settings
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PPS and Number of
Projects

Mount Sinai PPS
(10 projects)

Nassau Queens PPS
(11 projects)

Projects Selected
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine/ Population Health Management
2. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
3. 2.b.viii Hospital-Home Care Collaboration Solutions
4. 2.c.i Development of community-based health navigation
services
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.iii Implementation of evidence-based medication
adherence programs in community-based sites for behavioral
health medication compliance
3. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.c.i Evidence-based strategies for disease management in
high risk/affected populations
Domain 4:
1. 4.b.ii Increase access to high quality chronic disease
preventive care and management in both clinical and
community settings
2. 4.c.ii Increase early access to, and retention in, HIV care
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine/ Population Health Management
2. 2.b.ii Development of co-located primary care services in the
emergency department (ED)
3. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
4. 2.b.vii Implementing the INTERACT project (inpatient transfer
avoidance program for SNF)
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.ii Behavioral health community crisis stabilization services
3. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.c.i Evidence-based strategies for disease management in
high risk/affected populations
Domain 4:
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PPS and Number of
Projects

New YorkPresbyterian PPS
(10 projects)

New YorkPresbyterian Queens
PPS
(9 projects)

North Country
Initiative

Projects Selected
1. 4.a.iii. Strengthen mental health and substance abuse
infrastructure across systems
2. 4.b.i Promote tobacco use cessation, especially among low SES
populations and those with poor mental health
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine/ Population Health Management
2. 2.b.i Ambulatory Intensive Care Units (ICUs)
3. 2.b.iii ED care triage for at-risk populations
4. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.ii Behavioral health community crisis stabilization services
3. 3.e.i Comprehensive Strategy to decrease HIV/AIDS
transmission to reduce avoidable hospitalizations –
development of a Center of Excellence
4. 3.g.i Integration of palliative care into the PCMH Model
Domain 4:
1. 4.b.i. Promote tobacco use cessation, especially among low
SES populations and those with poor mental health
4.c.i. Decrease HIV morbidity
Domain 2:
1. 2.a.ii Increase certification of primary care practitioners with
PCMH certification and/or Advanced Primary Care Models
2. 2.b.v Care transitions intervention for skilled nursing facility
(SNF) residents
3. 2.b.vii Implementing the INTERACT project (inpatient transfer
avoidance program for SNF)
4. 2.b.viii Hospital-home care collaborative solutions
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
3. 3.d.ii. Expansion of asthma home-based self-management
program
4. 3.g.ii Integration of palliative care into nursing homes
Domain 4:
1. 4.c.ii Increase early access to, and retention in, HIV care
Domain 2:
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PPS and Number of
Projects
(11 projects)

NYU Langone
Brooklyn
(9 projects)

Projects Selected
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine/ Population Health Management
2. 2.a.ii Increase certification of primary care practitioners with
PCMH certification and/or Advanced Primary Care Models
3. 2.a.iv Create a medical village using existing hospital
infrastructure
4. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
3. 3.c.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.c.ii Implementation of evidence-based strategies to address
chronic disease – primary and secondary prevention projects
Domain 4:
1. 4.a.iii Strengthen Mental Health and Substance Use
Infrastructure across Systems
2. 4.b.ii Increase Access to High Quality Chronic Disease
Preventive Care and Management in Both Clinical and
Community Settings
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine/ Population Health Management
2. 2.b.iii ED care triage for at-risk populations
3. 2.b.ix Implementation of observational programs in hospitals
4. 2.c.i Development of community-based health navigation
services
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.c.i Evidence-based strategies for disease management in
high risk/affected populations
3. 3.d.ii Expansion of asthma home-based self-management
program
Domain 4:
1. 4.b.i. Promote tobacco use cessation, especially among low
SES populations and those with poor mental health
2. 4.c.ii Increase early access to, and retention in, HIV care
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PPS and Number of
Projects

OneCity Health
(11 projects)

Refuah Community
Health Collaborative
(7 projects)

SOMOS
(10 projects)

Projects Selected
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine/ Population Health Management
2. 2.a.iii Health Home At-Risk Intervention Program: Proactive
management of higher risk patients not currently eligible for
Health Homes
3. 2.b.iii ED care triage for at-risk populations
4. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
3. 3.d.ii Expansion of asthma home-based self-management
program
4. 3.g.i Integration of palliative care into the PCMH Model
Domain 4:
1. 4.a.iii Strengthen Mental Health and Substance Use
Infrastructure across Systems
2. 4.c.ii Increase early access to, and retention in, HIV care
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine/ Population Health Management
2. 2.a.ii Increase certification of primary care practitioners with
PCMH certification and/or Advanced Primary Care Models
3. 2.c.i Development of community-based health navigation
services
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.ii Behavioral health community crisis stabilization services
3. 3.a.iii Implementation of evidence-based medication
adherence programs in community-based sites for behavioral
health medication compliance
Domain 4:
1. 4.b.i Promote tobacco use cessation, especially among low SES
populations and those with poor mental health
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine / Population Health Management
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PPS and Number of
Projects

Staten Island PPS
(11 projects)

Projects Selected
2. 2.a.iii Health Home At-Risk Intervention Program: Proactive
management of higher risk patients not currently eligible for
Health Homes
3. 2.b.iii ED care triage for at-risk populations
4. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
3. 3.c.i. Evidence-based strategies for disease management in
high risk/affected populations (adults only)
4. 3.d.iii Implementation of evidence-based medicine guidelines
for asthma management
Domain 4:
1. 4.b.i Promote tobacco use cessation, especially among low SES
populations and those with poor mental health
2. 4.b.ii Increase Access to High Quality Chronic Disease
Preventive Care and Management in Both Clinical and
Community Settings
Domain 2:
1. 2.a.iii Health Home At-Risk Intervention Program: Proactive
management of higher risk patients not currently eligible for
Health Homes
2. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
3. 2.b.vii Implementing the INTERACT project (inpatient transfer
avoidance program for SNF)
4. 2.b.viii Hospital-based care collaborative solutions
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.iv Development of Withdrawal Management (e.g.,
ambulatory detoxification, ancillary withdrawal services) and
abstinence services
3. 3.c.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.g.ii Integration of palliative care into nursing homes
Domain 4:
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PPS and Number of
Projects

Suffolk Care
Collaborative
(11 projects)

WMCHealth
(11 projects)

Projects Selected
1. 4.a.iii Strengthen Mental Health and Substance Use
Infrastructure across Systems
2. 4.b.ii Increase Access to High Quality Chronic Disease
Preventive Care and Management in Both Clinical and
Community Settings
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine/ Population Health Management
2. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
3. 2.b.vii Implementing the INTERACT project (inpatient transfer
avoidance program for SNF)
4. 2.b.ix Implementation of observational programs in hospitals
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.b.i Evidence-based strategies for disease management in
high risk/affected populations
3. 3.c.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.d.ii Expansion of asthma home-based self-management
program
Domain 4:
1. 4.a.ii Prevent Substance Use and other Mental Emotional
Behavioral Disorders
2. 4.b.ii Increase Access to High Quality Chronic Disease
Preventive Care and Management in Both Clinical and
Community Settings
Domain 2:
1. 2.a.i Create Integrated Delivery Systems that are focused on
Evidence-Based Medicine/ Population Health Management
2. 2.a.iii Health Home At-Risk Intervention Program: Proactive
management of higher risk patients not currently eligible for
Health Homes
3. 2.a.iv Create a medical village using existing hospital
infrastructure
4. 2.b.iv Care transitions intervention model to reduce 30 day
readmissions for chronic health conditions
5. 2.d.i Implementation of Patient Activation Activities to
Engage, Educate and Integrate the uninsured and low/nonutilizing populations
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PPS and Number of
Projects

Projects Selected
Domain 3:
1. 3.a.i Integration of primary care and behavioral health services
2. 3.a.ii Behavioral health community crisis stabilization services
3. 3.c.i Evidence-based strategies for disease management in
high risk/affected populations
4. 3.d.iii Implementation of evidence-based medicine guidelines
for asthma management
Domain 4:
1. 4.b.i Promote tobacco use cessation, especially among low SES
populations and those with poor mental health
2. 4.b.ii. Increase access to high quality chronic disease
preventive care and management in both clinical and
community settings

Source: Authors’ compilation of NYS DOH documents. 147
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New York State Department of Health. (n.d.). DSRIP Performing Provider Systems (PPS) [interactive webpage].
Retrieved October 18, 2018 from
https://www.health.ny.gov/health_care/medicaid/redesign/dsrip/pps_map/index.htm
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Appendix 2. Algorithm to Attribute Members for Valuation and
Performance148
New York’s Delivery System Reform Incentive Payment (DSRIP) program attributes Medicaid
members and uninsured populations to the 25 Performing Provider Systems (PPS) based upon
geography, actual use of services, and enrollee-specific needs (developmental disability, longterm care, behavioral health, and “other”). Each Medicaid member is attributed to one, and
only one PPS, with a separate attribution for the initial valuation and thereafter the
performance periods. This attribution process is instrumental in calculating total project
valuation, ongoing payments, and some DSRIP measures (e.g., emergency department use,
readmissions, and other measures in each domain).
Attribution for Valuation
The attribution for valuation was based on membership on December 1, 2014; it represents the
maximum funding that a PPS could receive over its DSRIP duration. This fixed amount does not
change even if the PPS drop or add partners over time.
If there is a single PPS in a region, the attribution for valuation logic is fairly straight-forward. All
Medicaid enrollees in the region are attributed to the single PPS via the PPS partners in that
area, regardless of their actual use of Medicaid services or projects selected (i.e., low utilizing
and non-utilizing Medicaid members are attributed to the single PPS in the region). The
uninsured population in the region are attributed to the single PPS if the PPS added the “11th
project” (project 2.d.i, patient activation activities). For regions with single PPS providers, the
hierarchical attribution logic is not applicable.
In regions with more than one PPS, the attribution for utilizing Medicaid members149 is based
upon the attribution logic summarized in Exhibit A.2.1. The attribution logic for utilizing
Medicaid members is based upon two principles: hierarchy of health care needs (“swim lanes”),
and hierarchy of the health care settings/PPS partners where patients receive most of their
services (“loyalty”).
The first step is looking at the plurality of the care. If utilizing Medicaid members received more
than 50% of their qualifying services within a non-PPS participating service, they were removed.
The second step is hierarchical population selection, whereby Medicaid members are placed
into one of four swim lanes. On the diagram, these are represented by the arrows in the top
row moving from left to right. Developmental disability is the highest priority on the hierarchy,
followed by long-term care and behavioral health. Beneficiaries not assigned to these groups
are defined in a residual “all others” swim lane.
148

Appendix 2 is adapted from New York DSRIP program STC, Attachment I retrieved from
https://www.health.ny.gov/health_care/managed_care/appextension/2017-07-20_rev_att1.htm
149
Utilizing Medicaid members are defined as those having more than three interactions with the health care
system in the past year, and connectivity with a primary care physician or health home.
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In the third step, a hierarchical member service loyalty logic is used to attribute individuals to a
specific PPS. The loyalty logic is illustrated in Exhibit A2.1 by a movement from the top row
downwards. Each swim lane considers different health care settings for the loyalty attribution.
For Medicaid members with developmental disabilities, PPS attribution is first assigned based
on the where they receive their residential services. If those services are not used, PPS
attribution is subsequently assigned by their use of care management services, followed by
Article 16 clinics, and finally other waiver services from the Office of Persons with
Developmental Disabilities. For individuals assigned to the “all other” swim lane (i.e., they are
not identified as a member of the developmental disability, long-term care, or behavioral
health patient populations), the loyalty logic first considers the PPS in the region that contains
their health home. If they are not using health homes, their assigned primary care providers are
subsequently used to attribute them to a PPS. Subsequent considerations in the loyalty
hierarchy are other primary care providers or outpatient clinics, emergency departments, or
hospitals where they received the majority of their inpatient services.
For the purposes of attribution for valuation, low- and non-utilizing Medicaid members (defined
as having three or fewer interactions with the health care system in the past year, and no
connectivity with a primary care physician or health home) are attributed similarly to the
uninsured population. Attribution of the uninsured and low- utilizing and non-utilizing Medicaid
members is dependent on the types of PPS in the region and selection of the “11th project”
(project 2.d.i, patient activation activities). In regions with more than one PPS, including a PPS
that is led by or involves a public hospital (public hospital PPS) approved to do the 11th project,
the uninsured and low-utilizing and non-utilizing members in the region are attributed to the
public hospital PPS. As described in Section 2.2.4, non-public hospital PPS were allowed to
pursue the 11th project in certain circumstances. In regions where there are multiple PPS,
including non-public hospital PPS with approval for the 11th project, the uninsured and lowutilizing and non-utilizing Medicaid members are attributed based on the percentage of
Medicaid members assigned to PPS in the region (e.g., if a non-public hospital PPS has 60% of
the region’s Medicaid members they will get 60% of the uninsured and low-utilizing and nonutilizing members).
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Exhibit A2.1. Hierarchical Attribution Logic
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Although the method for attributing Medicaid members for performance is similar to
attribution for valuation, there are some differences. Attribution for performance does not
include a low-utilizing member category. For the purposes of performance, all utilizing
Medicaid members, including low-utilizing members, are attributed based on the hierarchical
logic presented in Exhibit A2.1 and described above in the attribution for valuation section.
Non-utilizing Medicaid members are captured separately. Non-utilizing Medicaid members with
a plan-assigned primary care provider (PCP) in a PPS network are included in the attribution
counts for that PCP’s PPS. If a non-utilizing Medicaid member is not assigned a PCP or a PCP tie
exists, the member is attributed to the PPS with the largest presence in the member’s zip code.
The uninsured are attributed to PPS for performance using the same methodology as
attribution for valuation.
Attribution for performance is determined monthly through the matching of the available
Medicaid utilization data stemming from claims and encounter reporting to the providers in a
PPS network. The member who was in PPS A who increases their utilization of a particular
provider in PPS network B, may shift over into PPS B’s attributed population for performance,
subject to the hierarchical loyalty algorithm. The final performance measurement is based on
the attributed population for performance of the final month of the measurement year.
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Appendix 3. Additional Details on Research Questions and
Hypotheses
The research questions (RQs) and hypotheses used in the Interim Report were edited and
reordered from the original text in the CMS-approved Independent Evaluation plan (section B,
pp. 5-9) for improved flow and presentation. These editorial changes were discussed with and
approved by NYS DOH.
Exhibit A3.1 provides a crosswalk of the RQs listed in the CMS-approved Independent
Evaluation plan and Interim Report. Key changes were:
• Reordering to match the presentation of findings in Section 4; the RQs in the Interim
Report were relabeled as A through G to avoid confusion with the numbering of the
CMS RQs
• Sub-questions from the expanded CMS-approved Independent Evaluation plan were
added to RQ-C and RQ-G
• Stylistic edits for consistency throughout the Interim Report
Exhibit A3.1. Crosswalk of CMS research questions from the approved expanded evaluation plan
Interim Report Research Questions
RQ-A. What were the successes and
challenges with respect to PPS planning,
implementation, operation, and plans for
program sustainability from the perspective
of DSRIP program planners, administrators,
and providers; and why were they successful
or challenging?
RQ-B. Did health care quality improve as a
result of clinical improvements in the
treatment of selected diseases and
conditions?
RQ-C. Did population health improve as a
result of implementation of New York’s
DSRIP initiative? (Sub-question: Were racial
and ethnic disparities on specific population
measures reduced following the DSRIP
program?)
RQ-D. Did utilization of behavioral health
care services increase as a result of the DSRIP
program?
RQ-E. Was avoidable hospital utilization
reduced as a result of the DSRIP program?
RQ-F. To what extent did PPS achieve health
care system transformation, including

CMS Research Questions
RQ7. What were the successes and
challenges with respect to PPS planning,
implementation, operation and plans for
program sustainability from the perspectives
of DSRIP planners, administrators and
providers, and why were they successful and
challenging?
RQ2. Did health care quality improve as a
result of clinical improvements in the
treatment of selected diseases and
conditions?
RQ3. Did population health improve as a
result of implementation of the DSRIP
initiative?

RQ4. Did utilization of behavioral health care
services increase as a result of DSRIP?
RQ5. Was avoidable hospital use reduced as
a result of DSRIP?
RQ1. To what extent did PPSs achieve health
care system transformation?
259

Interim Report Research Questions
increasing the availability of behavioral
health care?
RQ-G. Did the DSRIP program reduce health
care costs? (Sub-question: Was the DSRIP
program cost effective in terms of New York
and federal governments receiving adequate
value for their investments?)

CMS Research Questions

RQ6. Did DSRIP reduce health care costs?

Exhibit A3.2 provides a crosswalk of the hypotheses listed in the CMS-approved Independent
Evaluation plan and Interim Report. Key changes were:
• Reordering to be consistent with their corresponding RQs (see Section 3.1 for the
description of the RQs and hypotheses)
• Additional hypothesis related to supplemental sub-question RQ-C
• Stylistic edits for consistent wording and language
• Adjusted the terminology from “expenditure” to “costs,” to reflect the data available for
analysis; for example, capitation payments to plans – one component of expenditures –
were not examined
• Consistent language to clarify that all increases or decreases are in relation to the
baseline trend; this is clarified in more detail in the main text (see Section 3.1)
• Two-part hypotheses (CMS H5 and CMS H7) were split into separate hypotheses
• The two CMS hypotheses related to expenditures and costs for emergency department
and inpatient services (CMS H6, CMS H11) were reorganized into one hypothesis related
to emergency department costs (H11) and one hypothesis related to inpatient services
costs (H12)
Exhibit A3.2. Crosswalk of CMS hypotheses from the approved expanded evaluation plan
Interim Report Hypotheses
H1. Health care quality will increase in the
following areas: (a) behavioral health, (b)
cardiovascular health, (c) diabetes care, (d)
asthma, (e) HIV/AIDS, (f) perinatal care, (g)
palliative care, and (h) renal care.

H2a. Population health measures will
improve in the following areas: (a) mental
health and substance abuse, (b) prevention
of chronic diseases, (c) prevention of HIV and
STDs, and (d) health of women, infants, and
children.

CMS Hypotheses
CMS H8: Through clinical improvements
implemented under DSRIP, health care
quality in each of the following areas will
increase: a) behavioral health, b)
cardiovascular health, c) diabetes care, d)
asthma, e) HIV/AIDS, f) perinatal care, g)
palliative care, h) renal care
CMS H9: Population health measures will
show improvements in the following 4 areas:
a) mental health and substance abuse, b)
prevention of chronic diseases, c) prevention
of HIV and STDs, d) health of women, infants,
and children
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Interim Report Hypotheses
H2b. Racial and ethnic disparities in
premature deaths, newly diagnosed cases of
HIV, preterm births, adolescent pregnancy
rates, percentage of unintended pregnancy
among live births, and infants exclusively
breastfed in the hospital will decrease.
H3. Behavioral health care service utilization
will increase.
H4. Primary care utilization will increase.
H5. Avoidable hospital utilizations will
decrease.
H6. Health care service delivery integration
will increase.
H7. Health care coordination will increase.
H8a. Primary care, behavioral health, and
dental service utilization among the
uninsured, non-utilizing, and low-utilizing
populations will increase.
H8b. Emergency department utilization
among the uninsured, non-utilizing, and lowutilizing populations will decrease.

H9. Costs for primary care services will
increase.
H10. Costs for behavioral health care services
will increase.
H11. Costs for emergency department
services will decrease.

H12. Costs for hospital inpatient services will
decrease.

H13. Total cost of care will decrease.

CMS Hypotheses
None listed; related to the RQ-C sub-question
that was added in the expanded Evaluation
Plan

CMS H5: Utilization of, and expenditures for,
behavioral health care service will increase
CMS H3: Primary care utilization will show a
greater upward trend
CMS H10. Avoidable hospital use will be
reduced
CMS H1. Health care service delivery will
show greater integration
CMS H2. Health care coordination will
improve
CMS H7. Primary care, behavioral health, and
dental service utilization will increase among
the uninsured, non-utilizing, and low-utilizing
populations, while emergency department
use will decrease
CMS H7. Primary care, behavioral health, and
dental service utilization will increase among
the uninsured, non-utilizing, and low-utilizing
populations, while emergency department
use will decrease
CMS H4. Expenditures for primary care
services will increase
CMS H5. Utilization of, and expenditures for,
behavioral health care service will increase
CMS H6: Expenditures for emergency
department and inpatient services will
decrease; CMS H11: Costs associated with
hospital inpatient and ED services will show
reductions or slowed growth
CMS H6: Expenditures for emergency
department and inpatient services will
decrease; CMS H11: Costs associated with
hospital inpatient and ED services will show
reductions or slowed growth
CMS H12. Total cost of care will show
reductions or slowed growth
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Appendix 4: Key Informant Interview Guides
Appendix 4 includes the guides used for the key informant interviews in 2017 and 2018. Key
informant interviews were conducted by telephone and lasted between 60 and 90 minutes.
PPS Executive Team Key Informant Interview Guide 2017
Introductory Script (to be read to all informants prior to the interview):
Thank you for taking the time to speak with me today. My name is ______, and I am a member
of the NY DSRIP Independent Evaluation team. As you know from the email and the webinar
materials, I have been asked to interview PPS administrators to discuss the history of the PPS
formation as well as the successes, and challenges with the initiative.
We know your PPS has extensive reporting requirements to DOH. To that end, from publicly
facing sources like your website, the PPS applications, and Independent Assessor posted
quarterly reports we have collected a summary of your existing projects and would like to just
quickly go over them so you can confirm the information we have is accurate and up-to-date.
[Insert detailed PPS projects summary and other relevant information (geographic areas
serving, major changes to projects, other known issues)].
Before I pose any questions, I want to go over a few guidelines that will help us complete the
discussion:
● Please keep in mind that that there are no right or wrong answers. We are seeking your
candid feedback on the initiative so far.
● Because we are on the phone, please state your name before you answer a question for
the first time. This may feel awkward, but it will be easier as we proceed.
● I am having our discussion recorded. As a backup to the tape, I am having a research
assistant, Melissa, listen in with me and take notes.
Now let’s begin with introductions so I know who is here. Can all of you provide your names
and your titles with a short description of what you do at the PPS?
Have I missed anything about your PPS that I should know before we get started?
Great, now I will go through the questions we have prepared.
1. How was your PPS initially formed? (If knowledgeable about PPS development)
a. Probe: Who were the key champions (people, organizations) of the PPS in the
early stages of formation?
b. Probe: Who developed or contributed to the DSRIP application process (e.g., staff,
consultants, community partners)?
c. Probe: What worked well about the formation?
d. Probe: What about project selection?
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OR
1. How did you get involved with DSRIP teams or projects? (If not knowledgeable about
PPS development)
a. Probe: Please tell us about your involvement in any board, clinical, project
workgroups, regional community partner committees, etc.
b. Probe: Who are the champions and key members/member organizations of these
committees?
2. What are some of the biggest challenges your PPS experienced during the early phases
(e.g., years 0-2) of project implementation?
a. Probe: Specific project workflows, engagement with community partners,
communication approaches, staff buy-in, etc.
b. Probe: Did project(s) start dates get delayed or hit major road blocks along the
way? If so, please describe them.
c. Probe: Are projects not meeting speed and scale targets? If not, why?
d. Probe: In your view, which projects require more resources to operate?
i. Why do you think it’s these projects in particular?
e. Probe: What type of resources are the projects lacking?
i. e.g., Staffing, Leadership, Community Networks, IT, Physical
Infrastructure, Clinical Knowledge, Patient-related needs
3. What are some of the biggest successes that you have experienced during the early
phases (e.g., years 0-2) of project implementation?
a. Probe: Community needs assessment and the application process?
b. Probe: Specific project workflows, engagement with community partners,
communication approaches, etc.
c. Probe: Project innovations? If yes, please describe them.
d. Probe: Projects are meeting or exceeding speed and scale targets? If so, why?

4. Please tell us about PPS committees that are related to its governance and about the
effectiveness of your PPS’ committees in meetings its goals and objectives.
a. Probe: Have you restructured your committees since formation? From project
workgroup to performance focused workflow?
b. How are these committees used to communicate important information about
the PPS or projects?
c. Probe: Who are the champions and key members/member organizations of these
committees?
d. Probe: What has been challenging with regards to the committees?
e. Probe: What is the relationship between the PPS and external committees, such
as associated hospitals?
5. What data are being collected by your PPS and/or NYS DOH that you believe to be the
most important to understanding overall DSRIP program success?
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a. Probe: What are the least important aspects of data collection?
b. Probe: How is performance communicated to PPS staff? Community providers?
c. Probe: What about reporting: Partner to PPS reporting, PPS to state reporting?
6. From your perspective, how valuable is the account support provided by NYS and its
consultants? How valuable is the project implementation support?
a. Probe: What are the most effective types of TA provided to your PPS?
b. Probe: What are the least effective types of TA provided to your PPS?
c. Probe: Who is included in regional and/or statewide DSRIP meetings from your
PPS?
7. In your view, has DSRIP changed the health care system??
a. Probe: If yes, for whom? How?
b. Probe: If no, why do you think it has remained the same?
8. Is there anything you would like to comment on regarding DSRIP in general?
a. Probe: What would you ask another PPS if you could?
b. Probe: Suggestions for improvement
c. Probe: Anything we have not touched on in this interview
Should you have any questions about this interview or evaluation, please feel free to contact
Diane Dewar, Principal Investigator for this study at ddewar@albany.edu.

Project Leader Key Informant Guide 2018
Introductory Script (to be read to all informants prior to the interview):
Thank you for taking the time to speak with me today. My name is _______, and I am a
member of the NYS DSRIP Independent Evaluation team at the University at Albany. I am here
with my colleague(s) _______ who will be assisting me today. As you know from the emails and
FAQ sheet, we have been asked to interview PPS project leaders to discuss the planning,
implementation and operations of DSRIP projects as well as the successes and challenges with
the initiative.
Thank you to those of you who completed the pre-survey we sent out. Your responses were
very helpful in getting to know you all a little bit better and providing us with project-specific
information for [insert PPS name]. Today’s interview is going to build off of the questions that
were asked in the survey.
Before I pose any questions, I want to go over a few guidelines that will help us complete our
discussion:
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•

•

•
•
•

Our interview consists of a series of open-ended questions that are very broad in
nature, and this is intentional to elicit a wider response. Please free to answer these
questions based on your knowledge, feelings, understanding and experience.
Please keep in mind that that there are no right or wrong answers. We understand that
each of you may have different perspectives. We are seeking your candid feedback on
the initiative so far. What we learn from this interview will be included in reports
submitted to NYS DOH and your responses will be de-identified.
Because we are on the phone, please state your name before you answer a question for
the first time. This will help us accurately record your responses.
We are having our discussion recorded and as a backup to the tape, ______, is taking
notes.
We’ve built in some time (through our last question) to capture any of your final
thoughts or anything we may have missed, so feel free to share at that time.

Now let’s begin with introductions so we know who is here. Can all of you provide your names
and your titles with a short description of what you do at the PPS?
Great, now I will go through the questions we have prepared.
1. What are some of the biggest challenges your PPS experienced (during years 0-present)
of project implementation?
a. Probe: Specific project workflows, engagement with community partners,
communication approaches, funding and contracting challenges, staff buy-in, etc.
b. Probe: Did project(s) start dates get delayed or hit major road blocks along the
way? If so, please describe them.
c. Probe: Are projects meeting speed and scale targets? If not, why?
i. Did attribution shifts affect this?
d. Probe: In your view, which projects require more resources to operate?
i. Why do you think it’s these projects in particular?
e. Probe: What type of resources were the projects lacking?
i. e.g., Staffing, Leadership, Community Networks, IT, Physical
Infrastructure, Clinical Knowledge, Patient-related needs
f. Probe: Overlap with other PPS entities in your counties
2. What are some of the biggest successes that you experienced during project
implementation?
a. Probe: Specific project workflows, engagement with community partners,
communication approaches, etc.
b. Probe: Project innovations? If yes, please describe them.
c. Probe: Projects are meeting or exceeding speed and scale targets? If so, why?
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3. What data are being collected by your PPS and/or NYS DOH that you believe to be the
most important to understanding overall DSRIP project success?
a. Probe: What data do you wish you had access to?
b. Probe: How is performance communicated to PPS staff? Community providers?
c. Probe: What about reporting: Partner to PPS reporting, PPS to state reporting?
4. From your perspective, how valuable is the support provided by NYS DOH and its
consultants (i.e. KPMG, PCG- IA, ASTs)?
a. Probe: How valuable is the project implementation support?
i. Specific symposiums/meetings? MAX series? PPS meetings?
b. Probe: What are the most effective types of TA provided to your PPS?
c. Probe: What are the least effective types of TA provided to your PPS?
5. What have you done to prepare for the shift to value-based payment?
a. Probe: Are projects sustainable beyond DSRIP? Will VBP support them? If not,
what else is needed to support them (regulatory changes, billing changes,
practice/professional scope, etc.)
6. In your view, have DSRIP projects changed the health care system?
a. Probe: If yes, for whom? How?
b. Probe: If no, why do you think it has remained the same?
c. Probe: Has care changed for patients?
7. Is there anything you would like to comment on regarding DSRIP in general?

Thank you all for your time and feedback, it’s been very helpful to get all of your perspectives!
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Appendix 5: Focus Group Guide
Appendix 5 provides the template used for partner focus groups conducted in 2017 and 2018. The focus
group guide was tailored to the specific categories of providers that attended a given focus group.
Questions that were only asked of certain categories of providers are indicated in the template below.
Focus Group Guide 2017 and 2018
Welcome, everyone. Thank you for taking time out of your busy schedule to attend today’s focus group.
My name is [name], and this is [research assistant]. I will conduct the discussion, and my assistant
[name] will observe and take notes. We are from University at Albany, and we are conducting these
focus groups as part of an independent evaluation of DSRIP. The evaluation is also collecting feedback
and data from surveys.
The purpose of today’s focus group is to gather information that will contribute to our understanding of
how the Delivery System Reform Incentive Payment (DSRIP) transformation is affecting [PROVIDER
CATEGORY] in New York State. In today’s focus group, I will ask you several questions. Your personal
opinions and views are very important for us to understand. There are no right or wrong answers. Please
feel welcome to express yourself freely during the discussion – we appreciate your candor and your
willingness to participate.
There are a few practical issues I would like to discuss before we get started. The focus group today will
last for 90 minutes. We understand that you are busy health care professionals, so we fully understand if
you are paged or need to step outside to take a phone call or respond to a message.
We value the opinion of each and every one of you here, and we would like to give everyone the chance
to express their opinions during the conversation. We are only talking to a limited number of [provider
types] so feel free to express your opinion, even if it differs from everyone in the group, as your
perceptions may represent many others across New York State. We will be tape recording today’s
session to ensure that we accurately capture everything that is discussed. We want to be as attentive as
possible to what is shared today because we value your time and your participation. The recording will
help us expand upon the handwritten notes and catch any important details that are missed in the
notetaking process. None of what we record or write down today will be attributed to any individuals or
identified by name or organization. Tapes will be destroyed as soon as they are transcribed. If something
comes up that you do not want recorded, we can turn off the recorder at that point.
1. Tell us your name and your organization and briefly how your engagement with DSRIP began.
2. How has the DSRIP transformation affected your responsibilities at the organization you work
for?
3. What services does your organization provide? Do you bill Medicaid for those services? [only for
focus groups with mental health and substance use professionals]
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4. What type of services does your organization provide? [only for focus groups with communitybased organizations]
5. Looking back to when DSRIP began, how would you characterize implementation and operation
of DSRIP?
6. Looking back over the first few years, what has worked well with DSRIP?
7. What has worked less well over the first few years?
8. Have you formed any new connections with other practitioners [clinical groups/organizations]?
Prompt: If so, why?
Prompt: Self-initiated vs PPS project initiated?
9. How has the dynamic changed between primary care physicians and specialists? [only for focus
groups with primary care physicians, clinic managers, health home organizations, specialists]
10. The PPS you are involved with has selected certain projects to implement from the DSRIP
project toolkit. Some of those projects may directly or indirectly impact your areas of work.
Could you share a little about the impacts of these DSRIP projects?
Prompt: How are these projects influencing your work, if at all?
11. How has the population you serve changed since launching DSRIP? [only for focus groups with
community-based organizations]
12. What have you done to prepare for the change to value based payment? [only for focus groups
with category 1 (primary care physicians, clinic managers, health home organizations, and
specialists), category 2 (mental health and substance abuse professionals), or category 3
(hospitals, nursing home, hospice, and home care professionals) providers.
13. What are the barriers to achieving progress on value based performance?
Prompt: What support or resources do you need to overcome these barriers?
14. How has DSRIP’s focus on avoidable emergency department utilization affected your work?
15. As a behavioral health or substance abuse provider, how has the focus on integration with
primary care impacted your work with patients? [only for focus groups with mental health and
substance use professionals]
16. How have the efforts to improve population health and integrate delivery systems impacted
your daily work? [only for focus groups with hospitals, nursing homes, hospice, and home care
professionals and community-based organizations]
17. What’s one thing you would change right now?
Prompt: Why did you choose that aspect specifically?
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18. Our discussion today was to help us understand how [insert category of provider here] are
managing the DSRIP transformation. Have we missed anything?
Thank you so much for your participation today. Getting your feedback on DSRIP is essential to
our evaluation process, and we appreciate everyone’s willingness to discuss it with us today. If
you have any questions after today about the independent evaluation, please don’t hesitate to
contact us at the University at Albany.
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Appendix 6: Statewide Partner Survey Instruments
Appendix 6 includes the partner survey instruments used in 2017 and 2018.
Statewide Partner Survey Instrument 2017
1. What is your name?
2. What is the name of your organization?
3. What is your position?
4. How many PPS-selected DSRIP projects are you involved with and knowledgeable about?
If you are involved with more than 3 DSRIP related projects at your organization, please think of
the 3 projects with which you are most involved. The project(s) may be within one PPS or
several projects across multiple PPS depending on your service area and involvement.
5. Using the drop-down menu below, please indicate the first project you are involved with and
the corresponding PPS.
PPS:
Project:
6. Please indicate your level of satisfaction with <Project> implementation as related to working
with <PPS>.
Very satisfied (1)
Satisfied (2)
Neither satisfied nor dissatisfied (3)
Dissatisfied (4)
Very dissatisfied (5)
Not applicable (6)
I don't know (7)
7. Please indicate your level of satisfaction with the current operation of <Project> as related to
working with <PPS>.
Very satisfied (1)
Satisfied (2)
Neither satisfied nor dissatisfied (3)
Dissatisfied (4)
Very dissatisfied (5)
Not applicable (6)
I don't know (7)
8. How satisfied were you with <Project> operations at your organization overall during
Demonstration Years 0-2 (2014-2017)?
Very satisfied (1)
Satisfied (2)
Neither satisfied nor dissatisfied (3)
Very dissatisfied (4)
Not applicable (5)
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I don't know (6)
9. What would you change about current operation of the project within <PPS>?
________________________________________________________________
10. What would you change about the current operation of the project within your
organization?
________________________________________________________________
11. Please indicate the degree of change to which you perceive the project is changing patient
care.
Very positive change (1)
Positive change (2)
No change (3)
Negative change (4)
Very negative change (5)
12. How effective do you perceive the project to be at meeting its intended goals currently?
Extremely effective (1)
Very effective (2)
Moderately effective (3)
Slightly effective (4)
Not effective at all (5)
I don't know (6)
13. Why do you feel this way?
________________________________________________________________
<Items 5 through 13 were repeated up to three times for respondents participating in more than
one project.>
14. One focus of DSRIP was to integrate primary, specialty, and behavioral health care. Has the
clinical care at your organization changed since DSRIP was initiated?
Yes, very positive change (1)
Yes, positive change (2)
No change (3)
No, negative change (4)
No, very negative change (5)
I don't know (6)
Not applicable, my organization does not provide clinical services (7)
15. Have you observed any of the following benefits to primary care and behavioral health
services integration? (Please select all that apply).
Improved communication leading to more coordinated care (1)
Improved recognition of mental health disorders (2)
Increased primary care providers (PCPs) use of behavioral health intervention (3)
Decreased stigma of mental health conditions (4)
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Improved understanding of patient needs (5)
Improved patient and provider satisfaction (6)
Improved clinical outcomes (7)
Reduced avoidable hospital utilization (8)
Increased productive capacity (9)
Reduced medical costs (10)
Other (please specify): (11) ________________________________________________
N/A (12)
16. In your view, are patients experiencing better care since the launch of DSRIP?
Yes, very positive change (1)
Yes, positive change (2)
No change (3)
No, negative change (4)
No, very negative change (5)
I don't know (6)
17. Another focus of DSRIP was population health interventions. Do you believe DSRIP has
changed any aspect of population health within your service area?
Yes, very positive change (1)
Yes, positive change (2)
No change (3)
No, negative change (4)
No, very negative change (5)
I don't know (6)
18. Has DSRIP changed the way your organization provides services?
Yes (1)
No (2)
I don't know (3)
19. If yes, in what ways has DSRIP changed the way your organization provides services?
________________________________________________________________
20. How do you characterize your understanding of value based payment?
Very knowledgeable (1)
Somewhat knowledgeable (2)
Only at a little knowledgeable (3)
Not at all knowledgeable (4)
21. Have you made changes to your practice or organization to prepare for value based
payment?
Yes (1)
No (2)
I don't know (3)
22. Do you require more resources/knowledge for the shift to value based payment?
Yes (1)
No (2)
I don't know (3)
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23. How effective do you perceive DSRIP to be overall?
Extremely effective (1)
Very effective (2)
Moderately effective (3)
Slightly effective (4)
Not effective at all (5)
24. In what ways is it effective or ineffective?
________________________________________________________________
25. Please share any suggestions you may have for state-level changes or program
improvements for DSRIP as a whole.
Statewide Partner Survey Instrument 2018
The Independent Evaluator of the New York State Delivery System Reform Incentive Payment
(DSRIP) program is conducting a survey of project partners. The survey includes questions
about your perceptions of DSRIP and how DSRIP has affected organizations and patients.
Your feedback will help improve programs by letting the Department of Health and your PPS
know which aspects of DSRIP have been effective and which have not. Evaluating these changes
each year helps determine whether improvements are taking place over time.

1. What type of organization do you work for?151
Community-based organization
Primary care provider
Non-primary care practitioner
Clinic
Hospital
Behavioral health organization
Substance use treatment organization
Skilled nursing facility/ nursing home
Hospice/ palliative care center
Home care agency
Government office
Pharmacy
Health home/ care management program
Other (specify)
The next items ask about your perceptions of DSRIP overall. The survey will ask about your
specific projects in a later section.

151

This is a partner self-selected category type.
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2. How have the services or clinical care at your organization changed since DSRIP was
initiated?
Very positive change
Some positive change
No change
Some negative change
Very negative change
3. Have you observed any of the following benefits from DSRIP? (Please select all that
apply).
More coordinated care
Improved recognition of mental health disorders
Increased primary care provider use of behavioral health intervention
Improved understanding of patient needs
Improved patient satisfaction
Improved clinical outcomes
Reduced avoidable hospital utilization
Reduced medical costs
None of the above
4. [Skip if 3= none of the above] Do you expect these benefits to continue after DSRIP
funding ends?
[List each benefit respondent selected above with yes/no/ I don’t know options for
each]
5. In your view, are patients experiencing better care since the launch of DSRIP?
Yes, very positive change
Yes, some positive change
No change
No, some negative change
No, very negative change
I don't know
6. Do you believe DSRIP has changed any aspect of population health within your service
area?
Very positive change
Some positive change
No change
Some negative change
Very negative change
I don't know
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7. How effective do you perceive DSRIP to be overall?
Extremely effective
Very effective
Moderately effective
Slightly effective
Not at all effective
8. In what ways do you feel that DSRIP is working well?
9. Please share any suggestions you have for program improvements for DSRIP.
The next set of questions will ask about value based payment.
10. How do you characterize your understanding of value based payment?
Very knowledgeable
Somewhat knowledgeable
A little knowledgeable
Not at all knowledgeable
11. Has your practice or organization made changes to prepare for value based payment?
Yes
No
12. Do you require more resources to facilitate the shift to value based payment?
Yes
No
13. [If 12=yes] What types of resources would help your organization shift to value based
payment?
Additional training (specify training topics: ______)
One-on-one consulting
Additional funding for infrastructure changes
Peer training and support
Improved access to performance data (specify data types: ______)
Other (specify: ___________)
14. [If any responses selected in 13] Which of these resources would be MOST helpful to
your organization’s shift to value based payment? [List all selected in 10]
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The following section will ask for your perceptions of DSRIP projects.152
15. Please select each PPS you work with on projects.
16. Below is a list of [PPS] projects. Please select each project with which you are actively
involved. [List customized by PPS] [Repeat per PPS]
17. Please indicate your level of satisfaction with the past 12 months of operation of
<Project> at <PPS>.
Very satisfied
Somewhat satisfied
Neither satisfied nor dissatisfied
Somewhat dissatisfied
Very dissatisfied
Not applicable
18. Please indicate the degree to which you perceive the project is changing patient care.
Very positive change
Some positive change
No change
Some negative change
Very negative change
19. How effective do you currently perceive the project to be at meeting its intended goals?
Extremely effective
Very effective
Moderately effective
Slightly effective
Not at all effective
[#17,18, 19 repeated for each PPS’s projects]
20. [After all projects] Is there anything else you would like to share about DSRIP?

152

Partner responses were limited to up to 3 projects in the 2017 survey. There were no such limitations in the
2018 survey; partners could provide responses about all projects with which they participated.
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Appendix 7. Additional Details on DSRIP Dataset Measures
Used in the Interim Report
Appendix 7 provides additional details on the measures examined in the Interim Report to
address RQ-B through RQ-G (see Exhibit 3.1). Information is compiled from the DSRIP Measures
Specification Manual corresponding to Measurement Year 3 (July 10, 2017), and additional
consultation with NYS DOH. The “years available for trending” refers to the years available for
and used in the current Interim Report. Additional years will be available and used in the final
summative report.
RQ-B. Health Care Quality Measures
Asthma Medication Management for People Aged 5-64
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:

Denominator description:

Data source:
Years available for trending:

Medication Management for People with Asthma (5-64 Years)
– 75% of Treatment Days Covered
HEDIS® 2017
3.d.i – 3.d.iii
Number of people who filled prescriptions for asthma
controller medications during at least 75% of their treatment
period
Number of people, ages 5 to 64 years, who were identified as
having persistent asthma, and who received at least one
controller medication
MDW Claims
Monthly, from end of MY0 to end of MY3 (37 months)

Controller-to-Total Asthma Medication Ratio
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:

Asthma Medication Ratio (5 – 64 Years)
HEDIS® 2017
3.d.i – 3.d.iii

Number of people with a ratio of controller medications to
total asthma medications of 0.50 or greater during the
measurement year
Denominator description:
Number of people, ages 5 to 64 years, who were identified as
having persistent asthma
Data source:
MDW Claims
Years available for trending: Monthly, from end of MY0 to end of MY3 (37 months)
RQ-C. Population Health Measures
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Age-Adjusted Percentage of Adults Reporting Binge Drinking
Full measure name:
Projects associated with
measure:
Numerator description:

Denominator description:
Data source:
Years available for trending:

Age-adjusted percentage of adult binge drinking during the
past month
4.a.i – 4.a.iii
Number of respondents age 18 or older who reported binge
drinking on one or more occasions in the past 30 days. Binge
drinking is defined as men having 5 or more drinks or women
having 4 or more drinks on one occasion.
Number of people age 18 or older
eBRFSS
Annual: MY0, MY1, MY2, MY3

Age-Adjusted Percentage of Adults Reporting Poor Mental Health
Full measure name:
Projects associated with
measure:
Numerator description:

Denominator description:
Data source:
Years available for trending:

Age-adjusted percentage of adults with poor mental health
for 14 or more days in the last month
4.a.i – 4.a.iii
Number of respondents age 18 or older who reported
experiencing poor mental health for 14 or more days in the
last month
Number of people age 18 or older
eBRFSS
Annual: MY0, MY1, MY2, MY3

Age-Adjusted Suicide Death Rate per 100,000
Full measure name:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:
Years available for trending:

Age-adjusted suicide death rate per 100,000
4.a.i – 4.a.iii
Number of deaths of people age 18 or older with an ICD-10
primary cause of death code: X60-X84 or Y87.0
Number of people age 18 or older
NYS DOH Vital Statistics
Annual: MY0, MY1, MY2, MY3
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Percentage of Adults Reporting Current Smoking
Full measure name:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:
Years available for trending:

Percentage of cigarette smoking among adults
4.b.i – 4.b.ii
Number of people age 18 or older who report currently
smoking cigarettes
Number of people age 18 or older
eBRFSS
Annual: MY0, MY1, MY2, MY3

Percentage of Premature Deaths
Full measure name:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:
Years available for trending:

Percentage of premature death (before age 65 years)
4.a.i – 4.a.iii, 4.b.i – 4.b.ii, 4.c.i – 4.c.iv, 4.d.i
Number of people who died before age 65 in the
measurement period
Number of deaths in the measurement period
NYS DOH Vital Statistics
Annual: MY0, MY1, MY2, MY3

Percentage of Adults Aged 50-75 with Up-to-Date Colorectal Cancer Screening
Full measure name:

Projects associated with
measure:
Numerator description:

Denominator description:
Data source:
Years available for trending:

Percentage of adults who receive a colorectal cancer
screening based on the most recent guidelines - Aged 50-75
years
4.b.i – 4.b.ii
Number of respondents age 50-75 years who received a
colorectal cancer screening exam (used a blood stool test at
home in the past year; and/or, sigmoidoscopy in the past 5
years and blood stool test in the past 3 years; and/or, had a
colonoscopy in the past 10 years)
Number of people age 50-75
eBRFSS
Annual: MY0, MY1, MY2, MY3

Newly Diagnosed HIV Cases per 100,000
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Full measure name:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:
Years available for trending:

Newly diagnosed HIV case rate per 100,000
4.c.i – 4.c.ii
Number of people newly diagnosed with HIV, regardless of
concurrent or subsequent AIDS diagnosis
Number of people
NYS HIV Surveillance System
Annual: MY0, MY1, MY2, MY3

Ratio of Premature Deaths: Black Non-Hispanic versus White Non-Hispanic
Full measure name:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:
Years available for trending:

Percentage of premature death (before age 65 years) – Ratio
of Black non-Hispanics to White non-Hispanics
4.a.i – 4.a.iii, 4.b.i – 4.b.ii, 4.c.i – 4.c.iv, 4.d.i
Percentage of Black non-Hispanics who died before age 65
Percentage of White non-Hispanics who died before age 65
NYS DOH Vital Statistics
Annual: MY0, MY1, MY2, MY3

Ratio of Premature Deaths: Hispanic versus White Non-Hispanic
Full measure name:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:
Years available for trending:

Percentage of premature death (before age 65 years) – Ratio
of Black non-Hispanics to White non-Hispanics
4.a.i – 4.a.iii, 4.b.i – 4.b.ii, 4.c.i – 4.c.iv, 4.d.i
Percentage of Hispanics who died before age 65
Percentage of White non-Hispanics who died before age 65
NYS DOH Vital Statistics
Annual: MY0, MY1, MY2, MY3

Disparities in HIV Case Rates: Black Non-Hispanic versus White Non-Hispanic
Full measure name:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:
Years available for trending:

Newly diagnosed HIV case rate per 100,000—Difference in
rates (Black and White) of new HIV diagnoses
4.c.i – 4.c.ii
Rate of Black non-Hispanics newly diagnosed with HIV,
regardless of concurrent or subsequent AIDS diagnosis
Rate of White non-Hispanics newly diagnosed with HIV,
regardless of concurrent or subsequent AIDS diagnosis
NYS HIV Surveillance System
Annual: MY0, MY1, MY2, MY3
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Disparities in HIV Case Rates: Hispanic versus White Non-Hispanic
Full measure name:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:
Years available for trending:

Newly diagnosed HIV case rate per 100,000—Difference in
rates (Hispanic and White) of new HIV diagnoses
4.c.i – 4.c.ii
Rate of Hispanics newly diagnosed with HIV, regardless of
concurrent or subsequent AIDS diagnosis
Rate of White non-Hispanics newly diagnosed with HIV,
regardless of concurrent or subsequent AIDS diagnosis
NYS HIV Surveillance System
Annual: MY0, MY1, MY2, MY3

RQ-D. Behavioral Health Care Utilization Measures
Initiation of Treatment for Alcohol and Other Drugs
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:

Denominator description:
Data source:
Years available for trending:

Initiation of Alcohol and Other Drug Dependence Treatment
(1 visit within 14 days)
HEDIS® 2017
3.a.i – 3.a.iv
Number of people who initiated treatment through an
inpatient AOD admission, outpatient visit, intensive
outpatient encounter, or partial hospitalization within 14 days
of the index episode
Number of people age 13 and older with a new episode of
alcohol or other drug (AOD) dependence
MDW Claims
Monthly, from end of MY0 to end of MY3 (37 months)

Engagement in Treatment for Alcohol and Other Drugs
Full measure name:
Steward and specification
version:
Projects associated with
measure:

Engagement of Alcohol and Other Drug Dependence
Treatment (Initiation and 2 visits within 44 days)
HEDIS® 2017
3.a.i – 3.a.iv
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Numerator description:

Denominator description:
Data source:
Years available for trending:

Number of people who initiated treatment AND who had two
or more additional services with a diagnosis of AOD within 30
days of the initiation visit
Number of people age 13 and older with a new episode of
alcohol or other drug (AOD) dependence
MDW Claims
Monthly, from end of MY0 to end of MY3 (37 months)

Adherence to Antipsychotic Medications for People with Schizophrenia
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:
Denominator description:

Data source:
Years available for trending:

Adherence to Antipsychotic Medications for People with
Schizophrenia
HEDIS® 2017
3.a.i – 3.a.iv
Number of people who remained on an antipsychotic
medication for at least 80% of their treatment period
Number of people, ages 19 to 64 years, with schizophrenia
who were dispensed at least 2 antipsychotic medications
during the measurement year
MDW Claims
Monthly, from end of MY0 to end of MY3 (37 months)

Follow-up Within 30 Days of Hospitalization for Mental Illness
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:

Denominator description:

Data source:
Years available for trending:

Follow-up after hospitalization for mental illness – within 30
days
HEDIS® 2017
3.a.i – 3.a.iv
Number of discharges where the patient was seen on an
ambulatory basis or who was in intermediate treatment with
a mental health provider within 30 days of discharge
Number of discharges between the start of the measurement
year to 30 days before the end of the measurement year for
patients ages 6 years and older, who were hospitalized for
treatment of selected mental health disorders
MDW Claims
Monthly, from end of MY0 to end of MY3 (37 months)
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RQ-E. Hospital Utilization Measures
Potentially Preventable Readmissions
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:

Denominator description:
Data source:
Years available for trending:

Potentially Avoidable Readmissions +/3M
2.a.i – 2.a.v, 2.b.i – 2.b.ix, 2.c.i – 2.c.ii
Number of readmission chains (at risk admissions followed by
one or more clinically related readmissions within 30 days of
discharge)
Number of people as of June 30 of the measurement year
MDW Claims
Monthly, from end of MY0 to end of MY3 (37 months)

Potentially Preventable Emergency Visits
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:
Years available for trending:

Potentially Preventable Emergency Room Visits +/3M
2.a.i – 2.a.v, 2.b.i – 2.b.ix, 2.c.i – 2.c.ii
Number of preventable emergency room visits as defined by
revenue and CPT codes
Number of people (excludes those born during the
measurement year) as of June 30 of the measurement year
MDW Claims
Monthly, from end of MY0 to end of MY3 (37 months)

Potentially Preventable Emergency Visits for Persons with a Behavioral Health Diagnosis
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:

Potentially Preventable Emergency Room Visits (for persons
with BH diagnosis) +/3M
3.a.i – 3.a.iv
Number of preventable emergency room visits as defined by
revenue and CPT codes
Number of people with a BH diagnosis (BH definition used in
member attribution; excludes those born during the
measurement year) as of June 30 of the measurement year
MDW Claims
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Years available for trending:

Monthly, from end of MY0 to end of MY3 (37 months)

RQ-F. Health Care System Transformation Measures
Percent of Eligible Providers Meeting Meaningful Use Criteria Who Conduct Bidirectional
Exchange with Qualified Entities
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:

Denominator description:
Data source:
Years available for trending:

Meaningful Use Certified Providers who conduct bidirectional
exchange
NYS-specific
2.a.i – 2.a.v, 2.b.i – 2.b.ix, 2.c.i – 2.c.ii
Number of eligible providers meeting meaningful use criteria,
who both 1) make data available and 2) access data using
SHIN-NY with a QE
Number of eligible providers meeting meaningful use criteria
in the PPS network
Qualified Entity Survey
Annual: MY2, MY3 (note: survey question changed in MY2, so
it is inappropriate to compare to earlier time points although
MY1 is available)

Percent of Eligible Providers Meeting Meaningful Use Criteria Who Have Participating
Agreements with Qualified Entities
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:

Denominator description:
Data source:
Years available for trending:

Meaningful Use Certified Providers who have a participating
agreement
NYS-specific
2.a.i – 2.a.v, 2.b.i – 2.b.ix, 2.c.i – 2.c.ii
Number of eligible providers meeting meaningful use criteria,
who have at least one participating agreement with a
qualified entity (QE)
Number of eligible providers meeting meaningful use criteria
in the PPS network
Qualified Entity Survey
Annual: MY2, MY3 (note: survey question changed in MY2, so
it is inappropriate to compare to earlier time points although
MY1 is available)
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Hospital Care Transition Composite Measure
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:
Years available for trending:

H-CAHPS – Care Transition; CMS Data Set H_COMP_7_SA and
H_COMP_7_A
H-CAHPS V9.0 (Q23, 24, and 25)
2.a.i – 2.a.v, 2.b.i – 2.b.ix, 2.c.i – 2.c.ii
Average of hospital specific results for the Care Transition
composite using Strongly Agree and Agree responses
Hospitals with H-CAHPS participating in the PPS network
HCAHPS survey
Annual: MY1, MY2, MY3

Primary Care as Usual Source of Care
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:
Denominator description:
Data source:
Years available for trending:

Primary Care - Usual Source of Care
1351a_C&G CAHPS Adult Primary Care (version 3.0, Q2)
2.a.i – 2.a.v, 2.b.i – 2.b.ix, 2.c.i – 2.c.ii
Percent of Reponses ‘Yes’
All responses
CG-CAHPS survey
Annual: MY1, MY2, MY3

Up-to-Date Care Coordination Composite Measure
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:

Denominator description:
Data source:
Years available for trending:

Care Coordination
1351a_C&G CAHPS Adult Primary Care (version 3.0, Q13, 17
and 20)
2.a.i – 2.a.v, 2.b.i – 2.b.ix, 2.c.i – 2.c.ii
Number responses ‘Usually’ or ‘Always’ that provider seemed
to know important history, follow-up to give results from
tests, and talked about all prescription medicines
All responses
CG-CAHPS survey
Annual: MY1, MY2, MY3

Non-Use of Primary and Preventive Care Services among attributed Medicaid members
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Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:

Denominator description:

Data source:
Years available for trending:

Non-use of primary and preventive care services
NYS-specific
2.d.i
The percentage of Medicaid members who do not have at
least one claim with a preventive services CPT or equivalent
code in the measurement year
The percentage of Medicaid members who do not have at
least one claim with a preventive services CPT or equivalent
code in the baseline measurement year
MDW Claims
Annual: MY0, MY1, MY2, MY3

Emergency Department Use by Uninsured
Full measure name:
Steward and specification
version:
Projects associated with
measure:
Numerator description:

Denominator description:

Data source:
Years available for trending:

ED Use by Uninsured +/NYS-specific with SPARCS
2.d.i
The percentage of ED visits which are self-pay payer typology
only for all hospitals in the PPS network in the measurement
year
The percentage of ED visits for self-pay payer typology only
for all hospitals in the PPS network in the baseline
measurement year
SPARCS
Annual: MY0, MY1, MY2, MY3

Appendix 8: Clinician & Group CAHPS 3.0 Survey Composite
Score Items
Appendix 8 shows the items that were used to calculate the composite scores in Exhibit 4.14.
For each item, respondents were asked to consider how often they had a specific experience in
the past six months, and offered the response options of Never, Sometimes, Usually, and
Always. Responses were averaged to compute the composite scores.
Exhibit A8.1. Percent of patients answering “Usually” or “Always” to patient satisfaction items
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How Well Doctors Communicate with Patients
How often did this provider explain things in a way that was easy
to understand?
How often did this provider listen carefully to you?
How often did this provider show respect for what you had to
say?
How often did this provider spend enough time with you?
Care Coordination
How often did this provider seem to know the important
information about your medical history?
When this provider ordered a blood test, x-ray or another test
for you, how often did someone from this provider's office
follow up to give you those results?
How often did you and someone from this provider's office talk
about all the prescription medicines you were taking?
Getting Timely Appointment, Care, and Information
When you contacted this provider's office to get an appointment
for the care you needed right away, how often did you get an
appointment as soon as you needed?
When you made an appointment for a check-up or routine care
with this provider, how often did you get an appointment as
soon as you needed?
When you contacted this provider's office during regular office
hours, how often did you get an answer to your medical
question that same day?
Helpful, Courteous, and Respectful Office Staff
How often were clerks and receptionists at this provider's office
as helpful as you thought they should be?
How often did clerks and receptionists at this provider's office
treat you with courtesy and respect?

DY1
92.3%

DY2
91.1%

DY3
92.7%

92.1%

91.1%

92.9%

92.9%

91.5%

93.2%

94.0%

93.0%

94.1%

90.1%
83.9%

88.9%
82.9%

90.6%
84.0%

90.2%

89.2%

91.0%

84.1%

82.4%

82.9%

77.3%

77.3%

78.2%

85.1%

83.3%

86.0%

83.9%

81.5%

85.5%

87.4%

86.0%

88.4%

84.2%

82.4%

84.0%

89.6%

88.9%

90.5%

87.4%

86.1%

88.2%

91.9%

91.6%

92.7%

Source: Clinician & Group CAHPS 3.0 survey
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